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Nonsense mediated decay (NMD) is a translation-dependent RNA quality control
pathway that selectively degrades aberrant transcripts before they lead to trun-
cated proteins. NMD causes rapid degradation of target RNAs by assembling
multiple factors to drive poly-deadenylation and decapping of the mRNA.
NBAS (neuroblastoma amplified sequence) protein was identified to be required
for NMD in an RNAi screen in Caenorhabditis elegans. Subsequent evidence has
suggested it is a conserved NMD factor in zebrafish and human cells. NBAS is
localised to the endoplasmic reticulum (ER) suggesting it could be involved in a
novel branch of the NMD pathway specific to ER. The key NMD factor UPF1
has been shown to partially localise to the ER and interact with NBAS.
NMD targets harbour premature termination codons (PTC)s, upstream open
reading frames or long 3’ UTRs. However not all transcripts with these features
activate NMD, and many NMD targets appear not to contain any of these fea-
tures. Therefore, the previously defined rules regarding initiation of the NMD
pathway do not account for all variation seen in NMD efficiency.
This thesis presents the creation and investigation of a CRISPR cell line con-
taining an endogenously tagged NBAS protein. Immunoprecipitation mass spec-
trometry on these cells revealed that NBAS interacts with the ER translocon,
where the ribosome docks for translation at the ER membrane, suggesting the
presence of an NBAS-UPF1-translocon complex. This interaction was confirmed
by proximity ligation assay, a microscopy-based approach.
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In order to identify the effect of NBAS on transcript expression and stability,
RNA-sequencing was performed on total, nascent, cytoplasmic, and membrane-
associated fractions, upon siRNA depletion of either NBAS or UPF1 mRNA. Dif-
ferential expression analysis revealed a correlation in differentially expressed tran-
scripts when NBAS or UPF1 were depleted with an enrichment in ER-associated
RNAs specifically in NBAS targets. UPF1 was found to affect expression of a
similar number of transcripts in the cytoplasmic and membrane-associated frac-
tions confirming its role in NMD at the ER. Whereas depletion of NBAS led
to a 5-fold higher proportion of membrane-associated genes being increased in
expression than of non-membrane genes, showing its subcellular specificity.
Using both nascent and total RNA-sequencing datasets, estimates of differential
transcript stability upon depletion of either factor were made. Approximately
20% of transcripts increased in expression upon depletion of UPF1 were also
found to increase in stability, whereas the remaining 80% of expression changes
could be explained by changes in transcription, suggesting these were due to
secondary effects. Of those transcripts that changed in expression when NBAS
was depleted, none were identified as changed in stability in this study, suggesting
NBAS has subtle or negligible effect on transcript stability and is therefore likely
to be a peripheral factor in the NMD pathway.
Finally, whole genome sequencing was used in conjunction with total and nascent
expression datasets to identify correlation between genome variants and NMD
efficiency. I show that it is possible to identify heterozygous variants with allele-
specific processing and measure the effect of NMD to identify direct NMD activity.
This approach can be used in the future to systematically explore the rules of
NMD targeting in human cells.
In sum, this thesis reveals that NBAS interacts with the ER translocon and affects
the expression of hundreds of ER-associated transcripts. However, NBAS does
not appear to regulate transcript stability suggesting its role at the translocon is
distinct from NMD. My findings add to the understanding of NMD quality control
at the ER and the genome-wide rules governing NMD efficiency in human cells.
x
Lay abstract
Deoxyribonucleic acid (DNA) is a large molecule that carries the genetic instruc-
tions for all known living organisms. It functions like a cookbook, full of many
different recipes. Each recipe is called a gene and gives instructions to produce
one of the many different building blocks the cell needs, called proteins. DNA
resides within the nucleus of the cell, but the proteins are produced outside of
the nucleus in the cytoplasm. Therefore, individual genes are copied, and these
copies are taken out of the nucleus to be used in the cytoplasm. The copies
are made of ribonucleic acid (RNA) which contains triplets of nucleotide bases,
called codons. Each codon is a code for a certain amino acid. Ribosomes read
the codons in the RNA and collect the corresponding amino acids. The amino
acids are joined together in a chain to create a protein. At the end of the RNA
is a stop codon which tells the ribosome that the instructions are finished.
Sometimes when the DNA is copied into RNA, mistakes are made, and a stop
codon is present before all the instructions are complete. If the ribosome used this
RNA as an instruction, then the resulting protein would be too short and faulty.
Therefore, the cell has a quality control mechanism in place to spot RNAs with
premature stop codons and destroy them, called the nonsense-mediated decay
(NMD) pathway. Although much research has been done on this pathway, it is
not yet fully understood.
Recently, a new factor, called NBAS, was identified as essential for the pathway
to function, however its exact role is unknown. NBAS is found in a different
region of the cell to where NMD normally takes place, called the endoplasmic
reticulum (ER). Some RNAs are made into protein at the ER by the ribosome
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and it is unknown how these RNAs are quality checked. Furthermore, the key
NMD factor UPF1 has also been shown to partially localise to the ER and interact
with NBAS. These data suggest NBAS and UPF1 act as part of a separate branch
of the NMD pathway, specific to the ER.
This thesis includes the genome editing of human cells to make NBAS fluorescent
so it can be visualised. Investigation using these cells showed that NBAS interacts
with the ER translocon, a special part of the ER where the translating ribosome
attaches, suggesting the presence of an NBAS-UPF1-translocon complex. This
interaction was visualised using fluorescent microscopy.
To measure how NBAS affects RNA processing, the level of all RNAs was quan-
tified upon depletion of either NBAS or UPF1. Analysis revealed a correlation
in the changed level of RNAs when either NBAS or UPF1 were depleted. Also,
there was an enrichment in ER-associated RNA when NBAS was depleted. Next
the level of RNA found in the cytoplasm or ER were measured. UPF1 was found
to affect a similar number of RNAs in the cytoplasmic and ER fractions confirm-
ing its role in NMD at the ER as well as in the cytoplasm. Depletion of NBAS
led to a 5-fold higher proportion of ER RNAs being increased in level than of
cytoplasmic RNA, showing its specificity for the ER.
Using the level of newly made RNA in conjunction with total RNA levels, es-
timates of differential RNA stability upon depletion of either factor were made.
This is because the NMD pathway makes RNA less stable. Approximately 5%
of RNAs increased in level upon depletion of UPF1 were also found to increase
in stability, suggesting the remaining changes could be explained by changes in
transcription rate. This would mean these RNAs are not changed due to NMD.
Of those RNAs that changed when NBAS was depleted, none were identified as
changed in stability in this study, which seems to be contradictory. More research
is needed to understand this phenomenon.
In conclusion, this thesis reveals that NBAS interacts with the ER translocon
and affects the level of hundreds of ER-associated RNAs. However, this work did
not show evidence that NBAS regulates transcript stability, suggesting further
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1.1 Regulation of gene expression
1.1.1 Expression of genetic information
Whilst DNA contains the genetic information that makes up all living things,
RNA, transcribed from the DNA template, carries this coding information to
the site of protein synthesis: the ribosome. Here, the nucleic acid polymer is
translated into a chain of amino acids to form a protein. With RNA, as in DNA,
genetic information is encoded in the sequence of nucleotides arranged into codons
consisting of three bases each (Figure 1.1). Three nucleotides are present in both
RNA and DNA; adenine (A), cytosine (C) and guanine (G), DNA also contains
thymine (T), whereas in RNA, the base uracil (U) takes the place of thymine.
Each codon defines a specific amino acid, except the stop codons that terminate
protein synthesis (Matthaei et al., 1962; Nirenberg et al., 1965). Unlike the other
61 triplets of the genetic code, the termination codons UAA, UAG, and UGA
instead serve as translation termination signals.
When the human genome project was launched, many scientists were convinced
they would soon be able to identify the gene encoding every protein and many
mysteries would be solved. However, as well as the astounding discovery that
98% of the human genome does not code for proteins, it was surprising that only
∼19,500 genes were present (Lander et al., 2001; Venter et al., 2001; International
Human Genome Sequencing Consortium, 2004). For fewer than 20,000 genes
to produce the number different proteins expressed by human cells, currently
estimated between 40,000 (Adkins et al., 2002) and several billion (Smith et al.,
2013), each expressed spatially and temporally, requires a complex network of
processes regulating every step of gene expression (Figure 1.2).
Chromatin structure and accessibility affect the level to which a gene is tran-
scribed. For example, by having enough space between the histone protein com-
plexes that chromatin is wound around for the transcription machinery to assem-
ble. This can also be influenced by signals that promote or repress transcrip-
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Figure 1.1: The genetic code
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Figure 1.1: The genetic code
(A) DNA (right) and RNA (left) have a similar structure and are made up of
three of the same nucleotides; cytosine (C), guanine (G) and adenine (A). DNA’s
fourth nucleotide monomer is thymine (T) whereas RNA utilises uracil (U). DNA
is generally double-stranded, whereas RNA is generally single stranded. (B) The
code of amino acids from RNA three nucleotide codons. There is significant re-
dundancy in the system including three codons that signal translation termination.
tion including epigenetic marks on cytosine nucleotides and histone proteins, and
whether the gene’s promoter(s) is strong or weak according to its affinity for RNA
polymerase. Tissue specific enhancers and transcription factors allow expression
only in correct cell types. The regulation of gene expression by modulation of the
transcription process includes the activity of transcription factors (TFs), which
influence expression of their target genes and tissue specific enhancers which drive
temporal control of when the gene is transcribed. Although the rules governing
enhancer-promoter interactions are not fully understood, the interplay of multiple
promoters and enhancers for a single gene allows increased regulatory diversity.
Multiple proteins can be produced from a single DNA gene by way of alternate
mRNA isoforms, on average ten per gene in human cells. Alternative splicing
describes the differential inclusion of the exons and leads to the inclusion or ex-
clusion of protein domains and active sites, thereby altering the functions of the
resulting protein. Alternative start sites within the DNA sequence can also alter
the inclusion of multiple exons and it has been shown that the DNA sequence
can affect speed of transcription of RNA polymerase II (Pol II) which can also
lead to differential exon inclusion (Naftelberg et al., 2015). This ability to pro-
duce multiple proteins from the same gene allows for tissue-specific functions in
eukaryote cells.
All RNA species that localise outside the nucleus, must pass through the nuclear
pore complex from the nucleus to the cytoplasm, often with the aid of export
factors. This is a highly regulated process which relies on the assembly of large
ribonucleoprotein (RNP) particles.
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Figure 1.2: Regulation occurs at every step of gene expression
DNA is stored wrapped around histone proteins as chromatin. These histone
proteins can be modified by addition of various small chemical groups termed epi-
genetics which can either promote or suppress transcription. The DNA sequence
itself effects gene expression due to the effect on biding efficiency of proteins such
as transcription factors. DNA sequence can also effect speed of polymerase II
transcription could affect accuracy of the polymerase and influences alternative
splicing, levels of transcript produced and/or correct termination of transcription.
Enhancers and promoters also control the level of transcription of individual genes
both temporally and in different cell types. Splicing removes non-coding intronic
regions and joins together coding exonic regions, ready for translation. Alternative
splicing leads to the production of different transcripts from the same gene which
results in alternative proteins that can have differing functions. Nuclear export
and localisation of the mRNA is facilitated by binding of multiple proteins to form
the messenger ribonucleoprotein complex (mRNP). Local translation allows spatial
control of gene expression and has been demonstrated in a variety of subcellular
compartments. Translation of the RNA sequence into the amino acid chain of
the equivalent protein is tightly regulated, both on a global and transcript-specific
level. Post translational modification to individual amino acids of the peptide
chain can activate the protein to carry out a role or alternatively mark the pro-
tein for degradation. Folding of the peptide chain into a functional protein enable
the specific function of the protein whether enzymatic, structural or otherwise.
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Many different mechanisms regulate translation both on a global and transcript-
specific level (Gebauer and Hentze, 2004; Sonenberg and Hinnebusch, 2009, Sec-
tion 1.2.1). Local translation allows spatial control of gene expression and has
been demonstrated in a variety of subcellular compartments (Chouaib et al., 2020,
Section 1.2.6).
Post translational modifications affect the function and localisation of proteins,
leading to massive variation in protein function. This includes addition of vari-
ous functional groups to amino acid residues including methyl groups, ubiquitin,
SUMO, citrulline, phosphate groups and acetyl groups.
Furthermore, RNA itself can regulate the process of gene expression. RNAs
carrying information to form a protein are called messenger RNA (mRNA) but
the most abundant RNAs in the cell are transfer RNA (tRNAs) and ribosomal
RNA (rRNAs), both of which are involved in translation. Small nuclear RNAs
(snRNAs) are found within the nucleus and are instrumental in the spliceosome,
which splices the introns from pre-mRNA.
Many long noncoding RNAs (lncRNAs) are localised to the nucleus and can re-
cruit chromatin regulatory proteins to genomic DNA to regulate gene expression
(Young and Ponting, 2013; Quinodoz and Guttman, 2014). Whereas post tran-
scriptional gene expression is dominated by the action of micro RNAs (miRNAs).
miRNAs are short, roughly 22 nucleotides (nt) long, untranslated RNAs whose
biogenesis involves folding of RNA by the Drosha protein to form double-stranded
RNA and unwinding of this two stranded duplex regulated by the protein Dicer
to leave a single-stranded RNA molecule. miRNAs bind to their target mRNA
and trigger its degradation via cleavage by the Argonaute family of proteins or
by blocking translation. Therefore, miRNA binding ultimately results in little or
no protein being produced from the target mRNA. There is extensive literature
regarding this aspect of translational regulation, which will not be discussed in
detail here.
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Figure 1.3: Detail of a mature ribonucleoprotein (mRNP) particle
The messenger RNA molecule exists as part of a ribonucleoprotein (RNP) with
multiple subtypes of RNA-binding proteins (RBPs). After splicing, only the ex-
onic regions of RNA remain which includes both the protein coding sequence
(CDS) and 3’ and 5’ untranslated regions (UTR). The junctions where two exons
have been spliced together are marked by the exon-exon junction complex which
is made up of four core proteins and various peripheral factors. The 5’ end of
the mRNA is protected by the 5’ cap consisting of a three phosphate group bridge
and a terminal guanine. This is then bound by the cap binding protein complex.
The 3’ end of the mRNA is protected by up to ∼250 adenine nucleotides called
the poly-A tail. This tail is bound by specific poly-A binding proteins.
1.1.2 Processing of messenger RNA (mRNA)
Whilst mRNA is often referred to as a ”copy” of the DNA sequence of a gene,
the processing of a nascent transcript to a mature mRNA ready for translation
is actually multifaceted (Moore and Proudfoot, 2009). The complementary pre-
mRNA must be spliced, coated with RNA binding proteins (RBPs), exon-exon
junctions marked, a 5’ cap added, the resulting RNP complex exported from the
nucleus and localised to the ribosome ready for translation (Figure 1.3).
RNA is synthesised by the enzyme RNA polymerase, using the genomic DNA
as a template in a process termed transcription. Whereas prokaryotes have a
single RNA polymerase to transcribe all their genes, the nuclei of eukaryotes
contain three. Each is responsible for transcribing a unique set of RNAs. RNA
9
polymerase I (Pol I) synthesises most of the rRNA (discussed further in Section
1.1.3), RNA polymerase II (Pol II) synthesises the protein-encoding mRNA and
most snRNA, while RNA polymerase III (Pol III) synthesises a variety of small
untranslated RNAs, including tRNA and the smaller subunit of rRNA. Although
it only transcribes a single gene, RNA polymerase I is highly active, producing
∼50% of the nascent RNA in the cell (Russell and Zomerdijk, 2006) and in
growing cells, the combined activities of Pol I and Pol III can exceed 80% of
nuclear transcription (Paule and White, 2000).
The newly synthesised RNA molecules are referred to as nascent RNA, and gen-
erally require further processing before they become functional. Similar to DNA,
RNA base modifications can also occur, primarily in tRNA and rRNA soon af-
ter the RNA is transcribed. These modifications are essential for their proper
function in protein translation. However, the most significant modification to the
nascent RNA is pre-mRNA splicing.
Mammalian genes consist of exonic regions which contain the coding sequence and
the regulatory untranslated regions, and intronic regions which are generally non-
coding but can contain lncRNAs, miRNAs and cis-regulatory modules. In order
for mRNA to mature into a functional message, the correct removal of introns
must occur to produce a coding transcript (Will and Lührmann, 2011; Shi, 2017;
Wilkinson et al., 2020). Splicing consists of creating a break in the RNA molecule
at the 5’ splice site and the resulting free OH group of the upstream exon reacting
with and ultimately joining to the phosphate group of the downstream exon at
the 3’ splice site, thereby expelling the intron. These reactions can be self-splicing
either through the aid of either a free guanine ribose or an adenine within the
intron initially attacking the 5’ splice site. However, splicing can also take place
with the aid of up to 150 proteins and five small nuclear RNAs (snRNAs), together
termed the spliceosome (Shi, 2017; Wilkinson et al., 2020). The five snRNAs, U1,
U2, U4, U5 and U6, assembly in an ordered, stepwise manner on the pre-mRNA
substrate and facilitate the reaction between the intron embedded adenine and
the 5’ splice site. The resulting join between two exons is termed an exon-exon
junction. The three main splicing sequence triggers are found within the intron;
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a donor site at the 5’ end of the intron, the branch site towards the 3’ end of
the intron and an acceptor site at the 3’ end of the intron. The splice donor site
consists of a highly conserved sequence GU, within a larger, less highly conserved
region. The splice acceptor is also highly conserved, with an AG sequence at the
3’ end of almost all introns. The branchpoint contains the A nucleotide involved
in lariat formation (Wang and Aifantis, 2020).
Despite the strong sequence requirements for canonical splicing, it can sometimes
go wrong. For example, intron retention, a type of alternative splicing, can occur
in humans when consensus sequences are not recognised, meaning the intron is
not spliced out. If the intron that is retained contains stop codons or a shift
in the reading frame this could lead to mRNA degradation (Sibley et al., 2016;
Wang and Aifantis, 2020, (Section 1.2.2)). In addition, non-canonical splicing
events can occur at a low frequency at cryptic splice sites. Such splice sites
comprise a consensus akin to those at canonical splice sites, but are located in
non-canonical locations within the introns. Considering the volume of intronic
sequence in vertebrate genomes, it is unsurprising that this can occur by chance
(Sibley et al., 2016).
Eukaryotic messenger RNA does not exist by itself but rather in large complexes
consisting of multiple protein factors and non-coding RNAs, together forming
large messenger ribonucleotide particles (mRNPs). The combination of molecules
ultimately decides the fate of each transcript by influencing virtually every step
in gene expression.
One such protein complex loaded onto mRNAs is the exon-exon junction complex
(EJC). The EJC is a large protein complex loaded onto transcripts ∼20–24nt up-
stream of exon-exon junctions as a consequence of the splicing process (Le Hir
et al., 2000; Singh et al., 2012; Saulière et al., 2012). The EJC serves as a
positional landmark for the intron-exon structure of genes, and also directs post-
transcriptional processes in the cytoplasm. Most, although not all (Hauer et al.,
2016; Le Hir et al., 2016), exon junctions are loaded with EJC by the splicing
machinery, consisting of the hetero-tetramer core of eIF4A3, MAGOH, RBM8A
(Y14) and Barentsz (BTZ), as well as auxiliary factors including UPF2, UPF3B,
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MLN51 and RNPS1. The protein complex binds to mRNA in a splicing-dependent,
but sequence-independent, manner, triggered by the recruitment of eIF4A3 by
the spliceosome (Alexandrov et al., 2012; Barbosa et al., 2012; Steckelberg et al.,
2012). eIF4A3 is the main RNA-binding protein of the EJC, with the other three
core components mainly acting to keep eIF4A3 bound to the RNA and in the
correct orientation. The RNA binding of eIF4A3 does not involve the RNA bases
but occurs mainly via the ribose-phosphate backbone (Andersen et al., 2006;
Bono et al., 2006).
Once a mature RNA molecule is correctly processed, it must be exported from the
nucleus into the cytoplasm. Small RNAs (such as tRNAs and miRNAs) follow
relatively simple export routes by binding directly to export receptors, whereas
larger RNAs (including rRNAs and mRNAs) travel through the nuclear pore
complex via export factors (Köhler and Hurt, 2007). Several export proteins are
highly conserved and essential for correct mRNA localisation to the cytoplasm
(Huang et al., 2003; Carmody and Wente, 2009; Katahira, 2015). Direct interac-
tion with the nuclear pore complex is then possible which promotes export of the
mature mRNP to the cytoplasm (Lai and Tarn, 2004) and the carrier proteins
are subsequently recycled.
The research presented in this thesis focuses on understanding gene regulation
at the RNA level, specifically after nuclear export and at the translation step of
expression.
1.1.3 Translation of mRNAs
Once mRNP particles reach the ribosome, their cargo mRNA can be translated
into a polypeptide chain. mRNA translation is a highly complex process, which
is tightly regulated, both on a global and transcript-specific level (Gebauer and
Hentze, 2004; Sonenberg and Hinnebusch, 2009). Fundamentally, transfer RNA
(tRNA) molecules which recognise the three base codons bind sequentially to
the mRNA and thereby add their bound amino acid (aminoacyl-tRNA) to the
peptide chain. The translation process is conducted by the ribosome.
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Translation can be divided into three separate consecutive steps (Figure 1.4):
initiation, the process of assembly of the ribosomal subunits together with over
70 auxiliary factors; elongation, the actual synthesis of a peptide chain; and
termination, which entails the dissociation of the full-length peptide chain and
removal of the ribosome from the mRNA transcript. At each stage of the process
there is a high degree of both internal and external regulation by various RNA
binding proteins.
The majority of regulation occurs during the initiation phase, which requires nu-
merous RNA binding proteins (Sonenberg and Hinnebusch, 2009). Throughout
evolution of higher organisms, ribosome size has increased to provide an inter-
active landing site for auxiliary factors and facilitate customised mRNA trans-
lational landscapes (Simsek et al., 2017). Eukaryotes have 80S ribosomes, each
consisting of a small (40S) and large (60S) subunit. The 40S subunit is made up
of the 18S rRNA and 33 proteins, whilst the large subunit is composed of the 5S
rRNA, 28S rRNA, 5.8S rRNA and 46 proteins. During initiation, the small ribo-
somal subunit, typically bound to an aminoacyl-tRNA containing the first amino
acid methionine, recognizes the AUG start codon and binds, which recruits the
large ribosomal subunit to form the complete initiation complex.
After initiation, the ribosome proceeds to elongate the initial amino acid into a
polypeptide chain. As seen in Figure 1.1, there is a degree of redundancy in the
codon code; 18 of the 20 amino acids are encoded by up to 6 different codons.
The genetic code is almost universal which means that a given gene is most likely
translated into the same protein in any species. However, the frequency of use
of particular codons varies strongly between species. With increasing data from
comparative analyses of codon usage in different organisms, it has become clear
that synonymous codons are not randomly distributed along genomes and genes,
and that certain organisms seem to prefer some over others (Grantham et al.,
1980; Sharp and Li, 1986; Plotkin and Kudla, 2011). These codon biases have
been proposed to contribute to the variation of synonymous codon usage seen
13
Figure 1.4: Translation of mRNA into nascent peptide
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Figure 1.4: Translation of mRNA into nascent peptide
(A) Translation begins at a methionine “start” codon at the end of the 5’ UTR.
The small (40S) ribosomal small unit, already bound to a methionine aminocyl-
transferRNA (tRNA), recognises the methionine and attaches to the mRNA. The
large (60S) ribosomal subunit then binds to assemble the complete (80S) ribosome.
(B) As the ribosome translates in a 5’-3’ direction, it displaces RBPs including
the EJCs. Each three nucleotide codon is bound by a specific tRNA with an at-
tached amino acid residue. These amino acids are then joined to form a nascent
peptide chain. (C) When the ribosome reaches a stop codon, there is no corre-
sponding tRNA so instead the release factors eRF1 and eRF3 bind. This triggers
the termination of translation and disassociation of the ribosome and complete
peptide from the mRNA. The ribosome and release factors are recycled whilst the
peptide is further processed to produce a functional protein.
amongst genes within same genomes (Cannarozzi et al., 2010; Coleman et al.,
2008; Tuller et al., 2010). In this way, differential codon usage may act as a
regulator of translation dynamics on a genome-wide level, adding an additional
layer for fine-tuning gene expression (Quax et al., 2015).
Although translation initiation is commonly acknowledged as the rate limiting
step in translation, several studies have also shown that the elongation rate can
also vary. In mammalian cells, newly synthesised mRNAs undergo a pioneer
round of translation. The cap first binds to the cap-binding protein heterodimer
CBP80-CBP20 (Isken and Maquat, 2008) and one or more ribosomes are loaded,
depending on the efficiency of translation initiation and the length of the open
translational reading frame (Isken and Maquat, 2008; Isken et al., 2008). The
CBP80-CBP20 heterodimer is then replaced by eukaryotic translation initiation
factor 4E (eIF4E) and steady-state cycles of mRNA translation continue, gen-
erating most of the cell’s proteins. Translation factors, RNA-binding proteins,
and targets of signalling pathways that are particular to the newly synthesised
mRNA regulate critical functions of the pioneer round. It is also during the pi-
oneer round of translation that the EJCs are removed from the mRNA (Dostie
and Dreyfuss, 2002; Lejeune et al., 2002; Sato and Maquat, 2009).
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Because the abundance of the EJC proteins eIF4A3, MAGOH, Y14, and BTZ
is limited, and the number of exon-exon junctions is high in the steady-state
transcriptome, EJCs must be efficiently disassembled and recycled to ensure that
maturing mRNAs can be appropriately tagged (Gehring et al., 2009). Even so,
EJCs are not found at every exon-exon junction and have non-uniform occupancy
at transcripts (Hauer et al., 2016; Le Hir et al., 2016). Removal of the complexes
has been attributed to the activity of the translating ribosome and appears to be
sequential as the ribosome progresses along the transcript. The ribosome asso-
ciated protein PYM binds to the EJC heterodimer MAGOH/Y14 and facilitates
dissociation of the EJC (Gehring et al., 2009).
When the ribosome reaches a stop codon, there is no complimentary tRNA so
instead the release factors eRF1 and eRF3 bind and initiate translation termi-
nation (Zaher and Green, 2009a,b; Dever and Green, 2012). The three different
stop codons; amber (UAG), ochre (UAA) and opal (UGA) have been shown to
vary in their strength, or ability to successfully terminate translation. UAA is
the strongest stop codon, whilst UGA is the weakest signal. Approximately 57%
of mammalian genes are estimated to be affected by purifying selection acting on
stop codon preference. This proportion varies substantially by codon, with UGA
stop codons far more likely to be conserved. Notably, genes with conserved stop
codons were found to have longer 3’ UTRs and were also associated with shorter
mRNA half-life than other genes (Seoighe et al., 2020). Under certain conditions,
a near-cognate tRNA can be recruited when the ribosome reaches a stop codon,
meaning an amino acid is incorporated and translation continues until a later
stop codon is reached. This event is called stop codon readthrough (Palma and
Lejeune, 2020). Most eukaryotic genes terminate with multiple stop codons, but
if there is a single stop codon this is more likely to happen. Since the least effi-
cient stop codon is the most conserved, it seems probable that readthrough may
have useful functional consequences.
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Cytoplasmic mRNA degradation generally begins with shortening of the poly-A
tail by de-adenylases (Liu et al., 1998; Tucker et al., 2001), followed by de-capping
(Lai et al., 2012). The unprotected mRNA is then degraded by exonucleases from
both ends. Despite the spatial separation of mRNA synthesis, translation and
degradation, several studies have shown evidence that these processes are coupled
(Lotan et al., 2005, 2007; Harel-Sharvit et al., 2010). Indeed, compensatory
changes in degradation and synthesis have been revealed that indicate buffering
of mRNA levels to render gene expression robust in yeast (Sun et al., 2012) and
human cells (Slobodin et al., 2020).
1.1.4 Translation at the endoplasmic reticulum
The endoplasmic reticulum (ER) is an expansive, membrane-enclosed organelle
composed of smooth peripheral tubules and rough, ribosome-studded central
sheets, whose function can be summarised as synthesis and export of proteins
and membrane lipids. The binding site of the ribosome on the ER membrane is
the translocon (Figure 1.5) (Rapoport et al., 2017). However, the ribosomes are
not a stable part of this organelle’s structure as they are constantly being bound
and released from the ER membrane. A free ribosome only docks at the ER once
it has bound the mRNA of a protein destined for the secretory pathway.
Secretory proteins include transmembrane proteins such as receptors and ion
channels, as well as secreted proteins including neuropeptides and extracellular
matrix components. Many of these proteins have distinct interaction domains
on ribosomes that are involved in their targeting and transport. Transcripts are
targeted for transport to the ER via various N-terminal hydrophobic signals.
Many secretome proteins encode an initial signal peptide (SP), a short sequence
(usually 16-30 amino acids long) that is recognised by signal recognition particle
(SRP) (Walter and Blobel, 1981; Wild et al., 2004). SP sequences are extremely
heterogeneous, and the efficiency of protein secretion is strongly determined by
the specific SP (Kober et al., 2013). Proteins with amino-terminal transmembrane
domain are also recognised by SRP resulting in ∼15% of cellular transcripts be-
ing bound by SRP. Transmembrane domains biochemically resemble a SP but are
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Figure 1.5: Translation of secretome proteins at the endoplasmic retic-
ulum
(A) When the mRNA of a secretome protein begins to be transcribed, the N-
terminal of the peptide chain encodes an ER localisation signal such as a trans-
membrane domain (TMD) or signal peptide (SP). This triggers the localisation of
the ribosome-mRNA complex to the ER membrane. In the case of SP, it is bound
by the signal recognition particle (SRP) which is subsequently bound by the signal
recognition particle receptor (SRPR), which is anchored in the ER membrane near
the SEC61 translocon. (B) The translating ribosome docks at the translocon, the
SRP is released and the nascent peptide inserts into the channel. As the ribosome
continues to translate the peptide is deposited directly into the ER lumen. (C)
On completion of translation, the ribosome and mRNA are released from the ER
membrane. The complete peptide is folded and processed in the Er lumen. If one
or more TMD are present, the peptide is transferred from the translocon straight
to the ER membrane.
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not cleaved after localisation. While secreted proteins are threaded through the
channel, transmembrane domains may diffuse across a lateral gate in the translo-
con to partition into the surrounding membrane. SRP-independent mechanisms
of targeting include the transmembrane domain recognition complex of 40 kDa
(TRC40) pathway in mammals (Stefanovic and Hegde, 2007; Schuldiner et al.,
2008) and the recently discovered SRP-independent targeting pathway, which
preferentially targets proteins with transmembrane domains located downstream
of the N-terminal (Aviram et al., 2016).
Systematic analysis of the secretome in yeast showed that about 57% of predicted
secretory proteins are targeted by SRP whilst about 43% of secretome proteins
are SRP-independent (Ast et al., 2013). Regardless of translocation mechanism,
the vast majority of secretory proteins have been found to complete translation
at the ER in vivo. The translation of these proteins begins on a free ribosome
but once the localisation signal has been recognised, the ribosome and transcript
are transported to the ER membrane (Jan et al., 2014).
There has been some debate about whether the ribosome is stalled during the
relocation to the ER. By labelling mRNAs with various fluorescent tags, it is
possible to study translation in real time at the single-mRNA level in living cells
(Morisaki et al., 2016; Wang et al., 2016; Wu et al., 2016; Yan et al., 2016).
By fusing a fluorescent epitope and tag-bearing mRNA with an N-terminal ER
targeting signal, it is possible to visualise translation at the ER in live cells.
Wu et al. (2016) were able to observe co-translational insertion of the nascent
peptide into the ER and also found that the mRNAs were tethered to the ER only
during active translation. This technique also allowed observation of a fraction
of translating polysomes exhibiting rapid and directed motion in the dendrites
of neurons (Wang et al., 2016), suggesting that mRNAs can undergo translation
during transport and this is somehow repressed for ER-directed ribosomes.
Once at the ER membrane, the SRP interacts with the signal particle recognition
receptor (SPRP) which is closely associated with the translocon channel. The
ribosome-transcript complex docks at the translocon and the nascent peptide is
secreted directly into the ER lumen. The SEC61 translocon channel is made up
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of the SEC61A, SEC61B and SEC61G subunits. Once within the ER lumen, the
peptide will be folded and modified, and then released to be transported to the
correct cellular location. In addition to secretome proteins, up to 40% of cytosol-
encoding mRNAs may be translated at the ER in a typical mammalian cell (Reid
and Nicchitta, 2012). This shows the fluid nature of translation localisation, in
that for many transcripts, they may be translated at the ER or on a free ribosome
in the cytoplasm.
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1.2 RNA quality control
1.2.1 Surveillance mechanisms regulating RNA quality
Despite the many layers of regulation discussed thus far, errors still occur and
therefore eukaryotic cells utilise quality-control mechanisms that recognise and
degrade mRNAs that have not completed nuclear pre-mRNA processing or that
fail to encode a polypeptide faithful to the gene sequence. Such aberrant mRNAs
are degraded rapidly, before the accumulation of abnormal protein products that
could have adverse effects on the cell. The mechanisms that recognise and target
aberrant mRNA for degradation take place at every step of gene expression (Isken
and Maquat, 2007). Evolution pressure has led to evolving protective mechanisms
that prevent appearance of defective proteins by destroying the aberrant proteins
themselves or sensing the aberrations in the mRNA templates and degrading
them. In this thesis, I will focus on mechanisms of RNA quality control that
assess RNA and ensure aberrant transcripts do not lead to faulty proteins.
The No-Go Decay (NGD) mRNA surveillance pathway degrades mRNAs con-
taining stacks of stalled ribosomes. NGD occurs when translation elongation is
blocked by the presence of stable intramolecular or intermolecular RNA struc-
tures, enzymatic cleavage, chemically damaged sequences or rare codons. Ribo-
some stalling can result in a wide range of malignancies from protein misfolding to
oncogenesis. The best characterised example is mutations in the FMR1 gene, that
causes ribosomes to stall and translation to stop (Stefani et al., 2004; Shu et al.,
2020), and leads to fragile X syndrome and intellectual disability (Richter and
Coller, 2015). Correspondingly, NGD is evolutionarily conserved from yeast and
unlike most RNA quality control pathways, NGD is even conserved in prokaryotes
including archaea.
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Transcripts synthesised without a stop codon due to premature polyadenylation
also accumulate stalled ribosomes, that are initially detected by the non-stop
decay (NSD) pathway. However, it has been shown that this can also ultimately
lead to NGD. Translational readthrough, where the stop codon is skipped over,
into the 3’ UTR sequence can produce less protein but does not trigger non-stop
decay as there is no connection with poly-A sequence. The 3’ UTR sequence may
be used to control protein levels of such transcripts where readthrough occurs
(Arribere et al., 2016).
Staufen1 (STAU1)-mediated mRNA decay (SMD) is an mRNA degradation pro-
cess in mammalian cells that is mediated by the binding of STAU1 to a STAU1-
binding site within the 3’ untranslated region (3’ UTR) of target mRNAs. These
binding sites consist of double-stranded RNA formed by a stem-loop structure in
the 3’ UTR or an RNA duplex structure formed by intermolecular mRNA–mRNA
or mRNA–long noncoding RNA interactions (Ricci et al., 2014; de Lucas et al.,
2014; Sugimoto et al., 2015). The ATP-dependent helicase UPF1 is recruited to
mRNA via its interaction with STAU1 in a translation-dependent manner (Kim
et al., 2005; Park and Maquat, 2013). The recruited UPF1 interacts with proline-
rich nuclear receptor coregulatory protein 2 (PNRC2) and triggers rapid mRNA
degradation.
Besides SMD, STAUs perform multiple functions in post-transcriptional regula-
tory processes including alternative splicing, translation and spatial targeting of
mRNA (Thomas et al., 2009). STAU1 also promotes efficient replacement of the
cap-binding heterodimer CBP20:CBP80 with eIF4E, after the pioneer round of
translation (Jeong et al., 2019). This event is inhibited by interaction between
STAU1 and UPF1. Increased association between STAU1 and hyperphospho-
rylated UPF1 has also been seen after cell stress stimuli, which inhibits this
replacement. This could be explained by the interplay between UPF1, response
to cell stress and inhibition of translation which will be covered in Section 1.4.3.
22
Regnase-1, a member of the CCCH zinc finger protein family possessing RNase
activity, mediates post-transcriptional regulatory activity through degradation of
target mRNAs, termed regnase-1–mediated mRNA decay (RMD) (Uehata and
Akira, 2013). RMD is particularly important in regulating the magnitude of
innate and adaptive immune responses (Uehata and Takeuchi, 2017), and dys-
function of Regnase-1 in mice leads to the development of spontaneous systemic
inflammation (Konieczny et al., 2019).
Glucocorticoid receptor (GR) plays a role in rapid mRNA degradation by act-
ing as an RNA-binding protein. GR is loaded onto the 5’ UTR of a target
mRNA and recruits UPF1 through PNRC2 in a ligand-dependent manner, so as
to elicit rapid mRNA degradation, termed GR-mediated mRNA decay (GMD)
(Cho et al., 2015). GMD is thought to be a mechanistically unique pathway of
UPF1-dependent mRNA decay because it occurs in a translation-independent
manner.
It has also been shown that inefficient SRP interaction with the nascent pep-
tide can trigger a unique mRNA quality control mechanism that senses aberrant
secretory proteins and degrades their mRNAs preventing synthesis of harmful
products (Karamyshev et al., 2014). Termed regulation of aberrant protein pro-
duction (RAPP), Karamyshev et al., found that mutations in the signal sequence
changed the affinity of SRP and instead Ago2 argonaute protein was recruited.
Severity of the signal sequence mutations correlated with increased proximity of
Ago2 to the nascent peptide and subsequently to mRNA degradation, suggesting
a general mechanism of secretome translational quality control.
However, the most studied and well characterised co-translational quality control
mechanism is nonsense mediated decay (NMD). This pathway recognises tran-
scripts with a premature termination codon (PTC) and leads to degradation of
the aberrant mRNA and the nascent peptide, thus avoiding the production of
truncated proteins that could have problematic consequences such as dominant-
negative or deleterious gain-of-function effects (Leeds et al., 1991; Jacobson and
Peltz, 1996; Neu-Yilik and Kulozik, 2004; Maquat, 2004; Wilkinson, 2005; Chang
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et al., 2007; Lykke-Andersen and Jensen, 2015; He and Jacobson, 2015; Kurosaki
and Maquat, 2016; Karousis et al., 2016). NMD is evolutionarily conserved
through all eukaryotes, although no similar mechanism has been identified in
prokaryotes.
Because both SMD and NMD employ UPF1, SMD and NMD are competitive
pathways and are mechanistically related. GMD, NMD, and SMD all share the
pathway components UPF1 and PNRC2, and both NMD and SMD occur in a
translation-dependent manner, raising the question of how distinct these quality
control and degradation pathways are from each other in vivo and the level of
interplay between them.
1.2.2 Mechanism of nonsense mediated decay (NMD)
Nonsense mediated decay (NMD) was first described in yeast cells, when it was
noticed that the presence of nonsense mutations reduced the level of mRNA but
did not affect the rate of transcription (Losson and Lacroute, 1979). It was also
noted that the strength of this reduction depended on the position of the non-
sense codon within the locus. Soon after, whilst investigating a molecular defect
identified in four Kurdish Jews with homozygous, mRNA-deficient β-thalassemia,
it was found that whilst non-thalassaemic β-globin mRNA was stable during a
30min actinomycin D chase, 30%-75% of the thalassaemic mRNA molecules were
degraded during that period (Maquat et al., 1981). It was concluded that the
absence of β-globin mRNA in the patients was a result of rapid turnover of the
thalassaemic β-globin mRNA molecules. This mechanism was generalised by
Peltz et al. (1993) who stated that nonsense mutations in any gene can accel-
erate the decay rate of the mRNA transcribed from that gene, and termed this
phenomenon nonsense-mediated mRNA decay.
The canonical NMD pathway is translation-dependent (Carter et al., 1996; Wu
et al., 2020; Karousis et al., 2020) and occurs in the cytoplasm. The prevail-
ing model is that NMD is triggered by a translating ribosome stalling at a PTC
(Figure 1.6), however, recent work has shown that NMD activation is not accom-
panied by stable stalling of ribosomes at stop codons, and in fact, revealed similar
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ribosomal occupancy at the stop codons of NMD-sensitive and NMD-insensitive
reporter mRNAs (Karousis et al., 2020). The RNA helicase and ATPase UPF1 is
the central NMD factor, which binds directly to the RNA being translated (Zünd
and Mühlemann, 2013; Singh et al., 2019). Several mechanisms describing the
circumstances under which UPF1 binds to RNA have been proposed. Initially
UPF1 was thought to be recruited to the mRNA during translation, however
UPF1 has since been found to bind lncRNAs (Li et al., 2017a; Zhou et al., 2019).
Furthermore, it was originally suggested that UPF1 preferentially binds to the
3’ untranslated region (3’ UTR) but cross-linking immunoprecipitation (CLIP)
studies have shown UPF1 bound along entire mRNAs when cells were treated
with translation inhibitors, suggesting it binds non-specifically but transiently to
the entire length of RNAs whilst unphosphorylated but is displaced by active
translation (Zünd et al., 2013). In contrast, the NMD active phosphorylated
UPF1 has been shown to bind predominantly de-adenylated mRNA decay inter-
mediates (Kurosaki et al., 2018).
Translation stalls when the ribosome reaches the stop codon and is recognised
by the translation termination factor eukaryotic release factor (eRF) 1 which has
a similar structure to an aminoacyl-tRNA. eRF1 forms a complex with, and is
activated by the GTPase activity of eRF3, allowing it to interact with UPF1
and later UPF2 (Kashima et al., 2006). Binding of UPF1, eRF1 and eRF3
to SMG1, a phosphatidylinositol-3-kinase-related kinase, forms the surveillance
(SURF) complex (Isken and Maquat, 2008). SMG1-mediated phosphorylation of
UPF1 is the key step in NMD-activation and is thought to stabilise the binding of
UPF1 to the mRNA thereby determining the transcript for decay. Subsequently,
UPF1 interacting with EJC components UPF2 and UPF3B induces the formation
of the decay-inducing (DECID) complex. UPF1 is phosphorylated at multiple
sites along its amino and carboxyterminal regions which allows it to recruit the
homodimer endonuclease SMG6 and/or SMG5/SMG7 heterodimer, resulting in
endocleavage and exonucleolytic decay of the fragments (Gatfield and Izaurralde,
2004; Huntzinger et al., 2008; Eberle et al., 2009) or promotion of de-capping and
de-adenylation of the mRNA (Unterholzner and Izaurralde, 2004; Loh et al., 2013)
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Figure 1.6: Canonical nonsense mediated decay pathway
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Figure 1.6: Canonical nonsense mediated decay pathway
(A) When the ribosome reaches a stop codon it stalls and release factors eRF1
and eRF3 bind. However when the stop codon is premature the ribosome does not
dissociate in the usual manner. The RNA binding protein UPF1 usually tran-
siently binds RNA in a dynamic manner. (B) The kinase SMG1 is recruited and
facilitates the binding of UPF1 to eRF1 and eRF3 forming the SMG1-UPF1-
Release-Factor (SURF) complex. SMG1 phosphorylates UPF1 at multiple sites
along its amino and carboxyterminal regions, activating the NMD pathway. (C)
Hyperphosphorylated UPF1 and SMG1 transfer to interact with two peripheral
proteins of the EJC; UPF2 and UPF3B forming the decay inducing (DECID)
complex. (D) The DECID complex formation recruits the SMG6 homodimer
and/or SMG5/SMG7 heterodimer. The SMG6 homodimer performs endocleav-
age to break down the RNA molecule, whilst the SMG5/SMG7 heterodimer pro-
motes de-capping and de-poly-adenylation, making the RNA vulnerable to stan-
dard degradation mechanisms. (E) After de-capping, de-poly-adenylation and/or
endocleavage, the mRNA is degraded by the exosome and the 5’-3’ exoribonuclease
XRN1, and any nascent peptide degraded by the proteasome.
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respectively. UPF1 also recruits the de-capping complex itself either directly or
via proline-rich nuclear receptor co-activator 2 (PNRC2) (Cho et al., 2009, 2015).
Each of these processes reduces the stability of the transcript and targets the
RNA for decay, via the 5’-3’ exoribonuclease XRN1 and the exosome.
Whilst the NMD pathway core factors are conserved from yeast, more complexity
and accordingly more factors are involved in higher order organisms. Seven genes
(smg-1–7, for suppressor with morphological effect on genitalia) that are essential
for NMD were originally identified in the nematode Caenorhabditis elegans, and
orthologs of these genes have been found in several species. In Saccharomyces
cerevisiae, there are three main NMD factors; UPF1, UPF2 and UPF3, that
make up the conserved core of the NMD pathway. All three of these factors are
trans-acting elements called up-frameshift (UPF) proteins. In mammals, UPF3
has two paralogues; UPF3B which forms part of the EJC and the DECID complex
in NMD, and the NMD repressor, UPF3A which results in an increase in NMD
activity when depleted (Shum et al., 2016).
There is also strong evidence supporting an NMD autoregulatory circuit, first
noticed when mRNAs coding for NMD factors were found to be among NMD-
sensitive transcripts (Huang et al., 2011). Many NMD factor mRNAs possess
long 3’ UTRs, and some of them harbour uORFs. Using reporter gene assays,
it has been demonstrated that the long 3’ UTRs of UPF1, SMG5, and SMG7
mRNAs are the main NMD-inducing features of these mRNAs (Yepiskoposyan
et al., 2011). This negative feedback regulatory network has been identified as
acting on all the core NMD factors, although to varying degrees and is conferred
by different branches of the NMD pathway in a cell type-specific and developmen-
tally regulated manner (Huang et al., 2011). Reversal of this feedback regulation
in response to NMD perturbation is crucial for maintaining NMD (Goetz and
Wilkinson, 2017), suggesting the feedback network maintains both RNA surveil-
lance and the homeostasis of normal gene expression in mammalian cells.
28
1.2.3 NMD in human genetic disease
A pathway to specifically target PTCs is sensible given how abundant and po-
tentially drastic the clinical consequences can be. Approximately 20% of human
disease-associated single-nucleotide substitutions form a PTC (Mort et al., 2008)
and one third of inherited disorders are caused by a PTC (Bhuvanagiri et al.,
2010). PTC mutations can result in severe human genetic diseases such as vari-
ants of Duchenne and Becker muscular dystrophies (dystrophin), retinoblastoma
(RB1), neurofibromatosis (NF1, NF2), ataxia-telangiectasia (ATM), Tay-Sachs
disease (HEXA), cystic fibrosis (CFTR), Wilm’s tumour (WT1), β thalassemia
(β-globin), haemophilia A (factor VIII) and B (factor IX), von Willebrand disease
(Willebrand factor), p53-associated cancers (p53), and numerous others (Hol-
brook et al., 2004). In some cases, the aberrant mRNA is efficiently targeted by
the NMD pathway meaning any truncated nascent peptide is degraded by the
proteasome and no protein is present, whilst in others the aberrant transcript
escapes NMD meaning dysfunctional protein is produced.
Cystic Fibrosis (CF) can be caused by a plethora of mutations within the CFTR
gene leading to a non-functional Na+ ion channel. Class I mutations are those
that impair protein production, often nonsense mutations that generate prema-
ture stop codons triggering NMD. Common mutations in class I include G542X
(the second most common CF-causing mutation), R1162X and W1282X, which
accounts for 48% of the mutant alleles among Ashkenazi Jew CF patients. NMD
degrades most if not all PTC-containing mRNAs, meaning little to no CFTR
protein is produced. If the ribosome does terminate correctly then the resulting
protein is truncated and has either reduced or no function. However, some trun-
cated proteins retain at least partial function (Crawford et al., 2000; Kerr et al.,
2001) and the amino-terminal portion of CFTR has been shown to form a par-
tially functional Cl- channel (Sheppard et al., 1994). Aminoglycoside antibiotics
can suppress premature termination codons, thus permitting translation to con-
tinue to the normal end of the transcript. Therefore, the common aminoglycoside
antibiotic gentamycin has been administered to CF patients to promote in vivo
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read-through of nonsense mutations (Wilschanski et al., 2003). The drug forces
the ribosome past the PTC, shielding the nascent peptide from NMD and leads to
expression of almost full-length proteins. Whilst these resulting ion channels are
altered and have reduced function, they are beneficial to the patient compared
to complete absence of protein. Patients carrying stop mutations showed a sig-
nificant reduction in nasal potential difference upon treatment with gentamycin
(Wilschanski et al., 2003), indicating an increase in ion transport, in part due to
CFTR function (Rowe et al., 2011).
Duchenne muscular dystrophy (DMD) is also characterised by production of a
partial protein which would likely reduce the symptoms of the disease, but the
mutant RNAs harboring PTCs are degraded by NMD thereby aggravating the
disease. DMD is the most common type of muscular dystrophy with around 10%-
15% of cases caused by a point mutation introducing a premature stop codon (Roy
and Griggs, 2021). The drug ataluren binds to the ribosome and impedes the
recognition of the stop codon, thus promoting read through of the nonsense mu-
tation to produce a full-length functional protein (Siddiqui and Sonenberg, 2016).
Ataluren received conditional approval from the European Medicines Agency to
treat DMD patients aged five years or older with a nonsense mutation in August
2014, but the most recent phase III trial did not reach statistical significance at
the primary endpoint (McDonald et al., 2017).
However, read-through drugs are not the answer to all diseases involving NMD.
For this to be an effective strategy, the truncated protein must be at least par-
tially functional, and not harmful. β-thalassemia refers to a group of inherited
blood disorders in which there is reduced or absent synthesis of the β chains
of haemoglobin. Mutations in both copies of the HBB gene cause the more
severe thalassemia major or thalassemia intermedia, whereas patients with het-
erozygous HBB mutation usually do not have symptoms. The common form of
β-thalassemia occurs in homozygotes who possess NMD-competent PTCs in both
copies of HBB and the resulting defective β-globin mRNA is degraded by NMD
(Kugler et al., 1995). Heterozygous carriers of a single NMD-competent PTC
generally produce enough β-globin from the normal allele, however rare forms of
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dominant β-thalassemia, are caused by NMD-incompetent PTCs, usually within
the last exon of the β-globin gene (Hall and Thein, 1994). These PTCs give
rise to a large amount of truncated β-globin that cannot be sufficiently degraded
(Thein et al., 1990). This example indicates the protective effect NMD fulfils in
preventing many healthy heterozygotes from manifesting clinical disease.
Other NMD-associated phenotypes are due to altered or dysfunctional NMD fac-
tors. Mutations in the NMD gene UPF3B cause intellectual disability in humans
and are associated with neurodevelopmental disorders, including schizophrenia
and autism (Tarpey et al., 2007; Nguyen et al., 2014). Furthermore, copy number
variations in several NMD genes have been associated with human neurodevelop-
mental disorders and other neural diseases (Nguyen et al., 2013, 2014; Johnson
et al., 2019).
1.2.4 Global regulation of the transcriptome by NMD
Technologies such as northern blot analysis or qRT-PCR only allow low=throughput
measurements of mRNA levels requiring pre-selection of likely candidates or
reporter constructs. Therefore, increasingly, genome-wide analyses have been
utilised to identify all targets of NMD. This has allowed the discovery that NMD
is associated with the regulation of a larger proportion of the transcriptome than
first thought. As well as RNA surveillance, NMD has been described as a regu-
lator of normal gene expression through its ability to degrade a subset of func-
tional mRNAs. This conclusion has been drawn from NMD factor knockout and
knockdown experiments that result in between 3-20% of transcripts in eukaryotes
increasing in expression, suggesting they are regulated by NMD (Peccarelli and
Kebaara, 2014; Lykke-Andersen and Jensen, 2015). This additional function of
NMD has been identified in all species analysed, including S. cerevisiae (Lelivelt
and Culbertson, 1999; He et al., 2003; Kawashima et al., 2014), C. elegans (Ra-
mani et al., 2009; Longman et al., 2013), D. melanogaster (Rehwinkel et al., 2005;
Chapin et al., 2014), D. rerio (Longman et al., 2013) and H. sapiens (Mendell
et al., 2004; Wittmann et al., 2006; Yepiskoposyan et al., 2011; Longman et al.,
2013). In humans up to 10% of normal transcripts are thought to be affected in
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this way, suggesting NMD can fine tune many physiological processes such as de-
velopment, cell cycle, cell stress and tumourigenesis by controlling the expression
level of specific groups of RNAs (Mendell et al., 2004; Wang et al., 2011a; Lou
et al., 2016). This would mean NMD is important for both prevention of disease
and also homeostatic gene regulation.
NMD has been found to be a multifaceted pathway with non-canonical mecha-
nisms including UPF2-independent and EJC-independent quality control path-
ways (Bühler et al., 2006; He and Jacobson, 2015). mRNAs harbouring long 3’
UTRs have been shown to be sensitive to NMD, irrespective of the presence of an
EJC (Hogg and Goff, 2010). There has even been evidence that NMD can affect
lncRNAs (Li et al., 2017a; Zhou et al., 2019) which raises the question if these
supposedly non-coding RNAs are being translated or if NMD is working on them
in a non-co-translational manner.
In contrast to most known transcripts, T-cell receptor β (TCRβ) transcripts are
downregulated by PTCs closer than 50nt from the final EJC (Carter et al., 1996;
Wang et al., 2002), raising the possibility that an entity other than the classical
EJC can serve as the second signal for TCRβ NMD. Depletion of the NMD
factor and EJC component UPF3B, had no effect on stability of T-cell receptor β
transcripts containing PTCs. Furthermore, WT genes have been identified that
transcribe NMD-targeted mRNAs whose downregulation is hardly or not affected
by depletion of UPF3A or UPF3B (Chan et al., 2007b).
It has been suggested that NMD preferentially takes place during the pioneer
round of translation (Ishigaki et al., 2001; Maquat et al., 2010a,b), and that
a transcript that survives this is then immune to NMD. This is partly due to
the EJC being removed in the pioneer round of translation as the translating
ribosome moves along the transcript (Lejeune et al., 2002). It is also argued that
the cap binding heterodimer CBP80-CBP20, which is replaced with eIF4E after
the pioneer round, plays a critical role in NMD because CBP80 interacts directly
with UPF1, enhancing the efficiency of the NMD pathway (Isken et al., 2008).
However, this model is debated (Durand and Lykke-Andersen, 2013; Rufener
and Mühlemann, 2013) and recent findings show that NMD occurs with equal
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probability during each round of translation of an mRNA molecule (Hoek et al.,
2019). Using a novel real-time visualization of both mRNA translation and NMD
of single mRNA molecules in living cells, Hoek et al. produced real-time kinetic
measurements of degradation of the 3’ mRNA cleavage fragment generated by
NMD. They also showed that the probability of NMD occurring is variable and
suggest it depends on the exon sequence downstream of the PTC, the PTC-to-
intron distance, and the number of introns both upstream and downstream of
the PTC. These results call into question the long-accepted link between NMD
activation and the EJC since all EJCs are thought to be removed in the pioneer
round of translation so would therefore not be present in later rounds.
1.2.5 Target characteristics
Whilst a PTC can result in a truncated protein and potentially cause severe phe-
notypes (Section 1.2.3), not all PTCs trigger degradation by NMD. The efficiency
of NMD varies according to several characteristics, impacting the clinical outcome
of genetic mutations. Furthermore, residual levels of many PTC-containing tran-
scripts can be detected in steady-state measurements (Cheng and Maquat, 1993;
Cheng et al., 1994; Belgrader et al., 1994; Thermann et al., 1998; Trcek et al.,
2013; Boehm et al., 2014; Lindeboom et al., 2016).
The amount of residual mRNA for an NMD substrate appears to vary depending
on the gene and the position of the PTC (Lindeboom et al., 2016; Thermann
et al., 1998; Cheng et al., 1994). Activation of the NMD pathway is much less
likely if the PTC is in the last exon, or less than 50nt from the next exon-exon
junction (Nagy and Maquat, 1998). This is commonlyrefered to as the ”50nt rule”
It is thought this is necessary to allow the NMD machinery to interact with the
proteins of the EJC to modulate the SURF complex into the DECID complex.
Comparing the NMD efficiency of PTCs located upstream of the last EJC and
PTCs inside the last exon, NMD is significantly more inefficient in the latter case
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(84.7% versus 1.7% NMD efficiency (Lindeboom et al., 2016). This seems at odds
with the finding that show that NMD occurs with equal probability during latter
rounds of translation when the EJC would have presumably been removed (Hoek
et al., 2019).
Using paired tumour:normal exome data and tumour transcriptomics from the
cancer genome atlas (TCGA), Lindeboom et al. (2016), identified 2,840 high-
confidence PTCs and investigated their expression using the RNA-sequencing.
By normalising to the median expression of the WT transcript across all cancers
without the PTC variant, they calculated an “NMD efficiency” score for each PTC
and then measured how important each of the previously published NMD target
rules was for determining if a PTC would trigger NMD. They found that the most
variability could be explained by whether the PTC was in the last exon (45.8%)
and the second highest amount was how close the PTC was to the start codon
(17.2%). The 50 nucleotide rule often thought to be the most important accounted
for only 3.5% of the additional variance after the last exon rule was taken into
account. Overall, 74.2% of the variability in NMD response to PTC could be
explained by a combination of these rules plus exon length, mRNA half-life,
allele frequency, significant motifs and the distance from the PTC to the normal
stop codon. They validated these findings using heterozygous germline nonsense
variants in lymphoblastoid cell line RNA-sequenceing from healthy individuals
(Geuvadis study; Lappalainen et al., 2013).
Furthermore, although the first mRNA substrates identified for NMD encoded
PTCs (Losson and Lacroute, 1979; Maquat et al., 1981), it is now appreciated
that NMD degrades a variety of mRNAs that arise as a result of either mutations
or defects in pre-mRNA processing (Section 1.1.2) (Figure 1.7A), many with EJC-
independent mechanisms. NMD that occurs independent of a downstream EJC
is often as a consequence of translation termination at the normal termination
codon rather than at a PTC (Wang et al. 2002; Bühler et al. 2006; Matsuda et
al. 2007; Eberle et al. 2008). Cells define whether or not a termination codon
triggers either type of NMD depending on the ability of UPF1 to be recruited
and phosphorylated (He and Jacobson 2015; Karousis et al. 2016; Kurosaki et
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Figure 1.7: NMD target characteristics
al. 2019). The common theme is that substrates of NMD present non-standard
spatial relationships between the termination codon and other mRNA features
(Baker and Parker, 2004). Features that trigger NMD include alternative splic-
ing leading to inclusion of ”poison” exons which contain a PTC (Lareau et al.,
2007; Ni et al., 2007; Kurosaki et al., 2019a), mRNAs containing introns due
to defective splicing (Sibley et al., 2016; Wang and Aifantis, 2020), pseudogenes
(Weischenfeldt et al., 2008; Gatica and Rosa, 2016; Muir et al., 2018), alternative
up-stream open reading frames (uORFs) in the 5’ UTR (He et al., 2003; Mendell
et al., 2004; Wittmann et al., 2006; Yepiskoposyan et al., 2011), long 3’ UTRs
(Muhlrad and Parker, 1999; Yepiskoposyan et al., 2011) and the presence of in-
trons in the 3’ UTR (Mendell et al., 2004; Wittmann et al., 2006; Yepiskoposyan
et al., 2011). It is likely, these features cause a transcript to engage the NMD
machinery due to the continued presence of EJCs or other RBPs downstream of
a terminating ribosome.
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Figure 1.7: NMD target characteristics
(A) The NMD pathway targets both aberrant transcripts that could lead to dis-
ease phenotypes and also normal transcripts. Aberrant transcripts can occur due
to mutations or damage on the DNA, aberrant splicing leading to retained PTC-
containing-introns or inaccurate transcription leading to accidental incorporation
of a PTC. Targeting of normal transcripts has been identified in the case of a 5’
upstream open reading frame (uORF), alternative splicing that leads to inclusion
of a “poison” exon that contains a PTC, presence of a 3’ UTR intron and when
transcripts have a long 3’UTR (Figure adapted from Goetz and Wilkinson, 2017).
(B) Schematic with color-coded gene regions showing different NMD efficiencies;
boxes represent exons. Plots below show NMD efficiency trends (individual data
points not shown, 95% confidence intervals shown in grey). Bottom left; increase
in NMD efficiency across the first 200 coding nucleotides. Bottom right; vari-
ation in NMD efficiency around the last exon junction, the presumed location
of the EJC is demarcated at the top of the plot (Figure from Lindeboom et al.,
2016).(C) The amount of NMD efficiency variance explained by the identified
rules for NMD target discrimination according to an integrated model incorporat-
ing multiple rules. The total variance explained is 74.2%. Each identified rule
explains different amounts of variance in NMD efficiency between PTCs. The
predictive power of each feature was determined by sequentially introducing the
features to random forest models, on the basis of the order of the features sug-
gested by an initial analysis of the entire feature set (Figure from Lindeboom
et al., 2016).
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The long 3’ UTR model postulates that the failure of polyA-binding protein
(PABP) to interact with the terminating ribosome results in inefficient termina-
tion which triggers NMD. Based on current knowledge, a termination codon is
recognised as “normal” because of the interactions between the terminating ribo-
some complex and the proteins that are bound to the 3’ UTR and the poly-adenine
(poly-A) tail. Specifically, Singh et al. (2008) showed that if the interaction be-
tween the cytoplasmic poly-A binding protein PABPC1 and the release factors
eRF3 is impaired, eRF3 is able to interact with the core NMD factor UPF1, thus
triggering the NMD response. Therefore, if the ribosome stalls too far away from
the 3’ UTR, it cannot terminate properly. Accordingly, mRNAs with substan-
tially extended 3’ UTRs are targeted by NMD in yeast, human, drosophila and
plant cells (Kebaara and Atkin, 2009). More recently, Wu et al. (2020) showed
that readthrough efficiencies for a PTC increased in response to 3’ UTR length-
ening and suggest that inefficient termination is a trigger for NMD. This model
explains previous observation that EJC-independent degradation occurs in non-
sense mRNA having a long 3’ UTR. However, others have found that mRNAs
having long 3’ UTRs were not enriched in direct UPF1 targets (Tani et al., 2012).
Intron retention is a type of alternative splicing where an intron is not correctly
spliced out of the pre-mRNA. If the intron that is retained contains stop codons or
a shift in the reading frame, this could lead to mRNA degradation (Sibley et al.,
2016; Wang and Aifantis, 2020). Using RNA-sequencing and exome data from
cancer patients to identify single nucleotide variants (SNVs) that disrupt splic-
ing, Jung et al. (2015) found that 97% and 86% of SNVs causing intron retention
and intronic cryptic site activation, respectively, generated PTCs, suggesting why
this alternative splicing is such a strong trigger for NMD. For this reason, intron-
retained transcripts had been thought to be non-functional, however, advances in
next-generation sequencing technologies have enabled the detection of numerous
transcripts that retain introns, suggesting intron-retaining mRNAs play an essen-
tial conserved role in normal physiology and an emergent role in diverse diseases
(Lareau et al., 2007; Wong et al., 2013, 2016).
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Pseudogenes are non-functional genes or gene fragments that have accumulated
nonsense mutations by genetic drift, making them likely targets of NMD. They
have been identified as one of several structural classes of substrates targeted by
the NMD pathway including transcripts encoded by transposable elements and
bicistronic mRNAs, where the DNA codes for two gene products (He et al., 2003).
Pseudogene RNA was found to be specifically unregulated in NMD-deficient C.
elegans (Mitrovich and Anderson, 2005), indicating that NMD is required for the
downregulation of pseudogene expression.
However, these features do not characterise all known NMD targets and tran-
scripts meeting one or more of these rules have been found to escape NMD. For
example, in transcripts with intron-bearing 3’ UTRs, PTCs in the penultimate
exon may also strongly evade NMD despite the presence of a downstream EJC
(Lindeboom et al., 2016), suggesting that the EJC in 3’ UTRs may be less potent
in initiating NMD. Furthermore, not all mRNAs with uORFs are substrates for
NMD (Rehwinkel et al., 2006). It has been proposed that some yeast uORF-
containing transcripts harbour elements that stabilise their expression and allow
them to escape NMD regulation (Ruiz-Echevarŕıa and Peltz, 2000). In plants,
the uORF length determines whether the transcript is going to be degraded by
the NMD machinery (Nyikó et al., 2009). In mammals, the mechanism that al-
lows some uORFs containing transcripts to evade NMD regulation has not yet
been characterised (Rehwinkel et al., 2006). It has been suggested that some
of the described NMD pathways and target characteristics are cell type specific.
For example, purified spermatocytes from UPF2 knock out have long 3’ UTR-
dependent NMD compared to spermatocytes from control mice, and no detectable
EJC-dependent NMD (Bao et al., 2016).
1.2.6 Location specific NMD
NMD is a co-translational process and therefore is likely to occur at all sites of
translation. However, not all translation occurs in the cytoplasm. Local transla-
tion has been observed from bacteria and yeast to humans (Blower, 2013; Jung
et al., 2014; Eliscovich and Singer, 2017; Bovaird et al., 2018). It is commonly in-
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volved in the delivery of mature proteins to specific cellular compartments, while
allowing local regulation. In mammals, mRNA localization is involved in cell
polarization and motility, mainly through the localization of actin and related
mRNAs at the leading edge (Lawrence and Singer, 1986), and it is also involved
in axonal growth and synaptic plasticity of neurons (Van Driesche and Martin,
2018). Translation of mRNAs at specific sites may also be important for the
assembly of protein complexes (Pichon et al., 2016) or to avoid the deleterious
effects of releasing free proteins at inappropriate places (Müller et al., 2013).
Localised mRNAs are often subjected to spatial control of translation (Besse and
Ephrussi, 2008). RNA localisation and local translation provide ways to direct the
synthesis of proteins with spatial and temporal precision: at subcellular locations
where they are needed or in response to the timing of extracellular cues (Jung
et al., 2012). In the case of ash1 mRNA in yeast and β-actin mRNA in human
neurons, translation is repressed during transport and is activated at their final
location by phosphorylation-dependent mechanisms (Hüttelmaier et al., 2005;
Paquin et al., 2007). This spatial regulation of translation provides an additional
layer of control ensuring that mRNAs are translated only at the desired location.
The level of NMD in a particular cell can be modulated by the level of expression
of the NMD repressor UPF3A (Shum et al., 2016). High levels of UPF3A in a cell,
would strongly repress NMD and thus robustly stabilise NMD target transcripts,
a subset of which could encode proteins critical for that tissue. Conversely, a
tissue with low levels of UFP3A would be expected to have strong NMD, which
would robustly destabilise NMD substrates that might otherwise cause aberrant
events in that tissue. Both these examples could also be temporally regulated
whether through development, or in response to stimuli. In mice, UPF3A mRNA
levels have been found to differ in adult tissues, with particularly high expression
in the testis (Zetoune et al., 2008). UPF3A protein is also abundant in the adult
testis but is largely undetectable in other adult tissues. UPF3A mRNA and
protein are both expressed in a stage-specific manner during spermatogenesis,
with expression highest in spermatocytes, the stage of germ cell development in
which meiosis occurs (Shum et al., 2016).
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Most studies have investigated mechanisms that promote local translation, but
NMD has been shown to limit the translation of a localised mRNA in a mechanism
that operates with temporal and spatial specificity within the cell (Colak et al.,
2013). Neurons, being highly polarised cells, are well suited for studying localised
subcellular events and localised translation has been identified as a key process
in neuronal growth (Brittis et al., 2002). NMD has been shown to regulate levels
of the synaptic protein ARC (Giorgi et al., 2007), suggesting that NMD might
be localised to individual synapses.
Processing bodies (P-bodies) are cytoplasmic granules primarily composed of
translationally repressed mRNAs and proteins related to mRNA decay, suggesting
roles in post-transcriptional regulation. Nonsense-mutation-containing mRNPs
transit through P-bodies before undergoing NMD (Durand et al., 2007), however,
the function of P-bodies in translational repression and/or mRNA decay remains
contentious. It has been shown that P-body formation can be a consequence,
rather than a cause, of RNA-mediated decay and repression events (Eulalio et al.,
2007). Furthermore, activation of PTC readthrough has been shown to occur
concomitantly with the appearance of cytoplasmic foci containing UPF proteins
and mRNAs with nonsense mutations but lacking P-body markers (Jia et al.,
2017).
Germ cells don’t generally contain P-bodies but studies have found that several
NMD factors are highly concentrated in chromatoid bodies (CBs), and there is
little to no UPF1 in the cytosol, raising the possibility that CBs are sites of highly
active NMD (Meikar et al., 2014; Fanourgakis et al., 2016). CBs were also found
to have several characteristics in common with P-bodies (Kotaja et al., 2006) and
have been shown to support NMD (Jia et al., 2017). Together, these observations
lead to the intriguing model that CBs are, in some respects, the germ cell version
of P-bodies and that both are sites of active NMD.
NMD activity is regulated in a stage-, tissue-, and cell type-specific manner, al-
lowing it to accordingly alter the level natural target mRNAs (Karam et al., 2013;
Lou et al., 2016). The evidence described here suggest NMD is also regulated at
a subcellular level.
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1.3 Neuroblastoma amplified sequence
(NBAS) protein
1.3.1 Discovery of NBAS as a putative NMD factor
A genome-wide RNA interference (RNAi) screen for novel NMD factors in C.
elegans, identified two novel proteins as involved in NMD named smgl-1 and
smgl-2 (Longman et al., 2007). Transgenic worms carrying a GFP reporter with
a PTC were produced and the expression of GFP-PTC reporter mRNA moni-
tored by GFP fluorescence and semi-quantitative RT–PCR. The worms lack GFP
expression since the PTC means the transcript is broken down. However, GFP
expression is restored upon the inactivation of NMD by depletion of the positive
control, core NMD factor smg-2. In the GFP-PTC strain, the level of reporter
mRNA was significantly increased upon depletion of the NMD core factors smgl-2
or smgl-1. WT GFP reporter was not unregulated upon depletion of either fac-
tor. Unlike previously identified smg NMD genes, both smgl-1 and smgl-2 were
found to be essential for viability in C. elegans. Both nematode proteins are evo-
lutionarily conserved and have functional homologues in humans; neuroblastoma
amplified sequence (NBAS) and DExH-Box Helicase 34 (DHX34) respectively.
The human homologue of smgl-1 is NBAS (neuroblastoma amplified sequence),
previously known as NAG (Neuroblastoma Amplified Gene). The protein is so
named because it was first identified as upregulated in some neuroblastoma cell
lines (Wimmer et al., 1999; Frühwald et al., 2000). However, the increased NBAS
expression resulted from a large-scale genomic amplification of chromosome 2
containing both NBAS and the oncogene N-Myc. It has since been suggested
that only the 5’ region of NBAS is co-amplified and no link between NBAS and
oncogenesis has been found (Scott et al., 2003).
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NBAS is a large protein of 273kDa (2371 amino acids; Figure 1.8A), encoded
by a long gene of 52 exons. The protein is broadly expressed, with the highest
levels in heart and skeletal muscle, retinal ganglion cells, epidermal skin cells,
and leukocytes, and the lowest levels in liver, small intestine and thymus (Wim-
mer et al., 1999; Frühwald et al., 2000). The structure of human NBAS has
not been resolved, but from the sequence, functional domains have been identi-
fied. The first 420 amino acids of the N-terminal form a β-propeller structure; a
type of all-β protein architecture characterised by four to ten highly symmetri-
cal blade-shaped β sheets arranged toroidally around a central axis (Chaudhuri
et al., 2008). Protein-protein interactions can form with the top, bottom, central
channel, and side faces of the β-propeller but they are also involved in a diverse
set of functions (Chen et al., 2011). The β-propeller of NBAS is made up of
WD40 repeats; a short structural motif which has been shown to be involved in
coordinating multi-protein complex assemblies in other proteins. Therefore, it
is highly likely that the N-terminal domain of NBAS is involved in formation of
protein complexes. β-propellers have also been shown to function catalytically
and even to bind DNA (Vandermarliere et al., 2009; Chuankhayan et al., 2010;
Chen et al., 2011). NBAS also contains a sec39-like domain between 734–1355
amino acids, so called because of its homology with the sec39 protein in yeast
which has been shown to be required for Golgi-ER retrograde transport (Sasvari
et al., 2013). The C-terminal half of the protein is arranged in an α-solenoid;
a protein fold composed of repeating α helix subunits, arranged in antiparallel
fashion to form a superhelix (Fournier et al., 2013). α-solenoids are generally in-
volved in protein-protein interactions. The rare combination of a β-propeller and
an α-solenoid in the same protein has been previously identified in vesicle-coating
and nuclear pore complex components, including the clathrin heavy chain, the
α subunit of COPI complexes, and a subset of nucleoporins (Leksa et al., 2009;
Brohawn and Schwartz, 2009; Devos et al., 2004). NBAS has also been predicted
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Figure 1.8: NBAS is located at the endoplasmic reticulum
(A) Depiction of the NBAS protein including it’s annotated functional domains
and structural regions. (B) NBAS is an endoplasmic reticulum (ER) localised
protein with a role in ER secretion. Inset shows NBAS as part of the Syntaxin-
18 complex, which facilitates Golgi-to-ER retrograde transport of COPI vesicles
(Figure from Longman et al., 2020).
to contains two leucine zippers and a ribosomal S14 motif, coiled coils and two or
three transmembrane domains (Scott et al., 2003). Leucine zippers are protein-
protein oligomerisation motifs (Landschulz et al., 1988), whereas the ribosomal
S14 motif functions in the assembly of the ribosome (Chan et al., 1993).
NBAS protein is localised to the ER outer membrane. This is in contrast to
most other identified NMD factors which are found throughout the cytoplasm.
Notable exceptions are immunofluorescence studies that have shown yeast UPF3
is both nuclear and cytoplasmic (Moreno et al., 2013), and cellular fractionation
experiments that have identified that the majority of UPF2 is located in the
cytoplasmic perinuclear region and the remainder is detected in the intranuclear
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region (Tatsuno et al., 2016). This is likely due to both UPF2 and UPF3B having
a role as part of the EJC which is loaded onto mRNA within the nucleus during
splicing and is only removed during translation outside of the nucleus. They
are both also thought to have functions within the nucleus and when cytoplasm-
localised (Shirley et al., 2002).
1.3.2 The role of NBAS in vesicle transport
NBAS has been described to function in Golgi-ER retrograde transport. Since
there is no continuous membrane between the endoplasmic reticulum (ER) and
the Golgi apparatus, membrane-bound transport vesicles are necessary to shuttle
proteins between these two compartments. Vesicles are surrounded by coating
proteins called COPI and COPII (Barlowe and Helenius, 2016; Gomez-Navarro
and Miller, 2016). COPII targets vesicles to the Golgi apparatus and COPI
marks them to be brought back to the rough ER. The rough ER works in concert
with the Golgi complex to target new proteins to their proper destinations. The
COPI coated vesicles leave the cis end of the Golgi complex and are actively
transported on microtubules, most likely by dynein (Chen et al., 2005). The
vesicles contain proteins found in the lumen of the Golgi complex that need to be
transported to the lumen of the ER and transmembrane proteins which reside in
the ER (Cosson and Letourneur, 1997; Stornaiuolo et al., 2003; Ma and Goldberg,
2013). This pathway also allows misfolded or aberrant proteins to be sent back to
the ER for refolding and quality checking (Spang, 2013). Endocytosed proteins
may travel from the plasma membrane via the Golgi to the ER via this pathway
(Spang and Schekman, 1998). Retrograde transport is part of the organellar
homeostasis pathway essential to maintaining the identity of the ER and of the
Golgi apparatus.
When the vesicles reach the ER they encounter the tethering complex DSL1,
also referred to as the Syntaxin-18 complex. Syntaxins are a family of soluble
NSF attachment protein receptor (SNARE) proteins implicated in membrane
fusion (Hong, 2005; Jahn and Scheller, 2006). Mammalian syntaxin members
involved in transport between the ER and Golgi are Syntaxin-5 and Syntaxin-18,
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which are localised in the Golgi and the ER, respectively (Dascher et al., 1994;
Hatsuzawa et al., 2000). The presence of subdomains in the ER enables this
organelle to perform a variety of functions. By mediating the fusion of retrograde
membrane carriers with the ER membrane, Syntaxin-18 has an important role
in ER subdomain organization (Iinuma et al., 2009). Syntaxin-18 interacts with
three SNAREs (BNIP1, USE1 and SEC22B) and three peripheral membrane
proteins (SLY1, ZW10 and RINT1) (Hirose et al., 2004; Nakajima et al., 2004).
NBAS forms part of the NBAS-RINT1-ZW10 (NRZ) tethering complex which
associates with the SNAREs Syntaxin-18, USE1, BNIP1 and SEC22B (Figure
1.8B) and is believed to play a role in assembly of the multi-SNARE complex
(Hatsuzawa et al., 2000; Burri et al., 2003; Hirose et al., 2004; Tagaya et al.,
2014). The homologous complex to NRZ in yeast, Dsl1, also comprises three
subunits and has been shown using x-ray crystallography to form a two-legged
structure with a central hinge (Travis et al., 2020).
NBAS has been shown to interact directly with RINT1 and ZW10 somewhere
in its C-terminal region between 1036–2371 amino acids (Civril et al., 2010),
although the direct interaction between NBAS and RINT1 has been disputed
(Tagaya et al., 2014). Stability of NBAS appears to be linked to the stability of
ZW10, so that the levels of both proteins, as detected by western blotting, were
greatly decreased at 96h after siRNA transfection against ZW10 (Civril et al.,
2010). Although there was no reciprocal reduction in the stability of ZW10 when
NBAS was depleted. Both ZW10 and RINT1 have diverse cellular functions in
addition to retrograde transport including endosome-to-Golgi transport, cytoki-
nesis, cell cycle checkpoint and autophagy.
NBAS is structurally and evolutionarily related to a protein involved in mitotic
chromosome segregation ROD (Rough Deal). Both have N-terminal WD40 β-
propellers and sec39-like domains. ZW10 binds both ROD and NBAS but this is
mutually exclusive (Civril et al., 2010).
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1.3.3 Impact of NBAS on human health
Multiple studies have identified patients with compound heterozygous mutations
in NBAS, mainly located throughout the two annotated domains of the pro-
tein, that cause several complex syndromes, including short stature, optic nerve
atrophy, and Pelger-Huet anomaly (SOPH). SOPH is an autosomal recessive syn-
drome characterised by severe postnatal growth retardation, facial dysmorphism
with senile face, small hands and feet, normal intelligence, abnormal nuclear shape
in neutrophil granulocytes (Pelger-Huet anomaly), and optic atrophy with loss of
visual acuity and colour vision (Maksimova et al., 2010; Lacassie et al., 2020).
Osteogenesis imperfecta (OI), the most common inherited bone fragility disorder,
affects 1 in 15,000 live births resulting in frequent fractures and reduced mobility,
with significant impact on quality of life. Whole exome sequencing in patients
with OI identified, in two patients with a multi-system phenotype, compound
heterozygous variants in NBAS (Balasubramanian et al., 2017). One of the ho-
mozygous missense variants found to cause SOPH syndrome was also found in
one OI patient on one allele and a nonsense variant in the other allele.
Infantile liver failure syndrome 2 (ILFS2) is also caused by mutations affecting
NBAS. ILFS2 is a life-threatening disorder of hepatic function that manifests
with acute liver failure in the first few months of life. Clinical features include
anaemia, renal tubulopathy, developmental delay, seizures, failure to thrive, and
liver steatosis and fibrosis (Haack et al., 2015). These NBAS mutations could be
effecting the liver specifically due its generally low wild type expression in hepa-
tocytes (Wimmer et al., 1999; Frühwald et al., 2000), as reduction of functional
protein would therefore have a bigger effect.
NBAS mutations have also been found in unnamed multisystem diseases affect-
ing the liver, eye, immune system, connective tissue, and bone. Clinical man-
ifestations include a progeroid appearance, short stature, slender bones, epi-
physeal dysplasia with multiple phalangeal pseudo-epiphyses, cervical instability,
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myelopathy, elevated transaminases, hypogammaglobulinemia, reduced natural
killer cells, Pelger-Huet anomaly of granulocytes which describes an abnormal
nuclear shape, and in some cases retinal dystrophy and optic atrophy (Segarra
et al., 2015).
Whilst the evidence suggests that most of the NBAS mutations cause reduced
level of NBAS protein, it is not currently known by what mechanism the muta-
tions in NBAS lead to these phenotypes. They could be due to a lack of retrograde
transport in the secretome pathways, or a break down in NMD regulation leading
to production of truncated proteins, or a combination of these pathways.
1.3.4 Evidence for NBAS as an NMD factor
As well as C. elegans where it was first identified, NBAS has been described as
an NMD factor in Danio rerio (zebrafish) and human cells (Anastasaki et al.,
2011; Longman et al., 2013, 2020).
Zebrafish goldenb1 mutants carry a nonsense mutation in exon 5 of the slc24a5
mRNA. Expression of slc24a5 transcript was increased in melanocyte precursor
cells when either UPF1 or NBAS depleted, whilst the WT allele was unaffected,
suggesting NMD-mediated degradation (Anastasaki et al., 2011). In HeLa cells,
depletion of NBAS by siRNA causes an increase in the level of mRNA of a β-
globin NMD reporter containing a PTC. This increase can be rescued by the
addition of exogenous overexpressed FLAG-NBAS (Longman D., unpublished;
Figure 1.9A). This is surprising because β-globin is not a secreted protein and so
may not be expected to be translated at the ER, and therefore not be affected by
NBAS activity. However, as described in Section 1.1.4, translation localisation
is fluid and many non-secretome proteins can be translated at the ER. Both of
these experiments use change in level of mRNA as an indicator or changed NMD
activity. Whilst this has been common practice for identifying NMD effects, it is
not a true measure of NMD activity as NMD degrades the mRNA and therefore
specifically affects mRNA stability, whereas global abundance changes could be
due to other factors or processes. For the experiment in HeLa cells, an improve-
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ment could be to co-transfect the PTC-containing reporter and a WT β-globin
reporter, however introducing exogenous reporters and overexpressing protein
from transfected plasmid both have caveats as they create a non-physiological
state.
Significant co-regulation of endogenous transcripts was observed between core
NMD factor UPF1 and NBAS in C. elegans, D. rerio and human cells (Longman
et al., 2013). However the correlation was much stronger in zebrafish (r=0.74)
than HeLa cells (r=0.55) or C. elegans (r=0.42; all Spearman’s correlation tests).
This could be because the zebrafish were targeted for knock down using mor-
pholino (MO) which consists of antisense oligomers against the mRNA of interest
and was commonly used in the absence of tools for efficient targeted mutagenesis
in a range of models in the early 2000s. However, concerns have since arisen about
the off-target effects of MOs (Stainier et al., 2017). MO-induced phenotypes are
often more severe than those of corresponding genomic mutants, which could be
the result of various phenomena including off-target effects of the MO (Kok et al.,
2015) or genetic compensation in genetically mutated but not MO-injected ani-
mals (Rossi et al., 2015). It has been suggested that the major off-targeting effect
is mediated through p53 activation (Robu et al., 2007). This could explain the
much higher number of targets and stronger correlation between UPF1 effects
and NBAS effects seen in zebrafish compared to C. elegans or human cells.
It was also shown that upregulation of transcripts encoding NMD factors in re-
sponse to NMD abrogation included NBAS, suggesting that the conserved au-
toregulatory NMD circuit is mediated by NBAS in C. elegans and zebrafish in
addition to HeLa cells (Longman et al., 2013). More recently, separation of func-
tion experiments have shown a block of constitutive secretion does not affect
NMD activity (Longman et al., 2020), indicating that depletion of NBAS does
not inactivate NMD simply by impairing ER secretion, leading to cell stress.
Transfected, overexpressed NBAS and UPF1 co-immunoprecipitate and the in-
teraction between NBAS and UPF1 has also been shown by multiple techniques
including Förster resonance energy transfer (FRET), fluorescence lifetime imag-
ing microscopy (FLIM), fluorescence cross-correlation spectroscopy (FCCS) and
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Figure 1.9: Evidence of NMD function of NBAS
(A) Level of a β-globin NMD reporter containing a PTC was increased in HeLa
cells upon depletion of NBAS by siRNA. This was rescued to control levels by
addition of exogenous FLAG-NBAS (unpublished data, Longman D.). (B) A
direct interaction between endogenous NBAS and UPF1 was determined by PLA
using antibodies against endogenous UPF1 and NBAS proteins in HeLa cells.
The PLA signal in wild-type (WT) HeLa cells was compared with a HeLa NBAS
knockout (KO) cells, as a negative control. The PLA signal was quantified in the
graph where each point represents mean PLA count in one captured frame, relative
to NBAS KO negative control. Significance was determined by two-tailed Mann-
Whitney test p value < 0.0001 (Figure from Longman et al., 2020). (C) NBAS
recruits UPF1 to the ER. Fluorescence correlation spectroscopy (FCS) produces
average autocorrelation curves of a fluorescent protein in a given volume. The
curve of mCherry-UPF1 is shown at the ER or cell periphery in the presence
(si-control) or absence of NBAS (si-NBAS) (Figure from Longman et al., 2020).
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biochemistry techniques using overexpressed GFP-NBAS or FLAG-NBAS and
proximity ligation assay (PLA) of endogenous proteins (Figure 1.9B). FRET
quantifies the distance between two proteins by measuring the fluorescent sig-
nal given off by an acceptor molecule which is tagged to one protein of interest.
The acceptor emits signal when it comes into close contact (typically 10-100Å)
with a donor molecule that is tagged to the other protein of interest and is ex-
cited by laser during imaging (Liput et al., 2020). FLIM is one way of measuring
FRET and is often carried out in conjunction. FLIM measures the decrease in
lifetime of the donor molecule as FRET occurs. A shorter average lifetime indi-
cates the donor is nearer the acceptor. A shorter average lifetime indicates the
donor is nearer the acceptor. PLA is an antibody-based technique that indicates
when two proteins are in close contact. It uses specific antibodies against the
two proteins of interest and secondary antibodies with either a plus (+) or minus
(-) DNA oligo attached. When the secondary antibodies are less than approx-
imately 40nm apart, the oligos can anneal and rolling DNA synthesis can take
place. These nascent DNA clusters can be visualised with fluorescent marker
which is imaged as a red spot. However, this does not exclude the possibility
that the two proteins may be within the same protein complex and not interact-
ing directly. FCCS is an extension of fluorescence correlation spectroscopy (FCS)
which measures fluorescence intensity fluctuations in a given volume. FCCS mea-
sures two labelled particles’ movement through a predefined confocal volume to
identify if they are moving together and therefore likely to be interacting. FCS
of mCherry-UPF1 at the ER and at the cellular periphery show that UPF1 dif-
fuses more slowly at the ER than in the cytoplasm (Figure 1.9C), suggesting it is
tethered to the ER in some manner. Furthermore, upon depletion of NBAS with
siRNA, the diffusion rate of UPF1 at the ER was increased to the same level as
the cellular periphery, indicating it is likely NBAS is tethering UPF1 to the ER
membrane.
NBAS has also been shown to interact with the NMD factors SMG5, SMG6,
SMG7 and DHX34 by immunoprecipitation followed by western blot and probing
with specific antibodies (Longman et al., 2020).
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1.4 Endoplasmic reticulum stress
1.4.1 ER homeostasis
As touched on in Section 1.1.4, the ER has many roles within the cell: lipid
biosynthesis, glucose homeostasis, a Ca2+ store, protein export, and contacting
and regulating other organelles (Loi et al., 2018). ER homeostasis is therefore
an important part of maintaining overall cell stability. Cells respond to internal
and external cellular stressors by activating stress-response pathways to mitigate
the effects and re-establish balance. Physiological, chemical, and pathological
factors that compromise ER homeostasis lead to ER stress. If homeostasis is not
achieved in a timely manner, the stress pathways trigger apoptosis to preserve
organism integrity (Oyadomari et al., 2002; Chen et al., 2011; Wolff et al., 2014;
Schneider and Bertolotti, 2015). Therefore, it is important for the cell to regulate
ER homeostasis in order to maintain survival.
Many enzymes, foldases, and chaperones assist with protein folding and other
post-translational modifications, which ensure the maintenance of ER homeosta-
sis (Sicari et al., 2020). ER stress occurs when the balance between the protein
folding demand exceeds the capabilities of the ER, leading to an abnormal ac-
cumulation of improperly folded proteins within the ER lumen (Schröder and
Kaufman, 2005). Cells have evolved elaborate mechanisms to ensure the accu-
racy with which secreted, and membrane proteins are folded and assembled. The
correct folding of the nascent peptide is necessary before the protein can be trans-
ported to the Golgi and localised to the correct cellular location. However, if a
peptide is misfolded or cannot be folded at all, which could be due to the presence
of a PTC causing the peptide to be truncated, this can lead to formation of aggre-
gates within the ER lumen. Despite the multitude of different proteins recruited
to stabilise folding intermediates and overcome energy barriers (Balchin et al.,
2016), protein folding is inherently error prone, especially in the ER. 12–15% of
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newly synthesised polypeptides in human cells are co-translationally eliminated
by the ubiquitin-proteasome system (Duttler et al., 2013; Wang et al., 2013), how-
ever since at the ER, the nascent peptide is deposited directly into the lumen,
misfolded proteins must first be exported to the cytoplasm.
Many pathologies are characterised by formation of aggregates, especially neu-
rodegenerative diseases such as Alzheimer’s Disease. These protein aggregates
trigger ER stress (Zhu et al., 2020; Nilsberth et al., 2001). It has also been shown
that ER overload of pancreatic β cells in conditions such as hyperglycaemia, obe-
sity, and long-term treatment with sulfonylureas cause ER stress, which leads to
apoptosis and can result in type 2 diabetes (Oyadomari et al., 2002).
To counteract protein misfolding and maintain protein homeostasis in the secre-
tory pathway, multiple quality control mechanisms have evolved (Figure 1.10),
including ER-associated degradation (ERAD), ER-phagy and the Golgi quality
control pathway (GQC). Each process is regulated to some degree by the un-
folded protein response (UPR) and/or the heat shock response, which adjust
protein synthesis, chaperone levels, and the activity of protein degradation path-
ways (Travers et al., 2000; Bravo et al., 2013; Li et al., 2017b,c; Preissler and
Ron, 2019; Karagöz et al., 2019).
1.4.2 Mechanisms of ER stress
Considered the first line of defence, misfolded and damaged proteins, as well
as surplus single subunits of multi-subunit proteins are recognised by the ER-
associated protein degradation (ERAD) pathway (Roth and Zuber, 2017; Vem-
bar and Brodsky, 2008). These proteins are dislocated to the cytoplasm and
eventually degraded by the canonical ubiquitin–proteasome system (Bonifacino
and Weissman, 1998; Dikic, 2017; Grumati and Dikic, 2018; Varshavsky, 2017).
The ERAD has a conserved mechanism: misfolded proteins are recognised and
ubiquitinated through either the ERAD-L (ERAD of substrates with misfolded
lesions within the ER lumen), ERAD-C (cytoplasm), or ERAD-M (membrane)
pathways, depending on the location of the folding lesion (Huyer et al., 2004;
Vashist and Ng, 2004; Carvalho et al., 2006; Denic et al., 2006).
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Figure 1.10: Mechanisms of endoplasmic reticulum stress
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Figure 1.10: Mechanisms of endoplasmic reticulum stress
Translation at the SEC61 translocon leads to the nascent peptide being deposited
directly into the ER lumen. (A) If the protein is folded correctly then post-
translational modifications can be added and the protein continues to the Golgi.
(B) However if the peptide can not be folded or is misfolded then then quality
control mechanisms are activated to remove the peptide and prevent ER stress.
(C) The first line of defence is ER-associated degradation (ERAD), which dislo-
cates proteins to the cytoplasm, possibly by retrotranslocation through the SEC61
channel, where they are ubiquitinated and degraded. (D) Proteins that are too
large for the translocon channel or are otherwise ERAD-resistant, are bound by
ER-phagy receptors which then produce ER subdomains that pinch off from the ER
network and fuse with lysosomes to facilitate degradation. (E) If neither ERAD
or ER-phagy controls the level of misfolded protein they may begin to form ag-
gregates and activate ER stress. (F) Protein aggregation can itself be sufficient
to trigger lysosomal degradation. (G) Upon accumulation of unfolded proteins,
the chaperone BiP dissociates from the three unfolded protein response (UPR)
sensors and binds the aberrant proteins instead. This activates the three branches
of the UPR; (H) eukaryotic translation initiation factor 2 alpha kinase (PERK),
(I) inositol requiring enzyme 1 (IRE1) and (J) activating transcription factor
6 (ATF6). Via three different mechanisms all three lead to block of translation,
autophagy and activation of transcription factors that upregulate genes involved
in antioxidant response, increased folding capacity and apoptosis.
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Since ubiquitin ligase activity occurs in the cytoplasm, ERAD substrates with
lumenal lesions (those handled by the ERAD-L pathway), must be retrotranslo-
cated (Schoebel et al., 2017). Based on its function as the ER translocation
channel, SEC61 has been suggested to also act in reverse and function as a retro-
translocon. Evidence supporting this hypothesis includes experiments demon-
strating interaction between SEC61 and ERAD substrates, as well as the protea-
some (Wiertz et al., 1996; Kalies et al., 2005; Schäfer and Wolf, 2009). In ad-
dition, Apolipoprotein B is retrotranslocated and targeted for degradation when
forward translocation through SEC61 is interrupted (Mitchell et al., 1998), indi-
cating that the two functions for this channel, translocation and retrotransloca-
tion, can be uncoupled. Other studies have also suggested the HRD1 ubiquitin
ligase (Baldridge and Rapoport, 2016) and multi-spanning membrane protein
DER1 (Mehnert et al., 2014) promote movement of misfolded proteins through
the ER membrane. Retrotranslocated membrane proteins contain hydrophobic
transmembrane domains and are consequently aggregation prone (Wang et al.,
2011b).
In addition to misfolded proteins, some native proteins deemed unnecessary are
degraded by the ERAD pathway. For these substrates, adaptor protein binding,
ligand binding, and/or the display of a degron is essential. In this way, the ERAD
pathway can be hijacked by pathogens. The human cytomegalovirus encodes two
membrane adaptors, US2 and US11, which bind newly synthesised major histo-
compatibility complex (MHC) class I molecules and recruit the ERAD machinery
(Wiertz et al., 1996; Stagg et al., 2009). Cell-surface display of MHC class I is
reduced, thereby disabling the host immune response. A similar strategy is used
by the HIV-encoded adaptor Vpu, which directs CD4 to the proteasome (Fujita
et al., 1997; Schubert et al., 1998).
While most misfolded proteins in the ER are efficiently handled by the ERAD
pathway, the diameter of the pore in the retrotranslocon may preclude misfolded
oligomeric or aggregated proteins from being exported from the ER. Because
these substrates are toxic, the ER is equipped with another mechanism to protect
homeostasis; ER-phagy (Bernales et al., 2006, 2007). ER-phagy also disposes of
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ERAD-resistant misfolded proteins (Fregno and Molinari, 2019). In yeast, atg40
localises primarily to the cytoplasmic ER, resulting in autophagic sequestration
of ER subdomains. Expression of an aggregation-prone ERAD substrate induces
the expression of an alternate COPII subunit, lst1, which functions with Atg40 to
select ER-phagy sites. An lst1 homologue, SEC24C, similarly marks ER-phagy
sites in mammals (Cui et al., 2019). The discovery of various ER-phagy receptors
in mammals highlights the potential for substrate selection (Khaminets et al.,
2015; Fumagalli et al., 2016; Grumati et al., 2017; Smith and Wilkinson, 2018;
An et al., 2019; Chen et al., 2019; Chino et al., 2019). Each receptor contains
a domain that facilitates interaction with an autophagy-requiring factor. Even
though the identification of these ER-phagy receptors has helped define the nature
of cargo selection, how the ER-phagy machinery degrades most receptor-bound
cargo proteins remains an important open question (Wilkinson, 2019).
SEC62 is an ER transmembrane component of the SEC61/SEC62/SEC63
translocation machinery involved in the import of newly synthesised proteins into
the ER lumen (Section 1.1.4). SEC62 was identified as the ER-phagy receptor
that regulates ER turnover after conclusion of a transient ER stress. This function
is independent of its role during protein translocation (Fumagalli et al., 2016).
SEC62-regulated “recovER-phagy” resets ER volume and content after ER stress
and employs the autophagy core machinery.
The Golgi apparatus is the organelle encountered by secretory proteins after
leaving the ER and is where post-translational modifications occur including gly-
cosylation, acetylation, phosphorylation as well as proteolytical activation. The
Golgi also serves a quality control function (GQC) (Arvan et al., 2002; Potelle
et al., 2015). Misfolded proteins that escape ERAD, are recognised in the Golgi
and either delivered to the lysosome for degradation or are proteasome-targeted,
requiring retrograde transport to the ER (Vashist et al., 2001, Section 1.3.2). For
example, misfolded proteins with mutated transmembrane domains are specif-
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ically returned to the ER from the Golgi via a retrieval receptor, RER1 (Le-
tourneur and Cosson, 1998; Sato et al., 2003). COPI vesicle transport has been
shown to play an important role in retrieving unassembled T cell receptor α
subunit (TCRα) to the ER (Yamamoto et al., 2001).
Targeting for lysosomal degradation requires the sortilin receptor (for misfolded
lumenal/soluble proteins) or a ubiquitin ligase complex (for misfolded membrane
proteins). Sortilin resides primarily in the Golgi and plasma membrane and
mediates lysosomal cargo sorting (Nielsen et al., 1999, 2001; Lefrancois et al.,
2003; Amengual et al., 2018). While protein aggregation is sufficient to trigger
lysosomal degradation, trafficking is sortilin independent, suggesting that protein
aggregation is necessary, but not sufficient, for sortilin-mediated sorting.
When ERAD is unable to maintain ER homeostasis, the unfolded protein re-
sponse (UPR) is induced. The UPR is a highly conserved ER stress response,
that consists of a set of intracellular signalling pathways. One of the most
abundant proteins within the ER is the Hsp70-type chaperone, BiP (binding-
immunoglobulin protein; GRP-78). BiP binds to nascent polypeptide chains
initially to prevent their aggregation and has a role in correct peptide folding.
Under homeostatic conditions, BiP also binds the luminal domain of the UPR
transmembrane sensors, keeping them inactive. However, upon accumulation of
unfolded proteins, BiP preferentially binds to these in an attempt to refold them,
releasing the sensors and allowing activation of the three branches of the UPR.
The three ER transmembrane sensors are inositol requiring enzyme 1 (IRE1),
eukaryotic translation initiation factor 2 alpha kinase (PERK) and activating
transcription factor 6 (ATF6). The UPR functions to restore normal function of
the cell by global translational repression, expansion of the ER membrane net-
work, activating the signalling pathways that lead to increasing the production
of molecular chaperones and folding catalysts involved in protein folding, and en-
hancement of ERAD, ER-phagy, and GQC (Travers et al., 2000; Yoshida et al.,
2003, 2006; Smith and Wilkinson, 2017; Smith et al., 2018; Karagöz et al., 2019).
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Together, these events increase the folding capacity of the ER, limit the entry of
newly synthesised proteins into the ER, and facilitate the clearance of those that
have accumulated; however, if the stress is not alleviated, the UPR triggers cell
death.
IRE1 is the most conserved transducer of the UPR and can either lead to adap-
tive or death signals. This occurs through both unconventional splicing of XBP1
mRNA and regulated IRE1-dependent decay of mRNA (RIDD) (Hollien and
Weissman, 2006). Whereas XBP1 mRNA splicing is cytoprotective in response to
ER stress, RIDD can either preserve ER homeostasis or induce cell death. RIDD
involves IRE1 RNase activity, which cleaves ER-localised RNA in a sequence-
specific manner at XBP1-like consensus sites. The free 5’ and 3’ ends of the gener-
ated mRNA fragments are then substrates for cellular exoribonucleases leading to
their rapid degradation. Evidence supports altered IRE1 function in various dis-
eases such as diabetes, inflammatory and neurodegenerative disorders and, more
generally, in diseases associated with proteostasis imbalance (Hetz and Glimcher,
2011; Hetz et al., 2011). PERK phosphorylates eIF2a which leads to activation of
the transcription factors ATF4 and CHOP which then upregulate several apop-
totic genes, whilst part of the ATF6 receptor self-cleaves and acts as a TF on
similar genes. All three mechanisms lead to block of translation, autophagy and
activation of transcription factors that upregulate genes involved in anti-oxidant
response, increased folding capacity and apoptosis.
While physiologically beneficial, the UPR and other ER stress pathways require
tight regulation to provide a beneficial outcome and avoid lethal consequences.
Chronic activation of the UPR is linked to neurodegeneration (Yan et al., 2019;
Torkzaban et al., 2020; Li et al., 2020), malignancy (Giampietri et al., 2015; Rod-
vold et al., 2016), prion diseases (Shah et al., 2017) and viral infection (Blázquez
et al., 2014; Fung and Liu, 2014; Jheng et al., 2014; Torkzaban et al., 2020). In
these circumstances, cellular stress pathways can contribute to disease. There-
fore, the inhibition or modulation of the UPR represents a potential treatment
for several diseases and conditions.
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1.4.3 Effect of NMD on ER stress
Several studies have demonstrated that NMD serves as a regulator of the UPR
pathway (Figure 1.11) by preventing inappropriate UPR activation and promot-
ing the timely termination of the UPR to avoid apoptosis. NMD also regulates
responses to non-ER stressors, including hypoxia (Usuki et al., 2019), amino-acid
deprivation (Wengrod et al., 2013), and pathogen infection (Ajamian et al., 2008).
NMD regulates stress responses in species across the phylogenetic scale (Goetz
and Wilkinson, 2017), suggesting that it has conserved roles in shaping stress
responses.
A link between UPR regulation and RNA stability was first suggested when
ATF3 and ATF4 mRNA were found to be stabilised when NMD was suppressed
(Mendell et al., 2004), suggesting both transcripts are targets of the NMD path-
way. ATF3, which is downstream of the PERK branch of the UPR, regulates
several genes critical for responding to cellular stress. ATF4 also acts down-
stream of PERK and activates the transcription of genes encoding other UPR
pathway factors, including the ATF3 gene. Because NMD represses both factors,
it could dramatically downregulate the magnitude of the UPR. This was further
supported by the finding that the magnitude of the UPR was increased when
the NMD factor UPF1 was depleted (Gardner, 2008). The level of several UPR
factors, including ATF3, ATF4, CHOP, and GADD34, in the PERK and ATF6
branches of UPR, were increased in the absence of UPF1 whereas overexpres-
sion of UPF1 decreased expression of ATF3, ATF4 and CHOP, indicating that
hyperactivation of the NMD pathway suppresses UPR magnitude.
Microarray analysis identified several candidates of other UPR mRNAs might be
targeted by NMD (Karam et al., 2015). Depletion of the core NMD factor UPF1
and the branch-specific factor, UPF3B led to upregulation and stabilisation of
several UPR components, indicating that they are likely targets of the UPF3B-
dependent branch of NMD. This included the previously identified ATF3 and
ATF4, and also components of the other two UPR branches; IRE1α, TRAF2,
FSD1L, and TNRC5. In the same study, they found that HeLa cells depleted of
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Figure 1.11: The interplay between NMD and the UPR ER stress path-
way
(A) In basal conditions, NMD constantly represses the UPR via the degradation
of the mRNA of several components involved in the pathway. Upon ER stress,
the NMD pathway is downregulated to allow a robust UPR activation. However,
because sustained UPR activity can lead to apoptosis, when the ER stress is re-
solved, NMD acts to downregulate UPR genes and thus impacts cell fate after
ER stress. (B) If ER stress is not remedied, or NMD is not correctly restarted,
uncontrolled UPR leads to autophagy and apoptosis. (Figure adapted from Goetz
and Wilkinson, 2017)
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UPF3B exhibited UPR activation in response to low level ER stress that triggered
little or no response in control cells, suggesting the ability of NMD to suppress the
UPR confers a physiological benefit. UPF3B depletion increased the activation
of XBP1, phosphorylation of IRE1α, and cleavage of ATF6, providing evidence
that NMD can suppress all three branches of the UPR pathway. Furthermore,
UPF3B depleted and therefore NMD-deficient mice had a lower threshold for
UPR activation in hepatocytes than control mice. Altogether, these results show
that NMD protects cells from overreacting to harmless levels of ER stress.
Several studies have indicated that NMD protects cells from stress-induced apop-
tosis. SMG6-depleted HeLa cells treated with the ER-stress inducing drug tuni-
camycin exhibited ∼50% reduced cell survival compared to control cells, while
SMG6 overexpression increased HeLa cell viability (Sakaki et al., 2012). Termi-
nation of the UPR after stress has been resolved is vital because of the delete-
rious effects of extended stress response. NMD-deficient HeLa cells exhibited a
prolonged stress response when exposed to moderate doses of the ER stressor tu-
nicamycin, as measured by XBP1s, BIP and CHOP mRNA levels 15–18hrs post
exposure (Karam et al., 2015). In vivo mouse studies showed that UPF3B-null
mouse hepatocytes also exhibited an abnormally long UPR in response to moder-
ate doses of tunicamycin (Karam et al., 2015). These results indicate that NMD
also protects cells from prolonged UPR in response to bona fide stress.
Further evidence of the link between mRNA decay and stress response focuses
on their cytoplasmic structures. Although stress granules contain translation ini-
tiation factors and P-bodies are associated with miRNA/siRNA silencing and
mRNA degradation, they have many parallels. They share some protein com-
ponents, both can be induced by cellular stress (Teixeira et al., 2005; Raaben
et al., 2007) and both are in exchange with polysomes and contain translation-
ally stalled mRNAs that can re-engage in translation (Cougot et al., 2004; Bhat-
tacharyya et al., 2006). The two types of cytoplasmic granule have been shown to
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come into direct contact with each other (Kedersha et al., 2005; Souquere et al.,
2009). Under certain types of stress, P-bodies frequently dock with stress gran-
ules, and overexpress certain proteins that localise to both structures can cause
P-body/stress granule fusion (Franks and Lykke-Andersen, 2007).
Studies in D. melanogaster, zebrafish, and mammalian cell lines have shown the
importance of NMD in neural development and neural stem cell self-renewal vs.
differentiation decision (Lou et al., 2016; Jolly et al., 2013; Metzstein and Kras-
now, 2006; Wittkopp et al., 2009). The UPF3B-dependent branch of NMD in
particular, has been shown to function in neural differentiation and brain de-
velopment (Tarpey et al., 2007; Jolly et al., 2013; Nguyen et al., 2013). Taken
together these results suggest that the UPF3B-dependent branch of NMD may
regulate the transient UPR activation that occurs during normal neural differenti-
ation (Zhao et al., 2005; Luo et al., 2006; Weng et al., 2011), as well as the chronic
UPR activation that accompanies some forms of neural disease (Yan et al., 2019;
Torkzaban et al., 2020; Li et al., 2020). As highly secretory cells, neurons have a
highly active ER and therefore are particularly sensitive to ER stress. Support-
ing this line of thought, neural-specific miRNAs have been identified that target
NMD factors and thereby repress NMD (Bruno et al., 2011; Lou et al., 2014).
It has been suggested that UPF1 hyperphosphorylation is involved in the re-
placement of cap-binding complex from mRNA by eIF4E under stress conditions.
UPF1 becomes hyperphosphorylated by PI 3-kinase-related kinase (PIKK) family
kinases in circumstances such as when DNA replication is compromised (Kaygun
and Marzluff, 2005; Choe et al., 2014). In addition, members of PIKK fam-
ily ATM and SMG1, both of which induce UPF1 hyperphosphorylation, also
function in mitogenic and stress-induced signalling pathways in eukaryotic cells
(Brumbaugh et al., 2004). SMG1 which phosphorylates UPF1 to activate the
NMD pathway (Section 1.2.2) is also characterised as a genotoxic stress-activated
protein kinase and is required for optimal p53 activation after cellular exposure
to genotoxic stress.
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In response to strong ER stress, NMD is inhibited by the UPR to allow for a
full-magnitude UPR response (Figure 1.11. Illustrating the complex interplay
between ER stress and NMD, mild ER stress amplified NMD suppression. How-
ever, NMD suppression, evidenced by upregulation of NMD-sensitive mRNAs
and a decrease in UPF1 phosphorylation, was observed upon either oxidative or
ER stress in myogenic cells, cerebral cortical neuronal cells, and astroglial cells
(Usuki et al., 2019).
1.4.4 ER-NMD
Depletion of NBAS appears to cause a reduction in NMD activity in human cells,
however NBAS is located at the ER outer membrane, whilst canonical NMD
occurs in the cytoplasm. This indicates that if NBAS is directly partaking in
NMD, it is via a distinct pathway at the ER. Due to the movement of ribosome-
transcript complexes to the ER, the window of opportunity for cytoplasmic NMD
factors to assemble on these transcripts is narrow, suggesting that if a transcript
translated at the ER contains a PTC, it may be resistant to cytoplasmic NMD.
Together, these imply suggests an alternate NMD pathway specific to the ER
would be necessary to target transcripts with PTCs that are translated at the
translocon (Figure 1.12).
As described in Section 1.1.4, between 30% and 50% of transcripts are translated
at the ER. Therefore, it is reasonable to assume that NMD must take place
at the ER to regulate these transcripts. Although Staufen1 (STAU1), which
regulates SMD quality control, is localised to the ER, this does not protect against
translation of transcripts with PTCs.
Further supporting the hypothesis of an ER-specific NMD pathway, HaloTag
fusion UPF1 has been shown to interact with ER membrane proteins (Brannan
et al., 2016) and a fraction of UPF1 has also been shown to localise to the ER outer
membrane and interact directly with SEC61B, a component of the ER translocon
(Longman et al., 2020). As well as NBAS being located at the ER membrane
(Section 1.3.2) another putative NMD factor identified in C. elegans, SEC13, is
also localised to the ER (Casadio et al., 2015). Similar to NBAS, SEC13 comprises
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Figure 1.12: Theoretical model of ER-NMD
NBAS has been shown to function in the NMD pathway and localises to the mem-
brane of the endoplasmic reticulum (ER). NBAS recruits the core NMD factor
UPF1 and tethers it to the membrane of the ER. This suggest a local NMD re-
sponse that targets for degradation mRNAs that are translated at the ER.
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six WD40 domains and is located on transport vesicles budding from the ER as
well as being a constituent of the nuclear pore complex (Shaywitz et al., 1995).
Whereas NBAS functions in Golgi-to-ER vesicular transport, SEC13 forms part
of the COPII vesicle coat which promotes the formation of transport vesicles that
carry secretory proteins from the ER to the Golgi (Salama et al., 1997).
As already discussed more generally, NMD plays an important role in preventing
translation of truncated proteins. Protein aggregates made up of truncated or
misfolded proteins, which have likely escaped NMD regulation, trigger ER stress
which underlies many diseases (Blázquez et al., 2014; Fung and Liu, 2014; Jheng
et al., 2014; Giampietri et al., 2015; Rodvold et al., 2016; Shah et al., 2017; Yan
et al., 2019; Torkzaban et al., 2020; Li et al., 2020). The mutations underlying
several diseases associated with NMD occur in secretome genes. For example,
since CFTR is an ion channel, it has several transmembrane domains and is
likely translated at the ER. Therefore, quality control of RNA is arguably even
more important at the ER than in the cytoplasm.
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1.5 Aims and research outline
1.5.1 Specific motivations and importance
NBAS appears to be involved in NMD in human cells but unlike most other
identified NMD factors, is localised to the ER. This suggests that as well as the
canonical NMD pathway located in the cytoplasm and regulated by UPF1 and
other NMD factors, there is also a specific NMD pathway localised to the ER that
is regulated by NBAS as well as UPF1 and other NMD factors. This branch of
the NMD pathway would specifically target those transcripts that are translated
at the ER, although this is not exclusive to secretome proteins (Section 1.1.4).
Understanding more about NMD at the ER is important for knowledge of RNA
quality control and associated diseases.
More generally, there is still a lot of conflicting literature and differing opinions
about the NMD pathway and how its targets are identified. Therefore, further
clarifying NMD target characteristics will add to the understanding of both the
remit and the limits of this quality control pathway. This could be beneficial in
the area of designing therapeutics to force readthrough of stop codons to produce
truncated protein (Section 1.2.2).
Since several patient phenotypes have been caused by mutations in NBAS, it
is beneficial to understand more about the functions NBAS has within the cell,
both relating to NMD and how this is linked or distinct from its role in retrograde
transport. No mechanism is known by which these patient mutations cause their
phenotypes, so understanding more about NBAS may shed light on these cases
and potentially reveal therapeutic targets.
1.5.2 Main research questions
Throughout this thesis I aim to address the following questions:
1 What is the role of NBAS in the NMD pathway?
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(a) What proteins does NBAS interact with?
(b) What transcripts are targeted by NBAS?
(c) How does this subset differ from general NMD targets?
(d) Is NMD quality control occurring at the ER?
2 What are the characteristics of NMD targets and how do we define them?
(a) How does defining targets by change in stability compare with change
in expression?
(b) Is it possible to directly measure change in stability of individual tran-
scripts?
I will address the first main question through identification of the protein binding
partners of NBAS in human cells (Chapter 3) and identification and characterisa-
tion of transcripts increased in expression and/or stability when NBAS is depleted
(Chapter 4 and 5).
The second main question will be addressed through analysis of the differentially
expressed transcripts compared with differentially stabilised transcripts upon de-
pletion of both NBAS and the core NMD factor UPF1 (Chapter 4 and 5). Fur-
thermore, I will investigate the measurement of specific transcripts’ stability as a








2.1.1 Strains and plasmids
All experiments were carried out using HeLa cells (ATCC), obtained from lab
stocks in liquid nitrogen storage. 3xFLAG-tagged expression vectors for UPF1
and NBAS were generated by subcloning the 3xFLAG tag into the multiple
cloning site of pcDNA3 (Life Technologies). UPF1 deletion constructs (∆CT,
∆NT, ∆CH) were a generous gift from Andreas Kulozik (University of Hei-
delberg). NBAS deletion constructs (∆C1, ∆N2, ∆sec39 and ∆WD40+sec39)
were generated in house using the 3xFLAG pcDNA3 backbone. Small interfering
RNAs (siRNAs) used were ON-TARGETplus control pool (si-scramble; si-Scr),
hUPF1 pool (si-UPF1) and hNBAS pool (si-NBAS) (Dharmacon).
2.1.2 Cell culture
HeLa cells were grown in 1X Dulbecco’s Modified Eagle Medium (DMEM) with
high glucose, GlutaMAX supplement and pyruvate (Gibco Life technologies;
10569010) supplemented with 10% fetal calf serum (in-house technical services).
Cells were maintained in 5% CO2 at 37°C. HeLa 3xFLAG-eGFP-NBAS cells
were selected in the same conditions and media with the addition of 1g/ml of
Puromycin (Gibco; A11138043), and maintained in the same conditions and me-
dia with the addition of 1% Penicillin/Streptomycin (in-house technical services).
2.1.3 Bacterial DNA transformation
For all cloning applications, DNA was transformed into sub-cloning efficiency
DH5α Escherichia coli cells (Invitrogen). 50µl thawed cells were used per trans-
formation. After addition of DNA, cells were incubated on ice for 30min then
subjected to heat shock at 42°C for 45sec, followed by 2min on ice. 500µl of SOC
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medium [2% (w/v) Tryptone, 0.5% (w/v) Yeast extract, 10mM NaCl, 2.5mM
KCl, 10mM MgCl2, 20mM Glucose], was added and tubes were incubated at
37°C for 1h with shaking at 225 rpm. Transformants were plated on either Ampi-
cillin or Kanamycin agar plates, as appropriate, and incubated overnight at 37°C.
2.1.4 Cell transfections
All transfections were carried out in Opti-MEM reduced serum medium (Gibco,
31985047). Reverse transfections of siRNA oligos were carried out using Dharma-
FECT 1 transfection reagent (Dharmacon, T-2001-03) following manufacturer’s
protocol, with cells at 50-60% confluency. For total RNA-sequencing and subcel-
lular fractionation, cells were reverse transfected in 6-well plates with 30pmol of
indicated siRNAs. 48h later, cells were expanded into 10cm plates and reverse
transfected with 1µmol of the same siRNAs. Cells were harvested for analysis
24h after the second depletion. Plasmids were transfected using Lipofectamine
2000 (ThermoFisher Scientific, 11668019) following manufacturer’s protocol on
cells at 80% confluency. The amount of DNA used was dependent on the cell
vessel. For co-immunoprecipitation, cells were co-transfected with 2.4g total mix
of T7-tagged and FLAG-tagged expression vectors for 24-48h before harvesting.
2.1.5 RNA extraction
Cells were harvested by addition of TRIzol reagent (ThermoFisher Scientific;
15596018) and scraping. Samples were frozen at -80°C until further process-
ing. Total RNA was isolated by phenol-chloroform extraction and treated with
TURBO DNA-freeTM DNase I kit (Invitrogen Ambion; AM1907) according
to the manufacturer’s instructions. RNA concentration was measured using a




All agarose gels for electrophoresis were prepared using 1x TBE buffer [1M Tris
base, 1M Boric acid, 0.02M EDTA] supplemented with ethidium bromide (2
µl/100 ml). 1xTBE was used as the running buffer and the gel percentage was
adjusted to suit application.
2.1.7 Quantitative real time – polymerase chain reaction
(qRT-PCR)
Complementary DNA (cDNA) synthesis and qRT–PCR were performed using
Super-ScriptIII One-Step RT–PCR Kit (Invitrogen) following the manufacturer’s
instructions. To measure depletion of NMD factors and the corresponding block
of NMD, qRT–PCR analysis was performed to compare RNA levels corresponding
to a control mRNA, the mRNA targeted by siRNA and potential NMD target
mRNAs. Each gene was assayed in separate wells and four technical replicates
of each reaction were prepared for all samples. Primers used were designed using
Roche Real-Time Ready Configurator and combined with Roche Universal Probe
Library. All primer sequences are listed in Section 2.1.18. qRT-PCR was run on
an LC480 lightcycler (Roche) following the program: reverse transcription at
55°C for 30min, melting at 95°C for 2min, then 40 cycles of 95°C for 30sec, 55°C
for 20sec, 70°C for 20sec followed by the plate read step, and finishing with 5min
at 70°C. Gene expression data was analysed by the delta delta Ct method, with
each gene normalised to housekeeping gene POL2RJ. Student’s unpaired t-test
was used for statistical validations.
2.1.8 Western blotting
Cells were washed and harvested in ice-cold PBS, centrifuged to separate PBS and
then cell pellets were lysed with immunoprecipitation (IP) buffer [20mM Tris-HCl
pH 8, 150mM NaCl, 1mM EDTA, 1% NP-40, 0.2% NaDeoxycholate, Complete
Protease Inhibitor (Roche), PhosphoSTOP (Roche), 1mM DTT] for 20min on
73
ice. Proteins were resolved by SDS-PAGE using NuPAGE 3-8% Tris-Acetate
precast gels (Novex, Life Technologies, Invitrogen) run for 1h at 170V in 1x Nu-
PAG Tris-Acetate SDS Running Buffer (Invitrogen, LA0041). Protein transfer
was achieved using the iBlot2 Gel Horizontal Transfer Device (Invitrogen). Nitro-
cellulose membranes were blocked in 5% BSA in PBST (PBS; Tween 20 0.1%) for
a minimum of 1h at room temperature and probed with the appropriate primary
antibody diluted in blocking solution, overnight at 4°C. Secondary horseradish
peroxidase (HRP) antibodies were used for developing the signal diluted 1:10,000.
Antibodies used for western blot analyses are listed in Section 2.1.18. Blots were
developed using Pierce ECL Western Blotting Substrate (Thermofisher Scientific,
32209) and imaged with an ImageQuantLAS 4000 chemiluminescent camera (GE
Healthcare).
2.1.9 CRISPR strategy and cloning
CRISPR targetting was carried out using pSpCas9(BB)-2A-Puro (PX459) V2.0
plasmid, which encodes the Cas9 protein and the transactivating CRISPR RNA
(tracrRNA), and custom, sequence-specific CRISPR RNAs (crRNAs). The design
of the crRNAs was undertaken as in Ran et al. (2013b). Using 100 bp genomic
DNA sequence around the appropriate gene locus (Ensembl genome browser),
crRNAs were designed with the help of the two online tools sgRNA Designer
CRISPRko (Broad Institute, portals.broadinstitute.org/gpp/public/analysis-tools
/sgrna-design) and the Cas-Designer (RGEN Tools, rgenome.net/cas-designer/).
The suggested 20 nucleotide crRNA sequences required for Cas9 specific gene
targeting were preferentially selected by closest proximity to the start codon and
the highest score determined by the design programs. For each crRNA, the com-
plementary sequence was determined, and a BbsI restriction site added to both
oligos. Designed crRNAs were then ordered as custom single stranded DNA oli-
gos with an appended 5’ phosphate to facilitate ligation into the targeting vector
(Ran et al., 2013b). A table with crRNA sequences is given in Section 2.1.18. Top
and bottom strands of ordered crRNAs were resuspended in dH20 and annealed
at a concentration of 100µM at 95°C for 5min and subsequently allowed to slowly
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cool to room temperature. pSpCas9(BB)-2A-Puro (PX459) V2.0 was a gift from
Feng Zhang (Addgene plasmid #62988). Annealed crRNAs were cloned into the
PX459 vector using BbsI restriction cloning, directly before the tracrRNA to form
functional guide RNA (gRNA) sequences. 1µl of a 1:250 dilution of annealed cr-
RNAs was ligated using T4 DNA Ligase (NEB) into 36ng of the PX459 vector.
Ligation was performed at room temperature for 2hr. To assess cutting efficiency
of each gRNA/Cas9, each plasmid was transfected into HeLa cells (protocol as in
Section 2.1.4) and RNA extracted as in Section 2.1.5. PCR over the target region
was performed with custom primers (Section 2.1.18) and the resulting products
assessed by gel electrophoresis (Section 2.1.6). The PCR products were also sent
for Sanger sequencing (MRC PPU, Dundee) and the traces analysed using Track-
ing of Indels by DEcomposition (TIDE Brinkman et al., 2014) and Inference of
CRISPR Edits (ICE; Synthego) online tools to give exact cutting efficiencies for
each guide.
The repair template was designed using SnapGene (GSL Biotech) by combin-
ing the genomic sequence for eGFP and 3xFLAG (downloaded from SnapGene
repository) and integrating short linker sequences; a five amino acid linker be-
tween eGFP and 3xFLAG (sequence: tccggactcagatct) and a six amino acid
linker between 3xFLAG and the start of the NBAS coding sequence (sequence:
ggtaccagcggcggaagc). Homology arms of length 400 nucleotide were deemed nec-
essary as a consequence of the large size of the tag (Chan et al., 2007a). The full
repair template sequence was ordered from Integrated DNA Technologies Inc. on
a pUCIDT-AMP plasmid backbone. After bacterial amplification, the plasmid
was extracted using Plasmid Maxi Prep kit (Qiagen) following manufacturer’s
protocol.
2.1.10 CRISPR targeting and screening
The gRNA/Cas9 plasmid and repair template plasmid were transfected into HeLa
cells as described in Section 2.1.4, at a ratio of 2:1 (∼900ng : 500ng per well of
6-well plate). After 24h media was supplemented with 1g/ml puromycin to select
for cells expressing the gRNA/Cas9 plasmid. Once control cells were >90% dead,
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surviving cells’ fluorescence was measured by fluorescence-activated cell sorting
(FACS) and single cells deposited into wells of a 96-well plate. After approx. two
weeks of clonal expansion, wells containing growing colonies were treated with
30µl pre-warmed trypsin and subsequently quenched with 70µl of appropriate
cell culture media. Dispersed clones were then transferred into a new 96-well
plate containing 100µl fresh media. To remove residual trypsin, the media was
replaced after 24hr. After replica plating, cells were grown in 96-well plates for
1-2 days until growth media turned yellow within 24h. To extract genomic DNA,
cells were washed twice with PBS and subsequently lysed using the DirectPCR
Lysis Reagent (Cell) supplemented with 0.5 g/l Proteinase K (Roche). Following
the manufacturer’s instructions, lysates were incubated in a wet chamber placed
in a rocket shaker at 55°C overnight. After Proteinase K inactivation at 85°C for
45min, crude lysates were frozen until used for genotyping. Colony PCRs were
performed by adding primers and SYBR green Master Mix to each well. The fol-
lowing programme was carried out: initial denaturation at 98°C for 5min, followed
by 35 cycles of: denaturation at 98°C for 30sec, annealing at 55°C for 90sec and
extension at 72°C for 30sec. 1% TBE agarose gels supplemented with ethidium
bromide were used for visualisation of the PCR products and genotyping.
2.1.11 Flow cytometry and fluorescence-activated cell
sorting (FACS)
Cells were trypsinised, washed with cold PBS and placed on ice. FACS was
performed by the IGMM FACS core facility on an Aria II cell sorter (BD bio-
sciences). Cells were sorted based on GFP fluorescence, analysed by FACS BD
AccuriT (488nm excitation laser, FL-1: 533/30nm emission filter) running the
software BD AccuriTM C6. Gates were set using a non-fluorescent control. GFP
expression was analysed by gating the single cell population in a SSC-H/SSC-A
dot plot, followed by debris-exclusion gate in a SSC-A/FSC-A dot plot. 10,000
single cells were analysed for each sample. The mean GFP fluorescence was
calculated with FlowJoTM Software (version 10.6.0).
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2.1.12 Immunoprecipitation and co-immunoprecipitation
Cells were washed and harvested in ice-cold PBS before pellets were lysed with im-
munoprecipitation (IP) buffer [20mM Tris-HCl pH 8, 150mM NaCl, 1mM EDTA,
1% NP-40, 0.2% NaDeoxycholate, Complete Protease Inhibitor (Roche), Phos-
phoSTOP (Roche), 1mM DTT] for 20min on ice. Lysates were precleared with
Dynabeads Protein-G (Novex, Life Technologies) for 1h, rotating at 4°C. Appro-
priate antibody coupled magnetic beads were washed three times with IP buffer
before incubation with the precleared lysate overnight rotating at 4°C. Beads
were washed five times, each for 5min with IP buffer and then bound protein was
eluted by boiling in 4X SDS sample buffer supplemented with reducing agent for
5min. Antibodies used for immunoprecipitations are listed in Section 2.1.18.
2.1.13 Mass spectrometry
Cells were harvested and lysed as in Section 2.1.12. α-GFP antibody-coupled
magnetic beads (Sigma) were equilibrated with IP buffer. Lysates were resus-
pended in 500µl IP buffer for capture of GFP-NBAS bound proteins and subse-
quent mass spectrometry analysis. Immunoprecipitation and washing was per-
formed on a KingfisherDuo robot (Thermo) for 4h at 4°C. Beads were then trans-
ferred for two washes in IP buffer and three washes in TBS (300µl each). After
transfer into 100µl 2M urea, 100mM Tris, 1mM DTT containing 0.3g trypsin per
sample, beads were incubated at 27°C for 30min with mixing to achieve limited
proteolysis. The beads were then removed, and tryptic digest of the released
peptides was allowed to continue for 9h at 37°C. Following this, peptides were
alkylated by adding iodoacetamide to 50mM and incubating at room temperature
for 30min. Finally, peptides were acidified by addition of 8µl 10% TFA. An esti-
mated 10mg of the resulting peptide solution was loaded onto an activated (20µl
methanol), equilibrated (50µl 0.1% TFA) C18 StAGE tip, and washed with 50µl
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0.1% trifluoroacetic acid (TFA).The bound peptides were eluted into a 96-well
plate with 20µl 80% acetonitrile (ACN), 0.1% TFA and concentrated to less than
4µl in a vacuum concentrator. The final volume was adjusted to 15µl with 0.1%
TFA.
Mass spectrometry (MS) processing and analysis of raw data was carried out by
the IGMM Mass Spectrometry core facility. Liquid chromatography was per-
formed using a Dionex RSLC Nano (Thermo Fisher Scientific). 5g peptides were
injected onto a C18 packed emitter and eluted over a gradient of 2%-80% acetoni-
trile in 48min, with 0.5% acetic acid throughout. Eluting peptides were ionised at
+2.2kV before data-dependent analysis on a Thermo Q-ExactivePlus. First spec-
trometer measurement (MS1) was acquired with mz range 300–1650 and resolu-
tion 70,000, and top 12 ions were selected for fragmentation with normalised colli-
sion energy of 26, and an exclusion window of 30s. Second spectrometer measure-
ments (MS2) were collected with resolution 17,500. Raw MS data were analysed
using MaxQuant (v1.5.6.5) (Max Planck Institute of Biochemistry) in conjunction
with UniProt human reference proteome release 201611 (uniprot), with match
between runs (MS/MS not required), label-free quantification (LFQ) with 1 pep-
tide required, and statistical analyses performed using Wasim Aftab’s LIMMA
Pipeline Proteomics (github.com/wasimaftab/ LIMMA-pipeline-proteomics) im-
plementing a Bayes-moderated method. Interactome analysis including gene on-
tology was carried out by inputting protein hits into STRING (string-db.org
Szklarczyk et al., 2019).
2.1.14 Immunofluorescence
Cells were grown on coverslips, fixed with 4% paraformaldehyde, washed with
PBS and permeabilised with 0.5% Triton X-100. Coverslips were then incubated
for 1h with block buffer (1% BSA, 0.01% Triton X-100 in PBS). Primary antibod-
ies (Section 2.1.18) were diluted 1:500 in block buffer. Primary antibodies were
incubated with coverslips in a humidified chamber overnight at 4°C. Coverslips
were washed 3 times with wash buffer (0.01% Triton X-100 in PBS). Secondary
antibodies (Section 2.1.18) were diluted 1:1000 in block buffer and incubated with
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coverslips in a dark, humidified chamber for 1h at room temperature. Coverslips
were washed twice with wash buffer, incubated with DAPI diluted in wash buffer
(1:1000) and mounted in Vectrashield (Vector) sealed with clear nail varnish.
Where cells were treated with digitonin, media was aspirated, and cells incu-
bated for 10min in ice-cold PBS, on ice. Then cells were incubated in digitonin
buffer (110mM KoAc, 25mMK-HEPES, 2.5mM MgCl2, 1mM EGTA) with 0.01%
digitonin for 5min on ice, washed in room temperature PBS and fixed with 4%
paraformaldehyde as above. Images were acquired on a Nikon Confocal A1R
confocal microscope using a Plan Apochromat 100x1.4NA objective. A piezo-
electrically driven objective mount (PIFOC model P-721, Physik Instrumente)
was used to control movement in the z dimension. Step size for z-stacks was set
at 0.2µm. Hardware control and image capture were performed using NIS Ele-
ments AR software (Nikon Instruments Europe). Image analysis was performed
using FIJI/ImageJ software (USA National Institute of Health)(Section 2.2.12).
2.1.15 Proximity ligation assay
Cells were grown, fixed and permeabilised as in Section 2.1.14. Coverslips were
then incubated for 1h with PLA block buffer from Duolink In-Situ PLA Kit
(Olink Bioscience) at room temperature and incubated with primary antibodies
as for immunofluorescence. Coverslips were washed three times with wash buffer
A (Duolink In-Situ PLA Kit) and intermolecular interaction explored according
to the manufacturer’s instructions. The PLA reaction occurs between target
proteins that are located in close proximity (<40nm). PLA probes used were goat
PLUS (DUO92003, Sigma-Aldrich), rabbit MINUS (DUO92005, Sigma-Aldrich)
and mouse MINUS (DUO92004, Sigma-Aldrich). Cover slips were incubated
with DAPI diluted 1:1000 in 0.01X wash buffer B (Duolink In-Situ PLA Kit) and
mounted in Vectrashield (Vector). Images for PLA experiments were acquired as
for immunofluorescence experiments.
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2.1.16 Metabolic labelling and RNA fractionation
Sub-confluent HeLa cells in 10cm dishes were labelled with the uridine analogue
4-thiouridine (4sU) (SigmaAldrich; T4509), for 40min by mixing the 4sU into
normal media at a final concentration of 100µM. After 40min incubation at 37°C,
media was aspirated, and cells harvested by addition of 5ml TRIzol reagent (Ther-
moFisher Scientific; 15596018) and scraping. Samples were frozen at -20°C until
further processing. Total RNA was isolated by phenol-chloroform extraction (Sec-
tion 2.1.5) Nascent RNA pull-down was completed by adapting the method from
Russo et al. (2017). Biotinylation was achieved by assembling a 150ml reaction
containing 100µg of 4sU labelled total RNA, 15µl 10x biotinylation buffer (100mM
HEPES [pH 7.5], 10mM EDTA) and 10µl MTSEA-biotin-XX (Biotium; 90064)
1mg/mL dissolved in dimethylformamide, and incubating at room temperature
for 2hr. Excess biotin was removed by addition of an equal volume of chloro-
form and centrifugation in MaXtract High Density phase-lock gel tubes (Quiagen;
129065) at 13,000rpm for 5min at 4°C. RNA was precipitated using 0.1x volume
5M NaCl and 1x volume isopropanol and 1µg RNA kept as “total RNA”. MACS
streptavidin magnetic beads (Miltenyi; 130-074-101) were added 1:1 to RNA and
incubated at room temperature for 15min in the dark. Beads were isolated from
each sample by applying the sample to pre-equilibrated MACS magnetic columns
and washing with wash buffer [100mM Tris Ph7.5, 10mM EDTA, 1MNaCl, 0.1%
Tween 20]. Flow through of “pre-existing RNA” was collected and “nascent
RNA” was eluted from streptavidin beads by addition of 100mM dithiothreitol
(DTT, Thermo Scientific; 20291) and precipitation with 100% ethanol and 5M
NaCl at -80°C for 20min. Total RNA quantity and quality were assessed using
an RNA 6000 pico chip on an Agilent 2100 Bioanalyzer at the Wellcome Trust
Clinical Research Facility, Edinburgh. The Agilent Bioanalyzer reports RNA in-
tegrity numbers (RINs), which indicate how intact an RNA sample is (1 meaning
completely degraded and 10 meaning completely intact). Sample RINs ranged
from 8.6 to 10, indicating that the RNA quality was sufficient for sequencing.
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2.1.17 Library preparation and RNA-sequencing
RNA-sequencing was performed on both total and nascent RNA samples for
each condition. Libraries were prepared using NEBNext Ultra Directional RNA
Library Prep Kit for Illumina (New England Biolabs; E7420) and Agencourt
AMPure XP Beads (Beckman Coulter; A63881), following manufacturer’s proce-
dure. Total samples were fragmented for 15min and nascent samples for 5min,
both at 94°C. Samples were ligated to primers 1-40 from NEBNext Multiplex
Oligos for Illumina (Index Primers Set 1, 2 and 3; New England Biolabs; E7335,
E7500, E7710) and analysed using DNA High Sensitivity chip on an Agilent 2100
Bioanalyzer before being pooled. Library molarity for sequencing was calculated
using Qubit dsDNA high specificity quantification and fragment size information
from Bioanalyzer. 150 base pair, paired-end sequencing was performed using an
S2 chip on the NovaSeq platform (Illumina Inc.). Sequencing was performed by
Edinburgh Genomics, Edinburgh.
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2.1.18 Materials and reagents
Primary antibodies
Target Protein Species Company Product Number
GFP Mouse Roche 11814460001
FLAG Mouse Sigma-Aldrich #F3165
NBAS Rabbit Abcam #Ab122370
Calnexin Rabbit Enzo Life Sciences ADI-SPA-860-D
SEC61B Rabbit Proteintech 15087-1-AP
UPF1 Goat Bethyl Laboratories A300-038A
Tubulin Mouse Sigma-Aldrich #4026
T7 Mouse Novagen #69522
Fluorescent secondary antibodies
Target Species Fluorophore Company Product Number
Rabbit Alexa FlourR 488 Molecular Probes A11070
Mouse Alexa FlourR 594 Molecular Probes A21203
Mouse Alexa FlourR 488 Molecular Probes A11054
Rabbit Alexa FlourR 594 Molecular Probes A31632
HRP-linked secondary antibodies





PCR & sequencing primers
Primer Name Sequence Melting Temperature
KJJ 5 TGACTTGGCCGATCTCATGT 59.1°C
KJJ 6 AGCGACACTAACAATCCCCT 58.7°C
Guide RNAs







































2.2.1 Quality control of RNA-sequencing data
The .fastq.gz files containing raw read sequences from the total/nascent ex-
periment were downloaded from the Edinburgh Genomics delivery server and
md5sums were checked to identify any file corruptions or truncations. The
.fastq.gz files containing raw read sequences from the membrane/cytoplasm ex-
periment were retrieved from an external hard drive and md5sums were checked.
.fastq files were quality control checked for base and sequence quality scores,
and adapter contamination using fastQC (v0.11.7; Babraham Bioninformatics).
2.2.2 Mapping of RNA-sequencing data
Since no experimental purification of mRNA was used, many ribosomal RNA
(rRNA) reads were present in total RNA. Therefore, the rDNA reference U13369
sequence was downloaded from NCBI (www.ncbi.nlm.nih.gov/nuccore/555853/
?report=fasta) and Basic Local Alignment Search Tool (BLAST) used to identify
coordinates of high identity and long overlaps in the reference genome GRCh38/hg38.
These regions were then masked by changing the sequence to runs of Ns, and
a single copy of the U13369 sequence was added as an extra chromosome to
the genome. Reads were aligned and psedudoaligned separately. Alignment
was done using Spliced Transcripts Alignment to a Reference (STAR, v2.5.1b)
(Dobin et al., 2013) to the masked reference genome in paired-end mode and
default settings. Samtools flagstat (Li et al., 2009) was used to get informa-
tion about numbers of reads and bam files were sorted by name using samtools
sort (Li et al., 2009). Pseudoalignment was done using kallisto (v0.43.1) (Bray
et al., 2016). Kallisto index was created by combining “all basic gene annotation”
and “long non-coding RNA gene annotation” fasta files, downloaded from Gen-
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code (www.gencodegenes.org/ releases/current.html), release 27 (GRCh38.p10).
Kallisto was run with 100 bootstraps. Reads from the same sample but se-
quenced on separate lanes were initially processed individually to ensure that
they correlate well with each other, and then were merged for further analysis.
2.2.3 Differential expression analysis of total
RNA-sequencing
Reads per feature in STAR output files were counted using HTSeq (v0.9.1) (An-
ders et al., 2015). These output files and kallisto output abundance files were then
analysed for fold changes using DESeq2 (v1.14.1) differential expression analy-
sis, using wald test and standard parameters. Target lists were defined as all
genes significantly increased in expression in treated cells compared to control
cells (Benjamini-Hochberg false discovery rate multiple testing corrected p value
< 0.05).
2.2.4 Analysis of fractionated RNA-sequencing
Reads per feature in STAR output files was counted using HTSeq (v0.9.1) as
above. The resulting raw counts were transformed using the DESeq2 vst func-
tion to perform variance stabilizing transformations. These transformed counts
were then averaged across replicates and gene expression in the two fractions
from control cells was compared. Membrane-associated genes were defined as
those >2-fold higher expression in membrane fraction than cytoplasmic fraction
in these control cells, all other genes were termed non-membrane. Enrichment
for membrane genes was validated by overlap of these newly defined “membrane-
associated genes” with three experimental ER datasets (Section 2.2.14).
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Standard DESeq2 differential expression analysis using wald test and standard
parameters was then carried out on “membrane-associated genes” in the mem-
brane fraction and on “non-membrane genes” in the cytoplasmic fraction. Genes
were determined as regulated by UPF1, NBAS or UPF2 if they were signifi-
cantly (Benjamini-Hochberg false discovery rate multiple testing corrected p value
< 0.05) increased in expression when the relevant factor was depleted.
2.2.5 Characterisation of gene subsets
Gene Ontology (GO) analysis was carried out using Gene Ontology enRIch-
ment anaLysis and visuaLizAtion (GOrilla) (cbl-gorilla.cs.technion.ac.il/) (Eden
et al., 2009) and Database for Annotation, Visualization and Integrated Discovery
(DAVID) (david.ncifcrf.gov/home.jsp) (Dennis et al., 2003). To investigate genes
of specific GO terms, genes were annotated using the biomaRt Bioconductor R
package (Durinck et al., 2005) and filtered for the relevant categories. Overlap
with experimental ER-localisation was carried out by extracting relevant gene
lists from supplementary data of the following articles; APEX-seq (Fazal et al.,
2019), ER Fractionation (Reid and Nicchitta, 2012) and ER Ribosome Profiling
(Jan et al., 2014) (Section 2.2.14). For APEX-seq and ER Fractionation-Seq the
published ER gene lists were used. Gene names from ER Ribosome Profiling were
converted using DAVID and a threshold of 1.5-fold enrichment at ER applied.
2.2.6 Defining exonic and intronic reads
Genomic and exonic intervals from gencode.v27.annotation.gtf (EBI Gencode;
gencode-genes.org/human/) were used to define intronic and exonic regions of
each gene and Bedtools intersect function to determine categorisation of each
read (Figure 2.1). For this analysis, transcripts were merged, and all possible
exons were classified as exonic regions, producing obligate exons and facultative
introns. Reads that overlapped any intronic region by one base or more were
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Figure 2.1: Schematic of custom analysis pipeline to calculate change
in stability of genes in depleted cells compared to control
(A) “Exonic” regions (blue) were defined as any part of the gene body that is
defined as an exon in one or more transcripts and “intronic” regions (purple) as
those parts of the gene which are never defined as an exon, resulting in faculta-
tive exons and obligate introns. (B) “Exonic” reads were defined as those that
exclusively overlapped with “exonic” regions and “intronic” reads as those which
even partially overlapped with defined “intronic” regions.
classed as intronic reads since it was presumed they must originate from unspliced
pre-mRNA. Only reads that were fully within exonic regions were termed exonic
reads. The number of exonic and intronic reads were summed for each gene for
downstream analysis.
2.2.7 Differential stability analysis using total and
nascent RNA-sequencing data
To normalise for transcription rate, nascent RNA sequencing data as well as total
was analysed to extract exonic and intronic read counts per gene. An odds ratio
(OR) of each gene was calculated according to the follow equation:
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OR = (total exonic (mature mRNA)/total intronic (pre−mRNA))
/(nascent exonic (mature mRNA)/nascent intronic (pre−mRNA))
This produced a single value per gene in each condition which is a proxy for
the stability of the mRNA. Therefore, the stability (OR) of each gene could be
compared between conditions. To test significance of these changes, a paired t-
test was carried out for each gene between the two groups of ORs (five replicates
for each condition). This gave the magnitude and significance of the change in
OR, which is a proxy for change in stability. Replicates were then combined to
calculate a mean change in OR for each gene.
To analyse this data using DESeq2, a two-factor design was used to account for
total or nascent fraction and si-Scr or si-UPF1 treatment. A reduced likelihood
ratio test (LRT) was used to determine if the increased likelihood of the data us-
ing the extra terms in the full model was more than expected if those extra terms
were truly zero. The following commands were run, where “assay” represents the
siRNA treatment and “condition” represents the total or nascent fraction.
$ dds <- DESeqDataSetFromHTSeqCount(sampleTable = sampleTable, design=
∼ assay + condition + assay:condition)
$ dds <- DESeq(dds, test="LRT", reduced= ∼ assay + condition)
$ results <- results(dds)
Genes were determined to be differentially stabilised upon depletion of UPF1 or
NBAS if they were significantly changed after Benjamini-Hochberg false discovery
rate multiple testing correction (p < 0.05).
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2.2.8 Differential stability analysis using only total
RNA-sequencing data
To calculate change in stability using only total RNA, the ratio between exonic
reads (mature RNA) and intronic (pre-mRNA) reads for each gene was analysed.
To measure the effect of UPF1 or NBAS depletion on stability, an odds ratio
(OR) of each gene was calculated using the following equation:
OR = (treated exonic (mature mRNA)/treated intronic (pre−mRNA))
/(control exonic (mature mRNA)/control intronic (pre−mRNA))
Unlike the previous OR analysis, this OR produced a proxy for change in stability
so that si-UPF1, si-NBAS and si-Scr were all considered “treated” and mock cells
used as the “control” for all three. The stability (OR) values of si-UPF1 and si-
NBAS were then compared to those of si-Scr to identify changes beyond technical
noise.
These values were also analysed using DESeq2 using a two-factor design and a
reduced likelihood ratio test (LRT) to determine if the increased likelihood of the
data using the extra terms in the full model was more than expected if those
extra terms were truly zero. The following commands were run, where “assay”
represents the siRNA treatment and “condition” represents exonic or intronic
read count.
$ dds <- DESeqDataSetFromHTSeqCount(sampleTable = sampleTable, design=
∼ assay + condition + assay:condition)
$ dds <- DESeq(dds, test="LRT", reduced= ∼ assay + condition)
$ results <- results(dds)
Genes were determined to be differentially stabilised upon depletion of UPF1 or
NBAS if they were significantly changed after Benjamini-Hochberg false discovery
rate multiple testing correction (p < 0.05).
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2.2.9 Measuring expression of HeLa genome variants
HeLa genome datasets were downloaded from the US National Institutes of Health
(NIH) server. Data from Adey et al. (2013) included a haplotype resolved variant
call format (VCF) file, containing reference and alternate alleles. The variants
were originally called by comparing the HeLa genome to GRCh37/hg19, there-
fore variant positions were first lifted over to GRCh38/hg38 since this was the
genome used in the rest of the analysis. This was completed using LiftOver pro-
gram (UCSC) and a pre-generated GRCh37/hg19 to GRCh38/hg38 over.chain file
downloaded from hgdownload.soe.ucsc.edu/goldenPath/hg19/liftOver/.
Since this analysis was specifically focused on single nucleotide variants (SNVs),
.fastq.gz files from total and nascent RNA-sequencing were re-mapped using
STAR and a re-implementation of the allele-specific analysis method WASP (Van
De Geijn et al., 2015) as an additional filter. WASP substitutes the SNV base
with the alternative genotype in allelic reads and re-aligns those reads to cor-
rect for the reference bias. By excluding the allelic reads that are affected by
different genotypes, WASP obtains extremely low false positive rate when iden-
tifying allele-specific expression SNVs. Only reads that passed WASP filtering
were taken forward.
To find variants expressed in the total/nascent RNA-sequencing dataset, sam-
tools mpileup was run on the STAR output .BAM files for each sample, using the
STAR indexed genome file used for alignment and a position file containing the
chromosome and genomic position of each variant from the GRCh38/hg38 VCF
file. The mpileup output files were then passed through a custom script writ-
ten by Craig Anderson which counted the number of reads showing each of the
four bases across each variant and, using these values, annotated each variant
as being expressed as monoallelic (if only one base represented), biallelic (if two
bases represented) or multiallelic (if three or more bases represented). Variants
were also filtered for Phred quality score of 20 or above (equating to a 99% base
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call accuracy) and indels removed. Instances of a variant falling in an intronic
region, with a split read covering the region but not the intronic sequence, and
also where the variant falls within the insert region between the two paired end
reads were removed and subtracted from the coverage estimates.
Every variant was assigned a unique variant id comprised of the chromosome
number and the position on that chromosome, which was used henceforth. All
nascent samples were compared and only variants expressed >10 reads in every
replicate of both si-Scr nascent and si-UPF1 nascent were kept. Variants were
further filtered to only keep those that were annotated as biallelic in at least one
replicate of both si-Scr nascent and si-UPF1 nascent.
Heterozygous variants were identified from the GRCh38/hg38 VCF by filtering
for those variants where both the reference allele (REF) and the alternate allele
(ALT) were present in the whole genome dataset, as opposed to homozygous for
the alternative allele. Only variants that were annotated as biallelic in my RNA-
sequencing data and heterozygous in the GRCh38/hg38 VCF were taken forward.
Finally, the variants were filtered to keep only those that had one read mapped
in at least one replicate of both si-Scr total and si-UPF1 total.
2.2.10 Identification of NMD-targeted variants
genome-wide
Differentially processed variants were initially identified using DESeq2 analysis of
reference and alternate allele reads in both total and nascent from each replicate
of si-UPF1 and si-Scr treated cells. DESeq2 was run with a three-factor design to
account for all variables, and a reduced likelihood ratio test (LRT) to determine
if the increased likelihood of the data using the extra terms in the full model
was more than expected if those extra terms were truly zero. The following com-
mands were run, where “condition” represents the siRNA treatment, “fraction”
indicates total or nascent RNA and “allele” codes for REF or ALT nucleotide.
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$ dds <- DESeqDataSetFromHTSeqCount(sampleTable = sampleTable, design=
condition + fraction + allele + condition:fraction + condition:allele)
$ dds <- DESeq(dds, test="LRT", reduced= condition + fraction + allele)
$ results <- results(dds)
Variants were determined to be differentially processed upon depletion of UPF1
if they were significantly changed after Benjamini-Hochberg false discovery rate
multiple testing correction (p < 0.05).
Manual calculation of differential allele-specific processing was carried out by first
dividing raw counts over each variant by library size to produce a transcripts per
million (TPM) value. Using these values, an odds ratio (OR) was calculated
for both si-Scr samples and si-UPF1 samples independently using the following
equation:
OR = ((median ALT total TPM/median ALT nascent TPM)
/(median REF total TPM/median REF nascent TPM))
Variants behaving in line with an NMD-targeted variant were determined by a
si-UPF1 OR at least 3-fold higher than si-Scr OR and a si-UPF1 OR between –1
and 1.
To analyse this data using DESeq2, a two-factor design was used to account for
REF or ALT allele and total or nascent fraction. A reduced likelihood ratio test
(LRT) was used to determine if the increased likelihood of the data using the
extra terms in the full model was more than expected if those extra terms were
truly zero. The following commands were run, where ”allele” represents the REF
or ALT allele and ”fraction” represents the total or nascent fraction.
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$ dds <- DESeqDataSetFromHTSeqCount(sampleTable = sampleTable, design=
∼ allele + fraction + allele:fraction)
$ dds <- DESeq(dds, test="LRT", reduced= ∼ allele + fraction)
$ results <- results(dds)
This was carried out for both si-Scr samples and si-UPF1 samples independently
and Benjamini-Hochberg false discovery rate multiple testing correction applied
(p < 0.05). Variants were determined to be differentially processed upon deple-
tion of UPF1 if they were significantly changed upon si-Scr depletion but not
significantly changed upon si-UPF1 depletion.
2.2.11 Characterisation of differentially processed
variants
The ensembl ID for the gene(s) and specific transcript(s) each variant is located
within, as well as the strand (+ or -) and co-ordinates of the transcript(s) were
added to each variant using BEDTools intersect (Quinlan & Hall, 2010) and
genomic intervals of transcripts from the genome gene transfer format (GTF) file
used to create the STAR index. Official gene symbols were added to each variant
using bioMart rest API (Ensembl). The predicted effect of all analysed variant
was found by creating a new VCF file from the DESeq2 results and analysing
with the Ensembl Variant Effect Predictor (VEP) (McLaren et al., 2016) using
the inbuilt GRCh38/hg38 database.
2.2.12 Image analysis
Image analysis was carried out using the FIJI/ImageJ software (National Insti-
tutes of Health, Bethesda, MD, USA). All Z-stacks were flattened using maximum
intensity projection. PLA signal was measured by thresholding using MaxEn-
tropy settings and analysing particles to get a count per image. This PLA signal
count was normalised by dividing by number of nuclei in each image. Significance
of change in PLA signal was determined by two-tailed Mann-Whitney test.
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2.2.13 Statistical analysis
For information about the number of replicates, the meaning of error bars (e.g.,
standard error of the mean) and other relevant statistical analysis see the cor-
responding figure legend. For information about how data was analysed and/or
quantified, see the relevant section in methods and/or the figure legend. RStu-
dio was used for all statistical analysis. Specific packages and algorithms used
are listed in Section 2.2.15. Unless otherwise stated, a multiple testing corrected
value of p < 0.05 was considered significant. Unless otherwise stated, multiple
testing correction was performed using Bonferroni correction.
2.2.14 Deposited data used
Total, membrane-associated and cytoplasmic RNA-sequencing data described in
this thesis have been deposited in the NCBI Gene Expression Omnibus (GEO)
database under accession number GSE152437. Comparison of si-UPF1 differ-
ential expression targets with literature was carried out by downloading rele-
vant supplementary data from (Tani et al., 2012; Lykke-Andersen et al., 2014;
Schmidt et al., 2015). Overlap with experimental ER-localisation was carried out
by downloading relevant supplementary data; APEX-seq (Fazal et al., 2019, GEO:
GSE116008), ER fractionation sequencing (Reid and Nicchitta, 2012, PMID:
22199352) and ER proximity-specific ribosome profiling (Jan et al., 2014, PMID:
25378630). HeLa genome data from Adey et al. (2013) is maintained on the
American National Institute of Health (NIH, USA) server. Access was granted
by the director of the NIH in December 2018 and relevant files were downloaded
directly from the server.
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2.2.15 Software and packages used
Resource Source Identifier
FASTQC v0.11.7 Babraham Bioinformatics Team (2018) RRID:SCR 014583
STAR v2.5.1b Dobin et al. (2013) RRID:SCR 015899
HTSeq v0.9.1 Anders et al. (2015) RRID:SCR 005514
SAMtools v1.6 Li et al. (2009) PMID: 19505943
BEDTools v2.27.1 Quinlan and Hall (2010) RRID: SCR 006646
kallisto v0.43.1 Bray et al. (2016) RRID:SCR 016582
R v3.4.1 R Core Team (2018) https://www.r-project.org/
Tidyverse v1.3.0 Wickham et al. (2019) https://www.tidyverse.org/
Bioconductor v3.6 Gentleman et al. (2004) RRID: SCR 006442
DESeq2 v1.14.1 Love et al. (2014) RRID:SCR 015687
Integrated Genomics
Viewer
Robinson et al. (2011) RRID:SCR 011793










Eden et al. (2009) RRID:SCR 006848
STRING Szklarczyk et al. (2019) RRID:SCR 005223









NBAS has been shown to be localised to the endoplasmic reticulum (ER) as part
of the multi-protein Syntaxin-18 complex (Aoki et al., 2009), however, its mech-
anistic role in mRNA surveillance remains to be discovered. NBAS forms part
of the NBAS-RINT1-ZW10 (NRZ) tethering complex which associates with the
soluble NSF attachment protein receptors (SNAREs) Syntaxin-18, USE1, BNIP1
and SEC22B, and is believed to play a role in assembly of the multi-SNARE com-
plex (Hatsuzawa et al., 2000; Burri et al., 2003; Hirose et al., 2004; Tagaya et al.,
2014). In addition, both the α-solenoid at NBAS’ C-terminal and its N-terminal
β-propeller structure are generally involved in protein-protein interactions (Chen
et al., 2011, Section 1.3.1). This suggests that NBAS is proficient at protein
complex assembly, which is a fundamental process in the NMD pathway. There-
fore, I wanted to know what other proteins NBAS interacts with, especially those
involved in the NMD pathway.
Previous work has used transfected, tagged NBAS to study localisation and func-
tion (Longman et al., 2020, Section 1.3.4). Interaction studies show that overex-
pressed NBAS interacts with UPF1, preferentially in its unphosphorylated state
(Longman et al., 2020) suggesting NBAS is involved early in the NMD pathway.
In order to further investigate the function of NBAS in a more physiological con-
text, I wanted to identify protein binding partners of endogenous NBAS using
immunoprecipitation (IP) followed by mass spectrometry (IP-MS).
3.1.1 Endogenous tagging of protein allows optimised
isolation and imaging
Whilst transfecting tagged protein allows simple and fast expression in a vari-
ety of cell types, interactions determined using endogenously tagged proteins are
more likely to recapitulate physiological interactions than overexpressed protein,
especially because excess protein could form complexes in a non-physiological
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manner, since overexpression or additional expression of endogenous and trans-
fected protein leads to altered stoichiometry, whilst tagging the endogenous pro-
tein leaves this unaltered. Antibodies against human NBAS are commercially
available, however these are only recommended for western blot probing, whilst
reagents for numerous biochemical experiments have been optimised for various
protein tags, such as green fluorescent protein (GFP). Highly specific purification
tools have been developed for GFP which guarantee an efficient enrichment of
the bait. Endogenous tagging of the protein is also superior to transfection as
it removes the complication of both tagged and WT protein being present and
therefore allows the isolation of all NBAS proteins. Furthermore, since the tagged
cells will be clonal, they provide a homogenous population with the same number
of copies of NBAS gene as the WT cells.
Tagging of proteins with GFP has been used for decades to examining the sub-
cellular localization of these proteins in living cells (Wang and Hazelrigg, 1994).
Several hundred human cDNAs have since been cloned as N- or C-terminal gene
fusions and this methodology is still used widely to enable visualisation and use
of optimised reagents (Deal et al., 2020). Furthermore, the only available α-
NBAS antibodies are all raised in rabbit whereas GFP antibodies are available
from multiple species allowing greater compatibility with other antibodies for
immunofluorescence. eGFP has a greater folding efficiency at 37°C (Cormack
et al., 1996) making it more practical for use in mammalian cells. Other tags
commonly used, such as FLAG and HA, are much smaller than eGFP and there-
fore are small additions to a eGFP-tag and unlikely to interfere with folding or
function. Furthermore, a second tag allows an alternate method for isolating
and probing the tagged protein, and permits tandem affinity purification. The
3xFLAG system is an improvement upon the original system by fusing three
adapted tandem FLAG epitopes with improved affinity and expression. Detec-
tion of fusion proteins containing 3xFLAG is enhanced up to 200 times more than
any other system (Hernan et al., 2000). Therefore, I decided to generate a cell
line with endogenously eGFP-3xFLAG tagged NBAS.
100
HeLa cells are known to be genetically unstable and non-physiological in many
ways (Mittelman and Wilson, 2013; Frattini et al., 2015). However, there are
numerous advantages to using them. They are relatively amenable to transfection
(Kumar et al., 2019) and to genome editing using CRISPR techniques (Koch
et al., 2018). They also have a strong NMD response, unlike some other cell
lines (Baird and Hogg, 2018). Finally, all previous work with NBAS and NMD
in human cells, has used HeLa cells (Longman et al., 2013, 2020), so protocols
have already been optimised for the cells and it is preferable for this work to be
as comparable as possible.
Tags can be added to either the N- or C-terminal of the protein of interest.
Often the C-terminal is targeted because this is the last part of the protein to
be synthesised, so it limits the chance of the tag interfering with translation
and protein localisation. However, the specific domains and functions of the
target protein must also be considered. NBAS has been shown to bind p31 and
Syntaxin-18 somewhere in the amino half of the protein, whereas the C-terminal
half of NBAS was associated with ZW10 and RINT1 (Aoki et al., 2009, Section
1.3.1). It is not known what part of NBAS interacts with UPF1. However, the
plasmid-based GFP-NBAS and FLAG-NBAS constructs previously used, both
have the tag at the N-terminal. These constructs have been validated and shown
to interact with UPF1. Therefore, I decided to add the tag to the N-terminal of
endogenous NBAS.
3.1.2 CRISPR/Cas9 gene editing
CRISPR-associated RNA-guided endonuclease allows straightforward genome edit-
ing of virtually any genomic locus. The endonuclease proteins can be loaded with
a short sequence of RNA, called a guide RNA (gRNA), which directs it to the
complementary genomic destination to cleave a specific DNA target (Figure 3.1).
There are multiple examples of similar creation of human cells stably expressing
a C- or N-terminal GFP tag on the gene of interest using CRISPR technology,
followed by α-GFP IP and mass spectrometry analysis of endogenous protein-
protein interactions (Shen et al., 2009; Tachie-Menson et al., 2020).
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Figure 3.1: CRISPR/Cas9 type-II system from Streptococcus pyogenes
(A) The CRISPR/Cas system is a form of innate immune system in S. pyogenes.
In type-II CRISPR systems, the RNA guide exists within a duplex formed of
tracrRNA:crRNA that forms base pairs with a target DNA sequence. Once in
contact with the target, the nuclease induces a double-stranded break (DSB) in the
bound DNA. Importantly, for cleavage to occur the complex must recognise a short
consensus region termed a Protospacer adjacent motif (PAM) site downstream of
the base-paired DNA sequence to facilitate recognition of a correct target. (B)
In the repurposed CRISPR/Cas9 toolkit, the modified crRNA and tracRNA are
fused into a single chimeric RNA that has a designed sequence specific gRNA
to direct nuclease activity. The RNA hybrid and Cas9 gene are transfected into
target cells.
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Although there are various natural and engineered CRISPR/Cas systems, the first
to be harnessed for gene editing applications and the most popular CRISPR/Cas
methodology utilises a type-II system from Streptococcus pyogenes that utilises a
Cas9 nuclease (Lewis and Ke, 2017). CRISPR is an acronym for “Clustered Reg-
ularly Interspaced Short Palindromic Repeats.” This refers to the DNA repeats in
the bacterial genome between which short fragments of viral genome are encoded
as DNA, termed a protospacer, as a type of immune memory. Together the viral
sequence and the protospacer make up the CRISPR RNA (crRNA) which forms
a duplex with a trans-activating crRNA (tracrRNA). The entire RNA complex
is called the guide RNA (gRNA). Once the Cas9 protein has been recruited, the
gRNA forms base pairs with the target DNA sequence and the Cas9 nuclease
induces a double-stranded break (DSB) in the bound DNA (Doudna and Char-
pentier, 2014). Importantly, for cleavage to occur the complex must recognise a
short consensus region, termed the protospacer adjacent motif (PAM) site, down-
stream of the base-paired DNA sequence to facilitate recognition of the correct
target.
In the repurposed CRISPR/Cas9 system, the bacterial tracrRNA and a custom,
sequence-specific crRNA are fused into a single gRNA that can direct nuclease ac-
tivity which is highly advantageous from both a technical and design standpoint
(Cong et al., 2013; Ran et al., 2013a,b; Hsu et al., 2013, 2014). The sequence-
specific crRNA must be 18-22nt in length and have perfect sequence complemen-
tarity with the genomic target site. The suitability of a genomic locus is depen-
dent on the proximity of a PAM site to facilitate cleavage by Cas9. The canonical
Cas9 PAM is the sequence 5’-NGG-3’ (Anders et al., 2014). CRISPR/Cas9 cuts
4nt upstream from the PAM site.
After a DSB is made, the cell proceeds with DNA repair by one of two mecha-
nisms: non-homologous end joining (NHEJ) or homologous directed repair (HDR).
NHEJ ligates the free ends of DNA directly, often after paring back free ends,
leading to repair in an error prone manner and frequent occurrence of insertions
or deletions (indels) (Bothmer et al., 2013, 2017). In contrast, HDR requires a
homologous template to guide repair of the break, often the sister chromosome
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during S/G2 phase of the cell cycle. This pathway proceeds with high fidelity
although it can still lead to errors such as the use of sequence-similar regions
distinct from the cut site being used as a template. Nevertheless, HDR can be
harnessed for insertion of genetic sequence into a specific target site by providing
the cell with a repair template that has sequence complementarity to the targeted
genomic locus and includes the desired extra genetic information.
3.1.3 Aims
In this chapter I aim to facilitate an understanding of NBAS function in NMD
by creating a cell line with an NBAS protein that can be directly visualised and
effectively isolated.
To do this, I will design CRISPR/Cas9 gene editing tools to target the N-terminal
of endogenous NBAS and integrate eGFP and 3xFLAG tags. I will use these
tools to target HeLa cells to generate a cell line endogenously expressing eGFP-
3xFLAG-NBAS. To identify the putative protein binding partners of NBAS, I will
characterise the NBAS interactome by performing immunoprecipitation coupled
with mass spectrometry analysis (IP-MS) and generating interaction profiles. I
will also treat cells with RNase prior to IP-MS to determine if protein interactions
are RNA dependent and identify direct protein binding partners. I will validate
novel interacting partners identified by IP-MS using the imaging technique prox-
imity specific ligation (PLA).
In summary, the main aims of this chapter are:
a) To design and optimise a CRISPR/Cas9-based strategy to create an en-
dogenously tagged NBAS cell line




3.2.1 CRISPR design and strategy
Transiently transfected GFP-NBAS and 3xFLAG-NBAS have both been used
previously (Longman et al., 2013, 2020), with both constructs tagging NBAS at
the N-terminus. These transfected constructs are not cytotoxic or lethal and do
not disrupt NBAS binding with UPF1 or it’s localisation to the ER. Although
C-terminal tags have traditionally been more popular since they are less likely to
interfere with transcription or translation, N-terminal GFP tags have been used
successfully to tag many endogenous proteins (Hoffman et al., 2019; Ohashi et al.,
2020). Consequently, I designed the CRISPR strategy to target the endogenous
tag to the N-terminus of the NBAS protein in this cell line (Figure 3.2A).
To add the eGFP-3xFLAG tag to the NBAS locus, the CRISPR/Cas system with
the Cas9 nuclease enzyme was used. The eGFP tag allows for direct visualisation
of the protein and in conjunction with well validated α-GFP antibodies (Peters
et al., 2020) can be used for protein purification based assays. A 3xFLAG tag
was also incorporated since it is a small tag compared to eGFP and would allow
an alternate method for isolating tagged NBAS.
Four sequence-specific crRNAs were designed to target the NBAS N-terminus
(Figure 3.2B). The crRNAs were designed with the help of two online tools;
sgRNA Designer CRISPRko (Doench et al., 2016) and the Cas-Designer (Bae
et al., 2014), using 100 base-pair genomic DNA sequence around the NBAS start
codon retrieved from the Ensembl genome browser (Yates et al., 2020). Both
tools give suggested crRNA sequences based on PAM sequences in the provided
sequence and rank them based on a variety of parameters including off-target
matches, on-target efficacy score and number of mismatches and GC content.
Results were compared between tools and crRNAs ranked by scores from each
output. crRNAs were selected taking into account these scores as well as the
proximity of the cut site to the start codon, since that was where the insert was
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Figure 3.2: CRISPR/Cas9 strategy to target the NBAS genomic locus
(A) gRNAs were designed to target the N-terminal of the NBAS locus with a cut
site close to the start codon. (B) The four gRNAs chosen from the CRISPR tools
all cut near the NBAS start codon. (C) Summary schematic of targeting design
used to generate clones.
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targeted and the cut site should not be more than 10nt from the site of repair for
best HR efficiency. It was also considered whether the PAM could be mutated so
the CRISPR/Cas9 construct would not re-cut, without altering the amino acid
sequence. Four crRNAs were selected, and BbsI-compatible overhangs added to
both ends to aid integration into the Cas9 vector (crRNA sequences are listed in
Section 2.1.18).
The design of the repair template is essential to successful HDR. Short amino
acid linkers were included between the eGFP and 3xFLAG tags and between
3xFLAG and NBAS exon one (Figure 3.2C; Appendix A), to prevent misfold-
ing by ensuring physical space between the peptides of each protein. These two
linkers had been previously used and validated (Nele Hug & Michaela Raab, per-
sonal communication). Homology arms flanking the double-tag-linker sequence
aid homology directed repair (HDR) of the new DNA into the genomic locus.
Homology arms of length 400 nucleotide were deemed necessary as a consequence
of the large size of the tag (Chan et al., 2007a). Due to the size of the repair
template, it was synthesised as a complete sequence within a standard plasmid
(IDT).
3.2.2 Using CRISPR to create a stable tagged-NBAS
cell line
The four crRNAs were cloned into a pSpCas9(BB)-2A-Puro (PX459) V2.0 plas-
mid (Ran et al., 2013b) containing the scaffold section of the gRNA and Cas9
nuclease open reading frame, as well as a puromycin resistance gene (Figure
3.3A). Plasmids containing each of the four gRNAs were separately transfected
into HeLa cells to allow comparison of the cutting efficiency of each guide. Ge-
nomic DNA (gDNA) was extracted from the transfected cells and PCR amplified
using custom primers KJJ 5 and KJJ 6 (primer sequences detailed in Section
2.1.18) targeting the NBAS N-terminal region. The PCR products were run on
an agarose gel to visualise the size of the products produced (Figure 3.3B, C).
The amplified region was 655nt (lane 2 - uncut control). Any cutting by the Cas9
guided by the specific gRNA would lead to smaller bands or smears of various
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sizes of gDNA. These are caused by cutting of the gDNA followed by deletions of
differing lengths followed by re-annealing of the gDNA ends, in a heterogeneous
manner. Cells treated with gRNA #1, #4 and #6 showed smears of smaller PCR
products as well as a band at the uncut size. Whereas, gRNA #2 clearly had the
strongest effect as no gDNA appeared to remain full length.
To confirm these results, and quantify the cutting efficiencies, the PCR products
were subjected to Sanger sequencing. The resulting sequence reads contain mixed
signals due to the mixed population of cells used in the PCR reaction. Due to the
different sized deletions produced at the cut site, there is a loss of phase synchrony
of the fluorescent signals during the Sanger sequencing resulting in a mixed signal.
Using the online tools Inference of CRISPR Edits (ICE; Synthego) and Tracking of
Indels by DEcomposition (TIDE Brinkman et al., 2014), it is possible to compare
the heterogeneous cut sequence with the uncut control, to analyse the cutting
efficiency and effects of each gRNA. The two tools use different algorithms to
achieve the same outcome. Each algorithm reconstructs the spectrum of indels
from the mixed sequence traces. The identity of the detected indels and their
frequencies are reported as well as a cutting efficiency (Figure 3.3D). The identity
and frequency of indels would be more important if a loss of function mutation
was the desired outcome. In this case cutting efficiency was the most important
parameter. In general, both tools were proficient at identifying the cut site of each
gRNA. ICE gave similar cutting efficiencies for gRNAs #1, #4 and #6 (34%-38%)
but a higher efficiency of 47% for gRNA #2. TIDE gave the highest efficiency score
(65.8%) to gRNA #4 and failed to report a score for gRNA #2. However, TIDE is
not as efficient as ICE when dealing with complex indels (Martin Reijns, personal
communication), which the highly smeared DNA gel (Figure 3.3C) suggests may
be the case for gRNA #2. I therefore decided to carry out all further targeting
with gRNA #2.
With the exact cut site and PAM sequence determined, the repair template se-
quence could be finalised and ordered. The PAM site of gRNA #2 overlaps with
the original start codon so the inserted tag would mean the target sequence was
disrupted and would no longer be recognised by the gRNA. A new ATG start
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Figure 3.3: Assessment of Efficiency of CRISPR gRNA
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Figure 3.3: Assessment of efficiency of CRISPR gRNAs
(A) gRNAs were cloned into a PX459 plasmid containing the scaffold section of
the gRNA and Cas9 nuclease open reading frame. The plasmid also contains a
puromycin resistance cassette. (B) After transfection of the gRNA/Cas9 plasmid,
cells were selected by treatment with puromycin. Once >90% control cells were
dead, gDNA was extracted and the NBAS N-terminal locus amplified by PCR.
PCR products were analysed by gel electrophoresis or Sanger sequencing. (C)
Agarose gel showing PCR products from uncut control and cells trated with each
of the four gRNAs. (D) Example output from Synthego ICE online tool. The
right plot shows the discordance value of Sanger trace from uncut control and cells
treated with gRNA #2. The dotted line indicates the estimated cut point. The left
plot shows estimated frequency of indels of various sizes. The ICE score is an
indicator of how efficient the gRNA is.
codon was added before the eGFP and 3xFLAG sequences (Figure 3.4A). Specific
homology arms were added that matched the sequence 400nt either side of the
cut site. The full template was custom synthesised (Integrated DNA Technologies
Inc.) and provided within a pUCIDT-AMP plasmid backbone (Appendix A).
The gRNA/Cas9 plasmid and the repair template plasmid were co-transfected
at a ratio of 2:1 into HeLa cells followed by selection for successful transfection
using puromycin treatment (Figure 3.4B). Once >90% of control mock treated
cells were deemed dead by visual inspection, transfected cells were allowed to
recover in standard media for 24h. Cells were then sorted using fluorescence-
activated cell sorting (FACS) gated on GFP expression level (Figure 3.5A) to
deposit single GFP-positive cells into 96 well plates. Cells transfected with only
the repair template plasmid were used to set the GFP expression threshold. Only
0.1% of cells met the GFP threshold, nevertheless 1152 single cells were seeded
across two rounds of screening.
Cells were then grown into colonies with media changes every 48h for ∼2 weeks,
and 43.7% of single cells resulted in colonies. All wells containing colonies were
dispersed using trypsin, split into replicate plates and allowed to recover for 24h.
One set of cells were frozen in freezing media, whilst the matching set were lysed,
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Figure 3.4: Overview of workflow used for CRISPR targeting strategy
(A) Final HDR template including insertion of new start codon. (B) Successfully
transfected cells were selected for using fluorescence-activated cell sorting (FACS)
for GFP+ cells, normalised to HDR-plasmid only cells. Clones were expanded
from single cells over a maximum of three weeks, depending on growth rate, before
genomic DNA was screened for the insert using PCR and downstream sequencing
analysis to verify clones.
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Figure 3.5: Clonal selection and screening of CRISPR targeted cells
(A) Cells targeted using CRISPR to insert an eGFP tag were sorted using
fluorescence-activated cell sorting (FACS) gated on GFP expression level. Con-
trol cells were untreated, whilst HDR-only cells were transfected with the GFP-
containing repair template but not the gRNA/Cas9 plasmid. (B) Example screen-
ing gels showing products of PCR over the N-terminal of the NBAS locus run on
agarose gel; panel 1 and panel 2. Ladders are shown in panel 1 lanes A and T,
and panel 2 lanes A and R. Bands can be seen at expected sizes for WT (e.g.
panel 1 lane B, panel 2 lane H), full tag incorporation (panel 1 lane N and panel
2 lane D, red arrows) as well as various intermediates. Clone taken forward as
“heterozygous” can be seen in panel 2 lane O, blue triangle. (C) Sanger sequenc-
ing reads showing accurate insertion of complete tag with no mutations in clone
from lane 1N in panel C. (D) Number of GFP positive clones seeded, that suc-
cessfully formed colonies and that were confirmed to be homozygous for the full
tag. Efficiency is calculated as the number of homozygous clones as a percentage
of the total number of GFP+ cell seeded.
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and genomic DNA (gDNA) extracted. Using the same custom primers KJJ 5
and KJJ 6, the NBAS N-terminal locus from each clone was amplified by PCR
and the resulting products run on agarose gel to visualise the DNA fragment
sizes (Figure 3.5B). WT product was 655nt and full incorporation of the tag by
HDR would yield a product of 1468nt. Most clones gave bands discernible as
WT. Two clones with one larger band had no WT band present (Figure 3.5B;
panel 1 lane N and panel 2 lane D, red arrows). No samples cleanly produced
bands at both WT and full tag sizes, however several clones produced bands at
WT and full tag sizes but also intermediate sizes (eg. panel 1 lanes E and K,
panel 2 lane O). To confirm sequences, both putative homozygous and two of the
”heterozygous” clones were Sanger sequenced (Figure 3.5C). Both homozygous
clones were shown to have complete tags incorporated with no mutations. The
”heterozygous” samples resulted in mixed signals suggesting the presence of dif-
ferent PCR products from different alleles. Cytogenetic analysis of HeLa cells
by spectral karyotyping revealed the presence of three copies of chromosome 2
(Macville et al., 1999). This was also supported by sequencing over the NBAS
locus which also suggests three copies (Landry et al., 2013). However, since HeLa
cells are genomically unstable, it is not known how many copies of chromosome 2
these HeLa cells have or indeed how many copies of the NBAS locus. Therefore,
it was concluded that in the “heterozygous” cells one or more alleles were untar-
geted, one or more targeted efficiently and one or more inefficiently targeted. Of
the 1152 puromycin resistant, GFP positive cells seeded, only two homozygous
clones were detected. This represents a very low efficiency of 0.4% (Figure 3.5D),
since the cutting efficiency of the gRNA/Cas9 was high (Figure 3.3C), this is
assumed to be due to low HDR efficiency.
The two homozygous clones and one ”heterozygous” clone were thawed, and cells
allowed to recover for 24h. The ”heterozygous” clone, and only one of the two
homozygous clones recovered from the freeze-thaw process. Whole cell lysates
were made and visualised by western blot (Figure 3.6A). Probing with α-NBAS
antibody revealed that both the homozygous and the ”heterozygous” clones ex-
pressed only tagged NBAS protein at detectable levels. Tagged NBAS could
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also be detected by α-GFP and α-FLAG antibodies. Tagged NBAS produced
a band at the expected size, ∼30 kDa larger than WT control NBAS. Probing
with α-GFP shows successful integration of the GFP tag in both homozygous and
”heterozygous” cells. The different sensitivities of α-NBAS and α-GFP antibod-
ies can clearly be seen, confirming the greater sensitivity and stronger signal of
α-GFP compared with α-NBAS. NBAS protein expression appears to be higher
in the homozygous cells than the ”heterozygous” cells, consistent with only some
of the NBAS alleles being successfully targeted in these cells. However, expression
is not conclusive as western blots are not quantitative.
GFP expression, quantified by flow cytometry (Figure 3.6B), showed narrow
peaks for both ”heterozygous” and homozygous cell populations, suggesting ho-
mogenous, clonal populations of cells. Homozygous GFP expression was dis-
tinctly higher than heterozygous which in turn was higher than WT, in agreement
with higher expression of GFP-NBAS protein in homozygous cells, suggested by
western blot. At this point, I decided to only take the homozygous cells for-
ward for exploratory experiments. Henceforth, these cells will be referred to as
”GFP-NBAS cells”.
3.2.3 Validation of GFP-NBAS cell line
Immunoprecipitation (IP) using α-GFP antibody followed by western blot (IP-
WB) resulted in a strong enrichment of GFP-NBAS in the IP sample compared
to input samples (Figure 3.7A) showing efficient pull down of GFP-NBAS using
α-GFP beads. This blot also showed the stronger signal of the commercially
optimised α-GFP antibody compared to the α-NBAS antibody. A single clean
band was seen with both antibodies indicating GFP-NBAS cells express no WT
NBAS or independent GFP protein. To further check for off-target integration of
the GFP tag, an IP-WB was performed on the GFP-NBAS cells and the whole
membrane probed with α-GFP antibody. As well as taking images at optimal
exposure, I also overexposed the membrane to detect faint bands (Figure 3.7B).
Although there were several faint bands, all of these were also present in the
parental HeLa cell line lanes, suggesting weak off-target binding of the α-GFP
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Figure 3.6: Comparison of homozygous and heterozygous GFP-FLAG-
NBAS cell line
(A) Western blot of whole cell extract from CRISPR targeted homozygous (hom)
and genetically ”heterozygous” (het) clones, and the WT parental HeLa cell line.
Probing with α-NBAS shows both het and hom cells express only one form of
NBAS which is ∼30 kDa larger than WT NBAS. Probing with α-GFP shows
successful integration and expression of the eGFP tag in both het and hom cells.
The different sensitivities of α-NBAS and α-GFP antibodies can clearly be seen.
NBAS protein expression appears to be higher in hom cells than het cells. (B)
Flow cytometry measurement of GFP fluorescence of WT, het and hom cells.
Both het and hom result in narrow peaks indicating clonal populations. GFP ex-
pression in hom cells is higher than het cells, in agreement with higher expression
of GFP-NBAS protein in hom cells.
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antibody, rather than off-target integration of the GFP-tag. Whilst this result
does not confirm the absence of off-target integration into the genome which could
be non-expressed or non-translated, it does show that there is not substantial
off-target protein expression of the GFP antigen recognised by α-GFP, especially
since the other bands were all much fainter than the GFP-NBAS band. Therefore,
I judged the binding of the α-GFP antibody was suitably specific to NBAS.
To visualise GFP-NBAS within the cells, cells were subject to imaging, initially
without antibodies, showing that it was possible to detect native GFP-NBAS
(Figure 3.7C). The signal was similar in location and dispersion but clearer and
stronger when α-GFP and an appropriate secondary antibody were used, and
so all further imaging was done following immunofluorescence (IF) protocol for
visualising GFP-NBAS.
GFP-NBAS was located mainly in the perinuclear region, consistent with ER
localisation (Aoki et al., 2009) (Varma et al., 2006), but to explore this further I
also probed for calnexin, an ER marker. GFP-NBAS showed a clear overlap of
signal with calnexin (Figure 3.8A). To directly test ER membrane localisation,
cells were treated with the drug digitonin before fixing, to permeabilise the plasma
membrane but leave the ER membrane intact (Niklas et al., 2011). Thus, only
proteins tethered to the ER remain, and free protein disperses and is washed off
during the IF protocol. Upon digitonin permeabilisation, GFP-NBAS signal was
slightly reduced but still clearly present and overlapping with the signal of the ER
marker SEC61B (Figure 3.8B), confirming GFP-FLAG-NBAS is appropriately
localised to the ER.
I next wanted to confirm whether GFP-FLAG-NBAS reproduced the previously
identified interaction between NBAS and UPF1 (Section 1.3.4). Proximity lig-
ation assay (PLA) is an antibody-based technique that uses specific antibodies
against the two proteins of interest and secondary antibodies with either a plus
(+) or minus (-) DNA oligo attached (Figure 3.9A) (Söderberg et al., 2006).
When the secondary antibodies are less than approximately 40nm apart, the oli-
gos can anneal and rolling DNA synthesis can take place. These nascent DNA
clusters can be visualised with fluorescent marker which is imaged as a red spot.
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Figure 3.7: Validation of homozygous GFP-FLAG-NBAS cell line
(A) Immunoprecipitation with α-GFP antibody of GFP-NBAS CRISPR cells
and WT parental HeLa cells. Western blot was probed with α-NBAS, α-GPF
and α-tubulin antibodies and appropriate secondary antibodies. (B) Immuno-
precipitation with α-GFP antibody of homozygous and genetically “heterozygous”
GFP-NBAS CRISPR cells and WT parental HeLa cells. Whole membrane was
probed with α-GPF antibody and appropriate secondary antibody. (C) Confocal
image of native GFP-NBAS signal. Nuclei stained with DAPI.
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Figure 3.8: GFP-FLAG-NBAS is localised to the ER
(A) Wide field immunofluorescence of GFP-NBAS and the ER marker calnexin.
Nuclei stained with DAPI. (B) Confocal immunofluorescence of GFP-NBAS and
the ER translocon component SEC61B. Digitonin (DIG)+ cells were treated with
digitonin permeabilisation agent prior to fixation. DIG- control cells were mock
treated with PBS. Nuclei stained with DAPI.
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To test the interaction of the endogenous proteins, I performed PLA with anti-
bodies recognising UPF1 and GFP (Figure 3.9B). PLA signal was quantified as
number of red spots in a single frame divided by the number of nuclei. There was
a significant increase in PLA signal in the GFP-NBAS cells compared to the WT
control parental HeLa cell line, indicating GFP-NBAS was less than 40nm from
UPF1, suggesting direct interaction (Figure 3.9B, C). Altogether these results
suggest that the addition of the GFP-3xFLAG tags hasn’t disrupted the known
localisation or interactions of endogenous NBAS.
3.2.4 GFP-NBAS interacts with Syntaxin-18 complex
and also the ER translocon
To investigate global protein binding partners of NBAS, the GFP-NBAS cells
were subjected to immunoprecipitation-mass spectrometry (IP-MS). Efficient pull
down of GFP-NBAS using α-GFP beads was established (Figure 3.7A). A stronger
signal in the pull-down compared to input showed there was an enrichment of
NBAS in the immunoprecipitate. Therefore, I was confident to proceed with IP-
MS. IP of GFP-NBAS cell lysate and the parental HeLa cell lysate was carried out
using α-GFP beads as before, and resulting proteins digested into peptides. Sam-
ples were then submitted to the IGMM Mass Spectrometry core facility who car-
ried out MS processing and analysis of raw data. To identify binding of proteins
to GFP-NBAS, the abundance of each protein in the GFP-NBAS cells sample
was normalised to the control cells sample to give a fold change and significance
value. This was carried out by Jimi Wills of the IGMM Mass Spectrometry core
facility, using Wasim Aftab’s LIMMA Pipeline Proteomics (Section 2.1.13).
The most significantly enriched protein identified was NBAS (p = 5.8x10−8), con-
firming success of the experiment (Figure 3.10A). The next twelve most enriched
proteins detected have all been previously identified as part of the Syntaxin-18
complex (Figure 3.10B; Section 1.3.2), including both RINT1 and ZW10, the
two proteins that with NBAS make up the NBAS-RINT1-ZW10 (NRZ) complex,
confirming not only GFP-NBAS is in the correct subcellular location but that it
is interacting with the expected complexes. Binding studies show that the N- and
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Figure 3.9: Confirmation of interaction between GFP-FLAG-NBAS
and UPF1
(A) Proximity ligation assay (PLA) is an antibody-based technique that uses spe-
cific antibodies against the two proteins of interest and secondary antibodies with
either a plus (+) or minus (-) DNA oligo attached. When the secondary anti-
bodies are less than approximately 40nm apart, the oligos can anneal and rolling
DNA synthesis can take place. These nascent DNA clumps can be visualised with
fluorescent marker which is imaged as a red spot. (B) Representative PLA signal
(red) when antibodies against GFP and UPF1 were used in GFP-NBAS cells and
the parental HeLa cell line. DAPI staining shows cell nuclei (blue). (C) Quantifi-
cation of all replicates of PLA in parental WT HeLa cells and tagged GFP-NBAS
cells. Each spot is the PLA signal in a single image, calculated as the number of
red spots divided by the number of nuclei present. The mean and standard devi-
ation are indicated by the bold line and whiskers. A significant increase in PLA
signal was seen in the GFP-NBAS cells compared to WT HeLa cells (two-tailed
Mann-Whitney test; *** indicates p < 0.001).
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the C-terminal regions of NBAS interact with p31 and Syntaxin-18, and ZW10
and RINT-1, respectively (Civril et al., 2010; Tagaya et al., 2014). Therefore,
that interactions with all four of these proteins are detected, suggests that the N-
terminal tagged NBAS is able to interact correctly with its established partners.
No known NMD factors were identified as significantly enriched.
In addition to identifying known binding partners of NBAS in the Syntaxin-18
complex, there was also a significant enrichment of SEC61A (log(fold change)=2.66,
p=0.035; Figure 3.10C), a component of the trimeric SEC61 complex which makes
up the core channel of the ER translocon where the ribosome docks when trans-
lating directly into the ER lumen (Hartmann et al., 1994) (Figure 3.10D; Section
1.1.4). In addition to these robust interactions, there was a more suggestive (non-
significant) enrichment of SEC61B another subunit of the SEC61 translocon chan-
nel (Figure 3.10D), SEC63; which is thought to work with the SEC61 complex in
post-translational protein translocation into the ER, signal recognition particle 72
(SRP72), and signal recognition particle receptor (SRPR); which are involved in
transcript recruitment to the ER translocon for translation there (Section 1.1.4).
Analysis with the protein network tool STRING (Szklarczyk et al., 2019) shows
that these translocon complex components have previously been shown to interact
with members of the Syntaxin-18 complex (Figure 3.10E). Although, STRING
uses multiple sources and most of the interactions between the Syntaxin-18 com-
plex and the translocon components are based on co-expression data (black lines).
However, the interaction between the Vesicle Fusing ATPase NSF and SEC61A
has been experimentally determined (pink line). NSF is required for vesicle-
mediated transport and functions as part of the COPI-dependent Golgi-to-ER
retrograde traffic system.
IP-MS was also performed after treating GFP-NBAS cell lysates with RNase,
to identify whether identified GFP-NBAS interactions are RNA-dependent. Cal-
culating fold change of proteins in RNase- GFP-NBAS compared to RNase+
GFP-NBAS showed that the most significantly depleted proteins were all RNA
binding proteins (RBPs), indicating success of the experiment (Figure 3.11A).
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Figure 3.10: GFP-NBAS interacts with Syntaxin-18 complex and also
the ER translocon
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Figure 3.10: GFP-NBAS interacts with Syntaxin-18 complex and also
the ER translocon
(A) Enrichment of proteins from mass spectrometry of α-GFP immunoprecipi-
tation of GFP-NBAS cells compared to WT parental HeLa cell line. Top 13 most
significantly enriched proteins are labelled, all are associated with the Syntaxin-
18 complex. Dotted lines indicate thresholds for significance (p < 0.05) and
enrichment (>2-fold increase or decrease in detection). (B) Schematic of the
NBAS-RINT1-ZW10 (NRZ) complex within the larger Syntaxin-18 complex lo-
cated at the endoplasmic reticulum (ER) membrane. Figure adapted from Long-
man et al. (2020). (C) Comparison of enrichment of translocon channel compo-
nent SEC61A and core NMD factor UPF1 with enrichment of Syntaxin-18 com-
plex components by comparitive mass spectrometry. Dotted line indicates thresh-
old for enrichment (>2-fold increase in detection in GFP-NBAS sample compared
to WT parental HeLa cells). (D) Structure of the SEC61 complex which makes
up the endoplasmic reticulum (ER) translocon channel where the translating ri-
bosome docks. View of the lateral gate (top) or from the ER lumen (bottom)
of the SEC61 complex bound to the preprolactin signal peptide (cyan). The mo-
bile regions of SEC61A are blue; the comparatively immobile regions are red.
The SEC61B and SEC61G subunits are pale green and tan, respectively. (Fig-
ure adapted from Voorhees and Hegde, 2016). (E) STRING interaction analysis
showing evidence of interaction between proteins of the Syntaxin-18 complex and
SEC61A.
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The majority of the identified interactome was unchanged upon treatment with
RNase including Syntaxin-18 components and SEC61A (Figure 3.11B) suggesting
that NBAS interacts with both the Syntaxin-18 complex and the ER translocon
independently of the presence of RNA.
The interaction between GFP-NBAS and the SEC61 translocon was validated
using PLA. Figure 3.12 shows a significant increase in the PLA signal in GPF-
NBAS cells compared to the parental HeLa cells when α-GFP and α-SEC61B
antibodies are used, indicating that GFP-NBAS and SEC61B are <40nm apart,
either directly binding or within the same complex.
IP-MS did not result in a robust enrichment of any NMD factors. Even UPF1
was not enriched in any replicates despite being robustly shown to be directly
interacting with endogenous GFP-NBAS by PLA, and also by published work
using FRET/FLIM, PLA, FCCS and biochemistry techniques (Longman et al.,
2020).
3.2.5 NBAS interacts with UPF1 in a
domain-non-specific manner
NBAS has been shown to interact directly with RINT1 and ZW10 (Civril et al.,
2010) somewhere in its C-terminal region between 1036–2371 amino acids (Tagaya
et al., 2014), but interaction domains of other proteins have not been determined.
Both the α-solenoid at NBAS’ C-terminal and its N-terminal β-propeller structure
are generally involved in protein-protein interactions (Chen et al., 2011). To
understand the interplay between NBAS, UPF1 and the NMD machinery and
the Syntaxin-18 complex, I wanted to map the interaction domains of NBAS and
UPF1.
To investigate what NBAS domains are necessary for it to interact with UPF1,
I simultaneously co-expressed T7-epitope tagged full length UPF1 and FLAG-
tagged deletion mutants of NBAS and performed co-IP with α-FLAG magnetic
beads to pull down tagged protein mutants and any interacting proteins. Mutant
NBAS protein and co-IP full length UPF1 proteins were visualised by western
blot (Figure 3.13A). I also carried out co-IP of T7-tagged full length NBAS and
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Figure 3.11: GFP-NBAS interactome is RNA-independent
(A) Enrichment of proteins from mass spectrometry of α-GFP immunoprecipi-
tation of GFP-NBAS cells treated with RNase compared to untreated GFP-NBAS
cells. RNA binding proteins (RBPs) whose enrichment was significantly less in
RNase treated cells are highlighted in yellow ring. (B) Comparison of GFP-NBAS
RNase+ interactome with GFP-NBAS RNase- interactome, both normalised to
WT parental HeLa cells. Proteins are ordered by fold enrichment in RNase- cells.
Components of the Syntaxin-18 complex are in bold.
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Figure 3.12: GFP-NBAS interaction with ER translocon is validated
by PLA
(A) Representative PLA signal (red) when probes against GFP and SEC61B were
used in GFP-NBAS cells and the parental HeLa cell line. DAPI staining shows
cell nuclei (blue). (B) Quantification of all replicates of PLA shown in (A). The
mean and standard deviation are indicated by the bold line and whiskers. Signifi-
cance was determined by two-tailed Mann-Whitney test. *** indicates p<0.001.
FLAG-tagged deletion mutants of UPF1 to probe which domains of UPF1 are
important for the interaction (Figure 3.13B). Full length UPF1 co-IP with all
NBAS deletion mutants used and full length NBAS co-IP with all UPF1 deletion
mutants. Although the UPF1 deletion constructs only test a small portion of
the protein, the NBAS deletion mutants span almost the entirety of its length
and both identified domains. This could suggest that no single portion of NBAS
is solely required for interaction with UPF1, or it forms a dimer or higher or-
der complex. Alternatively, the small sections of NBAS that are present in all
mutants constructs could be the binding domain. The C-terminal of NBAS con-
sists of many α-solenoid repeats, which are known to be strong protein-protein
interaction domains so even the small portion present in the NBAS C-terminal
mutants could be sufficient.
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Figure 3.13: NBAS interacts with UPF1 in a domain-unspecific man-
ner
(A) Schematic of deletion mutant constructs of NBAS and immunoprecipita-
tion using α-FLAG. Cells were co-transfected with T7-UPF1 and FLAG-tagged
NBAS either full-length WT or the mutant indicated. Western blot is probed
with α-FLAG and α-T7 antibodies as indicated. (B) Schematic of deletion mu-
tant constructs of UPF1 and immunoprecipitation using α-FLAG. Cells were
co-transfected with T7-NBAS and FLAG-tagged UPF1 either full-length WT or




3.3.1 Creation of GFP-FLAG-NBAS cell line
NBAS has been shown to be involved in Golgi-to-ER retrograde transport; the
function is proposed to depend on its association in the NRZ complex which is
believed to play a role in SNARE assembly at the ER (Aoki et al., 2009). The
role of NBAS in vesicular transport is thought to be independent of its function in
RNA regulation (Longman et al., 2020), although little is understood regarding
the mechanism of its NMD activity.
Here, work aimed to create an endogenous model system in human cells to inves-
tigate the details of the NMD function of NBAS. A CRISPR/Cas9 strategy was
successfully designed and executed to endogenously tag the N-terminal of NBAS
with a 3xFLAG epitope and eGFP tag. Both homozygous and “heterozygous”
GFP-FLAG-NBAS cell lines were generated, and homozygous cells characterised.
These cells exhibit an ER staining pattern by immunofluorescence analogous to
the ER marker calnexin (Figure 3.8A) and IP-MS confirms interaction of GFP-
FLAG-NBAS with members of the Syntaxin-18 complex (Figure 3.10A).
The efficiency of the CRISPR targetting screen was very low efficiency (Figure
3.5D). Since the cutting efficiency of the gRNA/Cas9 was high (Figure 3.3C), this
is assumed to be due to low HDR efficiency. There are several techniques that
could be employed in the future to potentially increase success rate leading to
multiple clones that can be used as biological replicates. For example, using cell
synchronisation to increase HDR frequency because HDR is more active in S/G2
than other cell cycle phases (Lin et al., 2014). Furthermore, many “heterozygous”
clones appeared to have multiple products from the PCR of the N-terminal region
of the NBAS locus, strongly suggesting more than two NBAS loci in the HeLa cells
used. Targeting in more physiological cells such as mouse embryonic stem cells
may improve the efficiency of this technique as only two successful incorporations
need to occur to produce a homozygous clone.
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Whether the tagged NBAS in these cells is capable of full NMD function is to
be determined. To interrogate the function of GFP-NBAS in NMD, qRT-PCR
could be used to compare abundance of mRNA of previously identified NBAS
NMD targets (Longman et al., 2007, 2013, Chapter 4), after siRNA knockdown
of GFP-NBAS or WT NBAS in the GFP-NBAS cells compared to the parental
untagged HeLa cells.
In this chapter, I produced a useful tool cell line that can be used for future study
of NBAS and to further investigate ER-NMD. Tagged GFP-3xFLAG-NBAS be-
haved as expected in all validation experiments carried out. Further validation
that could be carried out on the cell line would be IP-WB to probe interaction
of NBAS with known interactors including Syntaxin-18 components and UPF1,
and the novel interactors identified in the IP-MS study including SEC61B and
SRPR.
3.3.2 Interaction of UPF1, NBAS and the ER translocon
The results of the IP-MS and PLA in this chapter suggest NBAS interacts di-
rectly with the SEC61 translocon where translating ribosomes dock at the ER
membrane. This would bring NBAS into close proximity to the transcripts being
translated. Taken together with evidence that UPF1 interacts with NBAS di-
rectly and also with SEC61B (Longman et al., 2020), this strongly suggests that
ER-NMD functions via a complex involving NBAS, UPF1 and the translocon
(Figure 3.14).
No robust enrichment of any NMD factors was observed, despite these interac-
tions previously being demonstrated by IP-WB (Longman et al., 2020, Appendix
C, Figure S6, S7). This may be due to the more transient nature of interactions
between NBAS and NMD factors compared to components of the Syntaxin-18
complex, meaning their interactions are not conserved through the IP-MS proto-
col. Repeating the IP-MS after crosslinking the cells could stabilise these interac-
129
Figure 3.14: Summary diagram of ER-NMD mechanism
Canonical NMD takes place in the cytoplasm where UPF1 and other factors target
a transcript with a premature termination codon for degradation. When a tran-
script has an endoplasmic reticulum (ER) localisation signal the ribosome and
transcript move to the ER and translation takes place at the translocon. Both
NBAS and UPF1 interact with the translocon channel and each other. This sug-
gests a model where NBAS, UPF1 and the ER translocon form a complex that is
involved in NMD quality control of transcripts translated at the ER.
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tions and aid in identifying the more transient interactions of NBAS. It could also
be that although transiently expressed tagged NBAS has been shown to interact
with UPF1, SMG5, SMG6 and SMG7 (Longman et al., 2020), expression of the
endogenous tag disrupts the interaction of NBAS with these proteins.
IP-MS studies of UPF1 have identified NMD interactions, although not with all
known NMD proteins. UPF2 and UPF3B have been found by published MS
studies on FLAG-UPF1 (Flury et al., 2014). Furthermore, the EJC components
CASC3 (MLN51) and eIF4A3 were identified. However, the UPF1 phosphory-
lating kinase SMG1, its regulators SMG8 and SMG9, as well as the downstream
NMD proteins SMG5, SMG6, and SMG7 were absent from the enriched proteins.
The previously reported interaction with Staufen homologue 2 (STAU2) was also
identified as an mRNA independent UPF1 interactor, while the more studied
homologue STAU1 was not identified. IP-MS of GFP-tagged NMD factor could
clarify whether it is the GFP tag that is preventing detection of NMD complexes
in this system. Alternatively, a more recent technique BioID uses proximity-
dependent trans-biotinylation by the Escherichia coli biotin ligase BirA mutant
R118G (BirA*) (Roux et al., 2012, 2013). This allows stringent streptavidin affin-
ity purification of proximal proteins and provides an alternative to co-IP or IP-
MS to identify protein-protein interactions. BioID using known NMD factors as
HA-BirA*-tagged bait proteins revealed new putative NMD-associated proteins
that presumably interact only transiently with the NMD complex (Schweingruber
et al., 2016). However, even this technique did not detect all known NMD pro-
tein interactions. For example, HA-BirA*-UPF1 selectively biotinylated UPF2,
but not UPF3B, and biotinylated SMG1, SMG6 and SMG7 were observed just
above the detection limit. HA-BirA*-UPF2 was found to biotinylate UPF3B
and HA-BirA*-SMG5 biotinylated SMG7, but SMG5 was not detected in the
HA-BirA*-UPF1 or HA-BirA*-UPF2 samples. MS is known to be influenced by
expression level of proteins. Even with ample input proteome, MS measurements
are heavily biased toward high abundance proteins, often omitting a majority of
the proteome in routine analyses (Picotti et al., 2007; Li et al., 2017a).
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Brannan et al. (2016) performed quantitative IP-MS on a HaloTag fusion UPF1
and showed that UPF1 interacts with ZW10, a member of the NRZ complex
which NBAS is also a subunit of. This suggests that perhaps the entire NRZ
complex is involved in ER-NMD. However, knockdown of ZW10 appeared to
have no impact on NMD (Longman et al., 2020). This could suggest UPF1
interacts with ZW10 as part of a separate function to NMD since UPF1 has
diverse non-NMD roles. These include regulation of RNA on multiple levels such
as RNA splicing, transport, translation, and mRNA turnover (Atkin et al., 1995;
Lykke-Andersen et al., 2000; Mendell et al., 2002; Wilkinson, 2005; Nazarenus
et al., 2005). For example, UPF1 has been identified as interacting with SRSF1
which plays a role in preventing exon skipping, ensuring the accuracy of splicing
and regulating alternative splicing (Aznarez et al., 2018), and UPF1 stabilizes
primary retroviral RNA so that UPF1 downregulation by siRNA decreases HIV
RNA and diminishes the synthesis of virion structural proteins (Ajamian et al.,
2008). The interaction of UPF1 and ZW10 could be indirect, via a larger complex
that could include NBAS, or even components of the translocon and Syntaxin-18
complex.
Full length UPF1 co-IP with all NBAS deletion mutants used and full length
NBAS co-IP with all UPF1 deletion mutants. Although the UPF1 deletion con-
structs only test a small portion of the protein, the NBAS deletion mutants span
almost the entirety of its length and both identified domains. This could suggest
that no single portion of NBAS is solely required for interaction with UPF1, per-
haps because NBAS forms a binding platform that brings UPF1 to the proximity
of translocon at ER. Alternatively, NBAS could form a dimer or higher order com-
plex, and overexpressed truncated proteins are functionally complemented by the
endogenous WT NBAS. To test this further, WT endogenous NBAS should be
degraded or knocked out and the experiment repeated with expression of each of
the mutants with full length UPF1. Whilst the interactions sites between UPF1
and many NMD factors has been identified, the direct interaction between UPF1
and UPF3B also still remains to be mapped (Lavysh & Neu-Yilik, 2020).
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3.3.3 Future work
The putative protein interactors of NBAS identified in the mass spectrometry
analysis will need to be confirmed by IP-WB analysis, and could be followed up
by PLA to validate via a different approach. Furthermore, to determine which
of the interactions are mediated by RNA, RNase treatment of control parental
cell line followed by IP-MS is necessary to allow normalisation of the RNase
treated GFP-NBAS sample to account for changes in solubility due to the lack
of RNA (Trevino et al., 2007). To verify whether the interactions are direct
or mediated by other proteins, in vitro binding assays could be performed and
potentially deletion mutants of NBAS and identified interacting proteins could
then be developed to map the protein regions/domains important for binding.
Interacting proteins could also be knocked down and NMD activity measured to
assess whether they are involved in the ER-NMD response.
The next question regarding involvement of NBAS in ER-NMD is its precise
function in the pathway. NBAS tethers UPF1 to the ER and potentially recruits
UPF1 initially (Longman et al., 2020). This suggests that NBAS has a structural
scaffold role in bringing UPF1 to the translocon and into close proximity with
the translating ribosome. In this case, the question arises whether NBAS only
recruits and tethers UPF1 when the ribosome stalls or whether NBAS recruits
UPF1 constitutively, but UPF1 will only act on NMD when specific complexes
are formed and UPF1 is phosphorylated by SMG1. Perhaps the interaction be-
tween NBAS and UPF1 is stabilised by the stalling of the ribosome in a similar
manner to how this appears to stabilise UPF1 binding to mRNA. Alternatively,
UPF1 could be trafficked to the ER translocon with the mRNA and ribosome
but is then kept at the ER by interaction with NBAS. One way to investigate
this would be comparing the transcripts bound by UPF1 in WT cells compared
to cells were NBAS is depleted. If transcripts translated at the ER are less
bound in the absence of NBAS, it would suggest NBAS stabilises UPF1 bind-
ing to these transcripts. To do this, a crosslinking immunoprecipitation (CLIP)
protocol could be used, which consists of crosslinking cells with UV to stabilise
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interactions between protein and RNA, followed by immunoprecipitation of the
protein of interest and RNA-sequencing of the co-immunoprecipitated RNA. This
comparative CLIP experiment would also have the likely advantage of producing
a result with less background signal as it would allow normalisation to wild type.
Furthermore, CLIP could be combined with subcellular fractionation (Brugiolo
2017) to specifically identify transcripts bound by UPF1 in the vicinity of the
ER.
It would also be interesting to test if NBAS and UPF1 bind the translocon at
the same time, and whether UPF1’s slower diffusion at the ER (Longman et al.,
2020) is due to it binding specifically to the translocon or to NBAS or both. To
test this, the interaction between UPF1 and SEC61B could be probed by IP-WB
in cells depleted of NBAS. If NBAS is required for the recruiting of UPF1 to the
translocon or stabilising the interaction, I would expect the interaction to be less
or abrogated when NBAS was depleted.
Another linked question is whether NBAS binds the transcripts that it helps regu-
late by NMD. Although NBAS does not have an annotated RNA binding domain,
such as an RNA-recognition motif, double-stranded RNA-binding motif or zinc-
finger motif, more than a third of RNA binding proteins (RBPs) have no prior
RNA binding related homology or annotation (Castello et al., 2013) and little is
known about the specific functions of the identified NBAS protein domains (Sec-
tion 1.3.1). Neither NBAS nor any of its paralogues feature in the RNA-Binding
Protein DataBase (Berglund et al., 2008; Cook et al., 2011), and NBAS is not
among the nearly 900 RBPs identified in human HeLa cells using interactome
capture; UV cross-linking of proteins to RNA followed by oligo(dT) capture and
mass spectrometry (Beckmann et al., 2015; Castello et al., 2012; Conrad et al.,
2016). However preliminary evidence suggests NBAS may bind RNA. Messenger
RNA capture assay uses UV crosslinking to stabilise protein-RNA interactions
and oligo(dT) beads to isolate all RNA species with poly-A tails, thereby puri-
fying RBPs. The presence of NBAS in mRNA-protein (mRNP) complexes was
revealed by western blot with α-NBAS antibody, suggesting that NBAS does
bind mRNA (Longman et al., 2020, Appendix C, Figure S6D). However, this
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could also indicate that NBAS is part of a protein complex and one or members
of the complex directly bind RNA, not NBAS, leading to indirect pull-down of
NBAS. This could be validated by IP of NBAS followed by degradation of protein
and DNA, and visualisation of RNA.
If NBAS is an RBP, then it would next be interesting to investigate whether
it is the transcripts regulated by ER-NMD that NBAS binds to or if this RNA
binding function is an independent role. A CLIP experiment coupled with RNA-
sequencing would enable identification of the RNAs that are directly bound by
NBAS. It is widely accepted that performing CLIP on some proteins is much
more challenging than others and a strong enrichment of the protein of interest
in the immunoprecipitation is essential. Therefore, a pertinent approach would
be to perform CLIP on the GFP tagged NBAS cell line described in this chapter
so an α-GFP antibody, which has already been shown to be successful (Meyer
et al., 2017; Tang et al., 2020), could be used to isolate NBAS.
3.3.4 Summary
In conclusion, in this chapter I describe the endogenously tagged NBAS cell line
created, which will be a useful tool for future studies. Using this cell line, I
have shown that NBAS interacts with components of the ER translocon where
the ribosome docks when translating at the ER. Treatment with RNase deter-
mined that protein interactions between NBAS, the Syntaxin-18 complex and
the translocon were RNA-independent. The novel interaction between NBAS
and the SEC61 translocon was validated by proximity specific ligation (PLA).
Taken together with the evidence that NBAS interacts with UPF1 and UPF1
also interacts with the ER translocon suggests that UPF1 and NBAS form a
complex with the translocon to regulate the ER-NMD.
The key findings presented in this chapter have been published in the follow-
ing article, which is attached as Appendix C:
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Longman D, Jackson-Jones KA, Maslon MM, Murphy, LC, Young, RS, Stod-
dart, JJ, Hug, N, Taylor, MS, Papadopoulos, DK, & Cáceres, JF (2020) Identi-
fication of a localised nonsense-mediated decay pathway at the endoplasmic retic-
ulum Genes & Dev. 2020. 34: 1075-1088. doi:10.1101/gad.338061.120
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Since NBAS is localised to the endoplasmic reticulum (ER), it has been hypothe-
sised that it is involved in a branch of nonsense mediated decay (NMD) specific to
transcripts translated at the ER (Longman et al., 2020). This ER-NMD pathway
would likely require the presence and activity of the core NMD factor UPF1. If
this is the case, a subset of UPF1 targets is expected to be translated at ER and
also regulated by NBAS. Therefore, I wanted to carry out an unbiased transcrip-
tomics approach to identify mRNA targets of NBAS and compare them to UPF1
targets.
4.1.1 Differential expression as a tool to identify targets
of NMD
The NMD pathway degrades the target RNA transcript, and the nascent pep-
tide is presumed to also be degraded, presumably by the proteasome, although
the mechanism is not known. Therefore, identifying differentially expressed tran-
scripts when specific NMD factors are depleted has been used as a standard for
identifying targets of those factors.
Many microarray analyses and, more recently, RNA-sequencing analyses of the
transcriptome of human cells after expression of UPF1 has been knocked down
have been carried out (Wang et al., 2011a; Tani et al., 2012; Hurt et al., 2013;
Lykke-Andersen et al., 2014; Schmidt et al., 2015; Lou et al., 2016). In line with
the variable nature of NMD, overlap of identified UPF1 targets between datasets
is generally low. Of the 533 targets identified by Lou et al. (2016), only 27% had
been previously identified by other studies. There have also been similar analyses
carried out when other NMD factors have been knocked down (Mendell et al.,
2004; Wittmann et al., 2006; Yepiskoposyan et al., 2011). Identification of how
the targets of various factors differ from those of canonical NMD have been used
to identify subclasses of NMD (Section 1.2.3).
139
NMD activity of NBAS has only previously been investigated by microarray anal-
ysis of mRNA upon depletion of NBAS (Longman et al., 2013). This study
showed a significant correlation between transcripts increased in abundance when
NBAS was depleted and those increased when UPF1 was depleted, indicating co-
regulation by the two factors in Caenorhabditis elegans, Danio rerio (zebrafish)
and HeLa cells (Longman et al., 2013).
Whilst microarray analysis is considered to be genome-wide, it is limited to those
transcripts for which probes are included in the microarray and ability to identify
specific transcripts is limited (Wang et al., 2009; Wilhelm and Landry, 2009). In
contrast, RNA-seq is unbiased and can detect novel transcripts, gene fusions,
single nucleotide variants, indels, and other previously unknown changes that
arrays cannot detect. Furthermore, RNA-seq can quantify expression across a
wider dynamic range since it produces discrete, digital sequencing read counts
(Wang et al., 2009; Wilhelm and Landry, 2009; Zhao et al., 2014; Rao et al.,
2018) which allows detection of rare and low-abundance transcripts. Compared to
microarrays, RNA-seq technology can detect a higher percentage of differentially
expressed genes, especially genes with low expression (Wang et al., 2014; Liu
et al., 2015), resulting in higher specificity and sensitivity. Several studies have
investigated the comparability between the microarray platform and RNA-seq
(Fu et al., 2009; Zhao et al., 2014; van der Kloet et al., 2020). Correlation of the
two techniques have been estimated between r = 0.62 and r = 0.75 (Fu et al.,
2009), with RNA-seq found to provide better estimates of absolute expression
levels, as background hybridisation and probe saturation in microarrays resulted
in limited sensitivity in both low and high expression levels (Zhao et al., 2014).
Performing RNA-seq on cells depleted of NBAS will allow more complete and
unbiased identification of transcripts regulated by NBAS. This will enable greater
understanding of the role NBAS has in NMD and the types of transcripts it
regulates. Comparing these results to those of the core NMD factor UPF1 will
indicate whether a distinct NMD pathway is occurring at the ER.
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4.1.2 Aims
In this chapter I aim to understand the similarities and differences of NBAS-
dependent gene expression changes and UPF1-dependent changes by implement-
ing RNA-seq upon depletion of either factor and then characterising and com-
paring the results.
To do this, I will deplete HeLa cells of either UPF1 or NBAS and subject the
total RNA to RNA-seq. Differential expression analysis will reveal transcripts in-
creased in expression when NBAS is depleted. To determine whether UPF1 and
NBAS targets are translated at the ER, I will compare the target lists to three
external, experimental datasets which identified ER-localised transcripts. Anal-
ysis of RNA-seq data from fractionated cells will allow comparison of membrane
and cytoplasmic effects of NBAS compared to UPF1 and UPF2.
In summary, the main aims of this chapter are:
a) To identify putative NBAS NMD targets by determining transcripts in-
creased in expression upon depletion of NBAS
b) To compare NBAS targets with those of core NMD factor UPF1




As well as differential expression, I wanted a single design that would allow the
discrimination of transcriptional changes from transcript stability changes, as di-
rect NMD effects are specifically expected to be exerted through altered transcript
stability. Measurement of stability required both total RNA and nascent RNA
from the same cells (described fully in Chapter 5) therefore as well as extract-
ing total RNA and sequencing it to measure differential expression, cells were
treated with the uridine analogue 4-thiouridine (4sU) and nascent RNA fraction-
ated (Figure 4.1A). RNA-seq libraries were prepared from both total RNA and
4sU labelled nascent RNA from the same cells. For comparison to previous gene
expression-based studies of NMD, only the total RNA was used in all analyses in
this chapter.
HeLa cells were depleted of either UPF1 or NBAS using siRNA pools. Control
cells were treated with a scrambled siRNA pool (si-Scr) or mock depleted as neg-
ative controls (Figure 4.1B). Five biological replicates were treated, and libraries
prepared resulting in a total of 40 sequencing libraries and corresponding datasets
(Figure 4.1C).
Figure 4.2A shows the level of depletion of NBAS and UPF1 mRNA in each
sample that was prepped for RNA-sequencing, normalised to mock treated cells.
UPF1 mRNA was depleted to 29.2% on average (p < 0.0001) when cells were
treated with si-UPF1, whilst NBAS was depleted to 23.4% on average (p =
0.0016) of untreated levels when si-NBAS was used. Although not meeting sta-
tistical significance, the level of NBAS mRNA was slightly increased upon UPF1
is depletion, suggesting NBAS is part of the NMD factor positive feedback loop
described by others (Longman et al., 2013; Huang et al., 2011; Yepiskoposyan
et al., 2011). Western blot of depleted samples shows protein levels of both fac-
tors were undetectable (Figure 4.2B). Since ∼25% of WT levels of mRNA were
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Figure 4.1: RNA-sequencing experimental design
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Figure 4.1: RNA-sequencing experimental design
(A) Labelling with the uridine analogue 4-thiouridine (4sU) allows isolation of
nascent RNA from total. 4sU is incorporating into nascent transcripts during
the labelling period and then cells are lysed with Trizol and RNA purified. Biotin
is added which strongly binds to the sulphur of the 4sU. 10% of the sample is
separated as ”total RNA”. Incubation with streptavidin beads allow purification
of the biotin tagged ”nascent RNA” from flow-through. Libraries can then be
prepared from matched total and nascent RNA originating from the same cells.
(B) Time course of the experiment proceeded with reverse transfection of HeLa
cells with appropriate siRNAs. 48hrs later, cells were expanded and depleted for a
second time with the same siRNA pools. 24hrs later, cells were labelled with 4sU
for 40min before being harvested and RNA extracted. Depletion of all samples
was carried out by qRT-PCR before library preparation. (C) Each condition was
replicated 5 times and then total and nascent RNA extracted from each sample,
resulting in 40 RNA-sequencing libraries.
detected by qPCR, this suggests that the that the protein level of knockdown
may have been stronger than measured by qPCR or could be an indicator that
qPCR detection limits are lower than western blot probing. However, it is dif-
ficult to directly compare qPCR results with western blot, as western blots are
not linearly quantitative. Analysis using qRT-PCR was used to assess the effect
of the depletions on previously identified UPF1 and NBAS NMD targets (Long-
man et al., 2013, Figure 4.2C). Although the level of depletion of both UPF1
and NBAS was similar, the increase in abundance of previously identified target
mRNAs was generally lower than seen previously (Longman et al., 2013).
RNA quantity and quality were assessed by Bioanalyzer. Sample RNA integrity
numbers (RINs) ranged from 8.6 to 10, indicating that the RNA quality was
sufficient for sequencing. RNA-sequencing libraries were produced from total
RNA and nascent RNA from the same samples. 1µg of each sample was reserved
as ”total RNA”, then 4sU-labelled nascent RNA was purified using biotinylation
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Figure 4.2: siRNA targeting of NBAS results in undetectable level of
protein and upregulation of NMD targets
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Figure 4.2: siRNA targeting of NBAS results in undetectable level of
protein and upregulation of NMD targets
(A) qRT-PCR analysis shows relative expression of NBAS and UPF1 mRNA in
each sample that was prepped for RNA-sequencing, normalised to mock treated
cells (each condition n=5). UPF1 mRNA was depleted to 29.2% on average
(p < 0.0001) when cells were treated with si-UPF1, whilst NBAS was depleted
to 23.4% on average (p = 0.0016) when si-NBAS was used. (B) Representative
western blot of depleted samples shows protein levels of both factors were unde-
tectable. (C) qRT-PCR analysis shows relative expression of mRNA of previously
identified NBAS NMD targets; CCL20 was increased 2.05-fold (p = 0.0068) and
INHBA was increased 1.66-fold (p = 0.0008). (D) Bioanalyzer plots show de-
creasing size of fragments upon sonication for increasing periods of time. (E)
Representative bioanalyzer plots of three total and three nascent RNA libraries
show the single peak spanning 300-1000nt.
and streptavidin beads. Ribosomal RNA (rRNA) depletion was not performed
on any samples due to the very low concentration of nascent RNA samples (1.96-
7.48ng/µl; total samples concentration 69.4-180ng/µl) and the desire to process
nascent and total RNA samples in the same way.
Integrity analysis of nascent RNA using Bioanalyzer implied very little RNA
present in nascent samples, and correspondingly samples were assigned very low
RIN values. Since bioanalyzer analysis relies on levels of rRNA present, this was
not surprising since very little rRNA is expected to be transcribed in a 40min
window. However, this raised the issue of choosing the correct fragmentation time
of RNA prior to library preparation, since this is usually calculated from the RIN
obtained with the Bioanalyzer. Therefore, to estimate optimal RNA fractionation
time, excess of two more concentrated nascent samples (mock and si-scramble)
were pooled to increase the concentration of RNA and split into aliquots. These
replicates were sonicated for 1.5, 3 or 5mins and the resulting fragment lengths
were analysed by Bioanalyzer (Figure 4.2D). Fragmentation for 1.5, 3 and 5min
all decreased the average fragment length from >4000nt to ∼1000nt. Even though
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after 5min the fragments were larger than the optimal fragment size of ∼200nt,
5min was chosen as optimal because it gave a clean peak at the lowest size of
the times tested and a longer fragmentation time could be too long for the other
samples with lower concentrations.
Libraries were prepared using NEBNext Ultra Directional RNA Library Prep Kit
for Illumina, following manufacturers protocol with NEBNext Multiplex Oligos
with unique barcodes for each library. After completing library preparation,
libraries were again assessed by Bioanalyzer (Figure 4.2E). All libraries produced
a single broad peak at ∼300nt-700nt in length. All 40 libraries were pooled and
submitted to Edinburgh Genomics for paired-end sequencing.
4.2.2 Processing of RNA-sequencing data
Reads were de-barcoded by Edinburgh Genomics and data received as fastq for-
mat files for each sample, split by lane of flow cell and by each end of the reads.
Average number of reads per library was ∼100 million, with a similar level of
variance across all samples (Figure 4.3A). Quality control analysis with fastqc
showed no tile biases, high per sequence quality scores (Figure 4.3B) and high
per base sequence quality (Figure 4.3C).
Each lane of each replicate was mapped using the quantification tool kallisto
(Bray et al., 2016) to a genome index consisting of protein coding genes and
long non-coding RNAs from GRCh38/hg38 human genome (Figure 4.3D). Kallisto
pseudo-aligns reads on a transcript level without alignment of individual bases,
and produces counts data, minimising downstream analysis steps. Mapping effi-
ciency was consistent across all samples with an average of 31.7% of reads being
successfully pseudo-aligned and counted (Table 4.1). This was expected as the
kallisto index excluded all non-coding regions except long non-coding RNAs and
many reads would likely have originated from those regions, especially rRNA and
tRNA since these are highly abundant in the cell.
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Figure 4.3: RNA-sequencing experimental design
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Figure 4.3: RNA-sequencing experimental design
(A) Number of reads per library in millions (n = 5) for each condition and
nascent (N) or total (T) RNA. (B) Representative per sequence quality score plot
output from fastqc. (C) Representative per base sequence quality score plot output
from fastqc. (D) Diagram illustrating building of a kallisto index. Rather than
use the full genome, specific regions of interest, in this case protein coding regions
and long non-coding RNA (lncRNA) regions, are assigned k-mers to produce the
index for pseudoalignment. (E) Representative plots of log10 transformed counts
of technical replicates. (F) Representative plots of log10 transformed counts of
biological replicates.
Technical replication across lanes was uniformly high (r ≥ 0.9) verifying all out-
puts were of consistent quality (Figure 4.3E), therefore resulting abundance files
from each lane were merged to produce one abundance file per sample (n = 40).
Plotting log-transformed counts of each replicate showed high correlation between
replicates across all conditions (Figure 4.3F).
To visualise coverage of reads across the genome, each replicate was mapped to
the GRCh38/hg38 human genome assembly using STAR and visualised using the
integrated genome viewer. Evidence of successful NMD abrogation was identified
by way of increased inclusion of ”poison” exons in a number of transcripts includ-
ing SRSF3 and TRA2A. These alterative unproductive isoforms are common in
splicing factors and have been found in all conserved members of the SR family of
splice regulators (Lareau et al., 2007; Ni et al., 2007). The exon, which is normally
skipped, contains a PTC, so when it is included via alternative splicing it targets
the transcript for degradation by NMD. Poison exons are therefore a mechanism
of post transcriptional gene regulation by way of the NMD pathway (Kurosaki
et al., 2019b). In samples where UPF1 was depleted, an increased number of
reads aligned to exon 3 and exon 4 of TRA2A and SRSF3 respectively, indicating
a reduction in the decay of transcripts containing these exons (Figure 4.4).
149
Figure 4.4: Poison Exon Alternative Splicing Confirms NMD abroga-
tion
(A) Exon diagrams of splicing factors TRA2A and SRSF3 showing alternative
splicing that leads to inclusion of poison exon containing premature termination
codon. Coverage over the relevant exons of (B) TRA2A and (C) SRSF3 are
shown for two replicates of mock treated, si-Scr treated or si-UPF1 treated dis-
playing the increased coverage over the poison exon in UPF1 depleted samples.
150
Table 4.1: Total and nascent RNA-sequencing mapping statistics
RNA-sequencing libraries were pseudoaligned to a custom kallisto index of
GRCh38/hg38 human genome coding regions and long non-coding RNA regions.
Table shows average (n = 5) number of reads analysed and aligned in millions
and as a percentage mapping efficiency for each library condition.
4.2.3 Hundreds of genes are differentially expressed
upon depletion of UPF1 or NBAS
DESeq2 was used to identify differentially expressed genes in si-UPF1 cells or si-
NBAS cells compared to si-scramble treated cells. Both NBAS and UPF1 were the
most decreased mRNA in the relevant samples (fold change -1.85, p < 2.3×10−16
and fold change -3.28, p < 1.14×10−148 respectively; Figure 4.5A, B). Whilst
confirming the successful depletion of each of these factors, this is surprising con-
sidering NBAS depletion was actually slightly stronger than UPF1 depletion as
measured by qPCR. Furthermore, neither of the targets identified as increased in
expression by qPCR, CCL20 and INHBA, were identified as significantly changed
in expression upon depletion of UPF1 or NBAS.
Depletion of UPF1 affected the expression of 4756 genes, 2411 of which were
increased, deemed UPF1 targets. A comparison of the UPF1 targets identified
with previously published UPF1 targets (Tani et al., 2012; Lykke-Andersen et al.,
2014; Schmidt et al., 2015), revealed an extensive overlap as well as led to the
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Figure 4.5: Hundreds of genes are differentially expressed upon deple-
tion of UPF1 or NBAS
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Figure 4.5: Hundreds of genes are differentially expressed upon deple-
tion of UPF1 or NBAS
Differential expression analysis using DESeq2 on kallisto abundance estimates
shows genes changed in expression when (A) UPF1 or (B) NBAS was depleted
by siRNA in HeLa cells. Genes significantly changed in expression marked in red
(p < 0.05). The siRNA targeted gene indicated in blue and labelled. (C) A com-
parison of the UPF1 targets identified in this analysis with previously published
UPF1 targets (Tani et al., 2012; Lykke-Andersen et al., 2014; Schmidt et al.,
2015), revealed an extensive overlap as well as identifying many novel NMD tar-
gets. Only significant genes are shown (p < 0.05), full details in Sections 2.2.5
and 2.2.15. (D) Comparison of differentially expressed UPF1 targets identified
in this dataset with those identified in the previous similar study (Longman et al.,
2013). Analysis with Pearson’s correlation test produces r = 0.83, p < 0.0001.
(E) Comparison of differentially expressed NBAS targets identified in this dataset
with those identified in the previous similar study (Longman et al., 2013). Anal-
ysis with Pearson’s correlation test produces r = 0.20, p = 0.035. (F) A com-
parison of the NBAS targets identified in this analysis with previously published
UPF1 targets.
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identification of many novel NMD targets (Figure 4.5C). Indeed, the overlap
between this study and others is stronger than between some previous studies.
Comparison of differentially expressed genes identified in this dataset with those
identified in the previous similar study (Longman et al., 2013) shows a high corre-
lation (r = 0.83, p < 0.0001, Pearson’s correlation coefficient; Figure 4.5D). This
indicates that despite the difference in sequencing technology (RNA-sequencing
compared to microarray), the effect of UPF1 depletion can be reasonably repro-
ducible by using the same siRNA pool and cell line.
Depletion of NBAS altered the mRNA levels of 421 genes. Of these, 209 genes
were increased in abundance, suggesting they are targets of NBAS that are nor-
mally broken down. This is the first RNA-sequencing experiment assessing the
effects of NBAS depletion. Comparison with the only other genome wide NBAS
profiling (Longman et al., 2013) shows a weak correlation that is not statistically
significant (r = 0.20, p = 0.035, Pearson’s correlation coefficient; Figure 4.5E).
This is in agreement with the variable results seen by qPCR upon depletion of
NBAS, demonstrating that the effects of NBAS depletion on gene expression are
more inconsistent than that of UPF1 depletion. Correspondingly, a comparison of
the NBAS targets identified with previously published UPF1 targets (Tani et al.,
2012; Lykke-Andersen et al., 2014; Schmidt et al., 2015), revealed very limited
overlap (Figure 4.5F).
4.2.4 NBAS and UPF1 co-regulate mRNA expression
specifically at the ER
A robust co-regulation of mRNAs was observed when UPF1 or NBAS was de-
pleted (Pearson’s correlation r = 0.67, p < 0.001) (Figure 4.6A), indicating that
UPF1 and NBAS function in a common pathway. Of all NBAS targets, 95 are
common targets of NBAS and UPF1 (45%), implying these are specifically tar-
geted by the ER-NMD pathway.
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Figure 4.6: NBAS and UPF1 co-regulate mRNA expression and affect
ER stress
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Figure 4.6: NBAS and UPF1 co-regulate mRNA expression and affect
ER stress
(A) Comparing fold change of genes when UPF1 or NBAS were depleted reveals
a correlation (Pearson’s correlation r = 0.67, p < 0.001). (B) Differential expres-
sion of NMD factors upon depletion of NBAS or UPF1. Change in abundance
shown as log2(fold change) and standard deviation from DESeq2. Stars indicate
significant changes (p < 0.05).(C) Gene Ontology (GO) analysis of all NBAS
targets. Top three terms are shown of biological process (BP), molecular func-
tion (MF) and cellular component (CC) GO terms. (D) Cellular component GO
analysis of mRNAs regulated by both NBAS and UPF1. (E) GO analysis of all
UPF1 targets as for NBAS targets. (F) Cumulative fold change of genes associ-
ated with the GO term ER unfolded protein response (UPR) (GO:0006986) when
UPF1 depleted or (G) when NBAS depleted compared to the global fold change
when each factor was depleted. Significant increase in fold change of these genes
was seen upon depletion of UPF1 or NBAS (p < 0.001 and p < 0.05 respectively;
Wilcoxon rank sum test).
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It has been shown that transcripts encoding NMD factors are themselves reg-
ulated by the NMD pathway, thus forming a feed-back auto-regulatory loop
(Huang et al., 2011; Yepiskoposyan et al., 2011; Longman et al., 2013, Section
1.2.2). Therefore, I was interested to see how the RNA of other NMD factors
was changed upon depletion of UPF1 and NBAS. Differential expression in either
condition compared to si-Scr treated samples showed that several NMD factors
were increased in expression upon depletion of UPF1 (Figure 4.6B, stars indicate
significant (p < 0.05). The core NMD factors UPF2, UPF3B, SMG1, SMG5,
SMG7 and SMG9 were all significantly increased in expression as well as the
exonuclease XRN1. The NMD repressor UPF3A was significantly decreased in
expression. NBAS mRNA was slightly increased in expression upon depletion of
UPF1 although it did not reach significance. A significant change in expression
was not detected for any of the NMD factors upon depletion of NBAS, suggesting
it does not trigger the NMD autoregulatory feedback loop.
Gene Ontology (GO) analysis of NBAS targets identified ion binding and regu-
lation of metabolic processes as common functions of proteins encoded by tran-
scripts (Figure 4.6C). Significant cellular component terms include endoplasmic
reticulum part (GO:0005783), Golgi membrane (GO:0000139) and Golgi appa-
ratus part (GO:0005794), demonstrating NBAS target transcripts encode for se-
cretome proteins. To identify the localisation of common targets, GO analysis of
the mRNAs regulated by both NBAS and UPF1 was carried out (Figure 4.6D),
resulting in all significant GO terms in the cellular compartment category relating
to either secreted, extracellular proteins or membrane-associated proteins, reveal-
ing a strong enrichment for mRNAs encoding secretome proteins in the common
targets, which are preferentially translated at the ER translocon (Ast et al., 2013,
Section 1.1.4). GO analysis of UPF1 targets revealed enrichment of genes associ-
ated with the GO terms response to endoplasmic reticulum stress (GO:0034976),
localised to endoplasmic reticulum part (GO:0005783) and bounding membrane
of organelle (GO:0098588), suggesting they are secretome proteins, likely to be
translated at the ER (Figure 4.6E). Whilst some secretome related terms are
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significant when GO analysis is carried out on all UPF1 targets, they account
for only a subset of the cellular component terms, indicating a subset of UPF1
targets are translated at the ER. Taken together this suggests that transcripts at
the ER that are regulated by UPF1 are also affected by NBAS.
There is a growing body of evidence that ER stress is regulated by NMD (Section
1.4.3; Mendell et al., 2004; Gardner, 2008; Sakaki et al., 2012; Karam et al., 2015;
Usuki et al., 2019), so I was particularly intrigued to know if NBAS also had links
to ER stress. To investigate effect on these pathways, genes associated with ER-
stress GO terms were analysed. There was a significant increase in fold change
in genes associated with the ER unfolded protein response (UPR) (GO:0006986)
when either NBAS or UPF1 was depleted, compared to the global fold change
when each factor was depleted (p < 0.05 and p < 0.001 respectively; Wilcoxon
rank sum test, Figure 4.6F, G), showing that ER stress response is increased
when either UPF1 or NBAS is depleted. This suggests that ER homeostasis is
perturbed when ER-NMD is not functional, supporting the hypothesis that an
ER-specific NMD pathway is essential for cellular homeostasis.
To further characterize the target mRNAs, the presence of gene annotations was
assessed across the three groups of UPF1 targets, NBAS targets and common
targets. Surprisingly, only 20% of UPF1 targets had an annotated NMD tran-
script, whilst this was even lower amongst NBAS targets (10%; Figure 4.7A).
Annotation of signal sequence and transmembrane helix, two common markers
of secretome proteins translated at the ER, were both higher in NBAS targets
than UPF1 targets, although still very low (Figure 4.7B, C).
To gain a more physiological characterisation of the targets, they were intersected
with three experimental datasets identifying transcripts localised and/or trans-
lated at the ER: APEX-seq, ER fractionation sequencing and ER proximity spe-
cific ribosome profiling (Section 2.2.15). APEX-seq, a method for RNA sequenc-
ing based on direct proximity labelling of RNA led to the identification of 1077
mRNAs localised at the ER (Fazal et al., 2019). Cell fractionation followed by
ribosome foot-printing coupled with deep sequencing identified 486 mRNAs (Reid
and Nicchitta, 2012). Finally, proximity-specific ribosome profiling, based on ER
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Figure 4.7: Targets of NBAS and UPF1 are translated at the ER
Enrichment of gene annotations was assessed across the three groups of UPF1
targets, NBAS targets and common targets. Red area represents percentage of
these targets that are annotated as (A) having an NMD transcript, (B) contain-
ing a signal sequence and (C) containing a transmembrane helix. (D) Overlap of
the three literature datasets identifying transcripts localised and/or translated at
the ER: APEX-seq, ER fractionation sequencing and ER proximity specific ribo-
some profiling (Section 2.2.15). (E) Enrichment of each of the three ER datasets
in the three groups of UPF1 targets, NBAS targets and common targets. Both
NBAS targets and common targets were significantly more enriched than UPF1
targets (2.4 − fold, p < 0.001 and 2.6 − fold, p < 0.001 respectively, Exact Bino-
mial test).
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membrane proximity labelling of ribosomes identified 686 mRNAs translated at
the ER (Jan et al., 2014). Surprisingly, overlap between the transcripts identified
as ER localised from the three datasets was only 7% even though all were carried
out in the same cell line; HEK293T (114 transcripts identified in all three studies
of 1616 total RNAs identifed; Figure 4.7D), however this low rate of intersection
could be partly due to inclusion thresholds used by each technique. Therefore,
mRNAs deemed ”significant” by one group could be almost but not quite sig-
nificant for another. By overlapping with all three datasets, NBAS targets were
found to be strongly enriched for experimentally validated ER genes (31.6%),
as compared to 14.4% of UPF1 targets. Furthermore, 18.2% of NBAS targets
were found in two or more of the datasets, as compared to only 6.3% of UPF1
targets. Considering NBAS and UPF1 common targets, 37.9% of targets were
found in at least one dataset, whilst 23.2% were found in two or more datasets
(Figure 4.7E). NBAS-regulated targets were strongly enriched for experimentally
identified ER-localised genes (oddsratio = 6.07, p < 0.001, Fisher’s Exact test),
whereas UPF1 targets were only modestly enriched (oddsratio = 2.44, p < 0.001,
Fisher’s Exact test). Compared to UPF1 targets, those targets which were also
regulated by NBAS were 2.6-fold more likely than expected by chance to be found
at the ER (p < 0.001, Exact Binomial test), confirming that NBAS and UPF1
together regulate NMD targets specifically at the ER.
4.2.5 UPF1-independent NBAS increases in expression
and NBAS decreases in expression
It is accepted that UPF1 is the core NMD factor and therefore all NMD tar-
gets are regulated by UPF1 (Zünd and Mühlemann, 2013; Singh et al., 2019).
Therefore only those NBAS targets that are also UPF1 targets are presumed to
be bona fide ER-NMD targets. However, since NBAS is not fully characterised
I was interested to profile the NBAS-dependent, UPF1-independent changes in
transcript expression.
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Gene ontology analysis of the 114 genes increased in expression only when NBAS
was depleted revealed membrane-associated and extracellular matrix-associated
cellular component, molecular function and biological process terms (Figure 4.8A).
Overlapping these genes with the three previously described ER datasets revealed
33.04% are also identified in these datasets (Figure 4.8B), a similar overlap to
common targets (37.9%) that were increased in expression when NBAS and UPF1
were depleted. NBAS does have a known role in processing of secretome proteins,
but it was surprising to find that NBAS appears to also affect expression of mR-
NAs that specifically encode secretome proteins in an NMD-independent manner.
212 genes were significantly downregulated upon depletion of NBAS. Overlap-
ping these genes with the three ER datasets revealed just 9.91% were identified
in these datasets (Figure 4.8B). This intersection is lower than that of UPF1
targets (14.4%), suggesting that the majority of these transcripts decreased in
abundance are not ER associated and therefore are likely to be indirect effects
of NBAS depletion. GO analysis of these downregulated genes resulted in dis-
perse cellular component and molecular function terms (Figure 4.8C). However,
in the biological processes category metabolic processes and RNA localisation to
cajal bodies were identified. Cajal bodies are regions within the nucleus that
are enriched in proteins and RNAs involved in mRNA processing (Hebert and
Poole, 2017). This suggests a downregulation of RNA processing upon depletion
of NBAS which is a standard cellular stress response.
4.2.6 Subcellular changes to mRNA expression
Evidence from GO analysis and comparison with ER datasets suggested that
the majority of NBAS regulated mRNAs and a proportion of UPF1 regulated
mRNAs are translated at the ER. However, GO analysis relies on generalisations
and often predicted rather than experimentally determined function and the three
ER datasets used were all performed in a different cell line to my RNA-sequencing
experiment. Carrying out RNA-sequencing on cells that have been experimentally
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Figure 4.8: UPF1-independent NBAS effects on mRNA expression
(A) Gene ontology (GO) analysis of the 114 genes increased in expression only
when NBAS was depleted. Top three terms are shown of biological process (BP),
molecular function (MF) and cellular component (CC) GO terms. (B) Overlaps
with the three literature datasets identifying transcripts localised and/or translated
at the ER: APEX-seq, ER fractionation sequencing and ER proximity specific
ribosome profiling (Section 2.2.15). Bars show percentage overlap of all genes
increased in expression when NBAS depleted (All NBAS Up), genes increased in
expression when NBAS and UPF1 depleted (Common Up), genes increased in
expression when NBAS depleted but not when UPF1 depleted (NBAS Only Up)
and all genes decreased in expression when NBAS depleted (NBAS Down). (C)
GO analysis of the 212 genes decreased in expression when NBAS depleted.
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Figure 4.9: Experimental design of fractionation RNA-sequencing
Schematic of experimental design of fractionation RNA-sequencing experiment.
Cells were double depleted with siRNA pools, fractionated and libraries prepared
from total RNA as well as membrane-associated and cytoplasmic fractions. All
conditions were sequenced in triplicate.
fractionated would give a more realistic picture of the localisation of transcripts
regulated by NBAS. Therefore, I next examined how NBAS depletion affected
transcripts specifically at the ER compared to the cytoplasm and how this differs
from depletion of core NMD factors UPF1 and UPF2.
Magda Maslon carried out fractionation of HeLa cells depleted of NBAS, UPF1,
UPF2 or mock-depleted control cells and then prepared RNA-sequencing libraries
from the cytoplasmic and membrane fractions, and total RNA. Cellular fractiona-
tion was performed as described before (Jagannathan et al., 2011) with some mod-
ifications (Longman et al., 2020). Briefly, cells were permeabilised with digitonin
to extract cytosolic fraction, then lysed and the membrane fraction recovered by
centrifugation (Figure 4.9). Paired-end illumina sequencing was performed by
BGI Genomics, reads de-barcoded and fastq files returned for analysis.
After quality control and mapping to GRCh38/hg38 using STAR (Section 4.2.2;
Appendix B), HTSeq was used to count reads per gene feature and differential
gene expression was analysed using DESeq2 (Figure 4.10A, B, C). In this dataset,
depletion of UPF1 significantly affected the expression of 8475 genes, 4397 of
which were increased, and 4078 were decreased. Although the numbers of genes
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changing up and down in expression are similar, a skew can be seen with generally
larger fold changes in genes increased in expression (Figure 4.10A). Comparison
between dataset 1, described earlier in this chapter, and dataset 2, the fraction-
ated experiment descried here, reveals a strong correlation between targets signif-
icantly changed upon UPF1 depletion in both datasets (r = 0.88, p < 2.2x10−16;
Figure 4.10D), demonstrating the comparable results of the two experiments. In
response to NBAS depletion 4813 genes were significantly changed in expression
in this dataset, far more than in dataset 1. However more genes were decreased
in expression (2614) than increased (2199). Despite the smaller number of NBAS
targets significantly changed in both datasets, compared to UPF1 targets, there
was also a strong correlation of differential expression with dataset 1 upon de-
pletion of NBAS (r = 0.71, p < 2.2x10−16; Figure 4.10E). The correlations of
UPF1-mediated changes, and especially NBAS-mediated changes, between the
two RNA-sequencing datsets is much stronger than either dataset compared to
the UPF1 and NBAS microarray (Longman et al., 2013, Figure 4.5D, E) De-
pletion of UPF2 significantly affected the expression of 1210 genes, far less than
when NBAS was depleted, despite UPF2 often being classed as a core NMD fac-
tor. However, of these, there was a clear skew to increased expression with 818
significantly increased in expression and 392 decreased (Figure 4.10C).
As with the first dataset in this chapter, I was interested to see how the mRNA of
other NMD factors was changed upon depletion of UPF1, UPF2 and NBAS. Dif-
ferential expression in depleted cells compared to si-Scr treated samples showed
that several NMD factors were increased in expression upon depletion of UPF1
and UPF2 (Figure 4.10F), stars indicate significant (p < 0.05). The core NMD
factors UPF3B, SMG5 and SMG9 were significantly increased in expression upon
depletion of UPF1 or UPF2. In contrast to datset 1 discussed earlier inn this
chapter, the NMD repressor UPF3A was also significantly increased in expres-
sion upon depletion of UPF1 or UPF2. The core factors SMG1 and SMG6 were
also increased in expression upon depletion of UPF1 only. Both UPF2 and NBAS
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mRNA were slightly increased in expression upon depletion of UPF1 although
neither reached significance. UPF1, UPF3B, SMG1 and SMG9 were all signif-
icantly decreased in expression upon depletion of NBAS, suggesting it does not
trigger the NMD autoregulatory feedback loop.
Despite the strong correlation of expression changes in response to depletion of
NBAS and UPF1 between this dataset and the one described earlier in this chap-
ter, the correlation between NBAS and UPF1 changes in mRNA expression was
weak, although still significant, unlike the same comparison in the first dataset
(r = 0.11, p = 4.6x10−8; Figure 4.11A). Whereas the correlation between changes
in response to depletion of UPF1 and UPF2 was strong (r = 0.89, p < 2.2x10−16;
Figure 4.11B).
Next, differential expression analysis was carried out on the cytoplasmic and
membrane fractions of each condition (Figure 4.11C-H). These analyses largely
reflect the total RNA, UPF1 has by far the largest effect and causes the largest
fold changes, especially for genes in the cytoplasmic fraction increased in expres-
sion (Figure 4.11E). Depletion of NBAS or UPF2 led to fewer changes in gene
expression, compared with UPF1. NBAS has more of an effect in the membrane
fraction (17.81% membrane genes vs. 3.51% non-membrane genes; Figure 4.11C,
F), whilst UPF2 has more of an effect in the cytoplasmic fraction (6.60% mem-
brane genes vs. 16.74% non-membrane genes; Figure 4.11E, H), However, many
genes were found to be not only present in both membrane and cytoplasmic frac-
tions but differentially expressed in both. Therefore, a classification of genes as
membrane-associated or non-membrane was necessary.
Gene expression in both fractions in control cells was compared by using vari-
ant stabilised transformation of transcripts per million (TPM), averaged across
replicates. A group of “membrane-associated” genes were defined that showed
≥2-fold higher expression in the membrane fraction, whereas all other expressed
genes were deemed “non-membrane” genes (Figure 4.12A). The validity of cell
fractionation was assessed by identifying genes in the previously described exper-
imentally validated ER datasets (Section 4.2.3) in this dataset. As expected, the
majority of genes present in any two ER datasets were found in the membrane-
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Figure 4.10: Validation of total mRNA expression changes from frac-
tionation experiment
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Figure 4.10: Validation of total mRNA expression changes from frac-
tionation experiment
Differential gene expression compared to si-Scr control cells when cells were de-
pleted of (A) UPF1, (B) NBAS or (C) UPF2. MA plots show log2 fold-change
of gene expression plotted over mean of normalised counts (gene expression).
Significantly changed genes (p < 0.05) are indicated in red. Comparison between
dataset 1, described earlier in this chapter, and dataset 2, the fractionated ex-
periment reveals strong correlations between differentially expressed genes upon
depletion of (D) UPF1 and (E) NBAS. Pearson’s correlation coefficient and p
value indicated in each plot. (F) Differential expression of NMD factors upon
depletion of NBAS, UPF1 or UPF2. Change in abundance shown as log2(fold
change) and standard deviation from DESeq2. Stars indicate significant changes
(p < 0.05).
associated set (OR = 66.94, p < 0.001, Fishers Exact test) (Figure 4.12B). Regu-
lation by each NMD factor was measured by percentage of ‘membrane associated’
genes in membrane fraction, and of ‘non-membrane’ genes in cytoplasmic fraction
that were increased in expression when the factor was depleted (Figure 4.12C,
D). Knock-down of UPF1 led to a robust increase in the abundance of mRNAs
in both membrane and cytoplasmic fractions, whereas depletion of NBAS led
to an upregulation of a higher percentage of membrane-associated genes than
of non-membrane genes (5−fold increase, p < 0.001, Exact Binomial test). In
contrast, depletion of UPF2 led to preferential upregulation of ‘non-membrane’
genes in the cytoplasm (> 2.5-fold increase, p < 0.001, Exact Binomial test). Of
the 356 ‘membrane associated’ genes in membrane fraction that were increased
upon NBAS depletion, 48.6% were also increased upon UPF1 depletion. The
gene most increased in abundance upon NBAS depletion was Matrix Gla pro-
tein (MGP) which is interesting since MGP plays a role in bone organization
and NBAS mutations have been shown to lead to osteogenesis imperfecta, the
commonest inherited bone fragility disorder (Balasubramanian et al., 2017).
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Figure 4.11: Correlations and differential expression of RNA fractions
(A) Comparing fold change of genes upon depletion of UPF1 and NBAS or (B)
UPF1 and UPF2. Pearson’s correlation coefficient and p value indicated in each
plot. Differential gene expression analysis compared to si-Scr control cells in
membrane fraction (C,D,E) and cytoplasmic fraction (F,G,H) when cells were
depleted of (C,F) NBAS, (D,G) UPF1 or (E,H) UPF2. MA plots show log2
fold-change of gene expression plotted over mean of normalised counts (level of
gene expression). Significantly changed genes (p < 0.05) are indicated in blue
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Figure 4.12: Effect of NMD factor abrogation on expression of
membrane-associated genes
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Figure 4.12: Effect of NMD factor abrogation on expression of
membrane-associated genes
(A) Experimentally validated ER genes are present in the membrane fraction.
Scatter plot of gene expression in membrane vs cytoplasmic fractions in mock-
depleted cells, with experimentally validated ER genes present in at least 2 of
the 3 ER datasets described in Fig. 2B are indicated in magenta. (Enrich-
ment OR = 66.94, p < 0.0001, Fishers Exact test). (B) Scatter plot shows
average transformed counts of each gene in membrane and cytoplasmic frac-
tions in mock-depleted cells. Transcripts >2-fold increased in expression in mem-
brane fraction over cytoplasmic section are shown in magenta and identified as
“membrane-associated genes”. (C) NBAS preferentially regulates membrane-
associated targets. Plot shows percentage of “membrane-associated” genes in the
membrane fraction and of “non-membrane” genes in the cytoplasm that are regu-
lated (p < 0.05) by each NMD factor. NBAS regulates over fivefold higher percent-
age of membrane-associated genes than non-membrane genes (p < 0.001, exact bi-
nomial test). In contrast, UPF1 regulates a similar percentage of both membrane-
associated and non-membrane genes (1.3-fold higher percentage of membrane-
associated genes, p < 0.001, exact binomial test), and UPF2 regulates 2.5-fold
higher percentage of non-membrane genes than membrane genes (p < 0.001, exact
binomial test). (D) Summary table of number and percentage of genes regulated
by NMD factors in each cellular fraction.
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4.3 Discussion
4.3.1 NBAS regulates a subset of UPF1 targets
Although comparing the UPF1 targets identified here and those identified in
previous studies produces a small overlap, this was not unexpected as overlap
between all NMD datasets is weak, evidence of the heterogeneous nature of the
NMD response and the variability in measuring it. In fact, better overlap is
seen between this study and others than between previous studies (Figure 4.5C).
Added to that, as well as NBAS having at least one non-NMD function in Golgi-
ER retrograde transport, UPF1 has several known functions beyond its role in
NMD. These include regulation of RNA on multiple levels such as RNA splicing,
transport, translation, and mRNA turnover (Atkin et al., 1995; Lykke-Andersen
et al., 2000; Mendell et al., 2002; Wilkinson, 2005; Nazarenus et al., 2005). UPF1
shuttles between the nucleus and cytoplasm, indicating that the protein has po-
tential roles in both the nucleus and the cytoplasm (Singh et al., 2019). For
example, UPF1 has been identified as interacting with SRSF1 which plays a role
in preventing exon skipping, ensuring the accuracy of splicing and regulating al-
ternative splicing (Aznarez et al., 2018), and UPF1 stabilizes primary retroviral
RNA so that UPF1 downregulation by siRNA decreases HIV RNA and diminishes
the synthesis of virion structural proteins (Ajamian et al., 2008). In addition, the
interaction of UPF1 with Staufen1-mediated mRNA decay directly affects RNA
stability (Kim et al., 2005; Park and Maquat, 2013). All these roles affect RNA
processing and so could be the cause of changes to transcription rate of various
transcripts, which would confound NMD studies of transcript expression after
UPF1 depletion.
Identification of NBAS targets has only previously been carried by microarray
analysis of NBAS depleted cells (Longman et al., 2013). Correlation between the
effects measured in that study and the effects described here was not strong but
was significant (Figure 4.5E). However, the difference in technical approach is
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likely to account for a large amount of the variability seen. Although the level
of knock down of NBAS achieved was similar to that of Longman et al. (2013)
(23.4% compared to ∼20%), the number of targets identified in this study was
∼36% of the number identified there and the magnitude of change generally lower.
However, the number of NBAS targets that were also found to be UPF1 targets
was very similar (106 and 95). Intersecting these two lists of joint targets reveals
only three mRNAs upregulated in all four experiments: NCOA7, SNAP25, MVD.
Whilst NCOA7 is a nuclear receptor coactivator, both MVD and SNAP25 are
involved in intracellular transport, MVD in transport to the Golgi and SNAP25
in vesicle fusion with the cell membrane to bring about exocytotic events.
NBAS has previously been shown to contribute to the autoregulatory loop affect-
ing levels of transcripts that encode NMD factors. RT-qPCR analysis of total
cellular RNA from NBAS-depleted HeLa cells showed a significant increase in
mRNA of UPF1, DHX34, UPF2, SMG5, SMG7 and SMG8 (Longman et al.,
2013). However, neither of the datasets analysed in this chapter identified sig-
nificant increases in the mRNA level of any NMD factors, indeed in the second
dataset, NBAS depletion lead to significant decrease in mRNA level of several
NMD factors including UPF1. It was also shown by Longman et al. (2013) that
NBAS mRNA was significantly increased upon UPF1 depletion, but this was also
not replicated by either of the differential expression analyses. Longman et al.
(2013) only showed changes measured by qPCR, so this difference in result could
be due to technical differences between the two techniques, however both the
RNA-sequencing datasets analysed here reproduced the qPCR results showing
increased mRNA of NMD factors upon depletion of UPF1.
Taken together the caveats discussed here show that identifying bona fide NMD
targets using only steady-state gene expression measures is challenging. Since
a similar knock down of NBAS by siRNA resulted in variable effect, an elegant
improvement to this experiment would be the creation of a cell line where NBAS
has an auxin-inducible degron tag. This could be created using CRISPR/Cas9
technology, utilising the methodology I have optimised (Chapter 3). The addition
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of this tag would allow acute and efficient knockdown of NBAS at the protein
level (Li et al., 2019). These cells could then be assessed for differential expression
by RNA-sequencing but a more accurate measure of NMD activity would be
measuring change of RNA stability since this is the process NMD directly affects.
I have shown that there is a significant overlap between genes increased in ex-
pression when NBAS is depleted and those increased in expression when the core
NMD factor UPF1 is depleted, in agreement with NBAS’ previously documented
role as an NMD factor (Longman et al., 2007; Anastasaki et al., 2011; Long-
man et al., 2013, 2020). NBAS affects a smaller number of genes than UPF1
but of those 45.5% are commonly affected. Characterising the overlapping genes
showed an enrichment for secretome genes, translated at the ER, compared with
UPF1 targets. This suggests NBAS and UPF1 are working together to regulate
transcripts specifically translated at the ER.
Although the three ER-localisation studies were performed in HEK293T cells,
the overlap between NBAS targets and each datasets is equally strong as the
overlap between each of the datasets, showing that NBAS targets are transcripts
not just part of the secretome, but actively translated at the ER translocon. The
overlap of the common UPF1 and NBAS targets with these data is even higher,
confirming that the NBAS targets also regulated by UPF1 are precisely those that
are translated at the ER. This indicates that the NBAS targets not regulated by
UPF1 are likely not NMD targets but linked to NBAS’ role in Golgi-ER retrograde
transport.
GO analysis of UPF1-independent NBAS targets, resulted in membrane and se-
cretome terms being significant in all three categories. This is not unexpected
since NBAS is involved in post-translational processing of secretome proteins and
is localised to the ER so is likely to affect transcripts also involved in this pathway.
However, since these changes are UPF1-independent, it is likely they are NMD-
independent and therefore it is not clear how NBAS is affecting mRNA abundance
rather than protein abundance and perhaps indicates a feedback mechanism that
links reduction in secretome protein processing to increased expression of the
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mRNA of those genes. Compared to all mRNAs that increased in expression
upon depletion of NBAS, those that decreased in expression were significantly
less enriched in the three experimental ER datasets, suggesting that they are
indirect effects since NBAS is located at the ER.
It would also be interesting to repeat this profiling in different cell lines, specif-
ically more physiological cell lines than HeLa cells and those where secretion is
more active such as U2OS cells which are bone osteosarcoma epithelial cells. This
would be especially relevant as NBAS compound heterozygous variants have been
identified in patients as a cause of atypical osteogenesis imperfecta (Balasubra-
manian et al., 2017).
4.3.2 ER-NMD is important for ER homeostasis
Evidence of a link between UPF1 or NBAS depletion and increased unfolded
protein response (UPR) is important because previous work has suggested a con-
nection between NMD and ER stress and the UPR (Section 1.4.3 Mendell et al.,
2004; Gardner, 2008; Karam et al., 2015). It has previously been shown that the
NMD factors UPF1 and UPF2 decreased the risk of death in an in vitro model
of Amyotrophic Lateral Sclerosis (ALS) (also known as motor neuron disease
(MND)) (Barmada et al., 2015). Patients commonly harbour a mutant form of
TDP43 that leads to aberrant cleavage and aggregation of the C-terminal region.
Primary rat neurons expressing human TDP43 with the patient mutation, were
found to have better survival when either UPF1 or UPF2 was overexpressed, but
not by expression of an RNA helicase defective UPF1 mutant protein, possibly
indicating a neuroprotective function of NMD (Barmada et al., 2015). It seems
likely that protection against aggregates would have increased importance at the
ER, where build-up of misfolded protein is of particular risk, and therefore it is
likely that the ER-NMD pathway is important for ER homeostasis and protection
against ER stress.
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Recent evidence (Karam et al., 2015; Carreras-Sureda and Hetz, 2015; Li et al.,
2017c) supports a role for NMD in modulating the ER stress response by en-
suring appropriate activation of the UPR; a pathway that senses and responds
to excessive amounts of misfolded proteins in the ER. Consequently, an appro-
priate level of NMD activity is required to protect cells from detrimental stress
response activation. In particular, pathological UPR activation is recognised as
a major causal mechanism in neurodegenerative diseases including Alzheimer’s
disease, Parkinson’s disease and prion diseases (Shah et al., 2017; Yan et al.,
2019; Torkzaban et al., 2020; Li et al., 2020). Therefore, modulation of the ac-
tivity of the ER-NMD pathway could be crucial to regulate the response to ER
stress. It is tempting to speculate that increasing the activity of the ER-NMD
pathway will have a neuroprotective effect by limiting excessive UPR signalling
in neurodegeneration.
4.3.3 Future work
As with all genome-wide studies it would be prudent to validate my findings using
orthogonal approaches. Firstly, the confirmation of expression changes of iden-
tified UPF1 and NBAS targets upon depletion of the relevant factors by qPCR.
Although the extent of change may be different due to the difference in measure-
ment techniques, the direction and relative magnitude should be reproducible. In
fact, it would be interesting to see how consistent the change in magnitude was
between genes, considering the seemingly low negative fold change in both UPF1
and NBAS measured by DE and the ∼80% decrease in mRNA level measure by
qPCR of the same samples. However, qRT-PCR only reports the average mRNA
levels of an NMD target in a population of cells and thus preclude insight into
differences within mRNA populations. Furthermore, like total RNA differential
expression analysis, it is reliant on steady-state mRNA levels which are likely
affected by differences in nuclear export rates and differences in the onset and
efficiency of translation of different mRNAs, in addition to NMD degradation.
These confounding factors mean differentiating legitimate RNA targets of NMD
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from downstream effects is near impossible, even with the high number of repli-
cates and sequencing depth in this study. Therefore, to understand fully the
effects of any given NMD factor, RNA stability should be measured and change
in stability of transcript used to define NMD targets.
4.3.4 Summary
In conclusion, in this chapter I have shown that NBAS regulates a subset of
NMD targets that are specifically membrane-associated and translated at the
ER. I have also shown that a subset of UPF1 targets are ER-translated, and that
these transcripts are also regulated by NBAS. Altogether, these results add to
the previous work indicating the existence of a specific ER-NMD pathway that
targets for degradation mRNAs that are translated at the ER.
The key findings presented in this chapter have been published in the follow-
ing article, which is attached as Appendix C:
Longman D, Jackson-Jones KA, Maslon MM, Murphy, LC, Young, RS, Stod-
dart, JJ, Hug, N, Taylor, MS, Papadopoulos, DK, & Cáceres, JF (2020) Identi-
fication of a localised nonsense-mediated decay pathway at the endoplasmic retic-
ulum Genes & Dev. 2020. 34: 1075-1088. doi:10.1101/gad.338061.120
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Chapter 5
Quantifying changes in RNA
stability reveals many expression




Measurements of mature RNA are in themselves poorly informative of the real
transcriptional state of genes (Furlan et al., 2020). For instance, the detection of a
mature RNA is typically taken as indication that the corresponding gene is tran-
scriptionally active. This is not necessarily the case for highly stable RNAs, which
might persist long after the gene has become silent. Furthermore, identifying the
cause of a change in mature RNA abundance is difficult without determining the
corresponding RNA dynamics. Therefore, several studies have attempted to ex-
tend traditional total RNA differential expression by using integrative analyses
of premature and mature RNA abundances (Zeisel et al., 2011; Gray et al., 2014;
La Manno et al., 2018; Bergen et al., 2020). However, the key limitation of all
these studies is having considered intronic expression as a proxy of synthesis rates.
RNA abundance is determined by the combined action of three main processes:
the synthesis of premature RNA, its processing into mature RNA and finally
degradation of the mature mRNA (Figure 5.1A). The dynamics of transcripts
metabolism are set by the rates governing the kinetics of those steps, ultimately
setting the abundance of premature and mature RNA species (Orphanides and
Reinberg, 2002; Shalem et al., 2008; Friedel and Dölken, 2009; Rabani et al.,
2011; Gray et al., 2014; Eser et al., 2016; de Pretis et al., 2017). Therefore, it is
important to incorporate both RNA synthesis and RNA maturation when trying
to elucidate RNA degradation from total RNA abundance.
5.1.1 Benefits of differential stability analysis to identify
targets of NMD
NMD is defined as rapid degradation of target RNAs (Gatfield and Izaurralde,
2004; Kebaara and Atkin, 2009), meaning those transcripts will be unstable.
Therefore, transcripts with increased stability upon NMD factor depletion are
likely to be direct NMD targets regulated by that factor. Whilst traditionally,
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Figure 5.1: Measuring RNA stability requires more than total RNA
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Figure 5.1: Measuring RNA stability requires more than total RNA
(A) RNA abundance is determined by three main processes: the synthesis of
premature RNA, its processing into the mature form, and the degradation of the
mature RNA. The dynamics of transcripts metabolism and ultimately the abun-
dance of both premature and mature RNA species, are set by the rates governing
the kinetics of those steps (k1, k2, k3). Figure adapted from Furlan et al. (2020).
(B) Three main types of experiment have been used to measure RNA stability on
a genomic scale. Top - in vivo metabolic labelling with uridine analogues using ei-
ther time course measurements or RNA fractionation to produce values for steady
state RNA abundance [mRNA] and transcription rate (TR). This allows calcula-
tion of RNA half life (HL). Middle - inhibition of transcription followed by RNA
abundance measurements over time. Decreasing abundance can then be plotted to
provide a decay curve from which kd and HL can be determined. Bottom - ge-
nomic run-on techniques which combine metabolic labelling with inhibition of new
transcription initiation using sarkosyl. RNA fractionation then allows for steady
state RNA abundance [mRNA] and transcription rate (TR) to used to calculate
of RNA half life (HL). Figure adapted from Pérez-Ort́ın et al. (2013).
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differential gene expression upon depletion of a putative NMD factor has been
used to identify probable targets of that factor, as described in the previous
chapter, there are several drawbacks to this method. Most significantly, the
fact that NMD does not affect transcription directly, and therefore increases or
decreases in gene expression could be due to altered transcription rate caused by
secondary or downstream effects. Accordingly, measures of transcript stability
have been more recently used to identify transcripts targeted by NMD. Many
different techniques have been employed to measure differential stability genome
wide, upon depletion of an NMD factor (Figure 5.1B).
Traditional measurements of transcript stability have relied on transcription block
followed by multiple sampling times to track decay of signal over time. This
consists of measuring abundance of a transcript at multiple time points to give
a decay constant from which a half-life can be calculated. This half-life can then
be compared between different conditions such as control cells and cells where an
NMD factor such as UPF1 has been depleted.
However, these methods are highly invasive, affect cell viability, and could alter
various pathways including translation and RNA decay, and confound interpre-
tation (Friedel and Dölken, 2009; Wada and Becskei, 2017; Russo and Angelini,
2014). Furthermore, it has been suggested that transcription and decay are cou-
pled processes, such that inhibiting one is likely to directly influence the rate of
the other (Sun et al., 2012; Haimovich et al., 2013). Therefore, there has been a
search for less disruptive techniques to measure RNA stability.
The majority of recent methods use metabolic labelling, which consists of the
addition of a uridine analogue to cells which is specifically incorporated into newly
transcribed, or nascent, RNA without needing to block transcription. Run-on
techniques involve pulse labelling for a set time period with the uridine analogue
which is then incorporated into the nascent RNA and then a wash out step so
endogenous uridine is once again the only option. In this way only the RNA
transcribed in the set time period will be measured at the multiple time points,
thereby allowing the RNA abundance to be measured without being affected by
transcription rate.
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Global run-on sequencing (GRO-seq) is a modified Run-On protocol to isolate
nascent RNA allowing unbiased mapping of nascent transcripts genome-wide
(Core et al., 2008). GRO-seq combines metabolic labelling with transcription
block. This method uses 5’-bromo-uridine (BrU) to label newly synthesised RNA,
then nascent RNA is isolated and ultimately converted into an RNA-sequencing
library. After isolation of nuclei, sarkosyl is added, which prevents the attachment
of RNA polymerase to the DNA and stops de novo assembly of the pre-initiation
complex. Therefore, only transcripts that were initiated at the time of nuclei
isolation will be further elongated by engaged RNA polymerase, to allow incor-
poration of radioactive nucleotides. Due to this, GRO-seq is a sensitive method to
estimate transcriptional activity throughout the entire genome and has generated
detailed results, for example, on RNA polymerase II density at different classes of
protein coding genes and evidence that that RNA is synthesised bi-directionally
at most mammalian promoters (Huang et al., 1996; Core et al., 2008; Andersson
et al., 2014; Duttke et al., 2015).
Metabolic labelling of RNA has increasingly been used to measure stability by
fractionation of labelled RNA and isolation of nascent transcripts without the
use of transcription inhibition (Johnson et al., 1991; Dölken et al., 2008; Schwanhäusser
et al., 2011). This is because under steady-state conditions, RNA transcription
is balanced with RNA decay to maintain stable total transcript levels. There-
fore, de novo synthesis rates are higher for unstable transcripts. Thus, assuming
steady-state conditions, mRNA decay rates can be determined by analysing the
ratio of nascent to total RNA derived from the same sample (Dölken et al., 2008).
BrU immunoprecipitation chase-deep sequencing (BRIC-seq) also uses BrU to la-
bel nascent RNA but in physiologically undisturbed conditions since no inhibitors
of transcription or translation are used. The “chase” here refers to a subsequent
removal of BrU after the initial treatment, leading to chronological decreases of
BrU-labeled RNAs. The RNA half-life of each transcript is calculated from the
decreasing number of BrU-labeled RNA sequence tags measured by deep sequenc-
ing of BrU-labeled RNAs at multiple time points (Imamachi et al., 2014).
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Another common uridine analogue is 4-thiouridine (4sU). This can be used to
label nascent RNA in the same way as BrU (Dölken et al., 2008; Miller et al.,
2011; Rabani et al., 2011; Sun et al., 2012; Fuchs et al., 2014; Russo and Angelini,
2014; de Pretis et al., 2015; Marzi et al., 2016; Schwalb et al., 2016; de Pretis et al.,
2017; Michel et al., 2017; Wissink et al., 2019). Russo and Angelini (2014) used
4sU labelling and then purified total and nascent RNA from the same cells. Using
digital droplet PCR (ddPCR) they showed that by using both RNA fractions it
was possible to measure RNA stability at a single time point and without the use
of transcription inhibitors. I extended this approach by using RNA-sequencing
to identify NMD targets genome-wide, by identifying transcripts increased in
stability when NMD factors are depleted.
5.1.2 Aims
In this chapter I aim to understand how NBAS affects transcript stability by iden-
tifying targets which increase in stability when NBAS is depleted and comparing
these with UPF1-dependent increases in stability.
To do this, I will further analyse the total RNA described in Chapter 4 by con-
sidering both intronic and exonic reads and also used matched nascent RNA to
assess stability independent of gene expression. To identify genuine NMD tar-
gets, I will compare changes in stability with changes in expression to determine
transcripts whose stability and expression were increased upon depletion of UPF1
and/or NBAS. This will allow a more accurate comparison of NBAS NMD targets
with those of the core NMD factor UPF1.
In summary, the main aims of this chapter are:
a) To use exonic and intronic reads from matched total and nascent RNA-
sequencing to determine stability changes at a single time point without
transcription inhibition.
b) To compare the resulting differentially stabilised transcripts with the dif-




5.2.1 Defining exonic and intronic reads
I first wanted to differentiate changes of RNA stability from changes in transcrip-
tion. To do this, reads needed to be defined as originating from pre-mRNA or
mature mRNA. Normally, the majority of reads produced by RNA-sequencing are
exonic and this is further emphasised by mapping using annotation files that only
map to coding regions. However, in this analysis I decided to normalise each gene
to its own internal control of pre-mRNA level. For this reason, it was necessary
to produce and keep intronic reads. Therefore, no poly-A selection protocol was
used when preparing the RNA libraries. Furthermore, the nascent RNA samples
had a very low amount of RNA and there were concerns that any manipulation
would reduce this further. Therefore, no ribosomal RNA (rRNA) depletion was
carried out on the samples. Total RNA samples were treated the same as nascent
RNA, even though there was an abundance of RNA in these samples, to ensure
the samples were as matched as possible for downstream analysis.
Unlike for differential expression (Chapter 4) kallisto pseudoalignment is not ap-
propriate for this analysis as reads need to be mapped precisely so they can be
defined as exonic or intronic rather than counted per transcript. Therefore, each
lane of each replicate was mapped to GRCh38/hg38 human genome assembly sep-
arately using STAR. STAR was used because it is a splice-aware aligner, meaning
the tool can deal with reads that span across introns (Dobin et al., 2013). Map-
ping efficiency was high across all samples with an average of 89.2% of reads being
successfully aligned (Figure 5.2A; Table 5.1). Since this required defining both
intronic and exonic reads and standard transcriptomic mapping doesn’t readily
accept intronic reads, alignment to GRCh38/hg38 with STAR was performed with-
out an annotation file, with default parameters. This is because when provided
with an annotation of gene regions, an aligner will only keep reads that map to
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Figure 5.2: Mapping reads with STAR allows identification of intronic
read coverage
(A) Percentage of reads per library successfully mapped to GRCh38/hg38 (n=5)
for each condition and nascent (N) or total (T) RNA. (B) Representative read
pile up tracks show the high level of intronic reads in nascent RNA, and lower
level but still present intronic reads in total RNA.
these defined regions and may even preferentially map reads to these regions than
non-coding regions even if the probability is higher. Visualising the read pileups
revealed a high amount of intronic signal in nascent RNA samples, and a lower
amount but still visible intronic signal in total RNA samples (Figure 5.2B).
Gene structure annotation was extracted from Gencode v27 to define intronic
and exonic regions of each gene. In the case of multiple overlapping transcripts
for the same gene, overlapping exon coordinates were merged into union exons.
Subtraction of these from transcripts extents produced obligate intron annota-
tions (Figure 5.3A). Reads that overlapped obligate intron regions were classed
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Table 5.1: Mapping efficiency of total and nascent RNA with STAR
Average number of reads per library in each condition, number and percentage of
reads mapped to GRCh38/hg38 using STAR and no annotation file, and percentage
of reads failed due to multi-mapping (n=5).
as intronic reads since it was presumed they must originate from unspliced pre-
mRNA. Only reads that were fully within union exonic regions were counted as
exonic reads (Figure 5.3B). Reads in union exon and obligate intron regions were
counted per gene using bedtools.
5.2.2 Using exonic and intronic reads from paired
nascent and total RNA normalises for mRNA
processing and transcription rate
Measuring stability of RNA using analysis of premature and mature RNA abun-
dances is an improvement on the assumptions and caveats of using total RNA-
sequencing alone (Section 5.1.1) and is being increasingly used in genome-wide
studies (Zeisel et al., 2011; Gray et al., 2014; La Manno et al., 2018; Bergen et al.,
2020). However, the key limitation in this type of analysis is assuming intronic
expression as a proxy of synthesis rates, when intronic reads actually result from
the joint action of two processes: the synthesis of premature RNA and its pro-
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Figure 5.3: Schematic of custom analysis pipeline to calculate change
in stability of genes in depleted cells compared to control
(A) “Exonic” regions (blue) were defined as any part of the gene body that is
ever defined as an exon and “intronic” regions (purple) as those parts of the gene
which are never defined as an exon, resulting in facultative exons and obligate
introns. (B) “Exonic” reads were defined as those that exclusively overlapped with
“exonic” regions and “intronic” reads as those which even partially overlapped
with defined “intronic” regions.
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cessing into mature RNA (Figure 5.1A). Therefore, to measure more accurately
the kinetics affecting each RNA species, direct measurement of transcription rate
should be included in calculations in addition to the use of intronic reads to
account for RNA processing.
Once counts for exonic and intronic reads in each sample had been determined, a
dataset with total exonic, total intronic, nascent exonic and nascent intronic read
counts for each gene was produced for each sample, to give four values for each
gene in each sample (Figure 5.4A). Odds ratio (OR) calculations were performed
using these four values, according to the follow equation:
OR = (total exonic (mature mRNA) / total intronic (pre-mRNA))
/ (nascent exonic (pre-mRNA) / nascent intronic (pre-mRNA))
This produced a single number for each gene. This allowed measurement of
change in OR when either NBAS or UPF1 was depleted, or when cells were
treated with si-Scr as a control, compared to mock treated cells.
Globally, an increase in stability was observed when either UPF1 or NBAS were
depleted which was significant compared to treatment with si-Scr (Figure 5.4B).
The shift when UPF1 was depleted was a 1.14-fold increase in stability compared
to si-Scr (p < 0.0001; paired t-test) and when NBAS was depleted the shift
compared to si-Scr was a 1.04-fold increase (p < 0.0001; paired t-test), consistent
with my previous results that NBAS affects fewer transcripts than UPF1 and the
resulting changes are more subtle.
To calculate significance, paired t-tests were carried out on a per gene basis.
This resulted in 859 transcripts being identified as increased in stability and 199
decreased in stability upon depletion of UPF1 (Figure 5.4C). This represents a
4.31-fold enrichment of increased stability (p < 0.001; Fisher’s exact test) when
UPF1 is depleted, in agreement with UPF1’s role as a core NMD factor. Upon
depletion of NBAS, 202 transcripts were increased in stability whereas 278 tran-
scripts were decreased in stability (Figure 5.4D), showing a slight enrichment in
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Figure 5.4: Measuring stability using paired nascent and total RNA
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Figure 5.4: Measuring stability using paired nascent and total RNA
(A) Total exonic, total intronic, nascent exonic and nascent intronic read counts
for each gene were produced for each sample, to give four values for each gene
in each sample. OR calculations were performed using these four values. (B)
RNA stability (OR) for each gene was normalised to mock treated cells to give a
measure of fold change upon si-Scr, si-UPF1 or si-NBAS treatment. Cummulative
distributions show the global change in stability in si-Scr control (black line), si-
NBAS (blue line) and si-UPF1 (red line) treated cells. Both UPF1 and NBAS
depletion resulted in a significant global increase in RNA stability (p < 0.0001;
paired t-test). Volcano plots show log2 fold change in stability and –log10 p-value
of transcripts upon depletion of (C) UPF1 and (D) NBAS. Significant changes
are indicated in red (p < 0.05, not multiple testing corrected, paired t-test). (E)
Correlation of significant (not multiple testing corrected) stability changes upon
depletion of NBAS and UPF1. Pearson’s correlation coefficient and p value are
indicated. (F) Overlap of significantly increased (not multiple testing corrected)
stability changes upon depletion of NBAS and UPF1.
decreased stability (non-significant). Plotting transcripts significantly changed in
stability upon UPF1 and NBAS depletion revealed a strong correlation in both
stabilised and destabilised transcripts (Figure 5.4E), although only 39 transcripts
were increased in stability when either factor was depleted (Figure 5.4F).
However, after correcting for multiple testing using a Bonferroni correction, no
RNAs showed a significant change in stability upon UPF1 depletion or NBAS
depletion. This is likely due to the relatively low number of replicates in genomic
data terms and that this methodology does not account for the variance between
replicates and samples. This reasoning is further supported by looking at indi-
vidual genes (Figure 5.5). Whilst the decrease in stability of both NBAS (Figure
5.5A) and UPF1 (figure 5.5B) mRNA can be seen in the appropriate depleted
sample, only NBAS is significant even before multiple testing correction, which
is likely due to the variability within conditions, in this case UPF1 mRNA in
control mock cells. Figures 5.5C and D show examples of a gene with increased
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stability when UPF1 was depleted (MDK) and a gene with increased stability
when either UPF1 or NBAS was depleted (EDARADD). Only the difference be-
tween EDARADD mRNA stability in si-UPF1 treated and mock control cells is
significant (p < 0.05).
5.2.3 DESeq2 provides an appropriate framework to
analyse differential transcript stability
The package DESeq2 (Love et al., 2014) was developed to identify deferentially
expressed genes in RNA-sequencing datasets, given two conditions eg. control
and experimental treatment, in this case represented by si-Scr and si-NBAS. Be-
fore calculating differential expression, DESeq2 estimates dispersion of each gene
which considers the variance and the expression level. The dispersion estimates
are inversely related to the mean, and therefore reflect the variance in gene ex-
pression for a given mean value. When replicate number per condition is low (3-6
replicates), the estimates of variation for each gene are often unreliable due to
the large differences in dispersion for genes with similar means. To address this
problem, DESeq2 shares information across genes to generate more accurate esti-
mates of variation based on the mean expression level of the gene. The dispersion
for each gene is estimated using a maximum likelihood estimation which assumes
that genes with similar expression levels have similar dispersion and calculates
the most likely estimate of dispersion. Therefore, using the DESeq2 algorithm
should account for the within-group variability seen in my dataset (Figure 5.5)
and provide a more robust measure of stability.
Furthermore, DESeq2 can be utilised to find differential changes when there are
more than one factor influencing the counts, for example total or nascent as well
as treated or untreated. This ability to analyse multi-factor experiments has
been suggested as useful for analysing ribosome profiling where two conditions
are compared whilst also accounting for the comparison of the bound and input
samples for each condition (Love et al., 2014).
192
Figure 5.5: Differential Stability of Individual Genes
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Figure 5.5: Differential Stability of Individual Genes
OR of individual genes in each condition (n=5) shows variability within conditions
and changes in RNA stability between conditions. The decrease in stability of both
(A) NBAS and (B) UPF1 mRNA can be seen in the appropriate depleted sample.
(C) Example of a gene with increased stability when UPF1 depleted and (D)
example of gene with increased stability when either UPF1 or NBAS depleted.
Results of paired t-tests between each condition and control are indicated below
each plot. None of the statistical tests are multiple testing corrected.
In regards to building multi-factor variables into the DESeq2 model, the DESeq2
vignette states:
”Can I use DESeq2 to analyse paired samples? Yes, you should use a multi-factor
design which includes the sample information as a term in the design formula.
This will account for differences between the samples while estimating the effect
due to the condition. The condition of interest should go at the end of the design
formula, e.g. ∼ subject + condition.”
This adaptation is similar in setup to my manual analysis of measuring a ratio
of ratios. However, because DESeq2 measures the change between conditions,
I decided to run DESeq2 on the total and nascent reads for each gene in si-Scr
and si-UPF1 treated conditions (Table 5.2), as measured by STAR mapping and
HTSeq counts per gene. In this way, the effect of knockdown on expression can
be measured normalised to transcription resulting in differential stability changes
being identified.
I first looked at stability changes when UPF1 was knocked down as a positive
control. The results of this analysis showed one gene destabilised when UPF1
was depleted, which was UPF1 (FC = 1.26, p < 0.05). This reflects the de-
creased stability of the target mRNA when treating with siRNA. 86 genes were
significantly increased in stability (Figure 5.6A). The most significantly stabilised
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Table 5.2: SampleTable for DESeq2 total and nascent analysis The DE-
Seq2 model requires a SampleTable detailing the variables describing each sample,
in this case whether each sample is total or nascent and si-Scr control or si-NBAS
treated.
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was CROCCP2 (ENSG00000215908), a pseudogene with six annotated processed
transcripts and one transcribed unprocessed transcript. 30 of the 86 genes have
an annotated splice variant and 39 are labelled with the keywords “alternative
splicing”.
Overlap of expression targets and stability targets identified 84 of the 86 tran-
scripts increased in stability were also increased in expression (Figure 5.6B),
strongly suggesting they are bona fide NMD targets. Both of the stability targets
not also found in expression targets, VIPR1 and TXNRD2, were not identified as
significantly changed in expression. Looking just at the fold changes, VIPR1 was
decreased in total RNA and in nascent RNA but was more decreased in nascent
suggesting that the transcripts could be stabilised. Furthermore, 11 of the 28
annotated transcripts of VIPR1 are not thought to be translated as are 11 of
the 32 annotated TXNRD2 transcripts, strongly suggesting that these are also
NMD targets. Overlap of UPF1 expression and stability targets from a similar
study that used BRIC-seq to calculate stability, found 76 RNAs that increased in
expression and stability (Figure 5.6B Tani et al., 2012). Comparison of change in
RNA stability upon UPF1 depletion from this study with relative half-life upon
depletion of UPF1 from Tani et al. (2012), results in a significant but weak corre-
lation (r = 31, p < 2.2x10−16, Pearson’s correlation test; Figure 5.6C). However,
this accounts for all measured changes as Tani et al. did not include p values.
Overlap of the 76 targets from Tani et al. that increased in expression and sta-
bility, with the 84 transcripts identified in this study resulted in eight common
targets between the two analyses.
Gene ontology (GO) analysis of the 84 targets increased in expression and stabil-
ity revealed many terms related to the immune system and chemotaxis (Figure
5.6D), suggesting it is mainly cellular response genes that are being destabilised
in an UPF1-dependent manner. Comparing these 84 targets with the previously
described ER datasets (Section 2.2.15, Section 4.2.4; Fazal et al., 2019; Reid and
Nicchitta, 2012; Jan et al., 2014) identified two targets, CYB561 and POFUT2,
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that were defined by APEX-seq to be ER translated and two targets, TMEM222
and LEMD2, that were defined by ER proximity-specific ribosome profiling to
be ER translated, equating to 6.35% of the UPF1 targets being experimentally
defined ER translated.
The clean results seen here with no apparent indirect effects, indicate that using
DESeq2 and matched total and nascent RNA sequencing allows stability calcu-
lations at a single time point without the use of transcription inhibition.
The same analysis when NBAS was depleted showed one gene to be significantly
changed in stability (Figure 5.6E). This gene was NBAS which was destabilised
(FC = −1.85, p < 0.01). The further increase in negative fold change compared
to previous analyses shows that this method further accounts for noise in the
data. This result coupled with the results of the positive control UPF1, strongly
indicate that NBAS has no effect on RNA stability. Whilst there could be changes
that are too subtle to be detected using this analysis, the combination of number
of replicates, depth of sequencing and strong statistical framework suggests that
another technique is necessary to identify any changes in stability that may be
occurring when NBAS is depleted.
It has been shown that transcripts encoding NMD factors are themselves reg-
ulated by the NMD pathway, thus forming a feed-back auto-regulatory loop
(Huang et al., 2011; Yepiskoposyan et al., 2011; Longman et al., 2013, Section
1.2.2). Therefore, I was interested to see how the RNA of other NMD factors
was changed in stability upon depletion of UPF1 and NBAS. Differential stabil-
ity in either condition compared to si-Scr treated samples showed that several
NMD factors were stabilised upon depletion of UPF1 (Figure 5.6F, stars indicate
significant (p < 0.05), although only the changes of SMG5 and SMG9 reached
significance. A significant change in stability was not detected for any of the
NMD factors upon depletion of NBAS.
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Figure 5.6: DESeq2 analysis of total and nascent RNA produces a
robust measure of stability
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Figure 5.6: DESeq2 analysis of total and nascent RNA produces a ro-
bust measure of stability
(A) Differential stability analysis using DESeq2 on total and nascent RNA shows
genes changed in stability when UPF1 was depleted by siRNA in HeLa cells.
Genes significantly changed in stability are marked in red (p < 0.05). UPF1 is
indicated in blue (B) Overlap of transcripts increased in expression and tran-
scripts increased in stability upon depletion of UPF1. For comparison, a similar
overlap of UPF1 expression and stability targets is shown from Tani et al. (2012).
(C) Comparison of change in RNA stability upon UPF1 depletion from this study
with relative half-life upon depletion of UPF1 from Tani et al. (2012). Genes sig-
nificantly changed in stability in this study are marked in red (p < 0.05). (D)
Gene Ontology (GO) analysis of all transcripts increased in stability when UPF1
depleted. Top three terms are shown of biological process (BP), molecular function
(MF) and cellular component (CC) GO terms. (E) Differential stability analysis
using DESeq2 on total and nascent RNA shows genes changed in stability when
NBAS was depleted by siRNA in HeLa cells. Genes significantly changed in sta-
bility marked in red (p < 0.05). NBAS is indicated in blue. (F) Differential
stability of NMD factors upon depletion of NBAS or UPF1. Change in stability
shown as log2(fold change) and standard deviation from DESeq2. Stars indicate
significant changes (p < 0.05).
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5.2.4 Comparing exonic and intronic reads normalises
for mRNA processing using only total RNA
Although not as elegant as using both total and nascent RNA, measuring stability
of RNA using exonic and intronic reads from total RNA-sequencing as a proxy for
mature mRNA and pre-mRNA is often used in genome-wide studies to determine
degradation rates (Zeisel et al., 2011; Gray et al., 2014; La Manno et al., 2018;
Bergen et al., 2020). In this study, it has the advantage of using only the total
RNA libraries which have been validated against other datasets (Figure 4.5 and
4.10).
Using just the read counts for total exonic and total intronic in each sample
gives a ratio of the mature mRNA and pre-mRNA levels, which can be used as a
proxy for transcript stability. To measure the effect of UPF1 or NBAS depletion
on RNA stability, the change of this ratio was calculated between treated and
control cells. An OR for each gene was calculated using the following equation:
OR = (treated exonic (mature mRNA) / treated intronic (pre-mRNA))
/ (control exonic (mature mRNA) / control intronic (pre-mRNA))
Unlike the previous OR analysis, rather than producing one value per condition,
this OR gives a measure of the change in stability. Negative control si-Scr, as
well as si-UPF1 and si-NBAS, were each defined as “treated” and all three were
measured against mock treated “control” samples, making them directly compa-
rable. The OR for si-UPF1 and si-NBAS was then compared to that of si-Scr
to identify changes beyond technical noise. An OR of 1 indicates that the likeli-
hood of an event to occur is not more than would be expected by chance. Since
we assume transcription is not affected by NMD abrogation (Carter et al., 1996;
Wu et al., 2020; Karousis et al., 2020), and each condition is normalised to the
same control, changes to the counts of mature mRNA (exonic) reads will drive
changes in OR. In this way, an increase in the OR compared to si-Scr indicates an
increase in stability of the mRNA. I compared the cumulative stabilities of four
subsets of genes, as defined in Chapter 4, in each condition; “UPF1 targets” which
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were increased in expression upon UPF1 depletion, “NBAS targets” which were
increased in expression upon NBAS depletion, “common targets” which were in-
creased in expression upon UPF1 and NBAS depletion, and “UPF1-independent
NBAS targets” which were increased in expression upon NBAS depletion but
not upon UPF1 depletion. Using random sampling with replacement, 95% con-
fidence intervals (CI) were calculated and added to each curve to allow statistical
determination of changes to global stability (Figure 5.7).
UPF1 targets were significantly increased in stability when UPF1 was depleted, as
seen by the shift to the right of the si-UPF1 line compared to the si-Scr line. This
is agreement with these transcripts being genuine NMD targets that are increased
in abundance and stability. There was no discernible difference in the stability
of UPF1 targets when NBAS was depleted, indicated by the highly overlapping
blue and black lines (Figure 5.7A). This could be explained by the fact that
only some UPF1 targets are also regulated by NBAS. However, a similar result
was seen for NBAS targets, where as a group, the transcripts were significantly
increased in stability when UPF1 was depleted but not changed in stability when
NBAS was depleted (Figure 5.7B). This indicates that these genes are increased
in abundance but do not have altered stability when NBAS is depleted.
As expected, given these results, common targets which increased in abundance
when either factor was depleted were increased in stability when UPF1 was de-
pleted but were largely unchanged when NBAS was depleted with the small shift
compared to si-Scr within the 95% CI (Figure 5.7C). Considering the UPF1-
independent NBAS targets, the 95% CI of all three lines overlap indicating no
significant changes in stability take place for these transcripts upon depletion of
either factor (Figure 5.7D), suggesting that UPF1 depletion does not increase
stability of all transcripts globally.
The cumulative distribution plots compare the global changes in stability upon
depletion of each factor, so I next wanted to compare the change in stability
for individual mRNAs. Plotting the log2 change in OR of UPF1 targets and
NBAS targets when NBAS was depleted against the change in OR when UPF1
was depleted, reveals that some mRNAs do appear to change in stability when
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Figure 5.7: Comparing exonic and intronic reads allows RNA stability
measurement using only total RNA
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Figure 5.7: Comparing exonic and intronic reads allows RNA stability
measurement using only total RNA
Using read counts for total exonic and total intronic in each sample gives a ratio
of the mature mRNA and pre-mRNA levels, which can be used as a proxy for
transcript stability. By calculating the change in this ratio when cells are treated
with siRNA compared to mock treated cells, the effect of each treatment on RNA
stability can be measured. Cumulative stabilities of subsets of genes, as defined
in Chapter 4, in each condition; (A) “UPF1 targets” which were increased in
expression upon UPF1 depletion, (B) “NBAS targets” which were increased in
expression upon NBAS depletion, (C) “common targets” which were increased
in expression upon UPF1 and NBAS depletion, and (D) “UPF1-independent
NBAS targets” which were increased in expression upon NBAS depletion but not
upon UPF1 depletion. Using random sampling with replacement, 95% confidence
intervals (CI) were calculated and added to each curve to allow statistical de-
termination of changes to global stability. (E) The log2 change in stability of
UPF1 targets (red) and NBAS targets (blue) when NBAS was depleted against
the change in OR when UPF1 was depleted. The dashed line shows correlation
of each set of targets.
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NBAS is depleted (Figure 5.7E), although this plot does not account for statistical
significance. As shown by the dashed lines, the correlation of change in OR upon
NBAS depletion or UPF1 depletion for both NBAS (blue line) and UPF1 (red
line) targets is skewed towards UPF1-mediated changes in stability.
As with the previous analysis using total and nascent RNA, this methodology
does not account for the variance between replicates and samples. Therefore, I
next analysed total exonic and total intronic samples using the DESeq2 frame-
work (Table 5.3). This resulted in 284 genes being identified as significantly
increased in stability when UPF1 was depleted, and 109 genes significantly de-
creased in stability (Figure 5.8A), showing an enrichment for increased stabil-
ity (OR = 2.6 compared to null hypothesis which would be equal numbers in-
creased and decreased, p < 0.0001; fishers exact test). Similar to the total and
nascent DESeq2 RNA analysis (Section 5.2.3), the enrichment of increased sta-
bility is in line with UPF1’s established role as an NMD factor regulating mRNA
stability. UPF1 was decreased in stability (FC = −0.498, p = 0.0024) as ex-
pected due to the siRNA treatment, although the most significantly decreased
mRNA was large ribosomal subunit protein L37A (RPL37A; ENSG00000197756)
(FC = −1.39, p < 0.0001), suggesting a global decrease in translation. The
gene most significantly increased in stability was DNAJC25 (ENSG00000059769)
(FC = 1.87, p < 0.0001). DNAJC25 is a member of the heat shock protein family
(Hsp40) which interestingly, is located at the ER and failure of hsp40-mediated
protein refolding machinery is known to cause aggregation of poly-glutamine pro-
teins commonly found in neurodegenerative disorders (Muchowski et al., 2000).
Conversely, the same analysis looking at changes when NBAS was depleted
showed only two genes changed in stability (Figure 5.8B). One of these was NBAS
which was decreased in stability (FC = −0.9, p < 0.001) as expected since it was
specifically targeted with siRNA. The other gene was WASH6P, a pseudogene
which was increased in stability (FC = 4.1, p < 0.05). This gene has 15 splice
variants, of which 14 are annotated as processed transcripts and the other one is
annotated as transcribed unprocessed pseudogene.
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Table 5.3: SampleTable for DESeq2 total exonic and intronic analysis
The DESeq2 model requires a SampleTable detailing the variables describing each
sample, in this case whether each sample is total exonic or total intronic and
si-Scr control or si-NBAS treated.
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Figure 5.8: DESeq2 analysis of total exonic and intronic RNA iden-
tifies hundreds in changes in stability upon UPF1 depletion but not
when NBAS is depleted
DESeq2 analysis of RNA stability using all total exonic and intronic reads of (A)
si-UPF1 vs si-Scr and (B) si-NBAS vs si-Scr. DESeq2 analysis of RNA stability
using total exonic and intronic reads of only universally expressed mRNAs com-
paring (C) si-UPF1 vs si-Scr and (D) si-NBAS vs si-Scr. In all plots, mRNA
significantly changed in stability are marked in red (p < 0.05) and the siRNA
targeted mRNA is indicated in blue.
206
This analysis included all genes that had at least one read in at least one sample.
Itwas therefore possible that the large number of genes with low expression might
be masking subtle changes leading to this lack of significant results in si-NBAS.
Therefore, I next filtered the input for only genes that were detected (at least one
read) in all replicates of all conditions and repeated the DESeq2 analysis.
This analysis found 425 genes changed in stability when UPF1 was depleted
compared to si-Scr treated cells (Figure 5.8C). 282 transcripts showed an increase
in stability and 143 showed a reduction in stability, an enrichment for increased
stability (OR = 1.98 compared to null hypothesis which would be equal numbers
increased and decreased, p < 0.0001; fishers exact test). UPF1 mRNA was
identified as decreased in stability (FC = −0.61, p < 0.0001) although the most
significantly decreased mRNA was again RPL37A (FC = −1.37, p < 0.0001).
The mRNA most significantly increased in stability was the pseudogene
ENSG00000187951 (FC = 1.12, p < 0.0001) which is annotated as a lncRNA
by ensembl but as microRNA mir-1255 by Rfam, either way suggesting it is not
translated. The RNA with the largest increase in stability was the pseudogene
PMS2P11 (ENSG00000241350) (FC = 2.36, p < 0.0001).
When si-NBAS was analysed compared to si-Scr, only one gene was significantly
changed in stability when NBAS was depleted (Figure 5.8D). This was NBAS
which was decreased in stability (FC = −1.4, p < 0.001). The difference in fold
change using this filtered dataset compared to the previous analysis demonstrates
the effect of only testing, and correcting significance thresholds for, relevant genes
rather than all genes. However, instead of resulting in subtler effects on stability
by NBAS being revealed, this analysis appears to confirm that NBAS does not
significantly affect stability of any transcript measured here.
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5.2.5 Comparing RNA stability measurements by
nascent and total RNA or total exonic and intronic
RNA methods indicates a good correlation
between the methodologies
The two methodologies used in this chapter to analyse RNA stability gave broadly
similar results. Both identified NBAS and UPF1 as destabilised in the relevant
samples and both show UPF1 depletion affected the stability of many transcripts
whereas both showed NBAS depletion appears to have limited effect on RNA
stability. To compare the two methods more specifically, I plotted the estimated
change in stability for individual genes upon UPF1 depletion produced by each
method (Figure 5.9). Both methods identified transcripts as changed in stability
that were not identified by the other method. However, the correlation of es-
timated change in stability of those genes identified as significantly changed by
both methodologies (black dots) was high (r = 0.81, p = 1.32x10−8; Pearson’s
correlation). Both UPF1 and NBAS were identified as significantly destabilised
in the appropriate samples, and the results of UPF1 knockdown were in line with
previous studies and understanding of UPF1’s function on transcript stability.
The clean results seen from the analysis of total and nascent RNA using the DE-
Seq2 framework, with no apparent indirect effects, indicate that using DESeq2
and matched total and nascent RNA sequencing allows stability calculations at
a single time point without the use of transcription inhibition.
5.2.6 Comparing changes in RNA expression and RNA
stability reveals many abundance changes are
dependent on transcription
To further investigate the effect of transcription and stability on RNA expression,
DESeq2 was used to analyse differential transcription using only nascent RNA
samples, mapped with STAR and counted per gene by HTSeq. Upon depletion
of UPF1, 18 mRNAs were differentially transcribed (Figure 5.10A), two were de-
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Figure 5.9: Comparison of RNA stability measurements by
nascent/total RNA and exonic/intronic RNA methods
(A)) Estimated change in stability for individual genes upon UPF1 depletion
produced by DESeq2 analysis of total and nascent RNA (x-axis, green) and by
DESeq2 analysis of total exonic and total intronic RNA (y-axis, purple). Black
dots indicate genes identified as significantly changed by both methodologies, cor-
relation of these points was r=0.81 (p = 1.32x10−8; Pearson’s correlation). (B)
Overlap of mRNAs identified as significantly increased in stability upon depletion
of UPF1 by both methodologies.
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creased in transcription and 16 increased. The two genes decreased in transcrip-
tion were the complement factor C3 (FC = −2.58, p < 0.0001) and a lncRNA
located in an intron of C3 (ENSG00000276980) (FC = −4.80, p = 0.0298). The
gene most significantly increased in transcription upon UPF1 depletion was the
lncRNA ENSG00000272068 (FC = 2.30, p < 0.0001). The UPF1 gene was not
changed in transcription, further validating effective targetting of UPF1 mRNA
by siRNA treatment. Upon depletion of NBAS, no genes were identified as
changed in transcription, including NBAS (Figure 5.10B).
Since the differential expression analysis carried out in Chapter 4 used DESeq2
on estimated counts per gene produced by kallisto pseudoaligning, I wanted to
repeat the differential expression analysis using DESeq2 on STAR aligned reads
and HTSeq counts per gene, so that the results from total RNA and nascent RNA
would be as comparable as possible.
This analysis identified 1968 transcripts as differentially expressed when UPF1
was depleted (Figure 5.10C). 1727 genes were identified as increased in abundance,
whereas 241 genes were identified as decreased in abundance, representing an
enrichment for increased abundance (OR = 7.16 compared to null hypothesis
which would be equal numbers increased and decreased, p < 0.0001; fishers exact
test). UPF1 mRNA was the most significantly decreased in abundance (FC =
−1.54, p < 0.0001). The gene most significantly increased in abundance upon
UPF1 depletion was the pseudogene CROCCP2 (ENSG00000215908) (FC =
2.43, p < 0.0001), whereas the gene with the biggest increase in abundance (and
second most significant increase), was the lncRNA ENSG00000272068 (FC =
3.70, p < 0.0001) which was the RNA most significantly changed in transcription,
suggesting this change in abundance is driven by transcription.
Comparing NBAS depleted cells to si-Scr using this analysis identified 17 genes
as changed in abundance (Figure 5.10D). 7 genes were increased in expression
whereas 10 were decreased in expression, a non-significant enrichment for a de-
crease in abundance (OR = 1.41 compared to null hypothesis which would be
equal numbers increased and decreased, p = 0.732; fishers exact test). NBAS
mRNA was the most significantly decreased in abundance (FC = −1.70, p <
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Figure 5.10: DESeq2 analysis of differential abundance and differential
transcription from STAR alignment
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Figure 5.10: DESeq2 analysis of differential abundance and differential
transcription from STAR alignment
DESeq2 analysis of change in transcription using nascent reads of (A) si-UPF1
vs si-Scr and (B) si-NBAS vs si-Scr. DESeq2 analysis of differential RNA abun-
dance using total reads, aligned using STAR and counted using HTSeq, of (C)
si-UPF1 vs si-Scr and (D) si-NBAS vs si-Scr. In all plots, mRNA significantly
changed in stability are marked in red (p < 0.05) and the siRNA targeted mRNA
is indicated in blue. (E) Number of targets identified as significantly (p < 0.05) in-
creased or decreased in expression by kallisto-DESeq2 pipeline and STAR-HTSeq-
DESeq2 pipeline upon depletion of UPF1 or NBAS. (F) Comparison of fold
change calculated by kallisto-DESeq2 pipeline and STAR-HTSeq-DESeq2 pipeline
upon depletion of UPF1. Colours indicate all genes analysed (grey), those called
as significant by STAR (blue), those called as significant by kallisto (pink) and
those called as significant by both (yellow).
0.0001). The gene most significantly increased in abundance upon NBAS de-
pletion was the cytoskeleton structural protein SORBS2 (ENSG00000154556)
(FC = 0.67, p = 0.0014), whereas the gene with the largest increase in abun-
dance was the membrane trafficking protein MALL (ENSG00000144063) (FC =
1.39, p = 0.0297).
Surprisingly, the results produced by this STAR-HTSeq-DESeq2 pipeline were
considerably different to those resulting from the kallisto-DESeq2 pipeline (Fig-
ure 5.10E). As well as identifying fewer transcripts as differentially changed, the
STAR-HTSeq-DESeq2 pipeline also showed a marked difference in the number
of targets increased and decreased in expression, whereas the kallisto-DESeq2
pipeline resulted in a similar number of genes identified as increased and de-
creased in expression. To investigate this discrepancy, I compared the log2(fold
change) calculated by the kallisto-DESeq2 pipeline and the STAR-HTSeq-DESeq2
pipeline in si-UPF1 treated cells compared to si-Scr treated cells (Figure 5.10F).
Whilst the correlation between the fold change calculated by the two analyses of
all genes was significant (r = 0.59, p < 2.2x10−16, Pearson’s correlation test), the
STAR-HTSeq-DESeq2 calculated fold changes as larger in general. Identifying
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those called as significant by STAR (blue), by kallisto (pink) and by both (yellow)
revealed further differences between the methods. The large number of pink dots
at near zero log2(fold change)m indicate that the kallisto-DESeq2 pipeline leads
to much smaller fold changes being identified as significant. This effect was more
pronounced for transcripts decreased in expression which accounts for the change
in number of targets seen in (Figure 5.10E).
The transcription and abundance changes from STAR-HTSeq-DESeq2 analysis of
total or nascent RNA were then compared to visualise how the kinetic processes
of RNAs changed upon depletion of UPF1 (Figure 5.11A) and NBAS (Figure
5.11B). For UPF1 depletion, as expected, all genes significantly changed in stabil-
ity (black dots) clustered around the y-axis indicating their change in expression
was not correlated with their change in transcription, whereas genes only changed
in expression (grey dots) splayed to each side of the y-axis showing their change
in abundance was driven by change in transcription, even if this change was not
identified as significant by the DESeq2 analysis run on nascent RNA only (Figure
5.10A). UPF1 is indicated by a red circle. For NBAS, since so few genes were
identified as changed in abundance (Figure 5.10D), the plot is quite empty even
with a generous significance cut off of p < 0.05. The only black dot is NBAS,
which was the only gene that was changed in stability (Figure 5.6E), and is indi-
cated by a red circle. It is on the x=0 line indicating no change in transcription
which is as expected since NBAS mRNA was targetted by siRNA which does not
affect transcription. The majority of the grey dots are splayed to each side of the
y-axis showing their change in abundance was driven by change in transcription,
even if this change was not identified as significant by the DESeq2 analysis run
on nascent RNA only (Figure 5.10B).
Whilst the UPF1 stability changes measures are in line with previous studies
(Tani et al., 2012), it was surprising to observe that all NBAS-dependent changes
in stability appeared to be due to transcriptional changes (Figure 5.11C) since this
does not agree with NBAS’ previously studied role as an NMD factor (Longman
et al., 2007; Anastasaki et al., 2011; Longman et al., 2013, 2020).
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Figure 5.11: Comparing changes in RNA expression and RNA stability
reveals many abundance changes are dependent on transcription
(A) Comparison of abundance change in total RNA and change in nascent RNA
of si-UPF1 compared to si-Scr control cells as measured by DESeq2 analysis.
Genes significantly changed in total RNA abundance are marked in grey and those
significantly changed in RNA stability (using total and nascent RNA) are marked
in black. UPF1 is marked with a red circle. (B) The equivalent plot for si-NBAS
depletion. (C) Summary table of number of genes changed in expression and
stability when either factor was depleted and the overlap of these.
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5.3 Discussion
5.3.1 It is possible to measure transcript stability at a
single time point without transcription inhibition
In this chapter I have shown that it is possible to achieve significant and specific
measurements of changing transcript stability by RNA-sequencing a single time
point without inhibiting transcription (Figure 5.8A).
This has important consequences for the future of measuring genome-wide tran-
script stability. The current standard stability experiment relies on taking mea-
surements of transcript abundance at multiple time points. This requires complex
experimental set up and also many individual samples, pushing up the cost of
sequencing which can still be prohibitive to some researchers. Removing the need
for multiple time points means that money can be spent on deeper sequencing
and/or more replicates, both of which increase the meaningful results that can be
gleaned from these experiments. From a biological standpoint, it is also impor-
tant to be able to measure transcript stability without the need for transcription
inhibition because transcription and decay are related processes and transcription
inhibition can have negative effects on the cell (Section 5.1.1).
The results in this chapter contrast with those of Chapter 4 as RNA abundance
changes resulting from the STAR-HTSeq-DESeq2 pipeline were markedly differ-
ent from those resulting from the kallisto-DESeq2 pipeline described in Chapter
4. As shown in (Figure 5.10F), this seems to be due to the kallisto-DESeq2
pipeline leading to smaller fold changes being identified as significant. This has
recently been noted by others who found only approximately half of the differen-
tially expressed transcripts detected using kallisto were also identified by STAR or
LAST (Shrestha and Frith, 2013) and in general, disagreement in low-expression
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genes was responsible for most of the discordance between methods (Kuo et al.,
2020). This was suggested to be due to kallisto tending to overestimate some low-
expression genes compared to other methods (Kuo et al., 2020; Everaert et al.,
2017).
The methodology used here is not however perfectly optimised. The uridine ana-
logue 4sU has been shown to cause harmful effects, whereas the alternative ana-
logue BrU does not appear to have these drawbacks (Friedel and Dölken, 2009).
It has been shown that the labelled RNA fraction can become contaminated with
unlabelled (pre-existing) RNA molecules (Furlan et al., 2020). A model based
on a constant rate of 4sU incorporation into nascent transcripts did not fit data
measuring the amount of labelled RNA that could be recovered with pulses of
4sU lasting from 10min to 2h. Whereas a model assuming a constant contami-
nation rate, not dependent on the 4sU pulse length fit the data better (Furlan
et al., 2020). The rate of contamination has been reported as 30% (Baptista and
Dölken, 2018; Furlan et al., 2020), although the rate is likely to depend on the
cell type and on the specific protocol used. There was a much lower level of reads
mapping to rRNA in the nascent libraries compared to the high level of rRNA
reads in the matched total RNA libraries. This could be evidence that 4sU is not
incorporated as efficiently by RNA polymerase I specifically. However, previous
studies have seen up to 30% of nascent RNA mapping to rRNA (Rabani et al.,
2011), although in that study the 4sU labelling time was longer.
Due to the need for intronic reads for this method, poly-A enrichment should
not be carried out, since this would deplete the samples of pre-mRNA. This
means deeper sequencing will be necessary to achieve the same depth of reads
over exonic regions. In this experiment, rRNA depletion was not carried out
mainly because the amount of RNA starting material in nascent RNA samples
was low and total RNA samples were treated the same as nascent RNA samples.
However, in hindsight, since rRNA reads accounted for a much lower percentage
of reads in nascent samples, it could be argued that rRNA depletion of only total
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samples would be appropriate since there was an excess of RNA starting material
for these samples and it would mean many more usable reads from total samples.
Indeed, if I were to repeat this experiment, I would deplete rRNA from the total
samples, but not the nascent samples, before preparation of the cDNA libraries.
Finally, this experiment was unusual in that both mock treated samples and si-Scr
treated samples were sequenced as negative controls. There were a small number
of significant differences between these two conditions. This is to be expected
as siRNA treatment induces a level of stress to the cell even when not targeting
a specific gene. Although normalising si-UPF1 and si-NBAS changes to si-Scr
would show changes beyond those caused by non-specific siRNA, the ability to
normalise all siRNA treatments to mock treated cells allows a measurement of
the magnitude of change caused by the specific knockdown of the gene of interest.
5.3.2 Only a subset of transcripts changed in expression
when UPF1 is depleted also change in stability
It has previously been suggested that UPF1 regulates up to 10% of the human
transcriptome (Mendell et al., 2004; Wittmann et al., 2006; Yepiskoposyan et al.,
2011; Longman et al., 2013). However, these studies used increase in RNA abun-
dance as an indicator of an NMD target. The results presented in this chapter
suggest a large proportion of expression changes seen when UPF1 is depleted
are NMD-independent, caused by transcriptional changes, rather than bona fide
NMD targets characterised by an increase in transcript stability. Tani et al.
(2012), who also carried out differential expression and stability analyses upon
depletion of UPF1, suggest that many NMD targets are stabilised yet not unregu-
lated, however the results presented here suggest the vast majority of transcripts
increased in stability also increase in expression. There are many possible expla-
nations for this result. Cellular pathways are highly interconnected and UPF1
destabilising a gene via the NMD pathways may in turn downregulate transcrip-
tion of downstream targets of these targets. Furthermore, UPF1 has many differ-
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ent roles within the cell which could account for its non-stability effects on gene
expression (Section 4.3.1). To further characterise the targets identified here, the
transcripts themselves could be analysed, for example is there an enrichment in
GC content, RNA length or secondary structures.
It should also be noted that the stability analysis carried out here merged tran-
scripts to give one measurement per gene. Since alternative splicing can lead
to transcripts being NMD targets, this methodology could mask more subtle
transcript-specific change in stability. Furthermore, transcripts with a retained
intron are known to trigger NMD, and these are not accounted for in this analy-
sis. A retained intron would lead to reads over that intronic region being wrongly
assigned to the pre-mRNA when they actually originate from the mature RNA.
However, intron retention is a very rare event and has only ever been seen for a
single intron within a transcript. Therefore, since I merged read counts across
all introns for each gene, one intron being retained is unlikely to have a strong
affect. Future analysis of this dataset could identify any retained introns by lo-
cating introns that have an increased read count compared to the other intronic
regions from the same gene.
The results of this study, build on previous literature suggesting that differential
stability is a far more accurate method to identify NMD targets than differen-
tial RNA expression (Tani et al., 2012; Furlan et al., 2020). However there are
differences in approach. Tani et al., utilised BRIC-seq to measure RNA stability
(discussed in Section 5.1.1) which is similar to the method used in this study
in that it does not block transcription, however multiple time points are used.
Making use of these multiple time points could explain why that study identi-
fied many more stabilised genes than this study (Figure 5.6B). However, Tani
et al. also used only two replicates for their BRIC-seq experiment, whereas this
study utilised five replicates which is likely to result in a more reproducibly af-
fects as greater variability is accounted for. Despite the exact genes identified not
matching between the two studies (Figure 5.6C), both clearly show that an in-
crease in RNA abundance measured by total RNA-sequencing does not represent
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an increase in RNA stability and therefore should not be used as a measure of
NMD activity. It would be very interesting to apply this methodology or indeed
BRIC-seq upon knockdown of other NMD factors including UPF2, UPF3B and
DHX34.
5.3.3 Effect of NBAS on RNA stability
Since previous work has suggested NBAS is an NMD factor in human cells (Long-
man et al., 2007; Anastasaki et al., 2011; Longman et al., 2013, 2020), my expec-
tation was that depletion of NBAS would lead to increased stability of a subset
of the genes increased in stability when UPF1 was depleted. Here I have used
four methodologies to determine change in RNA stability; manually using total
exonic, total intronic, nascent exonic and nascent intronic reads, manually using
just total exonic and intronic reads, using the DESeq2 statistical framework on
total exonic and intronic reads, and the cleanest and most robust method, using
DESeq2 to analyse total and nascent RNA reads. Whilst all four approaches
identified many mRNAs increased in stability upon depletion of UPF1, there was
no evidence that NBAS affects RNA stability. This suggests that NBAS is not
directly involved in the NMD pathway. Perhaps NBAS does aid UPF1 to perform
NMD at the ER but it is neither necessary nor sufficient for ER-NMD.
Depletion of NBAS has previously been shown to delay the decay of UPF1 mRNA
(Longman et al., 2013), suggesting it would normally be involved in degradation
of this transcript. However, this experiment used actinomycin D to block tran-
scription which, as previously discussed (Section 5.1.1), means that degradation
kinetics are also altered. Actinomycin D is also toxic and it has been shown that
HeLa cells are extremely sensitive to rapid actinomycin D-induced cell death, even
at concentrations as low as 1µg/ml (Sawicki and Godman, 1971). Furthermore,
as seen in Figure 4.2C, a non significant but noticeable increase in NBAS mRNA
was identified by qPCR when UPF1 was depleted but there was no change to
UPF1 mRNA levels when NBAS was depleted.
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There is a possibility that the methodologies used in this work are not sensitive
enough to identify subtle changes in stability due to NBAS depletion. However,
this seems unlikely due to both the subtle changes identified as significant when
UPF1 was depleted (Figure 5.8A), and also that no changes to stability were
identified when NBAS was depleted even non-significantly (Figure 5.8E).
Since none of the changes in expression when NBAS is depleted, identified in
Chapter 4, were also identified as changes in stability (Figure 5.11C), these
changes are likely due to altered transcription, or perhaps RNA processing (Fig-
ure 5.1A) as downstream effects of NBAS depletion.
While these findings suggest a non-NMD function for NBAS, since its depletion
does not affect RNA stability, they do not completely rule out the possibility of
NBAS being involved in the ER-NMD mechanism. Perhaps the knockdown of
NBAS was sufficient to cause effects at the ER but not strong enough to suffi-
ciently impair its NMD functions. It could also be that NBAS has a redundant
role in the ER-NMD mechanism so that upon depletion, its role is fulfilled by
another protein.
5.3.4 Future work
Since this is the first study to make use of single time-point metabolic labelling
without transcription inhibition to measure RNA stability genome-wide, it would
be worth validating the results using a second method that has been previously
utilised. One such experimental technique is BRIC-seq (Imamachi et al., 2014,
discussed in Section 5.1.1) which is similar to the one used in this study in that
it does not block transcription. Mathematical models, with various assumptions,
have also been developed specifically to estimate RNA stability such as cDTA
(Sun et al., 2012), DRiLL (Rabani et al., 2014), INSPEcT (de Pretis et al.,
2015) and pulseR (Uvarovskii and Dieterich, 2017), which utilise the quantifica-
tion of both nascent and total RNA species. Furthermore, there are also other
approaches that do not require the quantification of nascent RNA to estimate
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transcript stability (Zeisel et al., 2011; Gray et al., 2014; La Manno et al., 2018;
Furlan et al., 2020). These techniques focus on calculating the kinetic rates as-
sociated with RNA lifetime from only the total RNA levels to measure RNA
stability (Figure 5.1A).
Since only one other study (that I am aware of) has measured genome-wide
change in RNA stability upon depletion of UPF1 (without using transcription
inhibitors), it is currently difficult to extend the limited comparisons made in
this thesis. Nevertheless, it would be interesting to take into account the duration
of the depletion of UPF1 before cells were harvested and transcripts analysed.
Furthermore, a meta analysis bringing together any genome-wide measurements
of RNA stability could provide insight as to the reproducibility of the various
techniques being utilised and any biases between these. Another extension to
this analysis could be to compare the targets with UPF1-mediated changes in
stability, with transcripts found to be bound by UPF1 using CLIP experiments
(Kurosaki et al., 2018; Zünd et al., 2013). Since UPF1 binds many transcripts
transiently, and it’s phosphorylation is thought to stabilise these interactions,
CLIP specifically of P-UPF1 would be likely give a more accurate description of
NMD targets (Kurosaki et al., 2018).
As detailed in the introduction to this chapter (Section 5.1.1), there is an in-
tricate link between transcription and RNA decay and for this reason it would
not be prudent to carry out stability experiments that make use of transcription
inhibition as it is known these do not provide an accurate picture of in vivo RNA
processing.
5.3.5 Summary
In this chapter I present the first method allowing genome wide measurement of
stability of RNA at a single time point without transcription inhibition. This has
important consequences for the future of measuring genome-wide transcript sta-
bility. I also build on previous literature suggesting that differential stability is a
far more accurate method to identify NMD targets than differential RNA expres-
sion and suggest that a large proportion of expression changes seen when UPF1
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is depleted are NMD-independent changes caused by transcriptional changes. Fi-
nally, I find no evidence that NBAS regulates RNA stability, which whilst not
disproving its function as an NMD factor does call into question it’s direct role
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6.1.1 NMD target characteristics
Even though differential expression studies have been extensively used to identify
targets of NMD factors (Mendell et al., 2004; Wittmann et al., 2006; Yepisko-
posyan et al., 2011; Longman et al., 2013), there are always indirect effects caused
by downstream factors, such as an NMD-targeted TF that then affects expression
of many other transcripts, and these are challenging to differentiate from bona
fide direct NMD targets. Furthermore, although upon NMD-factor depletion an
increase in expression would be expected, there is often many decreases in steady
state transcript levels upon NMD-depletion. The number of transcripts that de-
crease in expression are usually roughly equal in number to those that increase
but are often disregarded or not even mentioned (Lykke-Andersen et al., 2014).
Studies assessing stability are an improvement on differential expression analyses
because NMD degrades mRNA but doesn’t directly affect transcription, so mea-
suring decay of transcript is a more direct measure of NMD activity. However,
this is still inferring NMD activity by change of stability and does not explain
why a transcript is being targeted by NMD.
Whole-genome sequencing of individual genomes allow detection of variants that
result in a premature termination codon (PTC) which are likely to make the tran-
script an NMD target. In healthy individuals, these transcripts would be rare
since they would be degraded by the NMD machinery, however, under some dis-
ease circumstances, NMD activity is altered. Using paired tumour:normal exome
data and tumour transcriptomics from the cancer genome atlas (TCGA), Linde-
boom et al. (2016), identified 2,840 high-confidence PTCs in the exome data and
investigated their expression using the matched RNA-sequencing data. By nor-
malising to the median expression of the WT transcript across all cancers without
the PTC variant, they calculated an “NMD efficiency” score for each PTC and
then measured how important each of the previously published NMD target rules
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was for determining to what extent a PTC would trigger NMD. They validated
these findings using heterozygous germline nonsense variants in lymphoblastoid
cell line RNA-sequencing from healthy individuals (Geuvadis study; Lappalainen
et al., 2013).
As discussed in Section 1.2.4, there is marked variability in the rules determin-
ing whether a transcript will trigger NMD. Lindeboom et al. (2016) found that
the biggest contribution to the NMD efficiency variability could be explained by
whether the PTC was in the last exon (45.8%) and the second highest amount
was how close the PTC was to the start codon (17.2%). The “50-nucleotide rule”
(Section 1.2.4), that states a PTC that is less than 50nt upstream of an EJC
will not trigger NMD, often thought to be the most important determinant, ac-
counted for only 3.5% of the additional variance after the last exon rule was taken
into account. Overall, 74.2% of the variability in NMD response to PTC could
be explained by a combination of these rules plus exon length, mRNA half-life,
allele frequency, significant motifs and the distance from the PTC to the normal
stop codon. This still leaves 25.8% variability unexplained. Uncovering the un-
derlying cause of this variability, as well as the factors that influence it, would
provide important insights into the mechanisms that control NMD efficiency and
would provide a better understanding of the clinical outcome of disease-associated
genetic mutations.
Most NMD datasets comprise either total or nascent RNA, whether at one time
point or several. Conversely, the dataset I have produced contains matched
nascent and total RNA at high sequence coverage. Therefore, it is possible to
track a variant within an individual transcript from transcription to steady state
levels in the same cells. This allows identification of transcripts that are actively
transcribed, and therefore represented in the nascent RNA samples, but are bro-
ken down by NMD, and are therefore absent in total RNA samples. For example,
if there were a heterozygous variant that triggered NMD, it could be the case
that one allele of a transcript is an NMD target whilst the other is not a target
and so survives. In this instance, both alleles would be detectable in the nascent
RNA sample but only the allele that is not an NMD target will be present at
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Figure 6.1: Matched nascent and total RNA-sequencing allows track-
ing of heterozygous variants
Diagram showing a hypothetical heterozygous variant that causes a stop gain.
Both alleles would be transcribed and therefore reads mapping to both the refer-
ence and alternative allele would be detectable in both control and depleted nascent
RNA-sequencing. During translation, the gain of stop codon would lead to one
allele being targeted by NMD and therefore in control total RNA-sequencing, only
reads mapping to the reference allele would be detectable. However, upon UPF1
depletion, NMD would be abrogated and the stop gain transcript would survive,
therefore reads mapping to both the reference and alternative allele would be de-
tectable.
a comparable level in the total RNA sample. When NMD is abrogated due to
depletion of the core NMD factor UPF1, the NMD target allele would survive and
therefore now also be detectable in the total RNA sample (Figure 6.1). By com-
paring the read counts over the variant in the four samples; si-Scr and si-UPF1




I am interested in directly measuring stability of individual transcripts genome-
wide upon abrogation of NMD, using heterozygous variants that result in an
NMD-triggering allele and a wild type allele that will be processed differently.
To do this I will find HeLa heterozygous genomic variants that are expressed
biallelically in my dataset by measuring the expression of each allele at each
variant location in the nascent RNA samples. I will then measure the abundance
of each allele in the total samples and use this to calculate differential stability
of the two alleles. Using the si-UPF1 depleted samples, I will measure the effect
of NMD abrogation on the differential stability of the heterozygous alleles.
In summary the main aims of this chapter are:
a) Determine whether it is possible to directly measure differentially stability
of heterozygous alleles when NMD is depleted




6.2.1 Stop gain variants that are destroyed in control
cells but survive when NMD is abrogated
To test whether it was possible to identify distinct alleles that are differentially
regulated in my dataset, I conducted a proof of principle study. I used the
mock treated nascent RNA samples since these are untreated and the least pro-
cessed sample and therefore provide the most accurate representation of tran-
scription. I called variants by comparing these reads to the human reference
genome GRCh38/hg38 using the variant caller strelka as it has an optional argu-
ment --rna whcih allows it to run on transcriptomic data. I then filtered the
identified variants for those that were expressed in a biallelic manner ie. those
where reads containing both the reference and alternate allele were present. I
used the variant effect predictor (VEP) from Ensembl to annotate each variant
with a predicted effect and filtered for those causing a stop gain ie. a PTC. This
resulted in the identification of nine variants (Table 6.1).
I then manually checked each of these variants in the control (mock) and depleted
(si-UPF1), total and nascent RNA samples by visualising the region of interest
using the integrated genome viewer (IGV). Four of the positions only had reads
mapping to the reference strand in the mock treated total RNA samples, suggest-
ing they had been broken down by NMD. Of these, two variants were identified
as biallelic in mock and si-UPF1 nascent RNA, monoallelic in mock treated total
RNA, but biallelic in si-UPF1 treated total RNA (Figure 6.2), suggesting that
the transcripts containing the alternate allele are normally degraded by NMD
and therefore when UPF1 is depleted the alternate allele containing transcripts
can survive.
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Table 6.1: Heterozygous stop gain variants identified in mock nascent
RNA-sequencing
Variants were called in mock nascent RNA-sequencing dataset compared to human
reference genome GRCh38/hg38 using the variant caller strelka and the argument
--rna to allow it to run on transcriptomic data. Variants were filtered for those
that appeared to be biallelic ie. those where reads containing both the reference and
alternate allele were present. The variant effect predictor (VEP) from Ensembl
was used to annotate each variant with a predicted effect and those predicted to
cause a stop gain are listed.
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Figure 6.2: It is possible to detect stop gain variants that are destroyed
in control cells but survive when UPF1 is depleted
Read pile-ups from RNA-sequencing of nascent and total RNA in mock treated
and si-UPF1 treated cells, visualised using the integrated genome viewer (IGV),
across the locus of variants in (A) ZNHIT3 (ENSG00000278259) on chromosome
17 and (B) GATS (ENSG00000213413) on chromosome 7. Both are annotated
as stop gain variants by the variant effect predictor (VEP).
233
6.2.2 Measuring expression of HeLa genome variants
identifies thousands of biallelic transcripts
This proof of principle study shows that it is possible to identify biallelic vari-
ants that have differing fates dependent on NMD activity. However, variants
are normally called using genome sequences rather than transcriptomics, since
variants at the RNA level could be due to errors in transcription or splicing,
or RNA-level editing rather than a reflection of a DNA change. Whole genome
sequencing of HeLa is tightly regulated due to the wishes and legal case of the
Lacks family. However, two research group have sequenced HeLa genomes and
published their findings (Adey et al., 2013; Landry et al., 2013). Access to the
data requires approval from the director of the American National Institute of
Health (NIH, USA). Permission was granted to access and analyse the data in
January 2019. However, the genomic data is restricted access and so identifiable
genomic information such as chromosomal co-ordinates and rs number (RSID)
accession identifiers must be redacted.
Adey et al. (2013) performed whole-genome sequencing (WGS) of the HeLa CCL-
2 strain, identified point- and indel-mutation variations, mapped copy-number
variations and loss of heterozygosity regions, and phased variants across chromo-
some arms into ”haplotype A” and ”haplotype B” (Figure 6.3). They then called
variants compared to human reference genome GRCh37/hg19. By comparing vari-
ation and copy-number profiles for the HeLa S3 cell line and eight additional HeLa
strains, they also showed that HeLa is relatively stable in terms of point variation,
with few new mutations accumulating after early passaging. This is important
because without WGC my HeLa cells, it is not possible to quantify the similarity
of the ”strain” of HeLa cells I have used to the cells used in this study. How-
ever, it is likely that the genome of he cells I have used is more similar to the
HeLa genome descried in this paper than to the human reference genome, and
I will validate the heterozygous genotypes by only considering regions that are
confirmed by RNA-sequencing. Therefore, I can consider my data to be made up
234
of matched WGS, total RNA and nascent RNA datasets. For clarity, I will use
”homozygous” and ”heterozygous” to refer to the genomic variant calls made by
Adey et al and ”monoallelic” and ”biallelic” to refer to the transcriptomic variant
calls in my transcriptomics datasets.
Since I was primarily interested in single nucleotide variants as these will gener-
ate putative NMD-inducing PTCs, mapping accuracy was extremely important
as technical errors could be wrongly interpreted as biallelic expression. There-
fore, I re-mapped all .fastq files from my total/nascent RNA-sequencing exper-
iment using STAR and a re-implementation of the allele-specific analysis method
WASP (Van De Geijn et al., 2015) as an additional filter. WASP substitutes
the SNV base with the alternative genotype in putative allelic-specific reads and
re-aligns those reads to correct for the reference bias. By excluding the allelic
reads that map discrepantly when alternate alleles are edited-in, WASP obtains
an extremely low false positive rate when identifying allele-specific expression
SNVs. Only reads that passed WASP filtering were taken forward. Percentage
of reads mapping was consistently high with an average of 89.27% of reads being
successfully mapped across all samples (Figure 6.4A).
The variants identified in the HeLa genome by Adey et al. (2013) were called
against GRCh37/hg19, whereas all the analysis done in this thesis has used
GRCh38/hg38. Therefore, I performed a lift-over to produce GRCh38/hg38 co-
ordinates for each variant. I could then identify which variants were expressed
in my cells and detectable in nascent RNA data by using samtools mpileup to
find reads covering each variant from the .BAM file output from STAR alignment
(Section 2.2.9). Using samtools mpileup and custom python scripts written by
Craig Anderson (Aitken et al., 2020), I next identified how many reads showed
each of the four nucleotides at the position of each variant, producing tables with
the number of total reads, A reads, C reads, G reads and T reads for each variant
in each sample. Samtools mpileup also identified reads that were split across two
exons, and therefore covered the genomic interval of intronic variants but did
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Figure 6.3: The haplotype phased genome of HeLa cells
Haplotype-resolved copy-number profile of HeLa cancer cell line genome from Adey
et al. (2013). Haplotypes are shown as orange and blue bars beside each chromo-
some, indicating copy number and specific regions present. Red links denote likely
contiguity and tandem duplications. Boxes indicate marker chromosomes identi-
fied by copy number breakpoints. Boxes are coloured by haplotype (orange or blue)
or black indicating unknown haplotype. Pink text represents uncertain locations
and an “S” indicates links confirmed by mate-pair sequencing.
236
Figure 6.4: Thousands of variants are biallelic whilst hundreds are
multiallelic
(A) Mapping of mock (D), si-Scr treated (S), si-UPF1 treated (U) and si-NBAS
treated (N) nascent (N) and total (T) RNA-sequencing using STAR with WASP
filter applied that ensures high accuracy of single nucleotide variants (SNVs) in
reads. After mapping, samtools mpileup was used to identify the nucleotides
present at each variant position identified by Adey et al. (2013). For each sample,
number of variants identified as (B) monoallelic, (C) biallelic and (D) multial-
lelic are shown.
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not provide nucleotide information, and also instances where the variant was in
the insert section, between the two paired end reads. As it was impossible to
determine which allele these reads originated form, they were removed from the
analysis. This resulted in 1,173,446 variants being taken forward.
From the read counts of each nucleotide, I was able to call each variants’ expres-
sion as monoallelic, meaning only one nucleotide was represented, biallelic, where
two nucleotides were expressed at the variant position, and in some rarer cases,
multiallelic, where three or even four nucleotides were identified at the position of
the variant (Figure 6.4B, C, D). The number of variants found to be expressed was
higher for all cases in nascent RNA which was unsurprising given the higher num-
ber of rRNA-originating reads in total RNA, and that nascent RNA represents
all transcribed regions more evenly compared to total RNA which mostly consists
of mature transcripts which are more uneven in their distribution. . An average
of 307,236 variants were identified as biallelically expressed in nascent samples,
whereas an average of 26,610 were identified as biallelic in total samples. Surpris-
ingly, several hundred variants were identified as multiallelic in nascent samples,
and an average of 38 variants were identified as multiallelic in total samples. The
identification of multiallelic reads suggests the presence of (at least) three copies
of the genomic locus with three different alleles represented. Whilst interesting,
this phenomenon is outwith the scope of this analysis and so these variants were
discarded.
Variants were next filtered (Figure 6.5), first to only retain those with 10 or
more reads in all si-Scr and si-UPF1 nascent samples, to remove lowly expressed
and more variable variants. Next, variants were filtered for those identified as
biallelic at the transcription level in at least one replicate of both si-Scr nascent
and si-UPF1 nascent RNA samples. This resulted in a total of 124,120 expressed
biallelic variants.
I also wanted to ensure that all biallelic variants were labelled as heterozygous
at the genome level in the original VCF file from Adey et al. (2013), as op-
posed to being labelled homozygous ALT. Surprisingly, almost 50,000 variants
that were identified as expressed biallelically in the transcriptomics dataset were
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Figure 6.5: Processing and filtering of HeLa genome variants
To identify heterozygous variants in the HeLa genome from Adey et al. (2013)
that were expressed in the RNA-sequencing transcriptomics from this thesis, the
output .BAM files from STAR-WASP were analysed with samtools mpileup using
the position of each variant from the variant calling format (VCF) file. Variants
were then filtered for those that were covered by 10 or more reads in every si-Scr
and si-UPF1 nascent RNA sample, that were identified as biallelic in at least one
si-Scr and one si-UPF1 nascent RNA sample. Variants also had to be identified
as heterozygous in the original VCF and that were expressed in at least si-Scr and
one si-UPF1 total RNA sample.
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not labelled as heterozygous in the original VCF. Comparing the number of het-
erozygous variants and biallelic variants on each chromosome revealed that all
heterozygous variants identified by Adey et al. (2013) that met the expression
threshold of at least ten reads in all si-Scr and si-UPF1 nascent RNA samples,
were expressed biallelically. Conversely, further heterozygous variants were iden-
tified on every chromosome in the HeLa cells used in this thesis compared to
those used by Adey et al. (Figure 6.6). Since all the variant positions were taken
from the original VCF file from Adey et al. (2013), these variants must have been
identified as homozygous ALT by WGS, suggesting that in the cells I have used,
either one allele has mutated to a second alternative nucleotide, or regressed to
the REF. This would be an interesting question to follow up, but for this analysis
I could not rule out the possibility of technical error being the source and so to
be conservative these variants were discarded.
Finally, the variants were filtered to keep only those that were expressed at all
in at least one replicate of both si-Scr total and si-UPF1 total, meaning the
effect of NMD on them could be measured. This resulted in 71,736 heterozygous,
biallelically expressed variants that were then analysed for NMD effect (Figure
6.5).
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Figure 6.6: Further heterozygous variants are present in the HeLa cells
used here than in Adey et al. (2013)
Bars show number of variants passing expression filters on each chromosome, that
are identified as heterozygous in Adey et al. (2013) and identified as biallelically
expressed in the nascent RNA-sequencing described in this thesis (blue), and those
that are biallelic but were not identified as heterozygous by Adey et al. (purple).
Variants were filtered for those that were covered by 10 or more reads in every
si-Scr and si-UPF1 nascent RNA sample. All heterozygous variants from Adey
et al. that met this threshold were expressed biallelically in nascent RNA from
this study.
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6.2.3 Assessing NMD efficiency on variants genome-wide
To identify variants where the two alleles were differentially processed by NMD,
I extended the best method I used for measuring RNA stability (Section 5.2.3)
by creating a DESeq2 model that accounts for three variables. The model design
was:
design= ∼ condition + fraction + allele
+ condition:fraction + condition:allele
Where ”condition” represents the siRNA treatment, “fraction” indicates total or
nascent RNA and “allele” codes for REF or ALT nucleotide. The interaction
terms define that I am interested in differences between the si-Scr and si-UPF1
conditions and that the fraction and allele are co-variables. This analysis resulted
in 42 variants being identified as significantly changed in expression (Figure 6.7).
These were spread across 13 chromosomes (Figure 6.8).
Figure 6.7: Significantly changed variants identified by DESeq2 model
Differential expression analysis using DESeq2 on read numbers of reference and
alternate alleles in nascent and total RNA when UPF1 was depleted compared to
si-Scr control cells. Genes nominally significantly marked in black (p < 0.05) and
those reaching multiple testing correction threshold marked in red (adjustedp <
0.05).
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Figure 6.8: Significantly changed variants are spread across the
genome
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Figure 6.8: Significantly changed variants are spread across the genome
Manhattan plot of the DESeq2 results identifying significantly changed variants.
The y-axis represents –log10(adjusted p value) from DESeq2. The horizontal
dashed line represents the threshold for significance (adjusted p < 0.05).
I first wanted to investigate stop gain variants that would cause a PTC. Therefore,
the predicted effect of each variant was found by creating a new VCF file from
the DESeq2 results and analysing with the Ensembl Variant Effect Predictor
(VEP) (McLaren et al., 2016). The output from VEP contained details about
the transcript(s) that each variant is predicted to effect as well as the severity
of the variant effect. The majority of variants were predicted to effect multiple
transcripts and have differing effects in each. I used this annotation to subset
those variants predicted to cause a stop gain in at least one of the transcripts
they were contained within. Of the 42 variants identified as significantly changed
by DESeq2, one was annotated as a stop gain variant by VEP. The variant was
on chromosome 1 and falls within the SMG5 gene (Figure 6.9A).
I wanted to examine the underlying values of this variant to understand if the
DESeq2 model was correctly identifying variants where the ratio of REF/ALT
was changed in the si-UPF1 total, normalised to the si-Scr total and both nascent
RNA samples. To do this, I plotted the sum of all reads over the variant, as well
as the number mapping to the reference allele (REF) and alternate allele (ALT)
in each condition (Figure 6.9B). This shows a greater number of reads in the
si-UPF1 nascent compared to the si-Scr nascent and also a greater number of
reads in the si-UPF1 total compared to the si-Scr total. The proportion of the
REF and ALT reads in each condition looked roughly equivalent, but the ratio
was hard to estimate. Therefore, I next plotted the number of REF reads against
the number of ALT reads for each replicate of each sample (Figure 6.9C). By
eye, all the points looked to be along a similar ratio, however plotting a linear
regression line for si-UPF1 total RNA showed a strong skew towards REF reads.
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Figure 6.9: The stop gain variant within the SMG5 gene in detail
Figure 6.9: The stop gain variant within the SMG5 gene in detail
(A) Read pile-ups from RNA-sequencing of nascent and total RNA in mock
treated and si-UPF1 treated cells, visualised using the integrated genome viewer
(IGV), across the locus of the identified stop gain variant within the SMG5 gene.
Grey bars indicate nucleotides where all reads match the reference. Coloured bars
indicate where two or more nucleotides have been identified. (B) Sum of all reads
(All), number mapping to the reference allele (REF) and number mapping to the
alternate allele (ALT) in si-scramble nascent RNA (SN), si-UPF1 nascent RNA
(UN), si-scramble total RNA (ST) and si-UPF1 total RNA (UT). Each condition
shows mean and standard deviation of n=5 replicates. (C) Ratio of REF reads to
ALT reads in each replicate (n=5) of each condition; si-scramble nascent RNA,
si-UPF1 nascent RNA, si-scramble total RNA and si-UPF1 total RNA . Dashed
blue line indicates linear regression line of si-UPF1 total RNA samples.
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However, this was not an accurate way of comparing the RNA processing in
each treatment, since number of counts could vary due to technical difference.
Therefore, I decided to manually calculate the change in ratio of ALT to REF
reads for every variant in each condition.
To do this, I first converted the read count over each variant into a transcripts
per million (TPM) value to make the libraries comparable. Since this analysis
is looking at single nucleotide variants, I did not normalise to transcript length,
only library size. I then took the median ALT TPM and REF TPM from each
condition (n=5) and calculated a ratio of total RNA ALT TPM to nascent RNA
ALT TPM and ratio of total RNA REF TPM to nascent RNA REF TPM for
both si-Scr treated cells and si-UPF1 treated cells (Figure 6.10A). The si-UPF1
ratios (purple) are overlaid on the si-Scr ratios (green) for comparison. In general,
the two distributions look very similar, however the density of points makes inter-
pretation difficult. Therefore, linear regression lines for si-Scr and si-UPF1 were
added. The coefficient of the lines were significantly different, however the regres-
sion for si-UPF1 was actually lower than that of si-Scr (0.48+/−0.004 compared
to 0.56 + /− 0.004; coefficient and standard error, linear regression), suggesting
a shift towards more REF allele than ALT allele when UPF1 is depleted.
Since only a small proportion of the variants will trigger NMD, I next used VEP to
annotate the effect caused by each of the 71,736 variants and then compared the
REF and ALT ratios for only those variants predicted to cause stop gains (Figure
6.10B). The linear regression line for si-UPF1 was steeper than the si-Scr line,
suggesting more of the PTC-containing variants are present in total RNA when
UPF1 is depleted. However, the coefficients of the lines were not significantly
different (0.87+/−0.092 si-UPF1 compared to 0.84+/−0.086 si-Scr; coefficient
and standard error, linear regression), likely due to the small number of variants
in this analysis.
To investigate the stop gain variant within the SMG5 gene, median TPM mapping
to REF and ALT, in si-Scr total and nascent RNA samples and si-UPF1 total
and nascent RNA samples was plotted (Figure 6.10C). The lines represent the
gradient between the total and nascent REF/ALT ratios. The nascent ALT/REF
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Figure 6.10: Calculating reference and alternate allele ratios allows
comparison of allele-specific RNA processing
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Figure 6.10: Calculating reference and alternate allele ratios allows
comparison of alelle-specific RNA processing
(A) Comparison of ratio of total RNA alternate allele (ALT) transcripts per
million (TPM) to nascent RNA ALT TPM on the y-axis to ratio of total RNA
reference allele (REF) TPM to nascent RNA REF TPM on the x-axis. Plotted
for both si-Scr treated cells (green) and si-UPF1 treated cells (purple). Black line
represents y=x. Dashed lines show linear regression model for each treatment.
(B) Comparison of REF and ALT ratios for only those variants predicted to
cause stop gains by the variant effect predictor (VEP). Plotted for both si-Scr
treated cells (green) and si-UPF1 treated cells (purple). Black line represents y=x.
Dashed lines show linear regression model for each treatment. (C) Median TPM
(n=5) mapping to REF and ALT of the stop gain variant within the SMG5 gene,
in si-Scr total and nascent RNA samples and si-UPF1 total and nascent RNA
samples. Line represent gradient between total and nascent ratios. (D) Model
data showing expected median TPM mapping to REF and ALT if a variant causes
the ALT transcript to be specifically targeted by NMD.
ratios are very similar and so are the gradients of the lines, although the gradient
is slighter steeper for si-Scr towards ALT (si-Scr gradient = 0.6861709, si-UPF1 =
gradient 0.5573066). However, the TPM of ALT and REF in si-UPF1 total RNA
is much higher than in si-Scr total RNA, suggesting that the stop gain variant
in SMG5 was identified by DESeq2 as significant due to the stabilisation of the
SMG5 transcript. Conversely, Figure 6.10D shows model data indicating the
expected values if a variant triggers NMD meaning the ALT transcript specifically
is degraded. The ALT/REF ratios in nascent si-Scr and si-UPF1 samples are very
similar showing there is no change in transcription, whereas the ratio is skewed
toward REF in si-Scr total showing that the ALT transcript is being degraded in
an allele specific manner. This effect is rescued when UPF1 is depleted showing
that the ALT transcript is likely an NMD target. The discrepancy between
the SMG5 plot and the model data confirms that the DESeq2 model used is not
identifying the changes that I am looking for in this analysis. Therefore, I decided
to use the manually calculated REF/ALT ratios to identify candidate variants.
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DESeq2 is well suited to the analysis of count-based sequence data, identifying dif-
ferences in expression between conditions (a ratio; Section 4.2.3) and can also be
adapted to capture a change in ratio between conditions (a ratio of ratios; Section
5.2.3). However, to quantify changes in allele-specific transcript stability between
conditions, requires the identification of a change in ratio between fractions, in-
fluenced by a treatment (a ratio of ratios of ratios). Figure 6.11A illustrates the
different variables involved. Total RNA (representing steady state abundance) is
normalised to nascent RNA (representing transcription). Calculating this ratio
for both ALT and REF allows comparison of the processing of the allele-specific
transcripts. If a variant caused a transcript to become an NMD-target, the ALT
transcript would be degraded and reduced in total RNA, therefore the ratio of
total to nascent for REF would be greater than the ratio of total to nascent for
ALT. However, upon depletion of UPF1, NMD would be abrogated and so the
ALT transcript would not be degraded and the ratio of total to nascent for REF
and ALT would be similar.
To visualise this model, an odds ratio (OR) can be calculated for both si-Scr
samples and si-UPF1 samples independently and then these compared by plotting
an x-y distribution (Figure 6.11B). The OR for each condition was calculated
using the following equation:
OR = ((median ALT total TPM / median ALT nascent TPM)
/ (median REF total TPM / median REF nascent TPM))
The majority of variants would be located along the y=x axis since they are not
processed in a differentially allele-specific manner upon depletion of UPF1 (black
oval). However, for variants that are affected by UPF1, their si-UPF1 OR would
be near zero, whilst their si-Scr OR would indicate the normal allele-specific bias
in RNA processing (orange oval). Those variants with a negative si-Scr OR and
a near zero si-UPF1 OR are likely to be targeted by NMD.
Calculating these OR using the median TPM for each sample revealed the ma-
jority of variants were located along the y=x axis as predicted (Figure 6.11C).
The stop gain variant identified in the SMG5 gene is indicated in red and shows
a near zero OR for both si-Scr and si-UPF1, in line with the absence of allele-
249
Figure 6.11: Calculating independent odds ratios for si-Scr and si-
UPF1 treated samples allows to quantification of changes in allele-
specific transcript stability between conditions
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Figure 6.11: Calculating independent odds ratios for si-Scr and si-
UPF1 treated samples allows to quantification of changes in allele-
specific transcript stability between conditions
(A) Pseudo equation illustrating the different variables involved in quantifying
changes in allele-specific transcript stability between conditions. Total RNA (rep-
resenting steady state abundance) is normalised to nascent RNA (representing
transcription). Calculating this ratio for both ALT and REF allows comparison
of the processing of the allele-specific transcripts. (B) Diagram showing plot of
model data comparing the odds ratio (OR) calculated for both si-Scr samples and
si-UPF1 samples independently. (C) Plot of 71,736 heterozygous HeLa genome
variants following calculation of the OR values outlined in (B) using the median
TPM for each sample (n=5). Red line shows y=x axis. The stop gain variant
identified within the SMG5 gene is indicated in red. Orange points are variants
with 3-fold higher si-UPF1 OR than si-Scr OR and si-UPF1 OR between -1 and 1.
(D) Example of orange highlighted variant from (C) that recapitulates the model
data showing differential allele-specific RNA processing upon depletion of UPF1.
Median TPM (n=5) mapping to REF and ALT, in si-Scr total and nascent RNA
samples and si-UPF1 total and nascent RNA samples. Line represent gradient
between total and nascent ratios.
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specific processing seen for this variant (Figure 6.10C). To identify those variants
behaving in line with an NMD-targeted variant, I highlighted those with a si-
UPF1 OR at least 3-fold higher than si-Scr OR and with a si-UPF1 OR between
–1 and 1. Although a complete loss of NMD activity would predict a y-axis
value very close to zero, since knock down of UPF1 was ∼80% (Section 3.2.1),
loss of NMD may be incomplete, so I extended this to include variants with a
si-UPF1 OR between –1 and 1. This resulted in 5,314 variants being highlighted.
Through manual inspection of the median TPMs of these variants, I identified
a variant on chromosome 17 that recapitulated the model data (Figure 6.11D),
indicating that this subset of variants contains the allele-specific UPF1-mediated
differentially processed targets I am interested in. This variant is not predicted
to cause a stop gain by VEP so is likely not the causative variant, but the change
in ALT/REF ratio in si-UPF1 total RNA compared to si-Scr total RNA is highly
suggestive of the transcript being targeted by NMD.
This analysis showed that it is possible to identify UPF1-targeted variants using
independent si-Scr and si-UPF1 ORs, and this is similar to the previous analysis I
have carried out using DESeq2 (Section 5.2.3). Therefore, I next carried out DE-
Seq2 differential analysis of ALT/REF ratio of total RNA, normalised to nascent
RNA of si-Scr and si-UPF1 independently. Plotting the log2(fold change) of
the si-Scr analysis against the log2(fold change) of the si-UPF1 analysis revealed
three distinct distributions along the y=x axis (Figure 6.12A). The majority of
variants are near zero on both axis, since they are not processed in a differentially
allele-specific manner upon depletion of UPF1. The higher and lower concentra-
tions of data points likely reflect ploidy. Two copies of the maternal haplotype
and one copy of the paternal would be expected to give a corresponding log2
expression ratio of 1 or -1 depending on whether the maternal was the REF or
ALT. However, there is a clear bias to negative OR in both si-Scr and si-UPF1
samples, indicating a systematic bias towards lower ALT expression. This is un-
derstandable given that many of the variants are predicted by VEP to have high
impact on protein function.
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Figure 6.12: Using DESeq2 to independently calculate si-Scr and si-
UPF1 odds ratios identifies differential allele processing
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Figure 6.12: Using DESeq2 to independently calculate si-Scr and si-
UPF1 odds ratios identifies differential allele processing
(A) Comparison of log2(fold change) of si-Scr DESeq2 analysis against log2(fold
change) of si-UPF1 DESeq2 analysis. All variants are shown in grey, and coloured
dots indicate specific genes; the stop gain variant identified in the SMG5 gene
(red), the example variant that recapitulates model data showing differential allele-
specific RNA processing upon depletion of UPF1 (blue). Black points indicate
variants significant in si-Scr DESeq2 analysis, whereas orange points indicate
variants significant in si-Scr DESeq2 analysis but not significant in si-UPF1 DE-
Seq2 analysis (B) Variant effect predictions of the 42 variants shown in orange in
(A) and with a negative si-Scr log2(fold change). Since the majority of variants
were predicted to effect multiple transcripts and have differing effects in each, the
number of predicted effects is greater than the number of variants. (C & D)
Example variants that appear to be NMD targets since they show evidence of dif-
ferential allele-specific RNA processing upon depletion of UPF1. Median TPM
(n=5) mapping to REF and ALT, in si-Scr total and nascent RNA samples and
si-UPF1 total and nascent RNA samples. Line represent gradient between total
and nascent ratios.
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Onto the background of all variants (grey), the stop gain variant identified within
the SMG5 gene is indicated in red. As with the manual OR analysis (Figure
6.11C) this variant shows a near zero fold change for both si-Scr and si-UPF1,
in line with the absence of allele-specific processing seen for this variant. The
variant identified in the manual OR analysis that behaves like an NMD target is
indicated in blue. It is above the x=y axis showing an increased ALT in total
RNA in si-UPF1 treated cells compared to si-Scr treated cells. However, this
variant was not identified as significantly changed in the si-Scr DESeq2 analy-
sis (p=0.443). Variants that were significant in the si-Scr DESeq2 analysis are
indicated in black whilst those significant in the si-Scr DESeq2 analysis but specif-
ically not significant in the si-UPF1 deseq2 analysis are shown in orange. The
distribution of these points recapitulates the model data in figure 6.11B. 42 of
these variants also had a negative log2(fold change) in si-Scr indicating that in
control cells the ALT allele is degraded. VEP annotation of these 42 variants
did not identify any predicted stop gain effects, however it is possible there are
PTCs elsewhere in the transcripts, possibly caused by the variants identified.
10 of the variants were predicted to be located within NMD-target transcripts.
The majority of predicted effects were within non-coding regions (Figure 6.12B),
including introns and the 3’ UTR. The variants in regulatory regions of the tran-
script could affect splicing leading to alternate isoforms or retained introns for
example, making them NMD targets. Since the majority of variants were pre-
dicted to effect multiple transcripts and have differing effects in each, the number
of predicted effects is greater than the number of variants. Despite the lack of stop
gain annotation, plotting the median REF and ALT TPM, indicated many of the
variants are NMD targets since they show evidence of differential allele-specific
RNA processing upon depletion of UPF1 (Figure 6.12C, D).
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6.3 Discussion
6.3.1 Measuring NMD efficiency genome-wide using
matched genome and RNA-sequencing requires
further optimisation
In this chapter I have shown that it is possible to identify expression of heterozy-
gous genome variants in nascent RNA-sequencing data and, by combining this
with total RNA-sequencing data, identify allele-specific RNA processing. The
analyses in this chapter provide a first look at the possibility of measuring di-
rect NMD effect on individual transcripts utilising expression of heterozygous
variants. This analysis provides interesting insights into differential processing
of heterozygous variants, however, it requires further optimisation to utilise the
dataset to its full potential.
Firstly, as shown by Figure 6.10C, the original integrated DESeq2 model I de-
signed did not identify the changes I was interested in. This does not mean
DESeq2 is not an appropriate way to perform this analysis. It is a statistical
framework that is well suited to the analysis of count-based sequence data with
replicates and has been successfully adapted to capture differences in expression
between conditions as well as change in allele ratio between conditions. However,
it is not readily adapted to capture the multiple variables required to quantify
changes in transcript stability between conditions. Therefore, instead of applying
a single unified framework, I developed a hierarchical strategy of quantifying allele
specific differences in stability for each condition (si-Scr and si-UPF1 knockdown)
and then classifying the discordance between conditions. This was a pragmatic
and robust solution, but the lack of variance sharing between the analysis of each
condition limits the power of this statistical test, and suggests that further work
to develop a unified framework for the joint analysis of a ratio of ratios of ratios
(Figure 6.11A) would be a useful endeavour.
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As the nature of NMD targets is that they are degraded, this could mean that
there are no reads over an ALT variant in control total RNA. Appropriately
dealing with these informative zero values is essential for identifying the most
efficiently targeted NMD targets. In the analysis presented in this chapter, I
added a pseudocount to all median TPM values to account for this issue, but
a more elegant solution would be identifying those variants with a zero count
of ALT in total RNA specifically, but both ALT and REF reads represented in
nascent RNA as these are likely NMD-targets. Finally, since this analysis requires
a complicated statistical model, it could be that this dataset is underpowered.
For example, the genotype-tissue expression GTEx project only shows summary
analyses of genotypes with a minimum of 70 replicates. Making use of the hap-
lotype information determined by Adey et al. (2013) would increase the power
of these analyses as it would allow the phasing of the variants to identify which
variants are within the same transcript and allow addition of the read counts
across the whole transcript. It may also be possible to then identify the causative
variant within a transcript that triggers NMD. Furthermore, this would allow the
various triggers for NMD to be measured in terms of their likelihood to result
in NMD degradation. It may even be possible to identify new characteristics or
rules regarding when and how a transcript triggers the NMD pathway.
There are also various elements to this dataset that were discounted in this first
pass analysis that would be interesting to follow up. Such as the ”novel” biallelic
variants identified in the transcriptomic data that were not heterozygous in the
HeLa WGS (Adey et al., 2013). These genomic positions were taken originally
from the HeLa genomic variants list, so must have been identified as homozygous
ALT by WGS. This could suggest errors in the genotype calls, or that in the cells
I have used, either one allele has mutated to a second alternative nucleotide, or
regressed to the REF. More likely, this could represent loss of heterozygosity in
the HeLa cells sequenced by Adey et al., that has been retained in the HeLa cells
used in this thesis. Visualising exactly where on each chromosome these variants
are located could identify specific chromosomes or large regions of them where
this has occurred.
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There were also a number of indels in the HeLa genome identified by Adey et al.,
that could lead to frameshifts and thereby creation of PTCs or aberrant splicing
that could trigger NMD. Therefore, heterozygous indels could be analysed in
a similar way to the SNVs to identify any that are targeted by NMD and are
therefore processed in an allele-specific manner.
A fundamental disadvantage of this analysis is that I do not know how similar
the HeLa cells that were WGS and the HeLa cells I performed RNA-sequencing
on are. Since WGS of HeLa cells is so tightly regulated, a more controlled exper-
iment would be to repeat this analysis in another cell line and carry out exome
sequencing as well as total and nascent RNA-sequencing in the same cells. It
would also be interesting to extend this to an in vivo model of NMD abroga-
tion. UPF1 has been shown to be commonly mutated in certain cancers (Liu et
al., 2014) so RNA-sequencing of these tumours would likely contain many NMD-
targeted transcripts that have survived due to lack of UPF1 activity. However,
since many pathways and processes are dysregulated in cancer, a more controlled
experiment would be a conditional knock out of UPF1 in an animal model which
would allow study not only of the effect of acute loss of NMD activity but also
the differing effect of NMD in different tissues.
6.3.2 Future Work
It has recently been proposed that there exists a mechanism of nonsense-induced
transcriptional compensation (NITC) (El-Brolosy et al., 2019; Ma et al., 2019).
Both papers show that NMD degradation of a transcript leads to increased tran-
scription of sequence similar genes and in the case of heterozygous mutants, in-
creased transcription of the WT allele. Dosage compensation was first reported
in Drosophila in 1932 (Muller and J, 1932), and genetic compensation in response
to a gene knockout was first reported in yeast in 1965 (Mukherjee and Beermann,
1965). Since then, genetic compensation has been documented many times in
a number of model organisms (Heard and Disteche, 2006; Raj et al., 2010; El-
Brolosy and Stainier, 2017; Ghanbarian et al., 2017), but the mechanism remained
elusive.
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Using zebrafish and mouse mutants that harbour a PTC or have their last exon
deleted, El-Brolosy et al. (2019) showed six zebrafish genes and four mouse genes
that, when mutated, trigger the NITC mechanism. (Ma et al., 2019) use the
term genetic compensation response (GCR) and studied knockdown and knockout
models of two zebrafish genes. They demonstrated that NITC is dependent on
both the presence of a PTC and the nucleotide sequence of the NMD-targeted
mRNA.
El-Brolosy et al. (2019) propose that mRNA fragments generated by NMD bind
selectively to complementary nucleotide sequences in related genes and carry un-
known regulatory factors to induce transcription. One of the factors suggested
was UPF3A, which Ma et al. show is crucial for the transcriptional compensatory
mechanism, suggesting that UPFA is binding to the NMD degradation fragments,
being transported with them into the nucleus and using them to identify sequence
similar genes which are then upregulated. The increased transcription of gene
paralogues was accompanied by increased occupancy of the genes’ promoter re-
gions by the transcription inducting epigenetic mark H3K4me3 (3 methyl groups
added onto the lysine in the fourth position from N-terminus, on the tail of the
H3 histone). Ma et al. (2019) found that UPF3A interacts with COMPASS — a
protein complex that has been shown to activate gene transcription by modifying
H3 histone proteins (Wysocka et al., 2006). Both groups find that COMPASS is
integral to the genetic compensatory response. Interestingly, whilst El-Brolosy
et al. found that knockout of UPF1 prevented NITC, Ma et al. observed that
NITC was not impaired by knockdown of UPF1, UPF2 or UPF3B, suggesting
the mechanism could be distinct from the canonical NMD pathway. This appar-
ent discrepancy could result from the use of different approaches for perturbing
UPF1, because of the different genes studied, or from other factors.
Although the details of this mechanism are currently rudimentary, this process
could explain why knock-out models that cause the target mRNA to become an
NMD target sometimes show no phenotype (El-Brolosy and Stainier, 2017; Rossi
et al., 2015). Ma et al. showed that capn3a-knockdown zebrafish embryos had
small livers, and nid1a-knockdown embryos had reduced body lengths, capn3a-
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null and nid1a-null mutants appeared normal. The null zebrafish were created
by introducing a PTC into the gene meaning all RNA was degraded by NMD,
whereas the knockdown zebrafish were targeted at the RNA level in an NMD-
independent manner. Therefore, the phenotypic differences were attributed to
the upregulation of other genes in the same families, specifically upon NMD
degradation.
Whilst intriguing, these studies are small scale and only show data for a handful
of genes. It remains unclear whether NITC is applicable to most genes. It
would be interesting to investigate how widespread and at what magnitude this
phenomenon is, and whether it is influenced by factors such as the characteristics
that mark a target as an NMD target. Although not designed to test this model,
the dataset I have created does provide a genome-wide description of change in
transcription upon depletion of the core NMD factor UPF1. Therefore, by using
the si-UPF1 treated cells as a control condition, it could be investigated whether
there is increased transcription of the WT allele or sequence similar genes of an
NMD target in the si-Scr treated cells. To do this, I would use the heterozygous
variants identified as targeted by UPF1 and compare the nascent RNA ALT
and REF transcription to determine if depletion of the ALT transcript leads to
an increase in REF transcription. I could also extend this to look at whether
transcription of sequence-similar genes is also affected due to NMD degradation.
6.3.3 Summary
In this chapter, I develop a methodology to identify NMD-triggering variants
using matched genome and transcriptome datasets. I show that it is possible
to directly measure differentially stability of heterozygous alleles when NMD is
depleted and use this methodology to identify endogenous aberrant transcripts
that are processed in an allele-specific manner. However, further optimisation of









7.1 Appropriate methodology is vital to study
NMD effects
My analyses clearly show the advantages of using differential RNA stability to
measure direct effects of NMD activity compared with simply using differential
abundance of total RNA. Whilst analysis of differential abundance of RNA upon
depletion of UPF1 resulted in many transcripts being identified that decreased
as well as increased, analysis of differential stability identified only one mRNA
that was destabilised which was UPF1 itself. This suggests that many changes
identified in total RNA differential expression analysis are indirect effects.
My results also indicate that a large proportion of the RNA abundance changes
seen by differential expression analysis were not due to changes in RNA stability
and therefore are NMD-independent effects. It seems likely that the large amount
of variability in the identification of NMD targets is due, in part, to these effects
being mistakenly categorised as NMD-dependent changes. Therefore, any future
studies on NMD activity should not use differential abundance as a read out
of NMD activity but instead measure change in RNA stability. An increasing
number of techniques are being developed and optimised in this area including
SLAM-seq and TT-seq making RNA stability measurements easier and more
accessible. Furthermore, my results add to the body of evidence that transcription
inhibition leads to altered results compared with undisturbed cellular conditions,
and that to understand clearly the processes governing NMD it is important to
use as biologically undisturbed a system as possible.
Despite this, RNA abundance and transcription inhibition continue to be used as
techniques to measure and characterise the NMD pathwya and identify targets
(Raxwal, 2020). Genome-wide measures of RNA stability are mostly found in
studies where RNA degradation kinetics or mechanism are of interest and the
affect of NMD is not addressed (Sorenson 2018).
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From my results and published work looking at RNA stability changes upon
depletion of UPF1 (Tani et al., 2012), it appears that UPF1 does not regulate
as many genes as previously estimated from differential expression analysis. The
identified stabilised genes, and increased in abundance account for∼1% of the
transcriptome. However, this does not indicate that NMD is unimportant, since
targetting of one factor in a complex pathway could alter the levels of many
different proteins and have strong affects on cellular signalling. Furthermore,
there is much evidence for the importance of NMD in development, differentiation
and stress response. Therefore, perhaps future studies on NMD should utilise
appropriate cell types or external stimuli to recreate these physiological contexts
that NMD may be most active.
It is also important to consider the kinetics of NMD, since harvesting RNA only
a short period after UPF1 depletion will give a more clear picture of the primary
effects, whereas at 72hr post depletion (as used here) the bigger picture is being
captured including downstream effects. This could also mean more transient
effects that are quickly mitigated by the cell are also undetected. Many gene
regulation networks are very rapid for example some RNA-binding proteins bind
and regulate their own mRNA. To truly appreciate the waves of affects caused
by depletion of a multi-functional protein such as UPF1 many time points should
be utilised.
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7.2 An ER-NMD pathway quality controls
transcripts translated at the ER
The results in this thesis support a role for UPF1 in regulation of transcripts at the
ER. Since NMD is co-translational, and these transcripts are translated when the
ribosome is docked at the translocon and UPF1 has been shown to interact with
the SEC61 channel, it seems sensible to conclude that UPF1-mediated quality
control is occurring at the ER membrane. Since not only secretome transcripts
are translated at the ER, this mechanism would regulate expression of a notable
proportion of cellular mRNAs. However, a lot about ER-NMD is still unknown.
For example, does UPF1 get carried to the ER whilst bound to mRNA or is it
specifically recruited when necessary? Longman et al. (2020) showed that UPF1
is tethered to the ER by NBAS which suggests it could always be present or that
perhaps the NBAS-UPF1 interaction stabilises the RNA at the ER membrane.
Also, in cytoplasmic NMD the incomplete nascent peptide is readily accessible to
the degradation machinery in the cytoplasm, whereas nascent peptide translated
at the translocon is deposited straight into the ER lumen so it must then be
recognised as incomplete and then actively exported out of ER. Is the ERAD
pathway then activated to retrotranslocate the peptide to the cytoplasm so it
can be degraded by ubiquitination or is another mechanism utilised?
Considering all the evidence thus far, it seems likely that a quality control mech-
anism does occur at the ER and since UPF1 is localised to the translocon and
affects both abundance and, crucially, stability of ER translated transcripts, it
seems probable that this is an NMD pathway at the ER membrane. What is
not clear is the exact mechanism by which this occurs. In this thesis, I showed
that UPF2 seems to have a very limited effect on expression of transcripts in the
membrane-associated fraction (Chapter 4), suggesting that ER-NMD could be
occurring in an UPF2-independent manner. Since UPF2 is the bridge between
UPF1 and UPF3B, this would likely mean that the EJC would not be involved in
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ER-NMD and the DECID complex would not form. Since the EJC can be fairly
heterogeneous in its composition, perhaps this suggests that EJC loaded onto se-
cretome transcripts are less likely to include UPF2. Or perhaps the non-uniform
distribution of EJC deposition on transcripts (Le Hir et al., 2016) is skewed away
from secretome transcripts. Furthermore, recent findings show that NMD occurs
with equal probability during each round of translation of an mRNA molecule
(Hoek et al., 2019) and since all EJCs are thought to be removed in the pioneer
round of translation so would therefore not be present in later rounds, this calls
into question whether NMD activation requires the EJC to proceed.
To understand more fully the ER-NMD mechanism, it would be interesting to un-
derstand more about the other putative NMD factor that localises there; SEC13.
Like NBAS, the C. elegans homologue of SEC13 was also found in an NMD factor
screen (Casadio et al., 2015). Like NBAS, SEC13 has been shown to increase the
abundance of the NMD reporter HBB construct with a PTC, and seems to have a
stronger effect than NBAS. However confusingly, the HBB gene is not part of the
secretome. One study that aimed to add localisation signals to transfected genes
found that a WT β-globin reporter was partially found in the membrane fraction
(Partridge et al., 1999), but it was not identified in any of the three experiential
datasets used in this thesis to denote ER-translocation. Whilst it has been shown
that up to 40% of cytosol-encoding mRNAs can be translated at the ER (Reid
and Nicchitta, 2012), this assumed to occur at low frequency. Therefore, the
increase in abundance of PTC-containing HBB mRNA upon depletion of NBAS
or SEC13 seems contradictory. A more clear measurement of ER-specific NMD
activity would be the change in stability of a PTC-containing gene with and
without an ER localisation signal, upon depletion of these factors as well as core
NMD factors such as UPF1 and UPF2. This would allow measurement of how
specific to ER-translated mRNAs the effects are.
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7.3 The role of NBAS in RNA quality control
requires further investigation
The question of whether NBAS is an NMD factor is still not conclusively answered
but the results presented here seem to point to a different mechanism that would
explain the seemingly contradictory results.
An overwhelming amount of evidence agrees that NBAS and UPF1 interact,
which makes the model of NBAS having a function in human NMD appealing.
However, as already discussed, UPF1 has many known cellular functions and in-
teracts with a variety of protein subtypes, the vast majority of which are not
thought to be involved in NMD. Therefore, this evidence is not sufficient on it’s
own to classify NBAS as an NMD factor. In this thesis I show that, as well as
UPF1, NBAS interacts with the SEC61 translocon (Chapter 3) where translation
takes place at the ER. However it is not clear whether these interactions are si-
multaneous and this would be an interesting point for further study. Three-colour
immunofluorescence and super-resolution microscopy may be able to determine
whether the three proteins are found in close proximity or whether their inter-
protein interactions are independent.
It has been argued that NBAS recruits UPF1 to the ER, however this has not
been shown conclusively and since UPF1 binds RNA it is likely that it could
be transported to the ER as part of the mRNP when an the RNA contains an
ER-localisation signal. One way to investigate the role of NBAS on UPF1’s
localisation to the ER would be to carry out a PLA on UPF1 and SEC61B in
the presence and absence of NBAS.
NBAS does appears to tether UPF1 at the ER, evidenced by UPF1’s faster dif-
fusion at the ER region in the absence of NBAS. An interesting experiment to
investigate the effect of NBAS on UPF1’s NMD activity at the ER, would be to
carry out UPF1 CLIP in the presence and absence of NBAS. UPF1 is a known
RBP and successful CLIP experiments have been performed that indicate the
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transcripts it binds. Therefore, comparing UPF1 binding in WT cells to those
depleted of NBAS would indicate the effect NBAS had on recruiting and/or sta-
bilising UPF1 on target RNAs translated at the ER. Since UPF1 binds many
transcripts transiently, and it’s phosphorylation is thought to stabilise these in-
teractions, CLIP specifically of P-UPF1 would be likely give a more accurate
description of NMD targets. The results of this experiment may shed light on the
mechanism by which NBAS affects abundance but not stability of ER translated
transcripts.
Transcripts with increased abundance when NBAS was depleted were identified
in the first RNA-sequencing experiment discussed in this thesis (Chapter 4).
These transcripts overlapped with UPF1 targets (Figure 4.6A), however these
were concluded to be lowly expressed RNAs with small fold changes (Figure
5.10F), and the vast majority did not reach significance in the STAR-HTSeq-
DESeq2 re-analysis of this dataset (Chapter 5, Figure 5.10D). A large number
of transcripts were identified as increased in abundance in the second dataset
analysed using the STAR-HTSeq-DESeq2 pipeline (Chapter 4), however these
correlated very weakly with UPF1 targets from that experiment (Figure 4.11A).
Whilst depletion of UPF2 or UPF1 in either experiment led to increased abun-
dance and stability of several NMD factors, depletion of NBAS did not lead to
increase in abundance or stability of any NMD factors in either dataset (Chapter
4, 5). Finally, no transcripts were identified as increased in stability by any of
the four methods used (Chapter 5), strongly suggesting that the few targets that
did change in abundance are affected in an NMD-independent manner.
NBAS has a known role in secretome protein localisation and post-translational
processing, so it is feasible that disrupting these processes would affect other
cellular systems such as RNA processing or transcription. Therefore, the loss of
NBAS from the vesicular transport system could be the cause of the changes in
RNA abundance seen. Since UPF1 has been shown to be localised to the ER,
the correlation of the lowly expressed transcripts with increased abundance when
either UPF1 or NBAS was depleted (Figure 4.6A) could represent on disruption
of a non-NMD mechanism at the ER. This would concur with the finding that
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many of the targets were ER-associated (Figure 4.7E). It would be interesting
to see if NBAS depletion affects mRNA localisation for example reducing the
likelihood that transcripts localise to the ER. To test this, the abundance of
specific transcripts could be compared in the membrane fraction and cytoplasmic
fraction of the fractionated RNA-sequencing dataset from this thesis (Chapter
4). This could reveal whether re-localisation is occurring between the ER and
the cytoplasm upon depletion of NBAS and/or UPF1.
UPF1 has been shown to be localised to the ER and a regulator of ER stress.
Therefore, the interaction between NBAS and UPF1 could be as part of an ER
stress pathway. UPF1 has recently been shown to promotes aggresome formation
(Park et al., 2020). Aggresomes are perinuclear non-membranous compartments
that contain potentially toxic misfolded polypeptides that are prone to aggre-
gation. The polypeptide aggregates are selectively recognized by aggresome-
targeting cellular factors and transported to the microtubule-organizing centre
(MTOC) via microtubule-mediated retrograde movement, and eventually cleared
from the cell via the autophagy pathway. Since the outer nuclear membrane is
continuous with the ER membrane, NBAS could be in close proximity to these
aggresomes, event potentially recruiting or tethering UPF1.
As well as being the site of ER translation, the SEC61 translocon has been
shown to be able to retrotranslocate faulty nascent proteins out of the ER lumen
into the cytoplasm for ubiquitination and degradation as part of the ERAD ER
homeostasis pathway. This is another avenue that would be interesting to follow
up in terms of NBAS function. Since NBAS appears to have no effect on transcript
stability, it would be interesting to investigate if it is involved in aberrant protein
degradation by facilitating the efflux of these proteins via the SEC61 translocon.
Since faulty proteins must be moved from the ER lumen to the cytoplasm to be
degraded, the ERAD and ER-NMD pathways are likely to be inherently linked.
Therefore, it seems plausible that abrogation of the ERAD machinery could have
a negative effect on the function and efficiency of ER-NMD.
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Since NBAS has a known role in protein complex assembly as part of Golgi-to-
ER retrograde transport, I think the most compelling explanation is that NBAS
functions to facilitate assembly of other protein complexes too. It could have a
role in the secure docking of the ribosome to allow translation to occur, in the
assembly of the SURF complex upon stalling of the ribosome at a PTC or in
modulating the SEC61 channel to facilitate retrotranslocation of faulty, nascent
peptides. To identify other avenues of investigation in understanding the other
functions of NBAS, further pathway analysis could be utilised to identify the
mechanisms that the targets identified as affected by NBAS are involved in. For
example, identifying any transcription factors that are affected by NBAS could
elucidate downstream effects due to altered levels of that transcription factor.
As discussed in Section 1.3.3, several patients have been identified to have harbour
in their NBAS gene. Phenotypes are complex and include short stature, optic
nerve atrophy, bone fragility, abnormal nuclear shape in neutrophil granulocytes,
small hands and feet, developmental delay, seizures and reduced natural killer
cells (Maksimova et al., 2010; Lacassie et al., 2020; Balasubramanian et al., 2017;
Haack et al., 2015; Wimmer et al., 1999; Frühwald et al., 2000; Segarra et al.,
2015). Whilst the evidence suggests that most of the NBAS mutations cause
reduced level of NBAS protein, it is not currently known by what mechanism the
mutations in NBAS lead to these phenotypes. The results in this thesis suggest
that it is likely not through a direct role in RNA stability.
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7.4 Closing Remarks
This project set out to investigate the mechanism by which the putative NMD
factor NBAS was involved in the pathway and whether a dedicated NMD path-
way at the ER was present in human cells. The conclusions in this thesis may
seem to contradict other work that has been done on NBAS and the ER-NMD
pathway. However, my findings taken together with the previous work do sup-
port the existence of an ER-specific NMD pathway. This pathway may well be
mechanistically different to canonical NMD, for example in an UPF2-independent
manner. However, given the conflicting findings regarding the role of NBAS in
ER-NMD it seems unlikely that NBAS is integral to the ER-NMD pathway and
it’s role appears to be largely redundant.
Utilising paired nascent and total RNA-sequencing to determine genome-wide
steady-state RNA expression levels and RNA decay rates is a powerful approach
for identifying bona fide targets regulated by RNA decay factors, including, but
not limited to, NMD factors. This approach could be applied to and shed new
light on various processes including quality control, checkpoint, and proofreading
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Sequence of eGFP-3xFLAG-NBAS repair template
Sequence of repair template ordered on plasmid backbone from IDT. eGFP
(green) and 3xFLAG (red) sequences are indicated
1 AAGCTTGAGC TCCTGTAGCA TCCTTCCTCT GCTACCTTTC ATTGGATAAC
51 TTTAGTTGTT TATTTTAAAA CCACTGTTTG AACTCTCTCT ACGTGTTAGG
101 CAAAGAATAT ACAAATGAAC ATTAGCATTT CAGTGGGGTA CCTTTACCAT
151 TTCTGTTTTA TGGAAACTGA GTTATAAGAG AGGCTCAATG ACTTGGCCGA
201 TCTCATGTAG ATTAATGAAC AAGGAGTGTA TCAGGACCGG GACACAAGTC
251 GTTCCCAAGA CAAGCAATAG TCCCTGTCCT TCCTACTCAT AAAAGGGTTA
301 ACCTAGCATT TCCTTGCCGT GAAACAAAAG CGGCCGCGGA TAGAGAAGAT
351 TGTCCTGTGA GGGATTCCGT AGAGACACTC CTCCGCTGCC TGAGTAATCG
401 GCGAACATGG TGAGCAAGGG CGAGGAGCTG TTCACCGGGG TGGTGCCCAT
451 CCTGGTCGAG CTGGACGGCG ACGTAAACGG CCACAAGTTC AGCGTGTCCG
501 GCGAGGGCGA GGGCGATGCC ACCTACGGCA AGCTGACCCT GAAGTTCATC
551 TGCACCACCG GCAAGCTGCC CGTGCCCTGG CCCACCCTCG TGACCACCCT
601 GACCTACGGC GTGCAGTGCT TCAGCCGCTA CCCCGACCAC ATGAAGCAGC
651 ACGACTTCTT CAAGTCCGCC ATGCCCGAAG GCTACGTCCA GGAGCGCACC
701 ATCTTCTTCA AGGACGACGG CAACTACAAG ACCCGCGCCG AGGTGAAGTT
751 CGAGGGCGAC ACCCTGGTGA ACCGCATCGA GCTGAAGGGC ATCGACTTCA
801 AGGAGGACGG CAACATCCTG GGGCACAAGC TGGAGTACAA CTACAACAGC
851 CACAACGTCT ATATCATGGC CGACAAGCAG AAGAACGGCA TCAAGGTGAA
901 CTTCAAGATC CGCCACAACA TCGAGGACGG CAGCGTGCAG CTCGCCGACC
325
951 ACTACCAGCA GAACACCCCC ATCGGCGACG GCCCCGTGCT GCTGCCCGAC
1001 AACCACTACC TGAGCACCCA GTCCGCCCTG AGCAAAGACC CCAACGAGAA
1051 GCGCGATCAC ATGGTCCTGC TGGAGTTCGT GACCGCCGCC GGGATCACTC
1101 TCGGCATGGA CGAGCTGTAC AAGTCCGGAC TCAGATCTGA CTACAAAGAC
1151 CATGACGGTG ATTATAAAGA TCATGACATC GACTACAAGG ATGACGATGA
1201 CAAGGGTACC AGCGGCGGAA GCGCAGCCCC CGAGTCAGGG CCGGCTTTGA
1251 GTCCAGGCAC TGCAGAGGGT GAGGAGGAGA CGATTCTCTA TGACTTGTTG
1301 GTCAACACCG AGTGGCCACC GGAGACTGAA GTACAGGTGA ACCAGGCCCA
1351 TCTACAGCAG CAGCCAGCTT GGCGCGGGCG CTTCGTGGGT AGAGCCACGT
1401 AGCAGGAGCC ACGTAGGGGA GTGGAGACGG GTGGGTGGGG GACTAGGGCC
1451 GGTTGGCTTG TGCGGTCGCC TTGGCAACGG CACCTTGGGC TAGCGGGGGT
1501 CTAGGGCGGG GTGGGGTGGT GGTCCCTGAG ATTCTTCCTG GGCTCAGAAT
1551 TCGGTTGTTG GGGGCTGGAA CTTCGTGCTC TGGGGAGCGT ACGATCCCAC
1601 TTTGGTTCTC AGTTTCGCTC TCGGATCC
326
Appendix B
Total and fractionated RNA-sequencing mapping
statistics
Total number of reads, number and percentage mapped by STAR and number
and percentage of those aaaigned to gene features by HTSeq. Sample name is
comprised of replicate number (E1, E2 or E3), siRNA treatment (si scr, si U1,
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Identification of a localized Nonsense-Mediated 
Decay pathway at the Endoplasmic Reticulum  
 
 
Dasa Longman,1 Kathryn A. Jackson-Jones,1 Magdalena M. Maslon,1 Laura C. 
Murphy,1 Robert S. Young,1,2 Jack J. Stoddart,1 Nele Hug1, Martin S. Taylor,1 




1MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, 
Crewe Road South, Edinburgh EH4 2XU, UK 
 
2Present address: Centre for Global Health Research, Usher Institute, University of Edinburgh, Old 
Medical School, Teviot Place, Edinburgh EH8 9AG, UK 
 
 
*Corresponding author: Javier.Caceres@igmm.ed.ac.uk 
 
Running title: NMD regulation at the ER 
 




Supplemental Material includes: 
Supplemental Figures: S1-S8 
Supplemental Tables: S1-S5 (All uploaded separately as Excel files) 
Additional Materials and methods 




     Longman et al. 
 3 
Supplemental Figure S1. Independent functions of NBAS in NMD and Golgi-to-ER transport, 
Related to Fig. 1.  (A) Top panel shows a schematic representation of the GFP-based reporter 
expressed in HeLa C1 cells used to measure constitutive secretion. SS: signal sequence; eGFP: 
enhanced green fluorescent protein; FM: FKBP mutated; FCS: furin cleavage sequence; hGH: human 
growth hormone, and numbers represent amino acid residues. Defects in secretion are manifested by 
the inability of cells to lose GFP fluorescence even after addition of the ligand. Lower panels show 
examples of flow-cytometry before (in red), and after the addition of ligand (in blue), for control-
depleted cells, cells depleted of NMD factors UPF1 and NBAS, and of secretion factor, STX18. (B) 
NMD activity is not affected by the depletion of secretion factors STX18 and STX5. HeLa cells were 
transfected with a fluorescent NMD+ reporter and depleted of NMD factors UPF2 or NBAS, or 
secretion factors STX18 or STX5. Depletion of both NMD factors increased the mean green 
fluorescence in comparison to mock-depleted cells, as expected, whereas STX18 and STX5 depletion 
did not affect the mean green fluorescence. Each point represents one biological replica, bars indicate 
mean with SEM. Significance was determined by two-tailed unpaired t-test: ***: p<0.0001; *: 
p<0.05; ns: not significant. (C) Brefeldin A treatment blocks constitutive secretion. HeLa C1 cells 
carrying a GFP-based secretion reporter were FACS-sorted to monitor their ability to secrete GFP. 
HeLa C1 cells (in orange) were able to secrete a GFP-based reporter following addition of ligand (in 
blue). Brefeldin A treatment led to a block in secretion and a concomitant accumulation of GFP even 
in the presence of ligand (in red). (D) Representative efficiency of depletion of NMD and secretion 
factors was determined by qRT-PCR relative to mock-depleted cells. In each case, relative expression 
of the depleted factor was normalized to POLR2J. Each point represents one biological replica, bars 
indicate mean with SEM.  
 




Supplemental Figure S2. Both NBAS and UPF1 regulate the ER stress response, Related to Fig. 2. 
Genes associated with the ER unfolded protein response (UPR) (GO: 0006986) show a significant 
increase in fold change compared to all genes, when either UPF1 (A) or NBAS (B) were depleted  
(p < 0.001 and p < 0.005 respectively; Wilcoxon rank sum test). 
  




Supplemental Figure S3. NBAS regulates membrane-associated RNA targets, Related to  
Fig. 2. (A) Experimentally validated ER genes are present in the membrane fraction. Scatter plot of 
gene expression in membrane vs cytoplasmic fractions in mock-depleted cells, with experimentally 
validated ER genes present in at least 2 of the 3 ER datasets described in Fig. 2B are indicated in 
magenta. (Enrichment OR = 66.94, p-value <0.0001, Fishers Exact test). (B) Summary table of genes 
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regulated by NMD factors in each cellular fraction. Genes were defined as membrane-enriched or 
non-membrane-enriched as described in Figure 2C. Genes were classified as regulated by the 
respective NMD factor if they were significantly (p<0.05) upregulated in that fraction, when the 
NMD factor was depleted. (C) Differential expression analysis of genes regulated by NMD factors in 
membrane fractions and in the cytoplasm. MA plots show log2 fold-change of gene expression plotted 
over mean of normalized counts (gene expression). Significantly changed genes (p<0.05) are 
indicated in blue. 
 
  





Supplemental Figure S4. Quantitation of SETD4 and FAP transcripts upon UPF1 and NBAS 
depletion in smRNA FISH experiments, Related to Fig. 3. Relative changes in the expression of a 
cytoplasmic NMD target (SETD4) or an ER-localized NMD target (FAP) were determined by 
counting discreet FISH signal in individual cells. The FISH signal of FAP upon UPF1 or NBAS 
depletion is likely underestimated, as clusters of FISH dots were counted as one. Each point 
represents counts in one cell, bars indicate mean with SEM. Significance was determined by 
Mann-Whitney test: ***: p<0.001; *: p<0.05; ns: not significant. 
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Supplemental Figure S5. Localization of endogenous NBAS and UPF2 proteins to the ER, 
Related to Fig. 4. (A) NBAS is part of the Syntaxin 18 complex.  Left panel depicts the strategy 
used to knock-in an eGFP/3xFLAG tag at the N-terminus of the NBAS locus, using CRISPR/Cas9-
mediated genome editing in HeLa cells. Right panel shows the top NBAS interacting partners, and 
SEC61A1, identified by Mass spectrometry of GFP-pulled down cell lysates. The protein-protein 
interaction cluster was generated by STRING (https://string-db.org). The full list of proteins 
identified by Mass Spectrometry is presented in Supplemental Table T4. (B) Direct interaction 
between endogenous epitope-tagged NBAS and SEC61B proteins was determined by PLA using 
anti-GFP and anti-SEC61B antibodies, in HeLa KI (epitope tag knock-in) cells or wild-type HeLa 
cells, as a control. The graph shows the quantification of the PLA signal. Each point represents 
mean PLA count per cell in one captured frame, relative to the HeLa negative control. Significance 
was determined by Mann-Whitney test: ****: p<0.0001. (C) UPF2 is localized in the close 
proximity of the SEC61 translocon component at the ER. Direct interaction between endogenous 
UPF2 and SEC61B proteins was determined by PLA using the anti-UPF2 and anti-SEC61B 
antibodies, in HeLa cells. The graph shows the quantification of PLA signal. Each point represents 
mean PLA signal per cell in one captured frame, relative to the HeLa negative control. Significance 
was determined by Mann-Whitney test: ****: p<0.0001. 
  





Supplemental Figure S6. NBAS interacts with UPF1 and preferentially associates with the SURF 
complex, Related to Fig. 5. (A) T7-tagged NBAS was co-expressed with FLAG-tagged UPF1 in HeLa 
cells. Cell lysates were subjected to Immunoprecipitation (IP) with anti-FLAG antibody in the 
presence of RNase. The NBAS-UPF1 interaction was revealed by Western Blot with anti-T7 
antibody. (B) Interaction of endogenous UPF1 with FLAG-tagged NBAS in the absence or presence 
of RNase A. FLAG-tagged-NBAS was transiently expressed in HEK293T cells and immunopurified 
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with anti-FLAG antibody. Co-Immunopurification of endogenous UPF1 was analyzed by Western 
Blot with anti-UPF1 antibody. RNA digestion was confirmed by RT-PCR for GAPDH. (C) T7-NBAS 
was co-expressed in HeLa cells with FLAG-tagged wild-type UPF1; C126S hypo-phosphorylated 
mutant UPF1 predominantly present in the SURF complex, or with K498A ATP-binding mutant 
UPF1, which is mainly associated with the DECID complex. Anti-FLAG IPs were performed in the 
presence of RNase and subjected to Western Blot analysis with the indicated antibodies. To detect 
phosphorylated UPF1, anti-FLAG-IPs were probed with a phospho-(Ser/Thr) ATM/ATR substrate 
antibody (anti-S/T-Q). (D) NBAS is bound to mRNAs. Hela cells were UV crosslinked and mRNP 
complexes were purified using oligo dT beads. The presence of NBAS in mRNP complexes was 




















Supplemental Figure S7. Interaction of endogenous NBAS with core NMD factors, SMG5, 6, 7, 
UPF1 and DHX34, Related to Fig. 5. (A) Endogenous NBAS interacts with several NMD factors 
independently of RNA. HEK293T cells were transiently transfected with FLAG-tagged SMG5, 
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SMG6, SMG7 and UPF1. Anti-FLAG Immunoprecipitations (IPs) were performed in the absence or 
presence of RNase A. Inputs and anti-FLAG IPs were subjected to Western Blot (WB) analysis with 
the indicated antibodies. The interaction with poly(A)-binding protein (PABP1) was used as a control 
for the RNase treatment. Successful RNA digestion of the cell lysate was further confirmed by RT-
PCR for the GAPDH housekeeping gene and analyzed on agarose gels. (B) T7-tagged full-length 
DHX34 interacts with endogenous NBAS. HEK293T cells were transfected with full-length (FL) and 
a truncated version of DHX34, lacking its OB-like domain (DOB). T7-DHX34 (FL and DOB) were 
immunopurified with anti-T7 antibody in the presence of RNase A. Inputs and T7-IPs were analyzed 




















Supplemental Figure S8. FCS control experiments, Related to Fig. 6. (A) Average autocorrelation 
curves obtained for FCS measurements indicate that mCherry alone shows an almost complete 
overlap of decay times upon depletion of NBAS by RNAi, or between the ER and the cytoplasmic 
periphery. (B) Overexpression of GFP-NBAS does not affect the mobility of mCherry control at the 
ER.   
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Supplemental Table S1. Gene expression analysis. 
 
Supplemental Table S2. GO term analysis of data presented in Supplemental Table S1. 
 
Supplemental Table S3. Gene expression analysis of membrane and cytoplasmic fractions. 
 
Supplemental Table S4. IP-Mass spectrometry protein interactors of an endogenously-tagged 
NBAS cell line. 
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Additional materials and methods 
Cell Culture and transfections. 
HeLa cells were maintained in DMEM media with high glucose, GlutaMAX™ Supplement, pyruvate 
(Gibco Life technologies; 10569010) supplemented with 10% FCS, at 37°C in the presence of 5% 
CO2. HeLa C1 cells and 3xFLAG-eGFP-NBAS cells were maintained in the same media with the 
addition of 1µg/ml of Puromycin. Cells were grown without antibiotic prior to transfections, which 
were carried out in Opti-MEM reduced serum medium (Gibco, 31985047). Transfections of siRNA 
oligos were done using DharmaFECT 1 (Dharmacon, T-2001-03) following manufacturer’s protocol. 
See Supplemental Table S5 for siRNA reagents information. Co-transfection of plasmids and siRNA 
oligos was achieved using Lipofectamine 2000 (ThermoFisher Scientific, 11668019) following 
manufacturer’s instructions. For depletions, cells were plated in 12-well plates and transfected with 
30 pmol of specific siRNAs. Cells were then expanded into 6-well plates and transfected with 50 
pmol of the same siRNAs on the third day and were harvested for analysis on day 5 after the first 
depletion. For fluorescence based NMD assays HeLa cells were treated as above, with the addition 
of 50 ng NMD+ reporter that was co-transfected with siRNAs during the second round of depletion. 
For total RNA-sequencing and subcellular fractionation, cells were plated in 6-well plates and 
transfected with 30 pmol of indicated siRNAs. Cells were expanded into 10 cm plates the following 
day and were transfected with 30 pmol of the same siRNAs on day 3 and were harvested for analysis 
on day 4 after the first depletion.   
 
Antibodies  
Anti-UPF1, Bethyl # A300-036A, RRID:AB_203272; Anti UPF1, Bethyl # A300-038A, 
RRID:AB_2288326; Anti-GFP, Roche # 11814460001, RRID:AB_390913; Anti-Sec61β, 
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Proteintech # 15087-1-AP, RRID:AB_2186411; Anti-NBAS, Abcam # Ab122370, 
RRID:AB_11129367; Anti-UPF2, Santa Cruz Biotechnology # sc-374230, RRID:AB_10988267; 
Anti-Calnexin, Enzo Life Sciences # ADI-SPA-860-D, RRID:AB_2038898; Anti-T7, Novagen # 
69522; Anti-FLAG, Sigma-Aldrich # F3165, RRID:AB_259529; Anti-Phospho-(Ser/Thr) 
ATM/ATR Substrate (anti-S/T-Q), Cell Signalling # 2851, RRID:AB_330318; Anti-Tubulin, Sigma-
Aldrich # 4026, RRID:AB_477577, Anti-PABP1 PABP1 (4992, Cell Signaling), Anti- DHX34 is a 
peptide-specific antibody raised against human DHX34 obtained from Eurogentec (Hug and Cáceres 
2014).  
 
Flow cytometry-based assay for measuring constitutive secretion 
The secretion assay was performed as previously described (Gordon et al. 2010). HeLa C1 cells 
constitutively express a secreted eGFP reporter fused to mutant FKBP proteins (FK506-binding 
protein), which form large aggregates that cannot be secreted. The F36M substitution leads to 
formation of dimers that can be dissociated by ligand binding, leading to efficient secretion 
(Gordon et al., 2010). HeLa C1 cells mock-depleted or depleted of UPF1, UPF2, DHX34, SEC13, 
NBAS, p31, RINT, ZW10 and STX18 were incubated with 1µM D/D Solubilizer (ligand) 
(Clontech 6350540 for 1.5 hours to facilitate secretion or left untreated for comparison. Cells were 
trypsinized, washed with cold PBS and placed on ice to stop further secretion. To measure the 
amount of GFP reporter remaining, cells were analyzed by FACS BD AccuriTM (488nm 
excitation laser, FL-1: 533/30nm emission filter) running the software BD AccuriTM C6. Gates 
were set using a non-fluorescent control. GFP expression was analyzed by gating the single cell 
population in SSC-H/SSC-A dot plot, followed by debris-exclusion gate in SSC-A/FSC-A dot plot. 
Between 5000 and 10000 single cells were analyzed for each sample. The mean GFP fluorescence 
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was calculated with FlowJo™ Software (Version 10.6.0). The relative GFP fluorescence 
remaining after secretion was calculated as a ratio between the mean fluorescence of depleted cells 
incubated with the ligand and depleted cells. The relative fluorescence remaining of untreated C1 
cells was set to 1, and the threshold for a secretion defect was set to two. 	
 
Cell fractionation 
HeLa cells were mock-depleted or depleted twice of UPF1, UPF2 and NBAS as described above. 
Cellular fractionation was performed as described before (Jagannathan et al. 2011) with some 
modifications. Briefly, four days after the first depletion, cells were detached using trypsin and 
washed twice in 1ml of ice-cold PBS (500g, 10 min, 4°C). Cellular pellets were resuspended in 0.4 
ml of permeabilization buffer (110 mM KOAc, 25 mM K-HEPES pH 7. 2, 2.5 mM Mg(OAc)2, 1mM 
EGTA, 0.015% digitonin, 1mM DTT, 1× Complete Protease Inhibitor Cocktail, 40 U/mL 
RNaseOUT™) and incubated for 5 min on a rotating wheel at 4°C. The resulting cytosolic fractions 
were recovered by centrifugation at 2000g for 10 minutes, 4°C.  Cells were then lysed in 0.4 ml of 
NP-40 lysis buffer (400 mM KOAc, 25 mM K-HEPES pH 7.2, 15 mM Mg(OAc)2, 1% (v/v) NP-40, 
1 mM DTT, 1× Complete Protease Inhibitor Cocktail, 40 U/mL RNaseOut) for 30 min on ice. The 
membrane fraction was recovered by centrifugation at 7000g for 10 min at 4°C.  Both cytosolic and 
membrane fractions were clarified by centrifugation at 7500g for 10 min at 4°C. Digitonin, DTT, 
Complete Protease Inhibitor Cocktail and RNaseOUT™ were added fresh to the buffers. RNA from 
both fractions was isolated using PureLink RNA Mini Kit (Life Technologies) according to 
manufacturer’s instructions. DNA was removed using TURBO DNA-free™ DNase I kit (Invitrogen 
Ambion; AM1907). 
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Gene expression profiling: RNA extraction, library preparation and RNA-sequencing 
Total RNA was isolated from depleted cells by phenol-chloroform extraction and treated with 
TURBO DNA-free™ DNase I kit (Invitrogen Ambion; AM1907). Libraries were prepared following 
NEBNext Ultra Directional RNA Library Prep Kit for Illumina (New England Biolabs; #E7420) and 
Agencourt AMPure XP Beads (Beckman Coulter; A63881). Samples were ligated to barcode primers 
1-20 of NE Next Index Primers for Illumina sets 1 and 2 (New England Biolabs) and libraries 
analyzed using DNA High Sensitivity chip on an Agilent 2100 Bioanalyzer before being pooled. 150 
base pair, paired-end sequencing was performed using the S2 flow cell on the NovaSeq 6000 System 
(Illumina Inc.). Library molarity for sequencing was calculated using Qubit dsDNA quantification 
results and fragment size information from Bioanalyzer results. Sequencing was performed by 
Edinburgh Genomics, Edinburgh, UK. 
 
RNA-sequencing analysis 
FASTQ files were quality control checked for base and sequence quality scores, and adapter 
contamination using fastQC (v0.11.7; Babraham Bioinformatics). Reads were aligned using Spliced 
Transcripts Alignment to a Reference (STAR, v2.5.1b) (Dobin et al. 2013) or pseudoaligned using 
kallisto (v0.43.1; (Bray et al. 2016)). Kallisto index was created by combining “all basic gene 
annotation” and “long non-coding RNA gene annotation” fasta files, downloaded from Gencode 
(www.gencodegenes.org/releases/current.html), Release 27 (GRCh38.p10). Kallisto was run with 
100 bootstraps. Reads per feature in STAR output files was counted using HTSeq (v0.9.1; ((Anders 
et al. 2015)). Abundance files were then analyzed for fold changes by running DESeq2 (v1.14.1) 
differential expression analysis (Love et al. 2014). Gene Ontology enRIchment anaLysis and 
visuaLizAtion (GOrilla) (http://cbl-gorilla.cs.technion.ac.il/) (Eden et al. 2009)) and Database for 
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Annotation, Visualization and Integrated Discovery (DAVID) (https://david.ncifcrf.gov/home.jsp) 
(Huang et al. 2009) were used for Gene Ontology (GO) analysis. To investigate genes linked to 
specific GO terms, genes were annotated using biomaRt Bioconductor R package (Durinck et al. 
2005). For NBAS and UPF1 targets overlap with experimentally ER-localized genes, we first 
downloaded relevant supplementary data. For APEX-seq data (Fazal et al. 2019), ER genes were 
defined as all those labeled “ERM_Gene” and for ER Fractionation sequencing data (Reid and 
Nicchitta 2012) those genes that were labelled “ER”. For ER Proximity-specific Ribosome Profiling 
data (Jan et al. 2014), gene names were converted from uniprot.protein.id to official gene symbols 
using DAVID (https://david.ncifcrf.gov/home.jsp) (Huang et al., 2009), and a 1.5-fold enrichment at 
ER cut off applied. For fractionated RNA-sequencing, gene expression in both fractions in control 
cells was compared by using variant stabilized transformation of tpm, averaged across replicates. 
Membrane-associated genes were defined as those >2-fold higher expression in membrane fraction 
than cytoplasmic fraction, all other genes were termed non-membrane. Membrane-enrichment was 
confirmed by overlap with three experimental ER datasets (see above). Changes in gene expression 
resulting from depletion of individual NMD factors was measured by percentage of ‘membrane-
associated’ genes in membrane fraction, and of ‘non-membrane’ genes in cytoplasmic fraction 
regulated. Genes were determined as regulated if they were significantly (p<0.05) increased in 
expression when the relevant factor was depleted. 
 
Quantitative RT-PCR 
Total RNA was isolated using RNeasy Mini kit and resuspended in nuclease-free water at 100ng/µl. 
qRT–PCR was performed using SuperScriptIII One-Step RT–PCR Kit (Invitrogen) following the 
manufacturer’s instructions. All RT-PCRs were run on the CFX96 Real-Time System (Bio-Rad 
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machine, following this program: RT at 50°C for 30 min, 95°C for 2 min, then 40 cycles of 95°C for 
30 sec, 55°C for 20 sec, 70°C for 20 sec followed by the plate read step. Each sample was run in 3 
technical replicates. Primers were designed using Roche Real-Time Ready Configurator and 
combined with Roche Universal Probe Library (See Supplemental Table S4). Gene expression data 
was analysed by the delta Ct method, with each gene normalised to housekeeping gene POL2RJ. 
Unpaired two-tailed t-test was used for statistical analysis. 
 
Immunofluorescence 
Cells were grown on coverslips, fixed with 4% paraformaldehyde at room temperature for 10 min, 
washed with PBS and permeabilized with 0.5% Triton X-100 at room temperature for 10 min. 
Coverslips were then incubated for 1 hour with block buffer (1% BSA, 0.01% Triton X-100 in PBS). 
Primary antibodies (diluted 1:500 in block buffer) were incubated with coverslips in humidified 
chamber overnight at 4°C. Coverslips were washed 3 times with wash buffer (0.01% Triton X-100 in 
PBS). Secondary antibodies (Alexa Flour® 488 or Alexa Flour® 594, Molecular Probes, diluted 
1:1000 in block buffer) were incubated with coverslips in a dark, humidified chamber for 1 hour at 
room temperature. Coverslips were then washed 3 times with wash buffer and stained with 4,6-
diaminidino-2-phenylidole (DAPI) at 50ng/ml, mounted in Vectashield (Vector) and sealed with nail 
varnish. For Digitonin treatment, media was aspirated, and cells incubated for 10 min on ice in cold 
PBS and later incubated in Digitonin buffer (110mM KoAc, 25mM K-HEPES, 2.5mM MgCl2, 1mM 
EGTA) with 0.01% Digitonin for 5 min on ice, washed in room temperature PBS and fixed with 4% 
paraformaldehyde, as above. 
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Design and screening of CRISPR cell lines 
The design of the guide RNAs (gRNAs) was undertaken, as previously described (Ran et al. 2013). 
gRNAs were designed using sgRNA Designer CRISPRko (Broad institute, 
https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design) and Cas-Designer (RGEN 
Tools, http://www.rgenome.net/cas-designer/). For the tagged-NBAS cell line, four gRNAs were 
selected by closest proximity to the start codon and highest predicted efficiency. For each guide RNA, 
the complementary sequence was determined and a BbsI restriction site added to both oligos. 
Designed gRNAs were ordered as custom single stranded DNA oligos with an extra G at the 5’ end, 
and 5’ phosphate at the reverse complement DNA strand (IDT).  Top and bottom strands of gRNAs 
were annealed at a concentration of 100μM and cloned into the px459 V2.0 vector using BbsI 
restriction cloning. 1 μl of a 1:250 dilution of annealed gRNAs was ligated with the T4 DNA Ligase 
(NEB) into 36 ng of the px459 V2.0 vector. To assess cutting efficiency of gRNAs, each plasmid was 
transfected into HeLa cells and RNA extracted as above. PCR over the target region was performed 
with custom primers (Supplemental Table S4) and the resulting products assessed by DNA 
electrophoresis. PCR products were also sent for Sanger sequencing and traces were analyzed by 
TIDE (REF) and ICE (REF) to give exact cutting efficiencies for each guide. Repair template was 
ordered as a custom plasmid from IDT on a pUCIDT-AMP backbone. For the generation of NBAS 
knock out (KO) HeLa cells, two guides (NBAS KO_A and NBAS KO_B) targeting the 5th exon of 
the NBAS gene were cloned into the pSpCas9n(BB)-2A-GFP vector encoding the (D10A nickase 
mutant (PX461), as described above. pSpCas9n(BB)-2A-GFP (PX461) (Addgene plasmid # 48140; 
http://n2t.net/addgene:48140; RRID: Addgene_48140). The gRNA/Cas9 plasmid and repair template 
plasmid were transfected into HeLa cells as described above. After 24hr media was supplemented 
with 1.5 ug/ml puromycin to select for cells expressing the gRNA/Cas9 plasmid. Once control cells 
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were dead, surviving cells’ fluorescence was measured by FACS and single cells deposited into wells 
of a 96-well plate. After approx. 2 weeks clonal expansion, genomic DNA was extracted by lysing 
with DirectPCR Lysis Reagent Cell (Peqlab, VWR) supplemented with 0.5 μg/μl Proteinase K 
(Invitrogen), at 55°C O/N.  PCR of the N-terminal locus of NBAS was performed using previously 
mentioned custom primers and SYBR green Master Mix. PCR products were resolved on an agarose 
gel for genotyping. The correct repair template integration was validated by genomic DNA 
sequencing and expression of tagged-NBAS was validated by Western blotting. Screening for the 
NBAS KO clones was performed as above. HeLa cells co-transfected with NBAS KO_A and _B 
pSpCas9n(BB)-2A-GFP plasmids were FACS-sorted into 96-well plates 48 h after transfection. 
Growing colonies were screened by PCR of genomic DNA as described, using NBAS KO F and R 
primers. NBAS expression was assessed by Western Blotting and genomic DNA of the NBAS KO 
was checked by sequencing. 
 
Image Capture and analysis 
For smRNA FISH experiment, epifluorescent images were acquired using a Photometrics Coolsnap 
HQ2 CCD camera and a Zeiss AxioImager A1 fluorescence microscope with a Plan Apochromat 
100x 1.4NA objective, a Nikon Intensilight Mercury based light source (Nikon UK Ltd, Kingston-
on-Thames, UK ) and either Chroma #89014ET (3 colour) or #89000ET (4 colour) single excitation 
and emission filters (Chroma Technology Corp., Rockingham, VT) with the excitation and emission 
filters installed in Prior motorized filter wheels. A piezoelectrically driven objective mount (PIFOC 
model P-721, Physik Instrumente GmbH & Co, Karlsruhe) was used to control movement in the z 
dimension. Step size for z stacks was set at 0.2 µm. Hardware control, image capture and analysis 
were performed using Nikon Nis-Elements software (Nikon UK Ltd, Kingston-on-Thames, UK). 
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Images were deconvolved using a calculated point spread function with the constrained iterative 
algorithm of Volocity (PerkinElmer Inc, Waltham MA). Image analysis was carried out using the 
FIJI/ImageJ software (2.0.0-rc-69/1.52p) (Schindelin et al. 2012). To measure the distribution of 
FISH signal within cells, a maximum intensity projection of each deconvolved z-stack was created 
and the DAPI signal was thresholded to create a mask of the nucleus. This mask was inverted and a 
euclidean distance map was created using the "Distance Map" function. This resulted in an image 
where all pixels that were inside the nucleus had a value of zero and the other pixels had values based 
on their distance from the closest nucleus edge (in pixels). To detect the centroids of FISH spots in 
the FISH signal channel, the ImageJ function "Find Maxima" was used with a prominence setting of 
800. The x-y co-ordinates of each maximum point was measured on the distance map, giving a 
distance of the FISH spots to the edge of the nucleus. These values were converted to microns using 
the pixel spacing value of the original image. For immunofluorescence and PLA experiments images 
were acquired on a Nikon Confocal A1R confocal microscope using a Plan Apochromat 100x 1.4NA 
objective. The microscope comprises a Nikon Eclipse TiE inverted microscope with Perfect Focus 
System and is equipped with 405nm diode, 457/488/514nm Multiline Argon, 561nm DPSS and 
638nm diode lasers. Detection is via four Photomultiplier tubes (2x standard Photomultiplier tubes 
and 2x GaAsP PMTs). Data were acquired using NIS Elements AR software (Nikon Instruments 
Europe, Netherlands). Z-stacks of images were acquired with a 0.2 µm step, scan size 1024x1024, 
1.2x zoom and 2x frame averaging. Image analysis was carried out using the FIJI/ImageJ software. 
 
Mass Spectrometry 
Cells were harvested and lysed as in immunoprecipitation protocol (see below). α-GFP antibody-
coupled magnetic beads (Sigma) were equilibrated with IP buffer. Lysates were resuspended in 500μl 
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IP buffer for capture of GFP-NBAS bound proteins and subsequent mass spectrometry analysis. 
Immunoprecipitation was performed on Kingfisher Duo robot (Thermo) for 4 h. All steps were carried 
out at 4°C. Beads were then transferred for two washes in IP buffer and three washes in TBS (300 μl 
each). After transfer into 100 μl 2M urea, 100 mM Tris, 1 mM DTT containing 0.3 μg trypsin per 
sample, beads were incubated at 27°C for 30 min with mixing to achieve limited proteolysis. The 
beads were then removed, and tryptic digest of the released peptides was allowed to continue for 9 h 
at 37°C. Following this, peptides were alkylated by adding iodoacetamide to 50 mM and incubated 
at room temperature for 30 min. Finally, peptides were acidified by addition of 8 μl 10% TFA. An 
estimated 10 μg of the resulting peptide solution was loaded onto an activated (20 μl methanol), 
equilibrated (50 μl 0.1% TFA) C18 StAGE tip, and washed with 50 μl 0.1% trifluoroacetic acid 
(TFA). The bound peptides were eluted into a 96-well plate (Axygen, Corning Inc., Corning, NY, 
USA) with 20 μl 80% acetonitrile (ACN), 0.1% TFA and concentrated to less than 4 μl in a vacuum 
concentrator. The final volume was adjusted to 15 μl with 0.1% TFA. Mass spectrometry was carried 
out by IGMM Mass Spectrometry core facility. Online LC was performed using a Dionex RSLC 
Nano (Thermo Fisher Scientific). Following the C18 clean-up, 5 μg peptides were injected onto a 
C18 packed emitter and eluted over a gradient of 2%-80% ACN in 48 minutes, with 0.5% acetic acid 
throughout. Eluting peptides were ionised at +2.2kV before data-dependent analysis on a Thermo Q-
Exactive Plus. MS1 was acquired with mz range 300–1650 and resolution 70,000, and top 12 ions 
were selected for fragmentation with normalised collision energy of 26, and an exclusion window of 
30 seconds. MS2 were collected with resolution 17,500. Raw MS data were analyzed using 
MaxQuant (v 1.5.6.5) (Max Planck Institute of Biochemistry) in conjunction with UniProt human 
reference proteome release 2016\_11 (uniprot.com), with match between runs (MS/MS not required), 
LFQ with 1 peptide required, and statistical analyses performed in R (RStudio 1.1.453 / R x64 3.4.4) 
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(rstudio.com) using Wasim Aftab’s LIMMA Pipeline Proteomics (github.com/wasimaftab/LIMMA-
pipeline-proteomics) implementing a Bayes-moderated method. Interactome analysis including gene 
ontology was carried out by inputting protein list into STRING (string-db.org/).  
 
Immunoprecipitation and Western Blotting 
Cells were washed and harvested in ice-cold PBS before pellets were lysed with 
immunoprecipitation (IP) buffer [20 mM Tris-HCl pH 8, 150 mM NaCl, 1mM EDTA, 1% NP-40, 
0.2% Deoxycholate, Complete Protease Inhibitor (Roche), Phosphor STOP (Roche), 1 mM DTT] 
for 20 min on ice.  Cell lysates were treated with 40–80 mg/ml RNase A per 1 ml of extract. 
Lysates were precleared with Dynabeads Protein-G (Novex, Life Technologies) for 1 h, rotating 
at 4°C. Anti-FLAG M2 antibody coupled magnetic beads (Sigma-Aldrich M8823) were washed 
x3 with IP buffer before incubation with the precleared lysate overnight rotating at 4°C. Beads 
were washed x5, each for 5 min with IP buffer and then bound protein was eluted by boiling in 
SDS sample buffer supplemented with reducing agent for 5min. Proteins were resolved by SDS-
PAGE using NuPAGE 3-8% Tris-Acetate precast gels (Novex, Life Technologies) run for ~1 h at 
170V in 1x Tris-Acetate running buffer. Protein transfer was achieved using the iBlot™ 2 Gel 
Horizontal Transfer Device (Invitrogen). Nitrocellulose membranes were blocked in 5% BSA in 
PBS/Tween 20 (0.1%) for a minimum of 1h at room temperature and probed with the appropriate 
primary antibody diluted in blocking solution 1:3000. FLAG antibody was used at 1:10,000 
dilution and T7 antibody was used at 1:5,000 dilution. HRP-conjugated secondary antibodies 
(BioRAD) were used at 1:10,000 and blots developed with ChemiGlow detection reagent and 
visualized using ImageQuant LAS 4000 chemiluminescent camera (GE Healthcare).  
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In situ UV cross-linking mRNP capture assay 
In situ UV cross-linking mRNP capture protocol was adapted from (Piñol-Roma and Dreyfuss 1992). 
Briefly, cells, grown in 150mm plates, were irradiated with 0.15Jcm−2 at 254-nm UV light, on ice, in 
ice-cold PBS. Cells were then scraped from plates in PBS and pelleted. Cells were lysed in 1ml of 
ice-cold lysis buffer (20 mM Tris-HCl (pH 7.5), 500 mM LiCl, 0.5% LiDS, 1 mM EDTA and 5 mM 
DTT), and then sonicated 30s on/30s off for 5 cycles at 4°C. After 10 min incubation at 4°C, the 
lysates were fractionated by centrifuge (15,000 xg, 4°C, 15 min), 10% sample was stored as input. 
100µl per sample oligo(dT)25 magnetic beads were equilibrated in lysis buffer and incubated with 
lysate overnight at 4°C with rotation. Beads were washed once with 1ml of lysis buffer, twice with 
Buffer 1 (20 mM Tris-HCl (pH 7.5), 500 mM LiCl, 0.1% LiDS, 1 mM EDTA and 5 mM DTT), twice 
with Buffer 2 (20 mM Tris-HCl (pH 7.5), 500 mM LiCl, 1 mM EDTA and 5 mM DTT) and twice 
with Buffer 3 (20 mM Tris-HCl (pH 7.5), 200 mM LiCl, 1 mM EDTA and 5 mM DTT). All washes 
for 5 min at 4°C. Captured mRNPs were eluted from the beads with 100µl elution buffer (20 mM 
Tris-HCl (pH 7.5) and 1 mM EDTA) for 3 min at 55°C and treated with 200 U of RNase A in 500 μl 
of 10× RNase buffer, for 1h at 37 °C. Liberated mRNA binding proteins were mixed 1:1 with SDS 
PAGE sample buffer (1x LDS sample buffer, 1x reducing agent), and resolved by 3-12% Tris-acetate 
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